{ "meta": { "tracker_site_url": "https://psilocybin-research.com", "publication_tracker_url": "https://psilocybin-research.com/", "generated_at_utc": "2026-07-11 22:07:00", "record_count": 984, "schema_variant": "rights-safe-core-v1", "text_redistribution": "Source-derived abstracts, descriptions, keywords, and unrestricted payload text are not redistributed." }, "papers": [ { "id": 1922, "title": "Phase 1 trial suggests benefit of psilocybin in OCD treatment", "authors": "", "journal": "The Brown University Psychopharmacology Update", "publication_date": "2026-07-31", "publication_year": 2026, "doi": "10.1002/pu.31474", "pubmed_id": null, "openalex_id": "https://openalex.org/W7166436628", "source_url": "https://doi.org/10.1002/pu.31474", "substance_tags": "psilocybin", "topic_tags": "OCD,Clinical Trial,Adverse Events", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:49:23", "last_checked": "2026-07-05 01:20:21", "bibtex": null, "source_record_id": "DOI:10.1002/pu.31474", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1002/pu.31474", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.1002/pu.31474", "source_url": "https://doi.org/10.1002/pu.31474", "doi": "10.1002/pu.31474", "pmid": "", "publication_date": "2026-07-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3502, "title": "PSilocybin Microdose for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site Phase 3 Double-blind, Placebo-controlled, Parallel-arm Clinical Trial", "authors": "Bruyère Health Research Institute.", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-09", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07063862", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,End-of-Life Distress,Receptor Pharmacology,Default Mode Network,Aging,Microdosing,Clinical Trial,Randomized Controlled Trial,Observational Study,Cancer Patients,Healthcare Workers,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-11 01:24:11", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07063862", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07063862", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07063862", "source_url": "https://clinicaltrials.gov/study/NCT07063862", "doi": "", "pmid": "", "publication_date": "2026-07-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3467, "title": "PSilocybin for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site, Open-label, Single Arm Phase I/II Proof-of-concept, Dose-finding, and Feasibility Clinical Trial", "authors": "Ottawa Hospital Research Institute", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-09", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04754061", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Receptor Pharmacology,Aging,Microdosing,Wellbeing,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Cancer Patients,Healthcare Workers,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-11 01:24:10", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04754061", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04754061", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04754061", "source_url": "https://clinicaltrials.gov/study/NCT04754061", "doi": "", "pmid": "", "publication_date": "2026-07-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5714, "title": "Psychedelics produce enduring enhancement of reward responsiveness in male rats", "authors": "Thomas Christopher W., LaMalfa Kayleigh S., Whelan Tobias P., Blackmore Thomas, Golden Caroline T., Pizzagalli Diego A., Bergman Jack, Gilmour Gary, Kangas Brian D.", "journal": "Neuropsychopharmacology", "publication_date": "2026-07-08", "publication_year": 2026, "doi": "10.1038/s41386-026-02475-2", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1038/s41386-026-02475-2", "substance_tags": "psilocybin", "topic_tags": "Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-11 19:28:11", "last_checked": "2026-07-11 19:28:11", "bibtex": null, "source_record_id": "DOI:10.1038/s41386-026-02475-2", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1038/s41386-026-02475-2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.1038/s41386-026-02475-2", "source_url": "https://doi.org/10.1038/s41386-026-02475-2", "doi": "10.1038/s41386-026-02475-2", "pmid": "", "publication_date": "2026-07-08", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3610, "title": "Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: A Randomized Phase II Clinical Trial Comparing One Versus Two Psychedelic Doses of Psilocybin (PSI-1V2)", "authors": "University Health Network, Toronto", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-08", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06341426", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Observational Study,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-11 01:24:11", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06341426", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06341426", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06341426", "source_url": "https://clinicaltrials.gov/study/NCT06341426", "doi": "", "pmid": "", "publication_date": "2026-07-08", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3537, "title": "Computationally, Electrophysiologically, and Qualitatively Characterizing Serotonergic Psychedelics; Transdiagnostic Therapeutic and Pro-Psychotic Effects", "authors": "Yale University", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-08", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06624137", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,OCD,Headache / Migraine,Brain Imaging,Aging,Wellbeing,Clinical Trial,Observational Study,Healthy Volunteers,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-11 01:24:10", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06624137", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06624137", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06624137", "source_url": "https://clinicaltrials.gov/study/NCT06624137", "doi": "", "pmid": "", "publication_date": "2026-07-08", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5686, "title": "Therapeutic potential of psilocybin in the pharmacological treatment of obsessive-compulsive disorder: a scoping review protocol.", "authors": "Raul Edison Luna Lazo, Nicole Milagritos Cardoso Azorza, Jatziri Yanina Vilca Yanac, Ahmad Kassem El Zein, Omar Abraham Ramírez Paucar, Luana Mota Ferreira, Roberto Pontarolo", "journal": "Open Science Framework", "publication_date": "2026-07-07", "publication_year": 2026, "doi": "10.17605/osf.io/guqxr", "pubmed_id": null, "openalex_id": "https://openalex.org/W7167787527", "source_url": "https://doi.org/10.17605/osf.io/guqxr", "substance_tags": "psilocybin,psilocin", "topic_tags": "OCD,Chronic Pain,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Clinical Trial,Review Article,Animal Study,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-11 01:20:14", "last_checked": "2026-07-11 19:28:11", "bibtex": null, "source_record_id": "DOI:10.17605/osf.io/guqxr", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.17605/osf.io/guqxr", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.17605/osf.io/guqxr", "source_url": "https://doi.org/10.17605/osf.io/guqxr", "doi": "10.17605/osf.io/guqxr", "pmid": "", "publication_date": "2026-07-07", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5676, "title": "Psilocybin therapy for adult females with anorexia nervosa: pilot study.", "authors": "Douglass HM, Spriggs MJ, Godfrey K, Danby JL, de Magalhaes FJC, Macdonald L, Alderton KL, Archer S, Ahmad K, Martell J, Frias JT, Sawicka G, Read T, Blemings A, Lafrance A, Nicholls D, Erritzoe D, Park RJ, Nutt DJ, Carhart-Harris RL.", "journal": "The British Journal of Psychiatry", "publication_date": "2026-07-07", "publication_year": 2026, "doi": "10.1192/bjp.2026.10687", "pubmed_id": "42414058", "openalex_id": "https://openalex.org/W7167587921", "source_url": "https://doi.org/10.1192/bjp.2026.10687", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Headache / Migraine,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-08 01:20:22", "last_checked": "2026-07-11 01:20:14", "bibtex": null, "source_record_id": "PMID:42414058", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1192/bjp.2026.10687", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42414058", "source_url": "https://doi.org/10.1192/bjp.2026.10687", "doi": "10.1192/bjp.2026.10687", "pmid": "42414058", "publication_date": "2026-07-07", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3652, "title": "Phase I Study of the Safety and Adjunctive Effects of Psilocybin in Adults With Opioid Use Disorder Maintained on a Buprenorphine/Naloxone Formulation", "authors": "University of Wisconsin, Madison", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-06", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04161066", "substance_tags": "psilocybin", "topic_tags": "Addiction,Chronic Pain,Clinical Trial,Observational Study,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-11 01:24:10", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04161066", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04161066", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04161066", "source_url": "https://clinicaltrials.gov/study/NCT04161066", "doi": "", "pmid": "", "publication_date": "2026-07-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3587, "title": "Neurobehavioral Mechanisms of Psilocybin-assisted Treatment for Alcohol Use Disorder", "authors": "NYU Langone Health", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-06", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06349083", "substance_tags": "psilocybin", "topic_tags": "Addiction,Brain Imaging,Mechanism of Action,Biomarkers,Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-11 01:24:10", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06349083", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06349083", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06349083", "source_url": "https://clinicaltrials.gov/study/NCT06349083", "doi": "", "pmid": "", "publication_date": "2026-07-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3495, "title": "A Multicenter Phase 1 Safety and Tolerability Trial of Psilocybin in Healthy Older Adults", "authors": "University of Colorado, Denver", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-05", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07516405", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Aging,Wellbeing,Clinical Trial,Observational Study,Healthy Volunteers,Older Adults,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-11 01:24:11", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07516405", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07516405", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07516405", "source_url": "https://clinicaltrials.gov/study/NCT07516405", "doi": "", "pmid": "", "publication_date": "2026-07-05", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3982, "title": "Policy Considerations for Psychedelics in Research and Medicine - What’s Next on the Schedule?", "authors": "Matthew A. Boehm, Oriana Mayorga", "journal": "Journal of Science Policy & Governance", "publication_date": "2026-07-01", "publication_year": 2026, "doi": "10.38126/jspg280103", "pubmed_id": null, "openalex_id": "https://openalex.org/W7167073096", "source_url": "https://doi.org/10.38126/jspg280103", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 01:20:30", "last_checked": "2026-07-09 01:20:16", "bibtex": null, "source_record_id": "DOI:10.38126/jspg280103", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.38126/jspg280103", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.38126/jspg280103", "source_url": "https://doi.org/10.38126/jspg280103", "doi": "10.38126/jspg280103", "pmid": "", "publication_date": "2026-07-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3976, "title": "Psilocybin as a Transdiagnostic Treatment for Eating Disorders and Comorbid Psychopathology: Implications for Clinical Nosology and Research Directions.", "authors": "Koning E, Richard J, Keshen A.", "journal": "International Journal of Eating Disorders", "publication_date": "2026-07-01", "publication_year": 2026, "doi": "10.1002/eat.70164", "pubmed_id": "42393007", "openalex_id": "https://openalex.org/W7167014213", "source_url": "https://doi.org/10.1002/eat.70164", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-04 01:20:05", "last_checked": "2026-07-09 01:20:16", "bibtex": null, "source_record_id": "PMID:42393007", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1002/eat.70164", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42393007", "source_url": "https://doi.org/10.1002/eat.70164", "doi": "10.1002/eat.70164", "pmid": "42393007", "publication_date": "2026-07-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3811, "title": "Investigating the impact of serotonergic psychedelic drugs, MDMA and ketamine on social cognition in psychiatric disorders: A scoping review.", "authors": "Smith SA, Mohammad H, Lee LHN, Dennett L, Smith S, Burback L, Winkler O, Greenshaw A, Jetly R, Kennedy SH, Bhat V, Swainson J, Vermetten E, Cao B, Li XM, Zhang Y.", "journal": null, "publication_date": "2026-06-30", "publication_year": 2026, "doi": "10.1007/s00213-026-07110-y", "pubmed_id": "42380668", "openalex_id": null, "source_url": "https://doi.org/10.1007/s00213-026-07110-y", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Emotional Processing,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 13:00:05", "last_checked": "2026-07-08 01:20:23", "bibtex": null, "source_record_id": "PMID:42380668", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s00213-026-07110-y", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42380668", "source_url": "https://doi.org/10.1007/s00213-026-07110-y", "doi": "10.1007/s00213-026-07110-y", "pmid": "42380668", "publication_date": "2026-06-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3547, "title": "A Phase 2, Open-Label Study Investigating the Safety and Efficacy of Psilocybin-Assisted Therapy for Sexual Assault-Related Posttraumatic Stress Disorder (PTSD)", "authors": "Sunstone Medical", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-30", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06902974", "substance_tags": "psilocybin", "topic_tags": "PTSD,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-07 01:23:04", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06902974", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06902974", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06902974", "source_url": "https://clinicaltrials.gov/study/NCT06902974", "doi": "", "pmid": "", "publication_date": "2026-06-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 171, "title": "Blinding Integrity in Psychedelic Randomized Clinical Trials: A Systematic Review.", "authors": "Orsini DK, Wong S, Di Luch S, Chan B, Vasudeva S, Lovell GFM, Le GH, Jones BDM, Chisamore N, Mollica A, Johnson DE, Kaczmarek ES, Goel A, Burke MJ, Mansur R, McIntyre RS, Husain MI, Rosenblat JD.", "journal": null, "publication_date": "2026-06-30", "publication_year": 2026, "doi": "10.1001/jamapsychiatry.2026.0255", "pubmed_id": "41984443", "openalex_id": null, "source_url": "https://doi.org/10.1001/jamapsychiatry.2026.0255", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-08 01:20:23", "bibtex": null, "source_record_id": "PMID:41984443", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1001/jamapsychiatry.2026.0255", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:41984443", "source_url": "https://doi.org/10.1001/jamapsychiatry.2026.0255", "doi": "10.1001/jamapsychiatry.2026.0255", "pmid": "41984443", "publication_date": "2026-06-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 107, "title": "Implementing psilocybin-assisted therapy in palliative care settings: A survey of stakeholders.", "authors": "Plourde L, Chang SL, Nguyen O, Garel N, Farzin H, Stephan JF, Fallu JS, Dorval M, P3A Research Group", "journal": "Palliative medicine", "publication_date": "2026-06-30", "publication_year": 2026, "doi": "10.1177/02692163261446141", "pubmed_id": "42154482", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/42154482/", "substance_tags": "psilocybin", "topic_tags": "End-of-Life Distress,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-08 01:20:05", "bibtex": null, "source_record_id": "PMID:42154482", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42154482/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42154482", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42154482/", "doi": "10.1177/02692163261446141", "pmid": "42154482", "publication_date": "2026-06-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 17, "title": "Psychedelics, entactogens and psychoplastogens for depression and related disorders.", "authors": "Hoyer D", "journal": "British journal of pharmacology", "publication_date": "2026-06-30", "publication_year": 2026, "doi": "10.1111/bph.70088", "pubmed_id": "40518133", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40518133/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Neuroplasticity,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Biomarkers,Aging,Clinical Trial,Treatment-Resistant Depression,Inflammation,Immune Function", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-08 01:20:06", "bibtex": null, "source_record_id": "PMID:40518133", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40518133/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40518133", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40518133/", "doi": "10.1111/bph.70088", "pmid": "40518133", "publication_date": "2026-06-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 14, "title": "Psychedelics as pharmacotherapeutics for substance use disorders: A scoping review on clinical trials and perspectives on underlying neurobiology.", "authors": "Wittenkeller L, Gudelsky G, Winhusen TJ, Amato D", "journal": "British journal of pharmacology", "publication_date": "2026-06-30", "publication_year": 2026, "doi": "10.1111/bph.70181", "pubmed_id": "40891276", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40891276/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Consciousness,Clinical Trial,Review Article,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-08 01:20:06", "bibtex": null, "source_record_id": "PMID:40891276", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40891276/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40891276", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40891276/", "doi": "10.1111/bph.70181", "pmid": "40891276", "publication_date": "2026-06-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 303, "title": "Study Protocol for \"Exploring the safety and therapeutic potential of psilocybin in the treatment of anorexia nervosa in adolescents and young adults\".", "authors": "Sjöström D, Schau Rybäck O, Claesdotter Knutsson E, Kajonius P, Jensen Sondén O, Carlbring P, Björkstrand J, Movahed Rad P.", "journal": "PLoS ONE", "publication_date": "2026-06-29", "publication_year": 2026, "doi": "10.1371/journal.pone.0352246", "pubmed_id": "42378255", "openalex_id": "https://openalex.org/W7166779507", "source_url": "https://doi.org/10.1371/journal.pone.0352246", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Brain Imaging,Aging,Wellbeing,Personality Change,Clinical Trial,Randomized Controlled Trial,Review Article,Adolescents,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:03", "last_checked": "2026-07-07 01:20:41", "bibtex": null, "source_record_id": "PMID:42378255", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1371/journal.pone.0352246", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42378255", "source_url": "https://doi.org/10.1371/journal.pone.0352246", "doi": "10.1371/journal.pone.0352246", "pmid": "42378255", "publication_date": "2026-06-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 22, "title": "Psychedelics in treatment-resistant depression: a comprehensive review of mechanisms, clinical evidence, and recommendations.", "authors": "Estela-Fernandez CA, Mohamed Yousif Elsheikh R, Beatrice DB, A Alhendal A, Irene Ewe C, Montesinos SY, Wensel J, Mishra AP, Yousif AA, Ali HT.", "journal": null, "publication_date": "2026-06-29", "publication_year": 2026, "doi": "10.1007/s40211-026-00584-4", "pubmed_id": "42377806", "openalex_id": null, "source_url": "https://doi.org/10.1007/s40211-026-00584-4", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression,Toxicity", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-07 01:20:36", "bibtex": null, "source_record_id": "PMID:42377806", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s40211-026-00584-4", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42377806", "source_url": "https://doi.org/10.1007/s40211-026-00584-4", "doi": "10.1007/s40211-026-00584-4", "pmid": "42377806", "publication_date": "2026-06-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3979, "title": "Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical Development", "authors": "Stefanie Enriquez Geppert, Lisa Bevers, Arvid Rosander, Peter Fodran, Vince Polito", "journal": "University of Groningen research database (University of Groningen / Centre for Information Technology)", "publication_date": "2026-06-28", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7167168218", "source_url": "https://research.rug.nl/en/publications/370a82bd-d8db-4a02-b644-bf0c9131680b", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 01:20:27", "last_checked": "2026-07-06 01:20:37", "bibtex": null, "source_record_id": "https://research.rug.nl/en/publications/370a82bd-d8db-4a02-b644-bf0c9131680b", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://research.rug.nl/en/publications/370a82bd-d8db-4a02-b644-bf0c9131680b", "source_url": "https://research.rug.nl/en/publications/370a82bd-d8db-4a02-b644-bf0c9131680b", "doi": "", "pmid": "", "publication_date": "2026-06-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3494, "title": "5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder", "authors": "Johns Hopkins University", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-28", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05452772", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-05 01:22:40", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05452772", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05452772", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05452772", "source_url": "https://clinicaltrials.gov/study/NCT05452772", "doi": "", "pmid": "", "publication_date": "2026-06-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 29, "title": "Novel approaches in depression treatment: from rapid-acting antidepressants to personalized interventions.", "authors": "Guidetti C, Fava M, Papakostas GI.", "journal": null, "publication_date": "2026-06-24", "publication_year": 2026, "doi": "10.1038/s41380-026-03722-0", "pubmed_id": "42350785", "openalex_id": null, "source_url": "https://doi.org/10.1038/s41380-026-03722-0", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Biomarkers,Clinical Trial,Review Article,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-02 23:03:30", "bibtex": null, "source_record_id": "PMID:42350785", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1038/s41380-026-03722-0", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42350785", "source_url": "https://doi.org/10.1038/s41380-026-03722-0", "doi": "10.1038/s41380-026-03722-0", "pmid": "42350785", "publication_date": "2026-06-24", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3986, "title": "Mechanistic insights toward dissociating therapeutic from psychedelic effects: bridging the gap between psychedelic research and mental health care", "authors": "Mauro Pettorruso, Giacomo d’Andrea, Antonio Inserra, Clara Cavallotto, Stefano Censi, Étienne Billard, Antonio Di Stefano, Luisa De Risio, Maria Giulia Tullo, Claudio D’Addario, Giorgio Di Lorenzo, Richard G. Wise, Stefano L. Sensi, Francesca Zoratto, Giovanni Martinotti", "journal": "Translational Psychiatry", "publication_date": "2026-06-23", "publication_year": 2026, "doi": "10.1038/s41398-026-04203-2", "pubmed_id": "42342649", "openalex_id": "https://openalex.org/W7165728379", "source_url": "https://doi.org/10.1038/s41398-026-04203-2", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Pharmacology,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Personality Change,Mystical Experience,Clinical Trial,Animal Study,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:34", "last_checked": "2026-07-04 06:34:34", "bibtex": null, "source_record_id": "PMID:42342649", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41398-026-04203-2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42342649", "source_url": "https://doi.org/10.1038/s41398-026-04203-2", "doi": "10.1038/s41398-026-04203-2", "pmid": "42342649", "publication_date": "2026-06-23", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3987, "title": "Psychedelics and autism spectrum disorder: Mechanistic insights, translational evidence and ethical challenges", "authors": "Júlio César Claudino dos Santos, Sofia Januário Bolan, Guilherme Lodetti da Silva, Germano Lapa Viana, Eduardo Pacheco Rico, Cinara Ludvig Gonçalves", "journal": "Journal of Psychiatric Research", "publication_date": "2026-06-22", "publication_year": 2026, "doi": "10.1016/j.jpsychires.2026.06.035", "pubmed_id": "42385294", "openalex_id": "https://openalex.org/W7165638399", "source_url": "https://doi.org/10.1016/j.jpsychires.2026.06.035", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Clinical Trial,Review Article,Animal Study,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:34", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42385294", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.jpsychires.2026.06.035", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42385294", "source_url": "https://doi.org/10.1016/j.jpsychires.2026.06.035", "doi": "10.1016/j.jpsychires.2026.06.035", "pmid": "42385294", "publication_date": "2026-06-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3650, "title": "Psilocybin-assisted Existential, Attachment and Relational (PEARL) Therapy for Caregivers of Patients With Advanced Cancer: A Phase II Open-Label Trial", "authors": "University Health Network, Toronto", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-22", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07048743", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Spirituality,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07048743", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07048743", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07048743", "source_url": "https://clinicaltrials.gov/study/NCT07048743", "doi": "", "pmid": "", "publication_date": "2026-06-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3637, "title": "Psilocybin-Assisted Therapy for Prolonged Grief", "authors": "University of Virginia", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-22", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06724289", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Aging,Spirituality,Mystical Experience,Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06724289", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06724289", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06724289", "source_url": "https://clinicaltrials.gov/study/NCT06724289", "doi": "", "pmid": "", "publication_date": "2026-06-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3574, "title": "Low-Dose Psilocybin Therapy for Palliative Care Patients With Chronic Cancer Pain Requiring Opioids", "authors": "Roswell Park Cancer Institute", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-21", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06827054", "substance_tags": "psilocybin", "topic_tags": "Addiction,End-of-Life Distress,Chronic Pain,Brain Imaging,Mechanism of Action,Aging,Spirituality,Clinical Trial,Cancer Patients,Safety,Toxicity,Inflammation", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06827054", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06827054", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06827054", "source_url": "https://clinicaltrials.gov/study/NCT06827054", "doi": "", "pmid": "", "publication_date": "2026-06-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3460, "title": "Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Phase II Open-Label Trial", "authors": "University Health Network, Toronto", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-21", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06416085", "substance_tags": "psilocybin", "topic_tags": "End-of-Life Distress,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06416085", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06416085", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06416085", "source_url": "https://clinicaltrials.gov/study/NCT06416085", "doi": "", "pmid": "", "publication_date": "2026-06-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3024, "title": "Sex-Specific Effects of Psilocybin Versus Escitalopram on Anxiety and Anhedonia: A Bayesian Reanalysis of Antidepressant Treatment Outcomes", "authors": "Frick A, Blest-Hopley G, Grin M, Erritzoe D, Nutt D, Carhart-Harris R.", "journal": "Research Square", "publication_date": "2026-06-18", "publication_year": 2026, "doi": "10.21203/rs.3.rs-9880403/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-9880403/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Wellbeing,Clinical Trial,Randomized Controlled Trial,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:45", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-9880403/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-9880403/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-9880403/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-9880403/v1", "doi": "10.21203/rs.3.rs-9880403/v1", "pmid": "", "publication_date": "2026-06-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1923, "title": "Psilocybin-assisted therapy in treatment-resistant depression: rapid remission, uncertain durability, and the next phase of clinical evidence", "authors": "Astrit Sabani, Adnan Khatak", "journal": "Annals of Medicine and Surgery", "publication_date": "2026-06-17", "publication_year": 2026, "doi": "10.1097/ms9.0000000000005244", "pubmed_id": null, "openalex_id": "https://openalex.org/W7165127045", "source_url": "https://doi.org/10.1097/ms9.0000000000005244", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Receptor Pharmacology,Aging,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:49:23", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.1097/ms9.0000000000005244", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1097/ms9.0000000000005244", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1097/ms9.0000000000005244", "source_url": "https://doi.org/10.1097/ms9.0000000000005244", "doi": "10.1097/ms9.0000000000005244", "pmid": "", "publication_date": "2026-06-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1924, "title": "Community engagement as a foundation for implementation research for group psilocybin assisted therapy in New Mexico", "authors": "Lawrence Leeman, Maya Armstrong, Dara Menashi, Hanifa Nayo-Washington, Elliot Marseille, Janus Herrera, Crystal Romero, Janet Page-Reeves", "journal": "Frontiers in Public Health", "publication_date": "2026-06-16", "publication_year": 2026, "doi": "10.3389/fpubh.2026.1845943", "pubmed_id": null, "openalex_id": "https://openalex.org/W7165032301", "source_url": "https://doi.org/10.3389/fpubh.2026.1845943", "substance_tags": "psilocybin", "topic_tags": "PTSD,Chronic Pain,Aging,Clinical Trial,Veterans,Healthcare Workers,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:49:23", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.3389/fpubh.2026.1845943", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpubh.2026.1845943", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3389/fpubh.2026.1845943", "source_url": "https://doi.org/10.3389/fpubh.2026.1845943", "doi": "10.3389/fpubh.2026.1845943", "pmid": "", "publication_date": "2026-06-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3997, "title": "THE PSYCHEDELIC AND KETAMINE RENAISSANCE IN THE FACE OF THE CRISIS IN MODERN PSYCHIATRY", "authors": "Julia Osipowska, Marlena Kwolek, Alicja Judzińska, Bartosz Piech, Kamila Sobczyńska, Justyna Ignarska, Magda Terbosh, Sabina Kubicz `Mzabi, Emilia Trojanowska, Magdalena Dubaj", "journal": "International Journal of Innovative Technologies in Social Science", "publication_date": "2026-06-14", "publication_year": 2026, "doi": "10.31435/ijitss.2(50).2026.5605", "pubmed_id": null, "openalex_id": "https://openalex.org/W7165128977", "source_url": "https://doi.org/10.31435/ijitss.2(50).2026.5605", "substance_tags": "psilocybin", "topic_tags": "Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-07-04 06:34:35", "bibtex": null, "source_record_id": "DOI:10.31435/ijitss.2(50).2026.5605", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.31435/ijitss.2(50).2026.5605", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.31435/ijitss.2(50).2026.5605", "source_url": "https://doi.org/10.31435/ijitss.2(50).2026.5605", "doi": "10.31435/ijitss.2(50).2026.5605", "pmid": "", "publication_date": "2026-06-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3440, "title": "Psilocybin-Assisted Psychotherapy for the Treatment of Severe Alcohol Use Disorder: A Double-Blind, Dose-Comparison Concurrent Control Randomized Trial", "authors": "Brigham and Women's Hospital", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-14", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07296094", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Addiction,Brain Imaging,Mechanism of Action,Biomarkers,Aging,Emotional Processing,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07296094", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07296094", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07296094", "source_url": "https://clinicaltrials.gov/study/NCT07296094", "doi": "", "pmid": "", "publication_date": "2026-06-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1927, "title": "Psilocybin and Mental Health Outcomes: Scoping Review with ☸SAIMSARA", "authors": "SAIMSARA", "journal": "SAIMSARA Journal", "publication_date": "2026-06-14", "publication_year": 2026, "doi": "10.62487/saimsara7a54f680", "pubmed_id": null, "openalex_id": "https://openalex.org/W7164845889", "source_url": "https://doi.org/10.62487/saimsara7a54f680", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Chronic Pain,Mechanism of Action,Clinical Trial,Review Article,Observational Study,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:49:23", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.62487/saimsara7a54f680", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.62487/saimsara7a54f680", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.62487/saimsara7a54f680", "source_url": "https://doi.org/10.62487/saimsara7a54f680", "doi": "10.62487/saimsara7a54f680", "pmid": "", "publication_date": "2026-06-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1926, "title": "Efficacy of Psilocybin-Assisted Therapy in Major Depressive Disorder: A Systematic Review and Meta-Analysis", "authors": "Angel Labra-Lorenzana, Dania Nimbe Lima Sanchez, Christian Alejandro Delaflor-Wagner, Diana Martínez-Hernández, Christian Ramos-Jiménez, Christian Gabriel Toledo-Lozano", "journal": "Psychiatry International", "publication_date": "2026-06-14", "publication_year": 2026, "doi": "10.3390/psychiatryint7030137", "pubmed_id": null, "openalex_id": "https://openalex.org/W7164820747", "source_url": "https://doi.org/10.3390/psychiatryint7030137", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety,Adverse Events,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:49:23", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.3390/psychiatryint7030137", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/psychiatryint7030137", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3390/psychiatryint7030137", "source_url": "https://doi.org/10.3390/psychiatryint7030137", "doi": "10.3390/psychiatryint7030137", "pmid": "", "publication_date": "2026-06-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 46, "title": "Music Playlist Use in Clinical Trials of Psychedelic Assisted Psychotherapy: A Systematic Review", "authors": "Lucas Cruz, Fernando R. Beserra, Julia M.K. Freind, Sandro E. Rodrigues, Daniel C. Mograbi", "journal": "Journal of Clinical Psychology", "publication_date": "2026-06-14", "publication_year": 2026, "doi": "10.1002/jclp.70167", "pubmed_id": "42296474", "openalex_id": "https://openalex.org/W7164838909", "source_url": "https://doi.org/10.1002/jclp.70167", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Chronic Pain,Clinical Trial,Systematic Review,Review Article,Toxicity", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42296474", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/jclp.70167", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42296474", "source_url": "https://doi.org/10.1002/jclp.70167", "doi": "10.1002/jclp.70167", "pmid": "42296474", "publication_date": "2026-06-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3565, "title": "Psilocybin as a Treatment for Chronic Pain in Smokers", "authors": "Yale University", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-08", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07118332", "substance_tags": "psilocybin", "topic_tags": "Addiction,Chronic Pain,Headache / Migraine,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07118332", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07118332", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07118332", "source_url": "https://clinicaltrials.gov/study/NCT07118332", "doi": "", "pmid": "", "publication_date": "2026-06-08", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3686, "title": "PRISMatic: A Phase 1b Randomized, Double-Armed, Parallel-Group, Placebo-Controlled Trial of Psilocybin Efficacy With or Without Pimavanserin Pretreatment", "authors": "Johns Hopkins University", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-07", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07610135", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Biomarkers,Wellbeing,Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07610135", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07610135", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07610135", "source_url": "https://clinicaltrials.gov/study/NCT07610135", "doi": "", "pmid": "", "publication_date": "2026-06-07", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3702, "title": "Multivariate Neural and Physiological Correlates of Psychedelic Sub-states: a Within-subjects, Healthy Volunteer Study With Experience-sampling", "authors": "Robin Carhart-Harris, PhD, MA", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-04", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05698511", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Aging,Clinical Trial,Healthy Volunteers", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05698511", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05698511", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05698511", "source_url": "https://clinicaltrials.gov/study/NCT05698511", "doi": "", "pmid": "", "publication_date": "2026-06-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 60, "title": "Prenatal stress, excitatory-inhibitory imbalance, and ADHD risk: a hypothesis-driven perspective on psilocybin-induced neuroplasticity", "authors": "Samaneh Ahmadian-Moghadam, Shiva Roshan-Milani, Ehsan Saboory", "journal": "Translational Psychiatry", "publication_date": "2026-06-04", "publication_year": 2026, "doi": "10.1038/s41398-026-04151-x", "pubmed_id": "42248832", "openalex_id": "https://openalex.org/W7163694045", "source_url": "https://doi.org/10.1038/s41398-026-04151-x", "substance_tags": "psilocybin", "topic_tags": "Addiction,Neuroplasticity,Brain Imaging,Mechanism of Action,Biomarkers,Aging,Emotional Processing,Clinical Trial,Animal Study,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42248832", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41398-026-04151-x", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42248832", "source_url": "https://doi.org/10.1038/s41398-026-04151-x", "doi": "10.1038/s41398-026-04151-x", "pmid": "42248832", "publication_date": "2026-06-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 59, "title": "Developing Methods for Observing Awe Narration in Psilocybin-Assisted Therapy", "authors": "Elise C. Tarbi, Ian Bhatia, Nabil Balach, Suzannah Buehler, Magdalena Demeo-Meres, Cailin Gramling, Tej Thambi, Julia Hart, Maija Reblin, Donna M. Rizzo, Robert Gramling, Manish Agrawal, Emily Manetta", "journal": "Healthcare", "publication_date": "2026-06-04", "publication_year": 2026, "doi": "10.3390/healthcare14111589", "pubmed_id": "42278842", "openalex_id": "https://openalex.org/W7163680882", "source_url": "https://doi.org/10.3390/healthcare14111589", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42278842", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/healthcare14111589", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42278842", "source_url": "https://doi.org/10.3390/healthcare14111589", "doi": "10.3390/healthcare14111589", "pmid": "42278842", "publication_date": "2026-06-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1, "title": "A cross-national comparison of nonmedical and medical use of psychedelic drugs in the international cannabis policy study", "authors": "Myfanwy Graham, Yimin Ge, Rosalie Liccardo Pacula, Seema Choksy Pessar, Chris Wilkins, Wayne Hall, David Hammond", "journal": "International Journal of Drug Policy", "publication_date": "2026-06-04", "publication_year": 2026, "doi": "10.1016/j.drugpo.2026.105348", "pubmed_id": "42247761", "openalex_id": "https://openalex.org/W7163656829", "source_url": "https://doi.org/10.1016/j.drugpo.2026.105348", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Clinical Trial,Observational Study,Safety,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42247761", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.drugpo.2026.105348", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42247761", "source_url": "https://doi.org/10.1016/j.drugpo.2026.105348", "doi": "10.1016/j.drugpo.2026.105348", "pmid": "42247761", "publication_date": "2026-06-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 66, "title": "Classic Psychedelics for Chronic Pain: A Critical Review of the Literature and Practical Advice for Clinicians", "authors": "Kevin F. Boehnke, Niloufar Pouyan, Jacob S. Aday", "journal": "Drugs", "publication_date": "2026-06-03", "publication_year": 2026, "doi": "10.1007/s40265-026-02339-5", "pubmed_id": "42243569", "openalex_id": "https://openalex.org/W7163536837", "source_url": "https://doi.org/10.1007/s40265-026-02339-5", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Headache / Migraine,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Observational Study,Animal Study,Healthcare Workers,Safety,Toxicity,Drug Interactions,Contraindications,Inflammation", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42243569", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1007/s40265-026-02339-5", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42243569", "source_url": "https://doi.org/10.1007/s40265-026-02339-5", "doi": "10.1007/s40265-026-02339-5", "pmid": "42243569", "publication_date": "2026-06-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 64, "title": "Changes in anxiety, quality of life, and functioning following psilocybin-assisted therapy in veterans with treatment-resistant depression", "authors": "Cecelia Kelly, Mathieu Fradet, Catherine M. Bostian, Anna Donnelly, Sara Ellis, Michael Ostacher, Scott Aaronson, Trisha Suppes", "journal": "Journal of Affective Disorders", "publication_date": "2026-06-03", "publication_year": 2026, "doi": "10.1016/j.jad.2026.122063", "pubmed_id": "42248535", "openalex_id": "https://openalex.org/W7163510976", "source_url": "https://doi.org/10.1016/j.jad.2026.122063", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Veterans,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42248535", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42248535", "source_url": "https://doi.org/10.1016/j.jad.2026.122063", "doi": "10.1016/j.jad.2026.122063", "pmid": "42248535", "publication_date": "2026-06-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3558, "title": "The Role of the Subjective Experience in Supporting Positive Effects Following Psilocybin: a Randomized, Controlled Clinical Trial Using Risperidone in Healthy Adults", "authors": "University of Calgary", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-01", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06768944", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Biomarkers,Wellbeing,Personality Change,Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06768944", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06768944", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06768944", "source_url": "https://clinicaltrials.gov/study/NCT06768944", "doi": "", "pmid": "", "publication_date": "2026-06-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4004, "title": "From Altered States to Altered Trajectories and From Molecules to Meaning: A Network Meta Analysis Mapping Comparative Efficacy of Psychedelic Assisted Therapies in Modern Psychiatry", "authors": "Gaurav Uppal, Naima Gul, Asha Dhandapani, Sathyan Soundararajan, Khushboo Kansal", "journal": "BJPsych Open", "publication_date": "2026-05-31", "publication_year": 2026, "doi": "10.1192/bjo.2026.11141", "pubmed_id": null, "openalex_id": "https://openalex.org/W7166698621", "source_url": "https://doi.org/10.1192/bjo.2026.11141", "substance_tags": "psilocybin", "topic_tags": "Addiction,Aging,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.1192/bjo.2026.11141", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1192/bjo.2026.11141", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1192/bjo.2026.11141", "source_url": "https://doi.org/10.1192/bjo.2026.11141", "doi": "10.1192/bjo.2026.11141", "pmid": "", "publication_date": "2026-05-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3647, "title": "Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST)", "authors": "Centre for Addiction and Mental Health", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-31", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06512220", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Brain Imaging,Receptor Pharmacology,Aging,Clinical Trial,Randomized Controlled Trial,Healthy Volunteers,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06512220", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06512220", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06512220", "source_url": "https://clinicaltrials.gov/study/NCT06512220", "doi": "", "pmid": "", "publication_date": "2026-05-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 77, "title": "Psilocybin Decreases Preference for Large Rewards Accompanied by Increased Activity of Parvalbumin Neurons With Perineuronal Nets in the Medial Prefrontal Cortex", "authors": "Jenna Houff, Andrew Williams, Obie Allen, Barbara Gisabella, Harry Pantazopoulos, Alberto Del Arco", "journal": "European Journal of Neuroscience", "publication_date": "2026-05-31", "publication_year": 2026, "doi": "10.1111/ejn.70574", "pubmed_id": "42226515", "openalex_id": "https://openalex.org/W7163205006", "source_url": "https://doi.org/10.1111/ejn.70574", "substance_tags": "psilocybin", "topic_tags": "Addiction,Chronic Pain,Neuroplasticity,Receptor Pharmacology,Biomarkers,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42226515", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/ejn.70574", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42226515", "source_url": "https://doi.org/10.1111/ejn.70574", "doi": "10.1111/ejn.70574", "pmid": "42226515", "publication_date": "2026-05-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 74, "title": "Expectations and Motivations for Participation in Clinical Trials Utilizing Psychedelics for Treatment-Resistant Depression: A Qualitative Study", "authors": "C. Poppe, Liisa Lyck, Laura Bechtold, Dimitris Repantis", "journal": "Brain and Behavior", "publication_date": "2026-05-31", "publication_year": 2026, "doi": "10.1002/brb3.71544", "pubmed_id": "42304595", "openalex_id": "https://openalex.org/W7164930745", "source_url": "https://doi.org/10.1002/brb3.71544", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Mechanism of Action,Clinical Trial,Treatment-Resistant Depression,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42304595", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/brb3.71544", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42304595", "source_url": "https://doi.org/10.1002/brb3.71544", "doi": "10.1002/brb3.71544", "pmid": "42304595", "publication_date": "2026-05-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3576, "title": "A Phase 2a Study of Group Retreat Psilocybin Therapy for Cancer-Related Anxiety and Depression", "authors": "University of Washington", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-28", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07336238", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Observational Study,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07336238", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07336238", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07336238", "source_url": "https://clinicaltrials.gov/study/NCT07336238", "doi": "", "pmid": "", "publication_date": "2026-05-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1940, "title": "Psilocybin shows rapid relief for depression symptoms", "authors": "Valerie A. Canady", "journal": "Mental Health Weekly", "publication_date": "2026-05-28", "publication_year": 2026, "doi": "10.1002/mhw.34890", "pubmed_id": null, "openalex_id": "https://openalex.org/W7162755829", "source_url": "https://doi.org/10.1002/mhw.34890", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:49:23", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.1002/mhw.34890", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/mhw.34890", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/mhw.34890", "source_url": "https://doi.org/10.1002/mhw.34890", "doi": "10.1002/mhw.34890", "pmid": "", "publication_date": "2026-05-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1939, "title": "Psilocybin shows mixed results for patients with treatment-resistant depression", "authors": "", "journal": "The Brown University Psychopharmacology Update", "publication_date": "2026-05-28", "publication_year": 2026, "doi": "10.1002/pu.31461", "pubmed_id": null, "openalex_id": "https://openalex.org/W7162787347", "source_url": "https://doi.org/10.1002/pu.31461", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:49:23", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.1002/pu.31461", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/pu.31461", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/pu.31461", "source_url": "https://doi.org/10.1002/pu.31461", "doi": "10.1002/pu.31461", "pmid": "", "publication_date": "2026-05-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1937, "title": "Effect of psilocybin-assisted psychotherapy on anxiety symptoms: A systematic review and meta-analysis", "authors": "Alex Hood, Gary ELKINS", "journal": "Journal of Psychedelic Studies", "publication_date": "2026-05-28", "publication_year": 2026, "doi": "10.1556/2054.2026.00507", "pubmed_id": null, "openalex_id": "https://openalex.org/W7162785692", "source_url": "https://doi.org/10.1556/2054.2026.00507", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Chronic Pain,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:49:23", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2026.00507", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2026.00507", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2026.00507", "source_url": "https://doi.org/10.1556/2054.2026.00507", "doi": "10.1556/2054.2026.00507", "pmid": "", "publication_date": "2026-05-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 93, "title": "A systematic review of the pharmacokinetics of classical serotonergic psychedelic compounds in healthy adult subjects", "authors": "Elliot Hampsey, Kirsty Martin, Michail Kalfas, Louis Benson, Sirid Wihlborg, Luke Jelen, Allan H. Young, James Rucker", "journal": "Journal of Psychopharmacology", "publication_date": "2026-05-28", "publication_year": 2026, "doi": "10.1177/02698811261453938", "pubmed_id": "42212869", "openalex_id": "https://openalex.org/W7162805790", "source_url": "https://doi.org/10.1177/02698811261453938", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Pharmacology,Clinical Trial,Systematic Review,Review Article,Toxicity", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42212869", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/02698811261453938", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42212869", "source_url": "https://doi.org/10.1177/02698811261453938", "doi": "10.1177/02698811261453938", "pmid": "42212869", "publication_date": "2026-05-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4006, "title": "Blinding integrity in psychedelic research: Evidence from a comparative randomized controlled trial of psilocybin, MDMA, and methylphenidate in healthy volunteers.", "authors": "L Belinger, N M Rieser, E J E Engeli, L Becciolini, M Clamote, M Pribis, F Saissi, G.A. Florineth, N L Hehl, M Herdener, K H Preller", "journal": "Open Access CRIS of the University of Bern", "publication_date": "2026-05-27", "publication_year": 2026, "doi": "10.48620/98266", "pubmed_id": null, "openalex_id": "https://openalex.org/W7163021326", "source_url": "https://doi.org/10.48620/98266", "substance_tags": "psilocybin", "topic_tags": "Addiction,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Healthy Volunteers,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.48620/98266", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.48620/98266", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.48620/98266", "source_url": "https://doi.org/10.48620/98266", "doi": "10.48620/98266", "pmid": "", "publication_date": "2026-05-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 97, "title": "Psilocybin-induced neurocardiogenic syncope: a case report", "authors": "Mazen A. Atiq, Eli Weisman, Rodrigo B. Guerra, Luis Luna Martinez, David B. Yaden, Frederick S. Barrett, Sandeep Nayak, Ceyda Sayalı", "journal": "Psychopharmacology", "publication_date": "2026-05-27", "publication_year": 2026, "doi": "10.1007/s00213-026-07079-8", "pubmed_id": "42207275", "openalex_id": "https://openalex.org/W7162662445", "source_url": "https://doi.org/10.1007/s00213-026-07079-8", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Brain Imaging,Consciousness,Aging,Emotional Processing,Clinical Trial,Case Report,Safety,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42207275", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1007/s00213-026-07079-8", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42207275", "source_url": "https://doi.org/10.1007/s00213-026-07079-8", "doi": "10.1007/s00213-026-07079-8", "pmid": "42207275", "publication_date": "2026-05-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 99, "title": "Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression (EPIsoDE): 6- and 12-Month Naturalistic Follow-Up of a Phase 2b Trial", "authors": "Lea J. Mertens, Felix Betzler, Manuela Brand, Ricarda Evens, Andrea Jungaberle, Henrik Jungaberle, Laura Kärtner, Tomislav Majić, Christian N. Schmitz, Andreas Ströhle, Dennis Scharf, Moritz Spangemacher, Max Wolff, Zahra Assadi, Scharif Bahri, Lilith Becher, Luca V. Färber, Henry Harder, Niklas Kirchen, Eugenia Kulakova, Linda C. Kunz, Andy Meijer, Barbara Rohrmoser, Stefan Wellek, Moritz M. Berger, Michael Koslowski, Gerhard Gründer", "journal": "Psychotherapy and Psychosomatics", "publication_date": "2026-05-26", "publication_year": 2026, "doi": "10.1159/000552272", "pubmed_id": "42201843", "openalex_id": "https://openalex.org/W7162570449", "source_url": "https://doi.org/10.1159/000552272", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42201843", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1159/000552272", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42201843", "source_url": "https://doi.org/10.1159/000552272", "doi": "10.1159/000552272", "pmid": "42201843", "publication_date": "2026-05-26", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5697, "title": "Active placebo control interventions in pharmacological trials: a scoping review of the development process and a terminological analysis.", "authors": "Laursen DRT, Salazar J, Jürgens G, Hróbjartsson A.", "journal": null, "publication_date": "2026-05-23", "publication_year": 2026, "doi": "10.1016/j.jclinepi.2026.112345", "pubmed_id": "42190765", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jclinepi.2026.112345", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Systematic Review,Review Article,Adverse Events", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-11 19:28:11", "last_checked": "2026-07-11 19:28:11", "bibtex": null, "source_record_id": "PMID:42190765", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jclinepi.2026.112345", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42190765", "source_url": "https://doi.org/10.1016/j.jclinepi.2026.112345", "doi": "10.1016/j.jclinepi.2026.112345", "pmid": "42190765", "publication_date": "2026-05-23", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4012, "title": "Psilocybin for Treatment-Resistant Depression: A Comprehensive Review of Mechanisms and Therapeutic Potential", "authors": "Dallas T Mason", "journal": "Digital Showcase Research, Scholarship, & Creative Works (University of Lynchburg)", "publication_date": "2026-05-21", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7162235135", "source_url": "https://digitalshowcase.lynchburg.edu/dmscjournal/vol8/iss1/6", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Aging,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "https://digitalshowcase.lynchburg.edu/dmscjournal/vol8/iss1/6", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://digitalshowcase.lynchburg.edu/dmscjournal/vol8/iss1/6", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://digitalshowcase.lynchburg.edu/dmscjournal/vol8/iss1/6", "source_url": "https://digitalshowcase.lynchburg.edu/dmscjournal/vol8/iss1/6", "doi": "", "pmid": "", "publication_date": "2026-05-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4011, "title": "The Use of Psilocybin for Managing Refractory Behavioral Health Conditions: A New and Promising Approach", "authors": "Rachel N Clark", "journal": "Digital Showcase Research, Scholarship, & Creative Works (University of Lynchburg)", "publication_date": "2026-05-21", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7162225828", "source_url": "https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3694&context=dmscjournal", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Pharmacology,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3694&context=dmscjournal", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3694&context=dmscjournal", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3694&context=dmscjournal", "source_url": "https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3694&context=dmscjournal", "doi": "", "pmid": "", "publication_date": "2026-05-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3614, "title": "Group Psilocybin-Assisted Therapy for Post-Traumatic Stress Disorder", "authors": "University of New Mexico", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-21", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07506395", "substance_tags": "psilocybin", "topic_tags": "PTSD,Clinical Trial,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07506395", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07506395", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07506395", "source_url": "https://clinicaltrials.gov/study/NCT07506395", "doi": "", "pmid": "", "publication_date": "2026-05-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3636, "title": "A Pilot Mechanistic Study of Psilocybin-Assisted Therapy as a Treatment for Depression", "authors": "Washington University School of Medicine", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-19", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07582120", "substance_tags": "psilocybin", "topic_tags": "Depression,Biomarkers,Psychological Flexibility,Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07582120", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07582120", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07582120", "source_url": "https://clinicaltrials.gov/study/NCT07582120", "doi": "", "pmid": "", "publication_date": "2026-05-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3529, "title": "Evaluating the Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant Obsessive-compulsive Disorder: An Open-label Clinical Trial", "authors": "Centre for Addiction and Mental Health", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-17", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06299319", "substance_tags": "psilocybin", "topic_tags": "Addiction,OCD,Brain Imaging,Receptor Pharmacology,Aging,Clinical Trial,Randomized Controlled Trial,Case Report,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06299319", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06299319", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06299319", "source_url": "https://clinicaltrials.gov/study/NCT06299319", "doi": "", "pmid": "", "publication_date": "2026-05-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 123, "title": "Short-Term and Late-Term Effects of Psilocybin on Symptoms in Major Depression", "authors": "Hampus Yngwe, Pontus Plavén-Sigray, Carl Johan Ekman, Eva Henje, Anders Berglund, Mikael Tiger, Maria Beckman, J O Lundberg", "journal": "JAMA Network Open", "publication_date": "2026-05-14", "publication_year": 2026, "doi": "10.1001/jamanetworkopen.2026.12589", "pubmed_id": "42138922", "openalex_id": "https://openalex.org/W7161294763", "source_url": "https://doi.org/10.1001/jamanetworkopen.2026.12589", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42138922", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1001/jamanetworkopen.2026.12589", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42138922", "source_url": "https://doi.org/10.1001/jamanetworkopen.2026.12589", "doi": "10.1001/jamanetworkopen.2026.12589", "pmid": "42138922", "publication_date": "2026-05-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3606, "title": "Exploring the Safety, Acceptability, and Efficacy of Psilocybin Among Non-Small Cell Lung Cancer Patients With Major Depressive Disorder: A Proof-of-Concept Trial (DREAM LUNG STUDY)", "authors": "Alan Davis", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-13", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07216404", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Observational Study,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07216404", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07216404", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07216404", "source_url": "https://clinicaltrials.gov/study/NCT07216404", "doi": "", "pmid": "", "publication_date": "2026-05-13", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3035, "title": "Low doses of psilocybin as adjunct pharmacological treatment to virtual reality exposure therapy for social anxiety disorder: A study protocol for a double-blind randomized controlled trial.", "authors": "", "journal": "PsyArXiv", "publication_date": "2026-05-13", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/3b9fx_v1", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Brain Imaging,Biomarkers,Aging,Microdosing,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/3b9fx_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/3b9fx_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/3b9fx_v1", "source_url": "https://osf.io/preprints/psyarxiv/3b9fx_v1", "doi": "", "pmid": "", "publication_date": "2026-05-13", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1944, "title": "Ethical Complexities and Best Practices in Informed Consent Processes for Psilocybin Services: A Qualitative Study", "authors": "Christina Chwyl, Alissa Bazinet, Adrianne R. Wilson-Poe, Kim Hoffman, Kellie Pertl, R. Cameron Wolf, P. Todd Korthuis, Jason B. Luoma", "journal": "Neuroethics", "publication_date": "2026-05-12", "publication_year": 2026, "doi": "10.1007/s12152-026-09645-5", "pubmed_id": null, "openalex_id": "https://openalex.org/W7160917606", "source_url": "https://doi.org/10.1007/s12152-026-09645-5", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Clinical Trial,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.1007/s12152-026-09645-5", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1007/s12152-026-09645-5", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1007/s12152-026-09645-5", "source_url": "https://doi.org/10.1007/s12152-026-09645-5", "doi": "10.1007/s12152-026-09645-5", "pmid": "", "publication_date": "2026-05-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3490, "title": "A Phase 2b/3, Multicentre, Randomised, Double-blind, Controlled Trial, With an Open Label Extension, to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder", "authors": "COMPASS Pathways", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-11", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07570654", "substance_tags": "psilocybin", "topic_tags": "PTSD,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07570654", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07570654", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07570654", "source_url": "https://clinicaltrials.gov/study/NCT07570654", "doi": "", "pmid": "", "publication_date": "2026-05-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1945, "title": "Rapid-acting interventions in treatment-resistant depression - a comparative review of esketamine and psilocybin", "authors": "Bartłomiej Kosiarski, Anna Skrzypek, Patrycja Markowicz, Mikołaj Zbrożek, Krzysztof Biłyk, Maciej Hutkowski, Zuzanna Chwostek, Hanna Maruchniak, Wiktoria Marzec, Paulina Biedroń", "journal": "Journal of Pre-Clinical and Clinical Research", "publication_date": "2026-05-11", "publication_year": 2026, "doi": "10.26444/jpccr/221219", "pubmed_id": null, "openalex_id": "https://openalex.org/W7160910785", "source_url": "https://doi.org/10.26444/jpccr/221219", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Case Report,Animal Study,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.26444/jpccr/221219", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.26444/jpccr/221219", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.26444/jpccr/221219", "source_url": "https://doi.org/10.26444/jpccr/221219", "doi": "10.26444/jpccr/221219", "pmid": "", "publication_date": "2026-05-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 113, "title": "Efficacy and Safety of a Single Dose of Psilocybin for Chronic Suicidal Ideation", "authors": "Andrew van der Vaart, Jeffrey LaPratt, Kimberly Swartz, Audrey Shoultz, Margo Lauterbach, Trisha Suppes, Harold A. Sackeïm, Scott T. Aaronson", "journal": "The Journal of Clinical Psychiatry", "publication_date": "2026-05-11", "publication_year": 2026, "doi": "10.4088/jcp.26m16338", "pubmed_id": "42138588", "openalex_id": "https://openalex.org/W7160906477", "source_url": "https://doi.org/10.4088/jcp.26m16338", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42138588", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.4088/jcp.26m16338", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42138588", "source_url": "https://doi.org/10.4088/jcp.26m16338", "doi": "10.4088/jcp.26m16338", "pmid": "42138588", "publication_date": "2026-05-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3022, "title": "Safety and Efficacy of Psilocybin in the Management of Treatment-Resistant Depression: A Systematic Review", "authors": "Walters CK, Chetty S, Rants’o TA, Gossayn S, Lerotholi LJ.", "journal": "Research Square", "publication_date": "2026-05-10", "publication_year": 2026, "doi": "10.21203/rs.3.rs-9283280/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-9283280/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Clinical Trial,Systematic Review,Review Article,Observational Study,Treatment-Resistant Depression,Safety,Adverse Events,Toxicity", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:45", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-9283280/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-9283280/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-9283280/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-9283280/v1", "doi": "10.21203/rs.3.rs-9283280/v1", "pmid": "", "publication_date": "2026-05-10", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4019, "title": "From Trials to Clinics: Considerations for Implementing Psychedelic-Assisted Therapy Into Clinical Practice", "authors": "Jessie Kim, Liam Lochhead, Cory R. Weissman", "journal": "Pharmacology Research & Perspectives", "publication_date": "2026-05-09", "publication_year": 2026, "doi": "10.1002/prp2.70262", "pubmed_id": "42108552", "openalex_id": "https://openalex.org/W7160830727", "source_url": "https://doi.org/10.1002/prp2.70262", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Mystical Experience,Clinical Trial,Review Article,Treatment-Resistant Depression,Healthcare Workers,Safety,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42108552", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/prp2.70262", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42108552", "source_url": "https://doi.org/10.1002/prp2.70262", "doi": "10.1002/prp2.70262", "pmid": "42108552", "publication_date": "2026-05-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 70, "title": "Trials, trips, and tribulations: pathways for implementing psychedelic therapy in Ireland", "authors": "John R. Kelly, Christopher Sheridan, Patricia Iusan, Lisa Coakley, Lisa Burke, C. Brennan, Annie Annie MacDonald, Jo-Hanna Ivers, Dominic Trepel, Garrath Tormey, Martha Finnegan, Gareth W. Young, Andrew Harkin", "journal": "The International Journal of Neuropsychopharmacology", "publication_date": "2026-05-08", "publication_year": 2026, "doi": "10.1093/ijnp/pyag028", "pubmed_id": "42113605", "openalex_id": "https://openalex.org/W7160867854", "source_url": "https://doi.org/10.1093/ijnp/pyag028", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Mechanism of Action,Aging,Clinical Trial,Treatment-Resistant Depression,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42113605", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/ijnp/pyag028", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42113605", "source_url": "https://doi.org/10.1093/ijnp/pyag028", "doi": "10.1093/ijnp/pyag028", "pmid": "42113605", "publication_date": "2026-05-08", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3570, "title": "The Safety and Efficacy of Psilocybin Therapy Compared to Low-dose Control in Reducing Depressive Symptoms in Patients With COPD, ALS, MS, or APD.", "authors": "University Medical Center Groningen", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-07", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06782724", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Brain Imaging,Biomarkers,Spirituality,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06782724", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06782724", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06782724", "source_url": "https://clinicaltrials.gov/study/NCT06782724", "doi": "", "pmid": "", "publication_date": "2026-05-07", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3496, "title": "Does Psilocybin Require Psychedelic Effects to Treat Depression? A4-Week, Double-Blind, Proof-of-Concept Randomized Controlled Trial", "authors": "Centre for Addiction and Mental Health", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-06", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05710237", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Healthy Volunteers,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05710237", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05710237", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05710237", "source_url": "https://clinicaltrials.gov/study/NCT05710237", "doi": "", "pmid": "", "publication_date": "2026-05-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1947, "title": "Psilocybin-Assisted Therapy in Depressive Disorders: Efficacy, Safety, and Persistence of Clinical Effects - A Narrative Review", "authors": "Kinga Zachar, Maksymilian Sito, Filip Jurkowski, Łukasz Wójcik, Natalia Gawron, Hubert Tomasz Bojanowski, Aleksandra Dobracka, Zuzanna Marczak, Monika Jarowicz, Jędrzej Czmyr", "journal": "Journal of Education Health and Sport", "publication_date": "2026-05-06", "publication_year": 2026, "doi": "10.12775/jehs.2026.91.70672", "pubmed_id": null, "openalex_id": "https://openalex.org/W7160694792", "source_url": "https://doi.org/10.12775/jehs.2026.91.70672", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Headache / Migraine,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.12775/jehs.2026.91.70672", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.12775/jehs.2026.91.70672", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.12775/jehs.2026.91.70672", "source_url": "https://doi.org/10.12775/jehs.2026.91.70672", "doi": "10.12775/jehs.2026.91.70672", "pmid": "", "publication_date": "2026-05-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 127, "title": "Psilocybin in the Treatment of Cocaine Use Disorder", "authors": "Peter S. Hendricks, Sara Lappan, Richard C. Shelton, Adrienne C. Lahti, Karen L. Cropsey, Matthew W. Johnson, Melissa Bradley, Otto Simonsson, Lori L. Davis, Daniel H. Grossman, Cynthia E. Ortiz", "journal": "JAMA Network Open", "publication_date": "2026-05-06", "publication_year": 2026, "doi": "10.1001/jamanetworkopen.2026.11029", "pubmed_id": "42096204", "openalex_id": "https://openalex.org/W7160534089", "source_url": "https://doi.org/10.1001/jamanetworkopen.2026.11029", "substance_tags": "psilocybin", "topic_tags": "Addiction,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42096204", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1001/jamanetworkopen.2026.11029", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42096204", "source_url": "https://doi.org/10.1001/jamanetworkopen.2026.11029", "doi": "10.1001/jamanetworkopen.2026.11029", "pmid": "42096204", "publication_date": "2026-05-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3620, "title": "A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of up to Two Doses of Psilocybin for the Treatment of Major Depressive Disorder in Adults With Cancer", "authors": "Sunstone Medical", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-05", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05947383", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Observational Study,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05947383", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05947383", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05947383", "source_url": "https://clinicaltrials.gov/study/NCT05947383", "doi": "", "pmid": "", "publication_date": "2026-05-05", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3613, "title": "Induction Protocol for Psilocybin-Assisted Therapy in Treatment-Resistant Depression (TRD): A Pilot Study", "authors": "University of North Carolina, Chapel Hill", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-05", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06303739", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Observational Study,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06303739", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06303739", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06303739", "source_url": "https://clinicaltrials.gov/study/NCT06303739", "doi": "", "pmid": "", "publication_date": "2026-05-05", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3536, "title": "A Phase 2 Randomized Study Examining the Safety, Feasibility, and Effectiveness of Masking Psilocybin Therapy With General Anesthesia in Major Depressive Disorder", "authors": "Stanford University", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-05", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07479550", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Brain Imaging,Wellbeing,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07479550", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07479550", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07479550", "source_url": "https://clinicaltrials.gov/study/NCT07479550", "doi": "", "pmid": "", "publication_date": "2026-05-05", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3577, "title": "A One-Year Observational Follow-up Study of Participants With Major Depressive Disorder Following a Randomized, Double-Blind Single-Dose of Psilocybin or Niacin-Control", "authors": "Usona Institute", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-03", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04353921", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04353921", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04353921", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04353921", "source_url": "https://clinicaltrials.gov/study/NCT04353921", "doi": "", "pmid": "", "publication_date": "2026-05-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3559, "title": "A Phase 2 Sequential Dose-Finding Study of Preparation for Group Retreat Psilocybin Therapy for Healthcare Clinicians With Loss of Meaning in Their Work and Symptoms of Depression", "authors": "University of Washington", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-03", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07565909", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Observational Study,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07565909", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07565909", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07565909", "source_url": "https://clinicaltrials.gov/study/NCT07565909", "doi": "", "pmid": "", "publication_date": "2026-05-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 120, "title": "Prevalence and Reasons for Microdosing Cannabis, Psilocybin, LSD, and MDMA Among U.S. Adults", "authors": "Kevin H. Yang, Nora Satybaldiyeva, Wayne Kepner, Joseph Friedman, Siyuan Ping, Eric C. Leas", "journal": "American Journal of Preventive Medicine", "publication_date": "2026-05-03", "publication_year": 2026, "doi": "10.1016/j.amepre.2026.108381", "pubmed_id": "42092643", "openalex_id": "https://openalex.org/W7160017394", "source_url": "https://doi.org/10.1016/j.amepre.2026.108381", "substance_tags": "psilocybin", "topic_tags": "Microdosing,Clinical Trial,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42092643", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42092643", "source_url": "https://doi.org/10.1016/j.amepre.2026.108381", "doi": "10.1016/j.amepre.2026.108381", "pmid": "42092643", "publication_date": "2026-05-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3004, "title": "Sa1731 A PILOT STUDY OF OPEN-LABEL PSILOCYBIN-ASSISTED THERAPY IN TREATMENT-REFRACTORY IBS", "authors": "Erin Mauney, Juliana Zambrano, Jenna Clukey, Helen Burton-Murray, Michael Datko, Vitaly Napadow, Braden Kuo, Franklin King", "journal": "Gastrointestinal Endoscopy", "publication_date": "2026-04-30", "publication_year": 2026, "doi": "10.1016/s0016-5107(26)04363-4", "pubmed_id": null, "openalex_id": "https://openalex.org/W7160172090", "source_url": "https://doi.org/10.1016/s0016-5107(26)04363-4", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Inflammation", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 11:03:06", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.1016/s0016-5107(26)04363-4", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/s0016-5107(26)04363-4", "source_url": "https://doi.org/10.1016/s0016-5107(26)04363-4", "doi": "10.1016/s0016-5107(26)04363-4", "pmid": "", "publication_date": "2026-04-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1955, "title": "1080 Psilocybin Elicits Non-Linear Night to Night Changes in Sleep Spectral Power", "authors": "Matthew Reid, Eli Weisman, Luis Luna Martinez, William Coon, Frederick Barrett", "journal": "SLEEP", "publication_date": "2026-04-30", "publication_year": 2026, "doi": "10.1093/sleep/zsag091.1079", "pubmed_id": null, "openalex_id": "https://openalex.org/W7160609961", "source_url": "https://doi.org/10.1093/sleep/zsag091.1079", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Brain Imaging,Pharmacology,Consciousness,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.1093/sleep/zsag091.1079", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/sleep/zsag091.1079", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1093/sleep/zsag091.1079", "source_url": "https://doi.org/10.1093/sleep/zsag091.1079", "doi": "10.1093/sleep/zsag091.1079", "pmid": "", "publication_date": "2026-04-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1949, "title": "Role of Psychological support in sustaining Antidepressants effects in Psilocybin - Assisted Clinical", "authors": "Gyandev Gupta, Ravina Yadav", "journal": "JOURNAL OF ADVANCE AND FUTURE RESEARCH", "publication_date": "2026-04-30", "publication_year": 2026, "doi": "10.56975/jaafr.v4i5.509087", "pubmed_id": null, "openalex_id": "https://openalex.org/W7160185913", "source_url": "https://doi.org/10.56975/jaafr.v4i5.509087", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Pharmacology,Receptor Pharmacology,Aging,Emotional Processing,Clinical Trial,Animal Study,Treatment-Resistant Depression,Healthcare Workers,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.56975/jaafr.v4i5.509087", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.56975/jaafr.v4i5.509087", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.56975/jaafr.v4i5.509087", "source_url": "https://doi.org/10.56975/jaafr.v4i5.509087", "doi": "10.56975/jaafr.v4i5.509087", "pmid": "", "publication_date": "2026-04-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 114, "title": "Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial - CORRIGENDUM", "authors": "Zeina Beidas, Anya Ragnhildstveit, Adam Blackman, Thomas Anderson, Emily Fewster, Omer A. Syed, Valentyne Sobolenko, Ismail Kaan Kanca, Tatiana Son, Norman Farb, Rotem Petranker", "journal": "BJPsych Open", "publication_date": "2026-04-30", "publication_year": 2026, "doi": "10.1192/bjo.2026.12000", "pubmed_id": "42125778", "openalex_id": "https://openalex.org/W7161014612", "source_url": "https://doi.org/10.1192/bjo.2026.12000", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Pharmacology,Microdosing,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42125778", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42125778", "source_url": "https://doi.org/10.1192/bjo.2026.12000", "doi": "10.1192/bjo.2026.12000", "pmid": "42125778", "publication_date": "2026-04-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5709, "title": "Acute Cardiovascular Effects of Psilocybin: A Pooled Analysis of 14 Studies with Safety Recommendations", "authors": "Nayak SM, Sepeda ND, Dick MN, Tiwari P, Zahid Z, Sayalı C, Weiss BM, Yaden DB, Garcia-Romeu A, Barnett BS, Barrett FS.", "journal": "medRxiv", "publication_date": "2026-04-28", "publication_year": 2026, "doi": "10.64898/2026.04.28.26351625", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.64898/2026.04.28.26351625", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-11 19:28:11", "last_checked": "2026-07-11 19:28:11", "bibtex": null, "source_record_id": "DOI:10.64898/2026.04.28.26351625", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.64898/2026.04.28.26351625", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.64898/2026.04.28.26351625", "source_url": "https://doi.org/10.64898/2026.04.28.26351625", "doi": "10.64898/2026.04.28.26351625", "pmid": "", "publication_date": "2026-04-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3509, "title": "Lysergic Acid Diethylamide (LSD) in Palliative Care: a Randomised, Double-blind, Active-placebo Controlled Phase II Study (LPC-Study)", "authors": "University Hospital, Basel, Switzerland", "journal": "ClinicalTrials.gov", "publication_date": "2026-04-28", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05883540", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05883540", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05883540", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05883540", "source_url": "https://clinicaltrials.gov/study/NCT05883540", "doi": "", "pmid": "", "publication_date": "2026-04-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1962, "title": "356. Psilocybin Therapy is Associated With Decreases in Markers of Mitochondrial Stress and Inflammation in an Open-Label Clinical Trial of Parkinson’s Disease", "authors": "Ellen Bradley, D Parker Kelley, Martin Picard, Balazs Szigeti, Kimberly Sakai, Gisele Fernandes, Jill Ostrem, Caroline Tanner, Patrick Finley, Connie Ludwig, Katiah Llerena, Zach Busby, Amber McKernan, Jose Rafael Zuzuarregui, Meredith Bock, Aliss Wang, Andrew Penn, Josh Woolley, Aoife O'Donovan", "journal": "Biological Psychiatry", "publication_date": "2026-04-24", "publication_year": 2026, "doi": "10.1016/j.biopsych.2026.03.590", "pubmed_id": null, "openalex_id": "https://openalex.org/W7155621718", "source_url": "https://doi.org/10.1016/j.biopsych.2026.03.590", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Pharmacology,Biomarkers,Mitochondrial Function,Clinical Trial,Inflammation", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.1016/j.biopsych.2026.03.590", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.biopsych.2026.03.590", "source_url": "https://doi.org/10.1016/j.biopsych.2026.03.590", "doi": "10.1016/j.biopsych.2026.03.590", "pmid": "", "publication_date": "2026-04-24", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 35, "title": "Serotonergic psychedelics for Autism spectrum disorder: Neurobiological mechanisms and translational prospects.", "authors": "Low ZXB.", "journal": null, "publication_date": "2026-04-22", "publication_year": 2026, "doi": "10.1016/j.pnpbp.2026.111717", "pubmed_id": "42034276", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.pnpbp.2026.111717", "substance_tags": "psilocybin", "topic_tags": "Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Animal Study,Safety,Inflammation,Immune Function", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:42034276", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.pnpbp.2026.111717", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42034276", "source_url": "https://doi.org/10.1016/j.pnpbp.2026.111717", "doi": "10.1016/j.pnpbp.2026.111717", "pmid": "42034276", "publication_date": "2026-04-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3658, "title": "Psilocybin-Enhanced Psychotherapy for Methamphetamine Use Disorder", "authors": "Portland VA Research Foundation, Inc", "journal": "ClinicalTrials.gov", "publication_date": "2026-04-21", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04982796", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04982796", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04982796", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04982796", "source_url": "https://clinicaltrials.gov/study/NCT04982796", "doi": "", "pmid": "", "publication_date": "2026-04-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3567, "title": "Toward Patient-Tailored Care for Treatment-Resistant Depression: A Pilot Patient-Preference Clinical Trial of Music and Mindfulness in Psilocybin-Assisted Psychotherapy", "authors": "Kyle Greenway", "journal": "ClinicalTrials.gov", "publication_date": "2026-04-21", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07373535", "substance_tags": "psilocybin", "topic_tags": "Depression,Wellbeing,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07373535", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07373535", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07373535", "source_url": "https://clinicaltrials.gov/study/NCT07373535", "doi": "", "pmid": "", "publication_date": "2026-04-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1968, "title": "Psilocybin as an alternative to conventional treatments: A systematic review", "authors": "Deivid Antonio Cahuasqui-Mendoza", "journal": "Gaceta Médica de Caracas", "publication_date": "2026-04-21", "publication_year": 2026, "doi": "10.47307/gmc.2026.134.s2.32", "pubmed_id": null, "openalex_id": "https://openalex.org/W7155199454", "source_url": "https://doi.org/10.47307/gmc.2026.134.s2.32", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Neuroplasticity,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.47307/gmc.2026.134.s2.32", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.47307/gmc.2026.134.s2.32", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.47307/gmc.2026.134.s2.32", "source_url": "https://doi.org/10.47307/gmc.2026.134.s2.32", "doi": "10.47307/gmc.2026.134.s2.32", "pmid": "", "publication_date": "2026-04-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3436, "title": "Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence in Patients Diagnosed With Early-stage Breast Cancer and Ovarian Cancer in Remission", "authors": "University of Colorado, Denver", "journal": "ClinicalTrials.gov", "publication_date": "2026-04-20", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06430541", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06430541", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06430541", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06430541", "source_url": "https://clinicaltrials.gov/study/NCT06430541", "doi": "", "pmid": "", "publication_date": "2026-04-20", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2978, "title": "The efficacy and safety of psilocybin-assisted therapy for major depressive disorder: a meta-analytic review of clinical outcomes", "authors": "Mohsen Khosravi, Domenico De Berardis, Massimo Tusconi", "journal": "Mental Wellness", "publication_date": "2026-04-20", "publication_year": 2026, "doi": "10.4081/mw.2026.40", "pubmed_id": null, "openalex_id": "https://openalex.org/W7155066504", "source_url": "https://doi.org/10.4081/mw.2026.40", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Observational Study,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:55:42", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.4081/mw.2026.40", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.4081/mw.2026.40", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.4081/mw.2026.40", "source_url": "https://doi.org/10.4081/mw.2026.40", "doi": "10.4081/mw.2026.40", "pmid": "", "publication_date": "2026-04-20", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2977, "title": "Efficacy and Safety of Psilocybin-Assisted Therapy for Depression: A Meta-Analysis of Randomised Controlled Trials", "authors": "Siti Nashria Rusdhy, Andrian Fajar Kusumadewi, Carla Raymondalexas Marchira, Mustika Suci Mahardikaningrum, Teresa Lalita Wiryarini, Devira Ayu Wulandari", "journal": "Open Access Indonesian Journal of Medical Reviews", "publication_date": "2026-04-20", "publication_year": 2026, "doi": "10.37275/oaijmr.v6i2.883", "pubmed_id": null, "openalex_id": "https://openalex.org/W7155091271", "source_url": "https://doi.org/10.37275/oaijmr.v6i2.883", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:55:42", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.37275/oaijmr.v6i2.883", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.37275/oaijmr.v6i2.883", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.37275/oaijmr.v6i2.883", "source_url": "https://doi.org/10.37275/oaijmr.v6i2.883", "doi": "10.37275/oaijmr.v6i2.883", "pmid": "", "publication_date": "2026-04-20", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5711, "title": "Sustained Effects of Low-to-Moderate Doses of Psilocybin on Brain Connectivity", "authors": "Bhagavan C, Dandash O, Carter O, Bryson A, Kanaan RA.", "journal": "medRxiv", "publication_date": "2026-04-18", "publication_year": 2026, "doi": "10.64898/2026.04.17.26351147", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.64898/2026.04.17.26351147", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Consciousness,Aging,Clinical Trial,Review Article,Observational Study,Healthy Volunteers", "study_type": "Clinical Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-11 19:28:11", "last_checked": "2026-07-11 19:28:11", "bibtex": null, "source_record_id": "DOI:10.64898/2026.04.17.26351147", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.64898/2026.04.17.26351147", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.64898/2026.04.17.26351147", "source_url": "https://doi.org/10.64898/2026.04.17.26351147", "doi": "10.64898/2026.04.17.26351147", "pmid": "", "publication_date": "2026-04-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 168, "title": "Psychedelics and Autism Therapy: A Review of Current Research and Future Directions", "authors": "Christopher S. Gondi, Manu Gnanamony, Tarun P. Gondi, Lilyt Nersesyan, Lusine Demirkhanyan", "journal": "Current Issues in Molecular Biology", "publication_date": "2026-04-17", "publication_year": 2026, "doi": "10.3390/cimb48040417", "pubmed_id": "42042077", "openalex_id": "https://openalex.org/W7154992046", "source_url": "https://doi.org/10.3390/cimb48040417", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Chronic Pain,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Consciousness,Emotional Processing,Psychological Flexibility,Clinical Trial,Review Article,Treatment-Resistant Depression,Toxicity,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42042077", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/cimb48040417", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42042077", "source_url": "https://doi.org/10.3390/cimb48040417", "doi": "10.3390/cimb48040417", "pmid": "42042077", "publication_date": "2026-04-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3117, "title": "Psilocybin’s Kinematic Effect on Manual Dexterity", "authors": "Klintefors P, Bhagavan C, Kanaan R, Bryson A, Berlowitz D, Attard Z, Carter O.", "journal": "Research Square", "publication_date": "2026-04-14", "publication_year": 2026, "doi": "10.21203/rs.3.rs-9291780/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-9291780/v1", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Review Article,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-9291780/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-9291780/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-9291780/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-9291780/v1", "doi": "10.21203/rs.3.rs-9291780/v1", "pmid": "", "publication_date": "2026-04-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 172, "title": "A phase 1 study of a second experience with Group Retreat Psilocybin Therapy for partial responders after a first experience", "authors": "Anthony L. Back, Bonnie A. McGregor, Leslie L. Thorn, Kalin Harvey, Dianna Blom, George Callan, John Guy, Sameet Kumar, Rob Hershberg, Melissa Layer, Jackie Levin, Susanna Myers, Juliana Perez, Kathy Salmonson, Peter Thompson, Joseph Whinney", "journal": "Frontiers in Public Health", "publication_date": "2026-04-13", "publication_year": 2026, "doi": "10.3389/fpubh.2026.1810904", "pubmed_id": "42058096", "openalex_id": "https://openalex.org/W7154396122", "source_url": "https://doi.org/10.3389/fpubh.2026.1810904", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Mystical Experience,Clinical Trial,Cancer Patients,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42058096", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpubh.2026.1810904", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42058096", "source_url": "https://doi.org/10.3389/fpubh.2026.1810904", "doi": "10.3389/fpubh.2026.1810904", "pmid": "42058096", "publication_date": "2026-04-13", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3578, "title": "CAPSI - Cancer Related Major Depression Treated With a Single Dose of Psilocybin: A Multicenter Randomized Placebo Controlled Double Blind Clinical Trial", "authors": "Section for Affective Disorders; Northern Stockholm Psychiatry", "journal": "ClinicalTrials.gov", "publication_date": "2026-04-12", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06319378", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06319378", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06319378", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06319378", "source_url": "https://clinicaltrials.gov/study/NCT06319378", "doi": "", "pmid": "", "publication_date": "2026-04-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1970, "title": "Psilocybin for Treatment of Prolonged Grief Disorder: An Open-Label Feasibility Study Protocol", "authors": "J. Morgan Penberthy, Fatma Wise, Nicholas P. Cherup, Evaline Mitchell, Madeline Burns, Oluwafunmilayo Akinlade, David Chung, Harshit Parmar, Jonathan Singer", "journal": "Psychoactives", "publication_date": "2026-04-12", "publication_year": 2026, "doi": "10.3390/psychoactives5020012", "pubmed_id": null, "openalex_id": "https://openalex.org/W7153973756", "source_url": "https://doi.org/10.3390/psychoactives5020012", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Brain Imaging,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.3390/psychoactives5020012", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/psychoactives5020012", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3390/psychoactives5020012", "source_url": "https://doi.org/10.3390/psychoactives5020012", "doi": "10.3390/psychoactives5020012", "pmid": "", "publication_date": "2026-04-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 178, "title": "Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depression", "authors": "Nikita Sanati Morel, Dea Siggaard Stenbaek, Johan Lundberg, Maria Beckman", "journal": "BMC Medical Education", "publication_date": "2026-04-07", "publication_year": 2026, "doi": "10.1186/s12909-026-09124-8", "pubmed_id": "41952163", "openalex_id": "https://openalex.org/W7151958593", "source_url": "https://doi.org/10.1186/s12909-026-09124-8", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41952163", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1186/s12909-026-09124-8", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41952163", "source_url": "https://doi.org/10.1186/s12909-026-09124-8", "doi": "10.1186/s12909-026-09124-8", "pmid": "41952163", "publication_date": "2026-04-07", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1971, "title": "A living systematic review, meta-analysis and open-data resource of randomized controlled trials of psilocybin treatment for symptoms of depression", "authors": "S. Parker Singleton, Brooke L. Sevchik, Analiese Lahey, Pim Cuijpers, Mathias Harrer, Megan T. Jones, Sandeep M. Nayak, Eric C. Strain, Simon Vandekar, Robert H. Dworkin, J. Cobb Scott, Theodore D. Satterthwaite", "journal": "Nature Mental Health", "publication_date": "2026-04-05", "publication_year": 2026, "doi": "10.1038/s44220-026-00630-8", "pubmed_id": null, "openalex_id": "https://openalex.org/W7151101131", "source_url": "https://doi.org/10.1038/s44220-026-00630-8", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.1038/s44220-026-00630-8", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1038/s44220-026-00630-8", "source_url": "https://doi.org/10.1038/s44220-026-00630-8", "doi": "10.1038/s44220-026-00630-8", "pmid": "", "publication_date": "2026-04-05", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3678, "title": "Role of Experience, Conscious Awareness, and Plasticity in Psilocybin's Behavioral Effects - Follow-Up Study (The RECAP 2 Study)", "authors": "University of Wisconsin, Madison", "journal": "ClinicalTrials.gov", "publication_date": "2026-04-02", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06692192", "substance_tags": "psilocybin", "topic_tags": "Neuroplasticity,Brain Imaging,Wellbeing,Emotional Processing,Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06692192", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06692192", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06692192", "source_url": "https://clinicaltrials.gov/study/NCT06692192", "doi": "", "pmid": "", "publication_date": "2026-04-02", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3542, "title": "Activating Neuroplasticity to ENHANCE the Perception Box Expanding Effects of Psilocybin", "authors": "University of Wisconsin, Madison", "journal": "ClinicalTrials.gov", "publication_date": "2026-04-02", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05866471", "substance_tags": "psilocybin", "topic_tags": "Neuroplasticity,Wellbeing,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05866471", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05866471", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05866471", "source_url": "https://clinicaltrials.gov/study/NCT05866471", "doi": "", "pmid": "", "publication_date": "2026-04-02", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3670, "title": "Acute Analgesic Effects of DMT on Experimentally Induced Acute Nociceptive Pain, Hyperalgesia and Allodynia in Healthy Participants", "authors": "University Hospital, Basel, Switzerland", "journal": "ClinicalTrials.gov", "publication_date": "2026-04-01", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06180759", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Headache / Migraine,Clinical Trial,Case Report,Healthy Volunteers", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06180759", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06180759", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06180759", "source_url": "https://clinicaltrials.gov/study/NCT06180759", "doi": "", "pmid": "", "publication_date": "2026-04-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1972, "title": "Therapeutic Potential of Psilocybin in Psychiatric Disorders: Mechanisms, Efficacy, and Clinical Implications", "authors": "Shakila Meshkat, Manish K. Jha, Venkat Bhat", "journal": "FOCUS The Journal of Lifelong Learning in Psychiatry", "publication_date": "2026-03-31", "publication_year": 2026, "doi": "10.1176/appi.focus.20250043", "pubmed_id": null, "openalex_id": "https://openalex.org/W7154344405", "source_url": "https://doi.org/10.1176/appi.focus.20250043", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Eating Disorders,End-of-Life Distress,Headache / Migraine,Neuroplasticity,Mechanism of Action,Aging,Emotional Processing,Clinical Trial,Review Article,Safety,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.1176/appi.focus.20250043", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.focus.20250043", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.focus.20250043", "source_url": "https://doi.org/10.1176/appi.focus.20250043", "doi": "10.1176/appi.focus.20250043", "pmid": "", "publication_date": "2026-03-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 188, "title": "Psychedelic Therapies for Comorbid Major Depressive Disorder and Chronic Pain: A Review of Putative Mechanisms of Action", "authors": "Jordana Kazdan, Karim S. Ladha, M. Ishrat Husain", "journal": "Pharmacology Research & Perspectives", "publication_date": "2026-03-31", "publication_year": 2026, "doi": "10.1002/prp2.70238", "pubmed_id": "41940853", "openalex_id": "https://openalex.org/W7150989008", "source_url": "https://doi.org/10.1002/prp2.70238", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Clinical Trial,Review Article,Toxicity,Inflammation", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41940853", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/prp2.70238", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41940853", "source_url": "https://doi.org/10.1002/prp2.70238", "doi": "10.1002/prp2.70238", "pmid": "41940853", "publication_date": "2026-03-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 185, "title": "An Open-Label Study of Single-Dose Psilocybin for Borderline Personality Disorder With Co-Occurring Major Depressive Disorder", "authors": "Jon E. Grant, Sophia Boutouis, Margaret O’Brien, Laurie Avila, Megha Neelapu, Dustin Ehsan", "journal": "Clinical Neuropharmacology", "publication_date": "2026-03-31", "publication_year": 2026, "doi": "10.1097/wnf.0000000000000683", "pubmed_id": "41973961", "openalex_id": "https://openalex.org/W7154114794", "source_url": "https://doi.org/10.1097/wnf.0000000000000683", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Personality Change,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41973961", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1097/wnf.0000000000000683", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41973961", "source_url": "https://doi.org/10.1097/wnf.0000000000000683", "doi": "10.1097/wnf.0000000000000683", "pmid": "41973961", "publication_date": "2026-03-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4054, "title": "Therapeutic Potential of Classical Psychedelics and NonHallucinogenic Psychoplastogens in Psychiatric Disorders", "authors": "Kenji Hashimoto, Feyza Arıcıoğlu, Mesut Çetin", "journal": "Psychiatry and Clinical Psychopharmacology", "publication_date": "2026-03-29", "publication_year": 2026, "doi": "10.65801/pcp.3512", "pubmed_id": null, "openalex_id": "https://openalex.org/W7143411647", "source_url": "https://doi.org/10.65801/pcp.3512", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Consciousness,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Review Article,Animal Study,Safety,Toxicity,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.65801/pcp.3512", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.65801/pcp.3512", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.65801/pcp.3512", "source_url": "https://doi.org/10.65801/pcp.3512", "doi": "10.65801/pcp.3512", "pmid": "", "publication_date": "2026-03-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3663, "title": "Engaging Mood Brain Circuits With Psilocybin: a Randomized Neuroimaging Trial in Depression", "authors": "Sunnybrook Health Sciences Centre", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-29", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06072898", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Aging,Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06072898", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06072898", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06072898", "source_url": "https://clinicaltrials.gov/study/NCT06072898", "doi": "", "pmid": "", "publication_date": "2026-03-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3478, "title": "Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use Disorder", "authors": "Indiana University", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-29", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07499583", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Brain Imaging,Default Mode Network,Mystical Experience,Clinical Trial,Treatment-Resistant Depression,Veterans,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07499583", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07499583", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07499583", "source_url": "https://clinicaltrials.gov/study/NCT07499583", "doi": "", "pmid": "", "publication_date": "2026-03-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2981, "title": "MedCheck: FDA Approves Novel Antipsychotic Milsaperidone; Designates Psilocybin Analogue as Breakthrough Therapy for Postpartum Depression, and More!", "authors": "Linda M. Richmond", "journal": "Psychiatric News", "publication_date": "2026-03-29", "publication_year": 2026, "doi": "10.1176/appi.pn.2026.04.4.3", "pubmed_id": null, "openalex_id": "https://openalex.org/W7143348770", "source_url": "https://doi.org/10.1176/appi.pn.2026.04.4.3", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:55:42", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2026.04.4.3", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2026.04.4.3", "source_url": "https://doi.org/10.1176/appi.pn.2026.04.4.3", "doi": "10.1176/appi.pn.2026.04.4.3", "pmid": "", "publication_date": "2026-03-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 81, "title": "Mapping cognitive-behavioral approach in psychedelic-assisted treatment: a systematic review across phases with classic and non-classic psychedelics", "authors": "Yves Martins Varela, Vagner Deuel de O Tavares, Luiza Macedo Delgado, Heitor Augusto Trindade de Faria, Lucas Queiroz Menezes, R. Z. H. Almeida, Pedro Moraes Dutra Agrícola, Bruna Santos de Carvalho, Bheatrix Bienemann, Marcelo Falchi-Carvalho, Patrícia Cavalcanti-Ribeiro, Fernanda Palhano-Fontes, Gisele Fernandes-Osterhold, Dráulio Barros de Araújo, Nicole Leite Galvão-Coelho", "journal": "European Archives of Psychiatry and Clinical Neuroscience", "publication_date": "2026-03-27", "publication_year": 2026, "doi": "10.1007/s00406-025-02188-5", "pubmed_id": "41902950", "openalex_id": "https://openalex.org/W7141898289", "source_url": "https://doi.org/10.1007/s00406-025-02188-5", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Clinical Trial,Systematic Review,Review Article,Toxicity", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 06:34:36", "bibtex": null, "source_record_id": "PMID:41902950", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41902950", "source_url": "https://doi.org/10.1007/s00406-025-02188-5", "doi": "10.1007/s00406-025-02188-5", "pmid": "41902950", "publication_date": "2026-03-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3696, "title": "Psilocybe Cubensis Mushrooms With or Without Fluoxetine for Refractory Depression", "authors": "Federal University of Latin American Integration", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-26", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06898606", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06898606", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06898606", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06898606", "source_url": "https://clinicaltrials.gov/study/NCT06898606", "doi": "", "pmid": "", "publication_date": "2026-03-26", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4057, "title": "Classic psychedelic medicines for adolescent refractory mental health disease", "authors": "Aly Shah Aziz", "journal": "Journal of Psychedelic Studies", "publication_date": "2026-03-25", "publication_year": 2026, "doi": "10.1556/2054.2026.00452", "pubmed_id": null, "openalex_id": "https://openalex.org/W7140928407", "source_url": "https://doi.org/10.1556/2054.2026.00452", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Observational Study,Adolescents,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2026.00452", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2026.00452", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2026.00452", "source_url": "https://doi.org/10.1556/2054.2026.00452", "doi": "10.1556/2054.2026.00452", "pmid": "", "publication_date": "2026-03-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3037, "title": "Safety and Efficacy of Psilocybin-Assisted Therapy for Alcohol Use Disorder: Open-Label Extension of a Phase II Randomized Controlled Trial", "authors": "", "journal": "PsyArXiv", "publication_date": "2026-03-25", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/7xfek_v1", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Randomized Controlled Trial,Observational Study,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/7xfek_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/7xfek_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/7xfek_v1", "source_url": "https://osf.io/preprints/psyarxiv/7xfek_v1", "doi": "", "pmid": "", "publication_date": "2026-03-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 214, "title": "Psilocybin in Neuropsychiatric Disorders: Seeking Valuable Evidence in History, Pure Science, Clinical Trials and Real-World Data (RWD)", "authors": "Piotr Skalski, Katarzyna Pękacka-Falkowska, Agnieszka Pluto-Prądzyńska, Michał K. Owecki", "journal": "Brain Sciences", "publication_date": "2026-03-25", "publication_year": 2026, "doi": "10.3390/brainsci16040358", "pubmed_id": "42041769", "openalex_id": "https://openalex.org/W7140611633", "source_url": "https://doi.org/10.3390/brainsci16040358", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42041769", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/brainsci16040358", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42041769", "source_url": "https://doi.org/10.3390/brainsci16040358", "doi": "10.3390/brainsci16040358", "pmid": "42041769", "publication_date": "2026-03-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3456, "title": "The QUANTUM Trip Trial - Psilocybin-assisted Therapy for Reducing Alcohol Intake in Patients With Alcohol Use Disorder: A Randomized, Double-blinded, Placebo-controlled Clinical Trial.", "authors": "Anders Fink-Jensen, MD, DMSci", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-23", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05416229", "substance_tags": "psilocybin,psilocin", "topic_tags": "Addiction,Brain Imaging,Biomarkers,Aging,Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05416229", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05416229", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05416229", "source_url": "https://clinicaltrials.gov/study/NCT05416229", "doi": "", "pmid": "", "publication_date": "2026-03-23", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3447, "title": "Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects: A Randomized, Open-Label, Cross-Over Functional Magnetic Resonance Imaging Trial", "authors": "Medical University of Vienna", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-23", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07490353", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Brain Imaging,Receptor Pharmacology,Aging,Wellbeing,Clinical Trial,Inflammation", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07490353", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07490353", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07490353", "source_url": "https://clinicaltrials.gov/study/NCT07490353", "doi": "", "pmid": "", "publication_date": "2026-03-23", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 217, "title": "Psilocybin: Chemical Foundations and Emerging Therapeutic Potential", "authors": "Shivaputra A. Patil, Holly C. Hunsberger", "journal": "Mini-Reviews in Medicinal Chemistry", "publication_date": "2026-03-23", "publication_year": 2026, "doi": "10.2174/0113895575429775260119043318", "pubmed_id": "41879500", "openalex_id": "https://openalex.org/W7140303704", "source_url": "https://doi.org/10.2174/0113895575429775260119043318", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Addiction,Neuroplasticity,Pharmacology,Receptor Pharmacology,Longevity,Clinical Trial,Review Article,Cancer Patients,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41879500", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.2174/0113895575429775260119043318", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41879500", "source_url": "https://doi.org/10.2174/0113895575429775260119043318", "doi": "10.2174/0113895575429775260119043318", "pmid": "41879500", "publication_date": "2026-03-23", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 186, "title": "Psychedelic-assisted pharmacotherapy: clinical applications and regulatory considerations", "authors": "Donatella Marazziti, Matteo Gambini, Riccardo Gurrieri, Gerardo Russomanno, Giorgia Sità, Elena Pescini, FRANCESCA RITA DIGIUSEPPE, Federico Mucci", "journal": "Expert Opinion on Pharmacotherapy", "publication_date": "2026-03-23", "publication_year": 2026, "doi": "10.1080/14656566.2026.2654682", "pubmed_id": "41944071", "openalex_id": "https://openalex.org/W7151630586", "source_url": "https://doi.org/10.1080/14656566.2026.2654682", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Mechanism of Action,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41944071", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/14656566.2026.2654682", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41944071", "source_url": "https://doi.org/10.1080/14656566.2026.2654682", "doi": "10.1080/14656566.2026.2654682", "pmid": "41944071", "publication_date": "2026-03-23", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 218, "title": "Editorial: Psychedelic-assisted psychotherapies: from clinical trials to credibility", "authors": "Malkanthi Evans, Andrew Charrette", "journal": "Frontiers in Neuroscience", "publication_date": "2026-03-22", "publication_year": 2026, "doi": "10.3389/fnins.2026.1816932", "pubmed_id": "41947857", "openalex_id": "https://openalex.org/W7140128776", "source_url": "https://doi.org/10.3389/fnins.2026.1816932", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Eating Disorders,Chronic Pain,Headache / Migraine,Neuroplasticity,Brain Imaging,Pharmacology,Mechanism of Action,Aging,Emotional Processing,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41947857", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fnins.2026.1816932", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41947857", "source_url": "https://doi.org/10.3389/fnins.2026.1816932", "doi": "10.3389/fnins.2026.1816932", "pmid": "41947857", "publication_date": "2026-03-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5, "title": "Psilocybin-assisted therapy for major depressive disorder: Perspective from meta-analysis", "authors": "Taro Kishi, Kenji Sakuma, Masakazu Hatano, Hiroyuki Uchida, Nakao Iwata", "journal": "Journal of Affective Disorders", "publication_date": "2026-03-21", "publication_year": 2026, "doi": "10.1016/j.jad.2026.121675", "pubmed_id": "41876058", "openalex_id": "https://openalex.org/W7140041737", "source_url": "https://doi.org/10.1016/j.jad.2026.121675", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41876058", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41876058", "source_url": "https://doi.org/10.1016/j.jad.2026.121675", "doi": "10.1016/j.jad.2026.121675", "pmid": "41876058", "publication_date": "2026-03-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3582, "title": "Psilocybin for Treatment-Resistant Depression in Autism: a Pilot Trial With Pre-Post Brain and Cognitive Measurement to Understand Mechanism", "authors": "Centre for Addiction and Mental Health", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-19", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06731621", "substance_tags": "psilocybin", "topic_tags": "Depression,Consciousness,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06731621", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06731621", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06731621", "source_url": "https://clinicaltrials.gov/study/NCT06731621", "doi": "", "pmid": "", "publication_date": "2026-03-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 131, "title": "Psychological support in psychedelic-assisted therapy clinical trials: A systematic review", "authors": "Bonnie Brusky, Katia M’Baïlara, François Alla, M. Barrault", "journal": "Journal of Psychopharmacology", "publication_date": "2026-03-19", "publication_year": 2026, "doi": "10.1177/02698811261424204", "pubmed_id": "41859988", "openalex_id": "https://openalex.org/W7139121355", "source_url": "https://doi.org/10.1177/02698811261424204", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Healthcare Workers,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41859988", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/02698811261424204", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41859988", "source_url": "https://doi.org/10.1177/02698811261424204", "doi": "10.1177/02698811261424204", "pmid": "41859988", "publication_date": "2026-03-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1974, "title": "PSILOCYBIN AS AN ADJUNCTIVE TREATMENT FOR DEPRESSION AND PSYCHOLOGICAL DISTRESS IN ONCOLOGY: CURRENT EVIDENCE AND CLINICAL IMPLICATIONS", "authors": "Anna Komarczewska, Michał Kociński, Patryk Iglewski, Michał Pietrasz, Jakub Idziński, Anna Lubomska", "journal": "International Journal of Innovative Technologies in Social Science", "publication_date": "2026-03-18", "publication_year": 2026, "doi": "10.31435/ijitss.1(49).2026.5034", "pubmed_id": null, "openalex_id": "https://openalex.org/W7164003040", "source_url": "https://doi.org/10.31435/ijitss.1(49).2026.5034", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Neuroplasticity,Receptor Pharmacology,Wellbeing,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Case Report,Cancer Patients,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.31435/ijitss.1(49).2026.5034", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.31435/ijitss.1(49).2026.5034", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.31435/ijitss.1(49).2026.5034", "source_url": "https://doi.org/10.31435/ijitss.1(49).2026.5034", "doi": "10.31435/ijitss.1(49).2026.5034", "pmid": "", "publication_date": "2026-03-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3641, "title": "Safety and Efficacy of Psilocybin-assisted Psychotherapy for Demoralization Syndrome in Patients Diagnosed With Advanced Stage Cancer: a Pilot Study", "authors": "Gustavo Vazquez", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-17", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06818994", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Aging,Clinical Trial,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06818994", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06818994", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06818994", "source_url": "https://clinicaltrials.gov/study/NCT06818994", "doi": "", "pmid": "", "publication_date": "2026-03-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3540, "title": "Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression: A Pilot Randomized Clinical Trial", "authors": "Centre for Addiction and Mental Health", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-17", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07211438", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07211438", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07211438", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07211438", "source_url": "https://clinicaltrials.gov/study/NCT07211438", "doi": "", "pmid": "", "publication_date": "2026-03-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 133, "title": "Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression", "authors": "Lea J. Mertens, Michael Koslowski, Felix Betzler, Manuela Brand, Ricarda Evens, Laura Kärtner, Andrea Jungaberle, Henrik Jungaberle, Tomislav Majić, Christian N. Schmitz, Andreas Ströhle, Dennis Scharf, Moritz Spangemacher, Max Wolff, Zahra Assadi, Scharif Bahri, Lilith Becher, Luca V. Färber, Niklas Kirchen, Eugenia Kulakova, Linda C. Kunz, Andy Meijer, Barbara Rohrmoser, Stefan Wellek, Moritz Berger, Gerhard Gründer", "journal": "JAMA Psychiatry", "publication_date": "2026-03-17", "publication_year": 2026, "doi": "10.1001/jamapsychiatry.2026.0132", "pubmed_id": "41848690", "openalex_id": "https://openalex.org/W7138853109", "source_url": "https://doi.org/10.1001/jamapsychiatry.2026.0132", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41848690", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1001/jamapsychiatry.2026.0132", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41848690", "source_url": "https://doi.org/10.1001/jamapsychiatry.2026.0132", "doi": "10.1001/jamapsychiatry.2026.0132", "pmid": "41848690", "publication_date": "2026-03-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4064, "title": "Editorial: Psychedelic substances and neurological diseases: from basics to clinical application", "authors": "Alessandra Linardi, Ariadiny Lima Caetano, Rodrigo Portes Ureshino", "journal": "Frontiers in Pharmacology", "publication_date": "2026-03-15", "publication_year": 2026, "doi": "10.3389/fphar.2026.1816812", "pubmed_id": "41919223", "openalex_id": "https://openalex.org/W7136503554", "source_url": "https://doi.org/10.3389/fphar.2026.1816812", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Consciousness,Mitochondrial Function,Oxidative Stress,Wellbeing,Spirituality,Clinical Trial,Review Article,Animal Study,Toxicity,Proteomics,Inflammation", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-07-04 06:34:36", "bibtex": null, "source_record_id": "PMID:41919223", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fphar.2026.1816812", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41919223", "source_url": "https://doi.org/10.3389/fphar.2026.1816812", "doi": "10.3389/fphar.2026.1816812", "pmid": "41919223", "publication_date": "2026-03-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1976, "title": "Explainable AI framework for psilocybin depression treatment optimization", "authors": "Akey Sungheetha, R. Rajesh Sharma, Oluwasegun Julius Aroba, Sheila Mahapatra, P. D. Mahendhiran", "journal": "Frontiers in Computer Science", "publication_date": "2026-03-15", "publication_year": 2026, "doi": "10.3389/fcomp.2025.1652190", "pubmed_id": null, "openalex_id": "https://openalex.org/W7136253679", "source_url": "https://doi.org/10.3389/fcomp.2025.1652190", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Brain Imaging,Pharmacology,Receptor Pharmacology,Aging,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.3389/fcomp.2025.1652190", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fcomp.2025.1652190", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3389/fcomp.2025.1652190", "source_url": "https://doi.org/10.3389/fcomp.2025.1652190", "doi": "10.3389/fcomp.2025.1652190", "pmid": "", "publication_date": "2026-03-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 231, "title": "The renaissance of research on psychedelics in child and adolescent psychopharmacology", "authors": "Marc-Antoine Crocq, Philippe Auby", "journal": "Child and Adolescent Psychiatry and Mental Health", "publication_date": "2026-03-12", "publication_year": 2026, "doi": "10.1186/s13034-026-01069-6", "pubmed_id": "41826990", "openalex_id": "https://openalex.org/W7135184973", "source_url": "https://doi.org/10.1186/s13034-026-01069-6", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,OCD,Eating Disorders,Neuroplasticity,Pharmacology,Receptor Pharmacology,Clinical Trial,Review Article,Adolescents,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41826990", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1186/s13034-026-01069-6", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41826990", "source_url": "https://doi.org/10.1186/s13034-026-01069-6", "doi": "10.1186/s13034-026-01069-6", "pmid": "41826990", "publication_date": "2026-03-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 134, "title": "A randomized clinical trial of repeated doses of psilocybin for the treatment of obsessive-compulsive disorder", "authors": "Francisco A. Moreno, Katja Ehrmann Allen, Christopher B. Wiegand, Rajan Dunne, James I. Prickett, Brian Bayze, John J. B. Allen", "journal": "Journal of Psychopharmacology", "publication_date": "2026-03-12", "publication_year": 2026, "doi": "10.1177/02698811261424214", "pubmed_id": "41825921", "openalex_id": "https://openalex.org/W7135170485", "source_url": "https://doi.org/10.1177/02698811261424214", "substance_tags": "psilocybin", "topic_tags": "Anxiety,OCD,Chronic Pain,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41825921", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/02698811261424214", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41825921", "source_url": "https://doi.org/10.1177/02698811261424214", "doi": "10.1177/02698811261424214", "pmid": "41825921", "publication_date": "2026-03-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3473, "title": "Safety, Feasibility, and Tolerability of Psilocybin Treatment for Individuals With Functional Impairment Related to Mood, Anxiety, Trauma and/or Addiction Symptoms: An Open-label Proof-of-concept Study", "authors": "Yale University", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-10", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06442423", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Receptor Pharmacology,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06442423", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06442423", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06442423", "source_url": "https://clinicaltrials.gov/study/NCT06442423", "doi": "", "pmid": "", "publication_date": "2026-03-10", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3228, "title": "Age moderates the relationship between psychedelics use and mental health in naturalistic settings", "authors": "Gregorio GD, Basset S, Manmohan H, Nixon WC, Pogaku A, Zhou J, Sanderson DJ, Lengieza ML, Bocchio M.", "journal": "Research Square", "publication_date": "2026-03-09", "publication_year": 2026, "doi": "10.21203/rs.3.rs-9022170/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-9022170/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Aging,Longevity,Mystical Experience,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-9022170/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-9022170/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-9022170/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-9022170/v1", "doi": "10.21203/rs.3.rs-9022170/v1", "pmid": "", "publication_date": "2026-03-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1936, "title": "Impact of formulation variables on the quality attributes of psilocybin-loaded oral thin films for early-phase development", "authors": "Vorawut Wongumpornpinit, K Ingkaninan, Prapapan Temkitthawon, Neti Waranuch, Rhannanda Copetti Pivetta, Jieyu Zuo, Gabriel Lima Barros de Araújo, Nádia Bou-Chacra, Vijay Somayaji, Raimar Löebenberg", "journal": "Journal of Drug Delivery Science and Technology", "publication_date": "2026-03-09", "publication_year": 2026, "doi": "10.1016/j.jddst.2026.108228", "pubmed_id": null, "openalex_id": "https://openalex.org/W7134964970", "source_url": "https://doi.org/10.1016/j.jddst.2026.108228", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:49:23", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.1016/j.jddst.2026.108228", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.jddst.2026.108228", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.jddst.2026.108228", "source_url": "https://doi.org/10.1016/j.jddst.2026.108228", "doi": "10.1016/j.jddst.2026.108228", "pmid": "", "publication_date": "2026-03-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 242, "title": "Psilocybin or Nicotine Patch for Smoking Cessation", "authors": "MW Johnson, Gideon P. Naudé, Peter S. Hendricks, Albert Garcia-Romeu", "journal": "JAMA Network Open", "publication_date": "2026-03-09", "publication_year": 2026, "doi": "10.1001/jamanetworkopen.2026.0972", "pubmed_id": "41805956", "openalex_id": "https://openalex.org/W7134891055", "source_url": "https://doi.org/10.1001/jamanetworkopen.2026.0972", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Randomized Controlled Trial,Adverse Events,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41805956", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1001/jamanetworkopen.2026.0972", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41805956", "source_url": "https://doi.org/10.1001/jamanetworkopen.2026.0972", "doi": "10.1001/jamanetworkopen.2026.0972", "pmid": "41805956", "publication_date": "2026-03-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3654, "title": "An Open-Label, Phase 1 Study of the Safety Pharmacokinetic Profile, and Preliminary Efficacy, of Organic Whole Psilocybin-Containing Mushrooms in Patients Suffering From PTSD", "authors": "Suzanne \"Sue\" Sisley MD", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-08", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07275970", "substance_tags": "psilocybin", "topic_tags": "PTSD,Pharmacology,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07275970", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07275970", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07275970", "source_url": "https://clinicaltrials.gov/study/NCT07275970", "doi": "", "pmid": "", "publication_date": "2026-03-08", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3626, "title": "The Therapeutic Potential of Psilocybin in Anorexia Nervosa in Young Adults", "authors": "Region Skane", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-05", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07169747", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Eating Disorders,Neuroplasticity,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Biomarkers,Aging,Personality Change,Emotional Processing,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Review Article,Animal Study,Adolescents,Healthcare Workers,Safety,Adverse Events,Toxicity,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07169747", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07169747", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07169747", "source_url": "https://clinicaltrials.gov/study/NCT07169747", "doi": "", "pmid": "", "publication_date": "2026-03-05", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 240, "title": "Efficacy and risks of psychedelics in the treatment of posttraumatic stress disorder: A systematic review", "authors": "Jennifer E. Thomas, Anna Dellarole, Joshua Caballero", "journal": "American Journal of Health-System Pharmacy", "publication_date": "2026-03-03", "publication_year": 2026, "doi": "10.1093/ajhp/zxag062", "pubmed_id": "41784123", "openalex_id": "https://openalex.org/W7133953253", "source_url": "https://doi.org/10.1093/ajhp/zxag062", "substance_tags": "psilocybin", "topic_tags": "Anxiety,PTSD,Pharmacology,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Veterans,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41784123", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/ajhp/zxag062", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41784123", "source_url": "https://doi.org/10.1093/ajhp/zxag062", "doi": "10.1093/ajhp/zxag062", "pmid": "41784123", "publication_date": "2026-03-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3616, "title": "A Phase 2b Double-blind, Randomized, Low-dose Comparator-controlled Clinical Trial to Assess the Efficacy and Safety of NPX-5 in Psilocybin-assisted Psychotherapy for the Treatment of Adjustment Disorder Associated With Cancer.", "authors": "Psyence Australia Pty Ltd", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-02", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07072728", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07072728", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07072728", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07072728", "source_url": "https://clinicaltrials.gov/study/NCT07072728", "doi": "", "pmid": "", "publication_date": "2026-03-02", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 230, "title": "Differential Effects of Acute and Chronic Fluoxetine on Psychedelic-Induced Behavior in Mice: Implications for Clinical Trials", "authors": "Bo Jarrett Wood, M. Frances Vest, Catharine Carfagno, Kyla Rose Bartley, Papori Sharma, Adam L. Halberstadt, Bruce E. Blough, Kevin S. Murnane", "journal": "ACS Pharmacology & Translational Science", "publication_date": "2026-03-02", "publication_year": 2026, "doi": "10.1021/acsptsci.5c00484", "pubmed_id": "41852641", "openalex_id": "https://openalex.org/W7133349014", "source_url": "https://doi.org/10.1021/acsptsci.5c00484", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Animal Study,Toxicity,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41852641", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1021/acsptsci.5c00484", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41852641", "source_url": "https://doi.org/10.1021/acsptsci.5c00484", "doi": "10.1021/acsptsci.5c00484", "pmid": "41852641", "publication_date": "2026-03-02", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 226, "title": "Synthesis and Characterization of Psilocybin Metabolites and Deuterated Analogs", "authors": "Samuel E. Williamson, Elise K. Burkhartzmeyer, Michael T. Faley, Rachel Friedman Ohana, Ilia A. Guzei, Mike Valley, James J. Cali, Alexander M. Sherwood", "journal": "ACS Chemical Neuroscience", "publication_date": "2026-03-02", "publication_year": 2026, "doi": "10.1021/acschemneuro.5c00879", "pubmed_id": "41773421", "openalex_id": "https://openalex.org/W7133308154", "source_url": "https://doi.org/10.1021/acschemneuro.5c00879", "substance_tags": "psilocybin,psilocin", "topic_tags": "Pharmacology,Receptor Pharmacology,Clinical Trial,In Vitro Study,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41773421", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1021/acschemneuro.5c00879", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41773421", "source_url": "https://doi.org/10.1021/acschemneuro.5c00879", "doi": "10.1021/acschemneuro.5c00879", "pmid": "41773421", "publication_date": "2026-03-02", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4075, "title": "A scoping review of mystical-type experiences and mood symptom outcomes in psychedelic therapy clinical trials: comparing life-threatening disease and depressive populations", "authors": "Ana Deutsch, Luis E. Contreras, Sarah Kratina, Leah M. Mayo", "journal": "Therapeutic Advances in Psychopharmacology", "publication_date": "2026-02-28", "publication_year": 2026, "doi": "10.1177/20451253261433836", "pubmed_id": "41918771", "openalex_id": "https://openalex.org/W7141801946", "source_url": "https://doi.org/10.1177/20451253261433836", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Mechanism of Action,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Review Article,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-07-04 06:34:36", "bibtex": null, "source_record_id": "PMID:41918771", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/20451253261433836", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41918771", "source_url": "https://doi.org/10.1177/20451253261433836", "doi": "10.1177/20451253261433836", "pmid": "41918771", "publication_date": "2026-02-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 258, "title": "Meaning and Psychedelics in Palliative Care: A Narrative Review.", "authors": "Alexander WB, Hansen ED, Anderson BT, Zarrabi AJ, Rogers AH, Loewen G, Ficarro ZR, Alexander MH, Schaefer D, Case AA", "journal": "Journal of pain and symptom management", "publication_date": "2026-02-28", "publication_year": 2026, "doi": "10.1016/j.jpainsymman.2025.10.015", "pubmed_id": "41173063", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41173063/", "substance_tags": "psilocybin", "topic_tags": "End-of-Life Distress,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-01 11:20:35", "bibtex": null, "source_record_id": "PMID:41173063", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41173063/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41173063", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41173063/", "doi": "10.1016/j.jpainsymman.2025.10.015", "pmid": "41173063", "publication_date": "2026-02-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 232, "title": "Digital Intervention for Psychedelic Preparation (DIPP): protocol for a randomised controlled feasibility trial comparing meditation- and music-based programmes in healthy volunteers", "authors": "Rosalind McAlpine, Magdalena Jaglinska, Krisztina Jedlovszky, Joanna Kuc, Ariel Castro, Alexandre Piot, Christopher Timmermann, Jeremy I Skipper, Matthew D Sacchet, Sunjeev K. Kamboj", "journal": "BMJ Open", "publication_date": "2026-02-28", "publication_year": 2026, "doi": "10.1136/bmjopen-2025-107512", "pubmed_id": "41819589", "openalex_id": "https://openalex.org/W7135149935", "source_url": "https://doi.org/10.1136/bmjopen-2025-107512", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Chronic Pain,Brain Imaging,Aging,Wellbeing,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Review Article,Healthy Volunteers,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41819589", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1136/bmjopen-2025-107512", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41819589", "source_url": "https://doi.org/10.1136/bmjopen-2025-107512", "doi": "10.1136/bmjopen-2025-107512", "pmid": "41819589", "publication_date": "2026-02-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4076, "title": "Psilocybin-assisted therapy for major depressive disorder: implications for clinical effectiveness, health economics, and regulatory decision-making", "authors": "C Faria, Diana Dias da Silva, João José Sousa", "journal": "Instituto Politécnico do Porto", "publication_date": "2026-02-26", "publication_year": 2026, "doi": "10.26537/prpaeh.v4i3.7173", "pubmed_id": null, "openalex_id": "https://openalex.org/W7166641777", "source_url": "https://doi.org/10.26537/prpaeh.v4i3.7173", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.26537/prpaeh.v4i3.7173", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.26537/prpaeh.v4i3.7173", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.26537/prpaeh.v4i3.7173", "source_url": "https://doi.org/10.26537/prpaeh.v4i3.7173", "doi": "10.26537/prpaeh.v4i3.7173", "pmid": "", "publication_date": "2026-02-26", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 260, "title": "Psychedelic therapy and cultural humility", "authors": "Alex Gearin, Jennifer Docherty, Xiaofan Sun, Emmanuel Hei-Lok Cheung, Peter Tanuseputro", "journal": "Translational Psychiatry", "publication_date": "2026-02-26", "publication_year": 2026, "doi": "10.1038/s41398-026-03913-x", "pubmed_id": "41748534", "openalex_id": "https://openalex.org/W7131675232", "source_url": "https://doi.org/10.1038/s41398-026-03913-x", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Pharmacology,Spirituality,Clinical Trial,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41748534", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41398-026-03913-x", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41748534", "source_url": "https://doi.org/10.1038/s41398-026-03913-x", "doi": "10.1038/s41398-026-03913-x", "pmid": "41748534", "publication_date": "2026-02-26", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1980, "title": "MedCheck: FDA Reviews NDA for Narcolepsy Drug, Green-Lights Psilocybin Trial for PTSD, and More", "authors": "Linda M. Richmond", "journal": "Psychiatric News", "publication_date": "2026-02-25", "publication_year": 2026, "doi": "10.1176/appi.pn.2026.03.3.5", "pubmed_id": null, "openalex_id": "https://openalex.org/W7131652481", "source_url": "https://doi.org/10.1176/appi.pn.2026.03.3.5", "substance_tags": "psilocybin", "topic_tags": "PTSD,Chronic Pain,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2026.03.3.5", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2026.03.3.5", "source_url": "https://doi.org/10.1176/appi.pn.2026.03.3.5", "doi": "10.1176/appi.pn.2026.03.3.5", "pmid": "", "publication_date": "2026-02-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 83, "title": "Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulations", "authors": "Kengo Yonezawa, M. Hirata, Hiroaki Takano, Keisuke Kusudo, Sota Tomiyama, Lisa Harada, Kota Suzuki, DJ Nutt, H. Uchida, Hideaki Tani", "journal": "Psychiatry and Clinical Neurosciences", "publication_date": "2026-02-25", "publication_year": 2026, "doi": "10.1111/pcn.70042", "pubmed_id": "41749057", "openalex_id": "https://openalex.org/W7131868995", "source_url": "https://doi.org/10.1111/pcn.70042", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,OCD,End-of-Life Distress,Chronic Pain,Brain Imaging,Aging,Spirituality,Clinical Trial,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41749057", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/pcn.70042", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41749057", "source_url": "https://doi.org/10.1111/pcn.70042", "doi": "10.1111/pcn.70042", "pmid": "41749057", "publication_date": "2026-02-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3608, "title": "Does Psilocybin Change Synaptic Density in the Brains of Patients With Amnestic Mild Cognitive Impairment", "authors": "Centre for Addiction and Mental Health", "journal": "ClinicalTrials.gov", "publication_date": "2026-02-24", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06041152", "substance_tags": "psilocybin", "topic_tags": "Neuroplasticity,Brain Imaging,Clinical Trial,Healthy Volunteers", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06041152", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06041152", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06041152", "source_url": "https://clinicaltrials.gov/study/NCT06041152", "doi": "", "pmid": "", "publication_date": "2026-02-24", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 263, "title": "Pilot study of psilocybin in patients with post-treatment lyme disease", "authors": "Albert Garcia-Romeu, Gideon P. Naudé, Alison W. Rebman, Sara So, Abigail Yaffe, Ian Geithner, Erica A. Kozero, Ting Yang, Mark J. Soloski, John N. Aucott", "journal": "Scientific Reports", "publication_date": "2026-02-24", "publication_year": 2026, "doi": "10.1038/s41598-026-38091-9", "pubmed_id": "41741501", "openalex_id": "https://openalex.org/W7131357000", "source_url": "https://doi.org/10.1038/s41598-026-38091-9", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Headache / Migraine,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Adverse Events,Inflammation", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41741501", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41598-026-38091-9", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41741501", "source_url": "https://doi.org/10.1038/s41598-026-38091-9", "doi": "10.1038/s41598-026-38091-9", "pmid": "41741501", "publication_date": "2026-02-24", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 244, "title": "Efficacy and Safety of Psychoactive Tryptamines in Addiction: A Systematic Review.", "authors": "van der Meer PB, Schukking N, Dik M, van Reemst A, Fuentes JJ, Kaptein AA, Schoones JW, Verboeket S, de Waal MM, Goudriaan AE, Kramers C, Schellekens A, Bossong MG, Somers M, Batalla A.", "journal": null, "publication_date": "2026-02-23", "publication_year": 2026, "doi": "10.1177/28314425251364182", "pubmed_id": "42130778", "openalex_id": null, "source_url": "https://doi.org/10.1177/28314425251364182", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:42130778", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/28314425251364182", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42130778", "source_url": "https://doi.org/10.1177/28314425251364182", "doi": "10.1177/28314425251364182", "pmid": "42130778", "publication_date": "2026-02-23", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3675, "title": "Inpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder: a Randomized Double-blind Trial", "authors": "Johns Hopkins University", "journal": "ClinicalTrials.gov", "publication_date": "2026-02-22", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06005662", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Healthy Volunteers,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06005662", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06005662", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06005662", "source_url": "https://clinicaltrials.gov/study/NCT06005662", "doi": "", "pmid": "", "publication_date": "2026-02-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3032, "title": "Safety and Efficacy of Microdosing Psilocybin over 8 Weeks for Major Depressive Disorder: A Randomized Clinical Trial", "authors": "Petranker R, Farb N, Syed O, Li E, Shore D, Anderson T, Blackman A.", "journal": "Research Square", "publication_date": "2026-02-22", "publication_year": 2026, "doi": "10.21203/rs.3.rs-8319478/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-8319478/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Microdosing,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-8319478/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-8319478/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-8319478/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-8319478/v1", "doi": "10.21203/rs.3.rs-8319478/v1", "pmid": "", "publication_date": "2026-02-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 264, "title": "Psychedelic medicine: mechanisms, evidence, and translation to practice", "authors": "Edward Jacobs, Zarmeen Zahid, Jared T. Hinkle, Sandeep M. Nayak, David B Yaden", "journal": "BMJ", "publication_date": "2026-02-22", "publication_year": 2026, "doi": "10.1136/bmj-2024-081723", "pubmed_id": "41730563", "openalex_id": "https://openalex.org/W7131088236", "source_url": "https://doi.org/10.1136/bmj-2024-081723", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Mechanism of Action,Emotional Processing,Psychological Flexibility,Clinical Trial,Review Article,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41730563", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1136/bmj-2024-081723", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41730563", "source_url": "https://doi.org/10.1136/bmj-2024-081723", "doi": "10.1136/bmj-2024-081723", "pmid": "41730563", "publication_date": "2026-02-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3182, "title": "Ethical Complexities and Best Practices in Informed Consent for Psychedelic Services: A Qualitative Study on Expert Perspectives", "authors": "", "journal": "PsyArXiv", "publication_date": "2026-02-18", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/mdz73_v2", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/mdz73_v2", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/mdz73_v2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/mdz73_v2", "source_url": "https://osf.io/preprints/psyarxiv/mdz73_v2", "doi": "", "pmid": "", "publication_date": "2026-02-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1982, "title": "Effects of Psilocybin and Select Pharmaceutical Interactions", "authors": "Jordan McDowell, Jada Middleton, Alanna Bluett, Alisa Kozachenko, Bayan Attar, Yuvraj Singh Saini, Jennifer Burke, Cayden McPhee, Mutahera Mutahera, Talya Ahmed, Nabila Ibrahim, Gilbert Atukwatsibwe, Sulabha Adhikari, Mohammad Esmaili, Jean-Vital Yambayamba", "journal": "MacEwan University Student eJournal", "publication_date": "2026-02-17", "publication_year": 2026, "doi": "10.31542/bcek6t76", "pubmed_id": null, "openalex_id": "https://openalex.org/W7130340064", "source_url": "https://doi.org/10.31542/bcek6t76", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Receptor Pharmacology,Aging,Clinical Trial,Older Adults,Toxicity,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.31542/bcek6t76", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.31542/bcek6t76", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.31542/bcek6t76", "source_url": "https://doi.org/10.31542/bcek6t76", "doi": "10.31542/bcek6t76", "pmid": "", "publication_date": "2026-02-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4900, "title": "Sense-Making Around Psilocybin in UK Women Experiencing Cancer-Related Existential Distress: An Interpretative Phenomenological Analysis", "authors": "Zaynab Khan, Sterre Weaver, Rachael V. Dando, Anne Katrin Schlag, Joanna C. Neill, Verity Wainwright", "journal": "Qualitative Health Research", "publication_date": "2026-02-16", "publication_year": 2026, "doi": "10.1177/10497323261419338", "pubmed_id": "41700878", "openalex_id": "https://openalex.org/W7129539813", "source_url": "https://doi.org/10.1177/10497323261419338", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Aging,Clinical Trial,Cancer Patients", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:51", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41700878", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/10497323261419338", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41700878", "source_url": "https://doi.org/10.1177/10497323261419338", "doi": "10.1177/10497323261419338", "pmid": "41700878", "publication_date": "2026-02-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3113, "title": "Mindfulness-Based Psilocybin-Assisted Therapy (MB-PAT) for cancer-related demoralization in Canada: the case for a hybrid group-based delivery model", "authors": "", "journal": "PsyArXiv", "publication_date": "2026-02-16", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/yrgkf_v1", "substance_tags": "psilocybin", "topic_tags": "End-of-Life Distress,Mechanism of Action,Aging,Clinical Trial,Cancer Patients", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/yrgkf_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/yrgkf_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/yrgkf_v1", "source_url": "https://osf.io/preprints/psyarxiv/yrgkf_v1", "doi": "", "pmid": "", "publication_date": "2026-02-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 269, "title": "Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial", "authors": "Zeina Beidas, Anya Ragnhildstveit, Adam Blackman, Thomas Anderson, Emily C. Fewster, Omer A. Syed, Valentyne Sobolenko, Ismail Kaan Kanca, Magdalena Jaglinska, Tatiana Son, Norman Farb, Rotem Petranker", "journal": "BJPsych Open", "publication_date": "2026-02-15", "publication_year": 2026, "doi": "10.1192/bjo.2025.10968", "pubmed_id": "41693474", "openalex_id": "https://openalex.org/W7129015437", "source_url": "https://doi.org/10.1192/bjo.2025.10968", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Pharmacology,Microdosing,Wellbeing,Creativity,Clinical Trial,Randomized Controlled Trial,Review Article,Observational Study,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41693474", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1192/bjo.2025.10968", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41693474", "source_url": "https://doi.org/10.1192/bjo.2025.10968", "doi": "10.1192/bjo.2025.10968", "pmid": "41693474", "publication_date": "2026-02-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 47, "title": "Psilocybin-assisted cognitive behavioral therapy for major depressive disorder: A pilot trial", "authors": "Marc J. Weintraub, Jessica Jeffrey, Megan Ichinose, R. Lindsey Bergman, Benjamin Shapiro, Gregory Barnett, Hewa Artin, Marc Lynn, Anabel Salimian, Shelby Grody, Rahul Ramesh, Lauren Eales, Charles S. Grob, David J. Miklowitz", "journal": "Journal of Affective Disorders", "publication_date": "2026-02-15", "publication_year": 2026, "doi": "10.1016/j.jad.2026.121423", "pubmed_id": "41707717", "openalex_id": "https://openalex.org/W7129028447", "source_url": "https://doi.org/10.1016/j.jad.2026.121423", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41707717", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41707717", "source_url": "https://doi.org/10.1016/j.jad.2026.121423", "doi": "10.1016/j.jad.2026.121423", "pmid": "41707717", "publication_date": "2026-02-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3541, "title": "A Phase 1 Translational Study to Assess Brain Activity Using Functional Magnetic Resonance Imaging (fMRI) and to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of MLS101 (Psilocybin) in Healthy Volunteers", "authors": "MycoMedica Life Sciences PBC", "journal": "ClinicalTrials.gov", "publication_date": "2026-02-12", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07050368", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Brain Imaging,Pharmacology,Aging,Clinical Trial,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07050368", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07050368", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07050368", "source_url": "https://clinicaltrials.gov/study/NCT07050368", "doi": "", "pmid": "", "publication_date": "2026-02-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3425, "title": "Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability", "authors": "Johns Hopkins University", "journal": "ClinicalTrials.gov", "publication_date": "2026-02-12", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07053917", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Animal Study,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07053917", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07053917", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07053917", "source_url": "https://clinicaltrials.gov/study/NCT07053917", "doi": "", "pmid": "", "publication_date": "2026-02-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 137, "title": "Trip sitting or just sitting? Session facilitators substantially influence psychedelic experiences in clinical trials but not in healthy ones", "authors": "Sean P. Goldy, Nathan D. Sepeda, Samantha Hilbert, Bilal A. Bari, Albert Garcia-Romeu, Natalie Gukasyan, Frederick S. Barrett, David B. Yaden, Sandeep M. Nayak", "journal": "Psychiatry Research", "publication_date": "2026-02-12", "publication_year": 2026, "doi": "10.1016/j.psychres.2026.117010", "pubmed_id": "41747432", "openalex_id": "https://openalex.org/W7128814597", "source_url": "https://doi.org/10.1016/j.psychres.2026.117010", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 06:34:36", "bibtex": null, "source_record_id": "PMID:41747432", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41747432", "source_url": "https://doi.org/10.1016/j.psychres.2026.117010", "doi": "10.1016/j.psychres.2026.117010", "pmid": "41747432", "publication_date": "2026-02-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4084, "title": "Psilocybin and Animal Testing: Charting an End to the Use of Animals in Drug Development Research", "authors": "Amanda L. Elyse", "journal": "Digital Commons at University of Maryland Carey Law (University of Maryland Francis King Carey School of Law)", "publication_date": "2026-02-11", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7128760314", "source_url": "https://digitalcommons.law.umaryland.edu/cgi/viewcontent.cgi?article=1002&context=jhclp_online_issue", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Clinical Trial,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "https://digitalcommons.law.umaryland.edu/cgi/viewcontent.cgi?article=1002&context=jhclp_online_issue", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://digitalcommons.law.umaryland.edu/cgi/viewcontent.cgi?article=1002&context=jhclp_online_issue", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://digitalcommons.law.umaryland.edu/cgi/viewcontent.cgi?article=1002&context=jhclp_online_issue", "source_url": "https://digitalcommons.law.umaryland.edu/cgi/viewcontent.cgi?article=1002&context=jhclp_online_issue", "doi": "", "pmid": "", "publication_date": "2026-02-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4083, "title": "Development and assessment of a psychedelic-assisted therapy music playlist for clinical trials: Theory, intentionality, and metrics", "authors": "Rafael Lancelotta, Paul Nagib, Stacey B. Armstrong, Adam W. Levin, A. B. Davis", "journal": "Journal of Psychedelic Studies", "publication_date": "2026-02-11", "publication_year": 2026, "doi": "10.1556/2054.2026.00462", "pubmed_id": null, "openalex_id": "https://openalex.org/W7128677415", "source_url": "https://doi.org/10.1556/2054.2026.00462", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Emotional Processing,Clinical Trial,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2026.00462", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2026.00462", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2026.00462", "source_url": "https://doi.org/10.1556/2054.2026.00462", "doi": "10.1556/2054.2026.00462", "pmid": "", "publication_date": "2026-02-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3704, "title": "Single Dose Psilocybin for a Post-surgical Trauma Inpatient Population for Pain, Mood, and Opioid Use Disorder", "authors": "Trent Emerick", "journal": "ClinicalTrials.gov", "publication_date": "2026-02-11", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07406828", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Clinical Trial,Review Article,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07406828", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07406828", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07406828", "source_url": "https://clinicaltrials.gov/study/NCT07406828", "doi": "", "pmid": "", "publication_date": "2026-02-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3624, "title": "Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use Disorder: A Pilot Randomized Clinical Trial", "authors": "Centre for Addiction and Mental Health", "journal": "ClinicalTrials.gov", "publication_date": "2026-02-11", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07405606", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07405606", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07405606", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07405606", "source_url": "https://clinicaltrials.gov/study/NCT07405606", "doi": "", "pmid": "", "publication_date": "2026-02-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1983, "title": "Low-income group psilocybin assisted therapy for depression: An Oregon feasibility study", "authors": "Matthew Hicks, Olivia Hicks, Ryan Bradley, Heather Zwickey", "journal": "Journal of Psychedelic Studies", "publication_date": "2026-02-11", "publication_year": 2026, "doi": "10.1556/2054.2026.00485", "pubmed_id": null, "openalex_id": "https://openalex.org/W7128687864", "source_url": "https://doi.org/10.1556/2054.2026.00485", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Observational Study,Adverse Events,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2026.00485", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2026.00485", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2026.00485", "source_url": "https://doi.org/10.1556/2054.2026.00485", "doi": "10.1556/2054.2026.00485", "pmid": "", "publication_date": "2026-02-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 275, "title": "Time-Dependent Effects of Rapid-Acting Antidepressants in iPSC-Derived Neurons from Treatment-Resistant Depression and Healthy Volunteers", "authors": "Johnston J, Jones G, Peng S, Yuan P, Yavi M, Kadriu B, Henter I, Quintanilla B, Elkahloun AG, Moaddel R, Schulmann A, Akula N, Kvarta M, McMahon F, Zarate C.", "journal": "Research Square", "publication_date": "2026-02-11", "publication_year": 2026, "doi": "10.21203/rs.3.rs-8733841/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-8733841/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Clinical Trial,Healthy Volunteers,Treatment-Resistant Depression,Transcriptomics,Proteomics,Inflammation", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-8733841/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-8733841/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-8733841/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-8733841/v1", "doi": "10.21203/rs.3.rs-8733841/v1", "pmid": "", "publication_date": "2026-02-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 86, "title": "Therapeutic effects of psilocybin in major depressive disorder: a systematic review and meta-analysis exploring dose effects", "authors": "Ziping He, Yijie Wang, Jie Chen, Junzhe Cheng, Yuxin Feng, Shuliang Niu, J. Yan", "journal": "European Archives of Psychiatry and Clinical Neuroscience", "publication_date": "2026-02-11", "publication_year": 2026, "doi": "10.1007/s00406-025-02165-y", "pubmed_id": "41677823", "openalex_id": "https://openalex.org/W7128718542", "source_url": "https://doi.org/10.1007/s00406-025-02165-y", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Pharmacology,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41677823", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41677823", "source_url": "https://doi.org/10.1007/s00406-025-02165-y", "doi": "10.1007/s00406-025-02165-y", "pmid": "41677823", "publication_date": "2026-02-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 48, "title": "Examining the effects of psilocybin-assisted psychotherapy on anhedonia in treatment-resistant depression", "authors": "Erica Kaczmarek, Nelson B. Rodrigues, Noah Chisamore, Zoe Doyle, Shakila Meshkat, Marc G. Blainey, Ryan M. Brudner, Shaun Ali, Kayla M. Teopiz, Roger S. McIntyre, Joshua D. Rosenblat", "journal": "Journal of Affective Disorders", "publication_date": "2026-02-11", "publication_year": 2026, "doi": "10.1016/j.jad.2026.121385", "pubmed_id": "41690631", "openalex_id": "https://openalex.org/W7128743161", "source_url": "https://doi.org/10.1016/j.jad.2026.121385", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41690631", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.jad.2026.121385", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41690631", "source_url": "https://doi.org/10.1016/j.jad.2026.121385", "doi": "10.1016/j.jad.2026.121385", "pmid": "41690631", "publication_date": "2026-02-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 222, "title": "Psychedelics in functional disorders: A scoping review", "authors": "Chiranth Bhagavan, Olivia P. Carter, Alexander Bryson, Orwa Dandash, Richard Kanaan", "journal": "Progress in Neuro-Psychopharmacology and Biological Psychiatry", "publication_date": "2026-02-09", "publication_year": 2026, "doi": "10.1016/j.pnpbp.2026.111642", "pubmed_id": "41679377", "openalex_id": "https://openalex.org/W7128528342", "source_url": "https://doi.org/10.1016/j.pnpbp.2026.111642", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Randomized Controlled Trial,Review Article,Observational Study,Safety,Adverse Events,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41679377", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.pnpbp.2026.111642", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41679377", "source_url": "https://doi.org/10.1016/j.pnpbp.2026.111642", "doi": "10.1016/j.pnpbp.2026.111642", "pmid": "41679377", "publication_date": "2026-02-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3690, "title": "Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy Volunteers", "authors": "Hadassah Medical Organization", "journal": "ClinicalTrials.gov", "publication_date": "2026-02-04", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07079930", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Brain Imaging,Receptor Pharmacology,Consciousness,Biomarkers,Clinical Trial,Observational Study,Animal Study,Healthy Volunteers,Safety,Toxicity,Inflammation", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07079930", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07079930", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07079930", "source_url": "https://clinicaltrials.gov/study/NCT07079930", "doi": "", "pmid": "", "publication_date": "2026-02-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3550, "title": "A Phase 2a, Open-label, Pilot Study to Assess the Safety and Efficacy of Oral Psilocybin (TRP-8802) Administration in Concert With Psychotherapy Among Adult Patients With Irritable Bowel Syndrome: A Randomized Delayed Treatment Control Design", "authors": "TRYP Therapeutics", "journal": "ClinicalTrials.gov", "publication_date": "2026-02-04", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06206265", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Brain Imaging,Aging,Clinical Trial,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06206265", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06206265", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06206265", "source_url": "https://clinicaltrials.gov/study/NCT06206265", "doi": "", "pmid": "", "publication_date": "2026-02-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3486, "title": "Psilocybin AsSisted pSychotherapy for the treatmENt of Gambling disordER: a Pilot Study", "authors": "Nantes University Hospital", "journal": "ClinicalTrials.gov", "publication_date": "2026-02-04", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07391332", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07391332", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07391332", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07391332", "source_url": "https://clinicaltrials.gov/study/NCT07391332", "doi": "", "pmid": "", "publication_date": "2026-02-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 138, "title": "Challenges with clinical trial participants in studies with classical psychedelics: A position statement from the National Network of Depression Centers’ task group on psychedelics and related compounds", "authors": "Benjamin R. Lewis, M. Carrington Reid, Andrew M. Novick, Kevin Byrne, Mark J. Niciu, Gregory A. Fonzo, Thomas D. Meyer, David Feifel, Rif S. El-Mallakh, Jair Soares, Trisha Suppes, Frederick S. Barrett", "journal": "Journal of Psychopharmacology", "publication_date": "2026-02-04", "publication_year": 2026, "doi": "10.1177/02698811251413490", "pubmed_id": "41645048", "openalex_id": "https://openalex.org/W7128008256", "source_url": "https://doi.org/10.1177/02698811251413490", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Healthcare Workers,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41645048", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/02698811251413490", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41645048", "source_url": "https://doi.org/10.1177/02698811251413490", "doi": "10.1177/02698811251413490", "pmid": "41645048", "publication_date": "2026-02-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 280, "title": "Acute psilocin increased cortical activity in rat", "authors": "Junhong Liu, Y. Lynn Wang, Ke Xia, Jia-Bin Wu, Danhao Zheng, Aoling Cai, Haitao Yan, Ruibin Su", "journal": "Frontiers in Neuroscience", "publication_date": "2026-02-03", "publication_year": 2026, "doi": "10.3389/fnins.2026.1593703", "pubmed_id": "41716660", "openalex_id": "https://openalex.org/W7127681443", "source_url": "https://doi.org/10.3389/fnins.2026.1593703", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41716660", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fnins.2026.1593703", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41716660", "source_url": "https://doi.org/10.3389/fnins.2026.1593703", "doi": "10.3389/fnins.2026.1593703", "pmid": "41716660", "publication_date": "2026-02-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 307, "title": "Ketamine, Psychedelics, and Psychotherapy: Reframing, Redefining, Renaming Treatment Models.", "authors": "Swainson J, Brietzke E, Khullar A, McIntyre RS, Soares CN", "journal": "Canadian journal of psychiatry. Revue canadienne de psychiatrie", "publication_date": "2026-01-31", "publication_year": 2026, "doi": "10.1177/07067437251389090", "pubmed_id": "41148143", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41148143/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:20:35", "bibtex": null, "source_record_id": "PMID:41148143", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41148143/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41148143", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41148143/", "doi": "10.1177/07067437251389090", "pmid": "41148143", "publication_date": "2026-01-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 288, "title": "Participant Experiences of Therapeutic Touch in Psilocybin-Assisted Therapy", "authors": "Rachel Ham, John Gardner, Adrian Carter, Paul Liknaitzky", "journal": "Brain and Behavior", "publication_date": "2026-01-31", "publication_year": 2026, "doi": "10.1002/brb3.71262", "pubmed_id": "41699875", "openalex_id": "https://openalex.org/W7129297531", "source_url": "https://doi.org/10.1002/brb3.71262", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Emotional Processing,Clinical Trial,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41699875", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/brb3.71262", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41699875", "source_url": "https://doi.org/10.1002/brb3.71262", "doi": "10.1002/brb3.71262", "pmid": "41699875", "publication_date": "2026-01-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1988, "title": "Psilocybin-Induced Neuroplasticity and Sustained Antidepressant Effects", "authors": "Anna Maria Komarczewska, Filip Matusiak, Klaudia Brzoza, Michał Kociński, Patryk Iglewski, Michał Pietrasz", "journal": "Quality in Sport", "publication_date": "2026-01-30", "publication_year": 2026, "doi": "10.12775/qs.2026.51.68216", "pubmed_id": null, "openalex_id": "https://openalex.org/W7126403964", "source_url": "https://doi.org/10.12775/qs.2026.51.68216", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Neuroplasticity,Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Meta-Analysis,Review Article,Animal Study,Cancer Patients,Treatment-Resistant Depression,Toxicity", "study_type": "Meta-Analysis", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.12775/qs.2026.51.68216", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.12775/qs.2026.51.68216", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.12775/qs.2026.51.68216", "source_url": "https://doi.org/10.12775/qs.2026.51.68216", "doi": "10.12775/qs.2026.51.68216", "pmid": "", "publication_date": "2026-01-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 194, "title": "PSilocybin for psYCHological and existential distress in PALliative care (PSYCHED-PAL): A single arm unblinded clinical trial", "authors": "James Downar, Julie Lapenskie, Koby Anderson, Gaelle Parsons, Nadia Polskaia, Genevieve Lalumiere, Peter G. Lawlor", "journal": "Palliative Medicine", "publication_date": "2026-01-29", "publication_year": 2026, "doi": "10.1177/02692163261416269", "pubmed_id": "41617652", "openalex_id": "https://openalex.org/W7126258550", "source_url": "https://doi.org/10.1177/02692163261416269", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Microdosing,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41617652", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/02692163261416269", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41617652", "source_url": "https://doi.org/10.1177/02692163261416269", "doi": "10.1177/02692163261416269", "pmid": "41617652", "publication_date": "2026-01-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1989, "title": "PSILOCYBIN IN PSYCHIATRIC PRACTICE AND PSYCHEDELIC-ASSISTED THERAPY FOR TREATMENT-RESISTANT DEPRESSION", "authors": "Łukasz Deska, Cezary Kosmecki, Dawid Głaz, Natalia Kamińska, Wojciech Sołtys, Magdalena Stolarczyk, Maksymilian Głaz, Mateusz Stronczyński, Aleksandra Jagura-Sukiennik, Julia Wawerska", "journal": "International Journal of Innovative Technologies in Social Science", "publication_date": "2026-01-27", "publication_year": 2026, "doi": "10.31435/ijitss.1(49).2026.4711", "pubmed_id": null, "openalex_id": "https://openalex.org/W7125929049", "source_url": "https://doi.org/10.31435/ijitss.1(49).2026.4711", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Adverse Events,Toxicity", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.31435/ijitss.1(49).2026.4711", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.31435/ijitss.1(49).2026.4711", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.31435/ijitss.1(49).2026.4711", "source_url": "https://doi.org/10.31435/ijitss.1(49).2026.4711", "doi": "10.31435/ijitss.1(49).2026.4711", "pmid": "", "publication_date": "2026-01-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 315, "title": "High hopes? Precision psychedelic addiction medicine", "authors": "Rayyan Raja Zafar, Patrick Kleine, Danielle L. Kurtin, Matthew B. Wall, David Erritzoe", "journal": "Frontiers in Psychiatry", "publication_date": "2026-01-27", "publication_year": 2026, "doi": "10.3389/fpsyt.2025.1681795", "pubmed_id": "41684524", "openalex_id": "https://openalex.org/W7125975363", "source_url": "https://doi.org/10.3389/fpsyt.2025.1681795", "substance_tags": "psilocybin", "topic_tags": "Addiction,Neuroplasticity,Brain Imaging,Pharmacology,Biomarkers,Aging,Emotional Processing,Clinical Trial,Review Article,Cancer Patients,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41684524", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2025.1681795", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41684524", "source_url": "https://doi.org/10.3389/fpsyt.2025.1681795", "doi": "10.3389/fpsyt.2025.1681795", "pmid": "41684524", "publication_date": "2026-01-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 316, "title": "A Promise Without Panacea: Psychedelic-Assisted Therapies in Modern Psychiatry", "authors": "Mohsin Raza, Jasleen Kaur", "journal": "Cureus", "publication_date": "2026-01-26", "publication_year": 2026, "doi": "10.7759/cureus.102421", "pubmed_id": "41769492", "openalex_id": "https://openalex.org/W7125808618", "source_url": "https://doi.org/10.7759/cureus.102421", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Neuroplasticity,Emotional Processing,Clinical Trial,Treatment-Resistant Depression,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41769492", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.7759/cureus.102421", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41769492", "source_url": "https://doi.org/10.7759/cureus.102421", "doi": "10.7759/cureus.102421", "pmid": "41769492", "publication_date": "2026-01-26", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 223, "title": "Psilocybin-induced alterations in EEG power, connectivity and network dynamics in healthy subjects: Correlations with subjective experience and implications for therapeutic applications", "authors": "Cheng-Teng Ip, Sebastian Olbrich, Mateo de Bardeci, Anna Monn, Andres Ort, John W. Smallridge, Franz Vollenweider", "journal": "Progress in Neuro-Psychopharmacology and Biological Psychiatry", "publication_date": "2026-01-26", "publication_year": 2026, "doi": "10.1016/j.pnpbp.2026.111626", "pubmed_id": "41611012", "openalex_id": "https://openalex.org/W7125776842", "source_url": "https://doi.org/10.1016/j.pnpbp.2026.111626", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Default Mode Network,Consciousness,Biomarkers,Clinical Trial,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41611012", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.pnpbp.2026.111626", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41611012", "source_url": "https://doi.org/10.1016/j.pnpbp.2026.111626", "doi": "10.1016/j.pnpbp.2026.111626", "pmid": "41611012", "publication_date": "2026-01-26", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4101, "title": "Psychedelics in psychiatric treatment: a literature review", "authors": "Adam Wolski, Ewa Szplit, Mikołaj Franciszek Patalong, Roman Cemaga, Mateusz Kubicki, Przemysław Kołodziej, Natalia Bruska, Bartłomiej Błaszkowski, Andrii Bilyk, Katarzyna Więckowska", "journal": "Quality in Sport", "publication_date": "2026-01-25", "publication_year": 2026, "doi": "10.12775/qs.2026.50.68013", "pubmed_id": null, "openalex_id": "https://openalex.org/W7125801196", "source_url": "https://doi.org/10.12775/qs.2026.50.68013", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Mechanism of Action,Clinical Trial,Systematic Review,Review Article,Safety,Toxicity", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.12775/qs.2026.50.68013", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.12775/qs.2026.50.68013", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.12775/qs.2026.50.68013", "source_url": "https://doi.org/10.12775/qs.2026.50.68013", "doi": "10.12775/qs.2026.50.68013", "pmid": "", "publication_date": "2026-01-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4100, "title": "The therapeutic efficacy of psilocybin in major depressive disorder: A review of recent clinical and mechanistic evidence", "authors": "Fernando Mora López, Johynny Solís Solís, Ekaterina Daniela Hernández Baker, Olger Herrera Barboza, David Diaz Polo, Daniela Consumi Cordero", "journal": "Zenodo (CERN European Organization for Nuclear Research)", "publication_date": "2026-01-25", "publication_year": 2026, "doi": "10.5281/zenodo.18375715", "pubmed_id": null, "openalex_id": "https://openalex.org/W7125699554", "source_url": "https://doi.org/10.5281/zenodo.18375715", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Neuroplasticity,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Biomarkers,Aging,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Review Article,Treatment-Resistant Depression,Safety,Adverse Events,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.5281/zenodo.18375715", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5281/zenodo.18375715", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5281/zenodo.18375715", "source_url": "https://doi.org/10.5281/zenodo.18375715", "doi": "10.5281/zenodo.18375715", "pmid": "", "publication_date": "2026-01-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1991, "title": "The Evaluation of the Efficacy and Safety of the Use of Psilocybin in the Treatment of Adults with Treatment-Resistant Depression", "authors": "Rishika Scott, James Smith", "journal": "Emerging Minds Journal for Student Research", "publication_date": "2026-01-24", "publication_year": 2026, "doi": "10.59973/emjsr.317", "pubmed_id": null, "openalex_id": "https://openalex.org/W7125652025", "source_url": "https://doi.org/10.59973/emjsr.317", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Pharmacology,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.59973/emjsr.317", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.59973/emjsr.317", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.59973/emjsr.317", "source_url": "https://doi.org/10.59973/emjsr.317", "doi": "10.59973/emjsr.317", "pmid": "", "publication_date": "2026-01-24", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 195, "title": "Methodological moderators of psilocybin-assisted therapy in depression: A systematic review and meta-analysis", "authors": "Omer A. Syed, Benjamin Tsang, Sean M. Nestor, Nir Lipsman, Muhammad Ishrat Husain, Fahad Alam, Peter Giacobbe", "journal": "Neuroscience & Biobehavioral Reviews", "publication_date": "2026-01-23", "publication_year": 2026, "doi": "10.1016/j.neubiorev.2026.106573", "pubmed_id": "41587629", "openalex_id": "https://openalex.org/W7125613611", "source_url": "https://doi.org/10.1016/j.neubiorev.2026.106573", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Healthcare Workers", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41587629", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.neubiorev.2026.106573", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41587629", "source_url": "https://doi.org/10.1016/j.neubiorev.2026.106573", "doi": "10.1016/j.neubiorev.2026.106573", "pmid": "41587629", "publication_date": "2026-01-23", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3673, "title": "A Phase 2 Trial of Psilocybin as an Adjunctive Treatment for OUD Patients Who Continue to Use Illicit Opioids Despite Adherence to Methadone Treatment", "authors": "NYU Langone Health", "journal": "ClinicalTrials.gov", "publication_date": "2026-01-22", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06796062", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06796062", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06796062", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06796062", "source_url": "https://clinicaltrials.gov/study/NCT06796062", "doi": "", "pmid": "", "publication_date": "2026-01-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1992, "title": "THE PSYCHEDELIC RENAISSANCE: A SYSTEMATIC REVIEW OF PSILOCYBIN AND LSD IN THE TREATMENT OF PSYCHIATRIC DISORDERS", "authors": "Jakub Klepacz, Radosław Swędrak, Marzena Swojnóg, Zuzanna Dobrakowska", "journal": "International Journal of Innovative Technologies in Social Science", "publication_date": "2026-01-22", "publication_year": 2026, "doi": "10.31435/ijitss.1(49).2026.4582", "pubmed_id": null, "openalex_id": "https://openalex.org/W7127606273", "source_url": "https://doi.org/10.31435/ijitss.1(49).2026.4582", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Chronic Pain,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.31435/ijitss.1(49).2026.4582", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.31435/ijitss.1(49).2026.4582", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.31435/ijitss.1(49).2026.4582", "source_url": "https://doi.org/10.31435/ijitss.1(49).2026.4582", "doi": "10.31435/ijitss.1(49).2026.4582", "pmid": "", "publication_date": "2026-01-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 196, "title": "Consistency of protocol and safety data reporting in clinical trial registrations and corresponding publications of interventions involving MDMA and psilocybin", "authors": "Marija Franka Žuljević, Antonija Mijatović, Renata Orhanović, Glenn Goasdoué, Diana Gujinović", "journal": "Journal of Clinical Epidemiology", "publication_date": "2026-01-22", "publication_year": 2026, "doi": "10.1016/j.jclinepi.2026.112170", "pubmed_id": "41581835", "openalex_id": "https://openalex.org/W7125471543", "source_url": "https://doi.org/10.1016/j.jclinepi.2026.112170", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Clinical Trial,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41581835", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41581835", "source_url": "https://doi.org/10.1016/j.jclinepi.2026.112170", "doi": "10.1016/j.jclinepi.2026.112170", "pmid": "41581835", "publication_date": "2026-01-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4107, "title": "Is psilocybin only effective as part of psychotherapy?", "authors": "Tripdatabase", "journal": "Zenodo (CERN European Organization for Nuclear Research)", "publication_date": "2026-01-21", "publication_year": 2026, "doi": "10.5281/zenodo.18339347", "pubmed_id": null, "openalex_id": "https://openalex.org/W7125431792", "source_url": "https://doi.org/10.5281/zenodo.18339347", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Chronic Pain,Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.5281/zenodo.18339347", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5281/zenodo.18339347", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5281/zenodo.18339347", "source_url": "https://doi.org/10.5281/zenodo.18339347", "doi": "10.5281/zenodo.18339347", "pmid": "", "publication_date": "2026-01-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4108, "title": "Psychological Therapy Quantity and Depressive Symptom Reduction in Psychedelic-Assisted Therapy: A Systematic Review and Meta-Analysis.", "authors": "Florineth, Gianluca Andri, Klima, Isabell, Boeker, Anna Laura, Catzeflis, Polina, Wopfner, Alexander, Denier, Niklaus, Bracht, Tobias, Adorjan, Kristina, Pfammatter, Mario, Müller, Felix, Soravia, Leila Maria", "journal": "Open Access CRIS of the University of Bern", "publication_date": "2026-01-20", "publication_year": 2026, "doi": "10.48620/94398", "pubmed_id": null, "openalex_id": "https://openalex.org/W7128014083", "source_url": "https://doi.org/10.48620/94398", "substance_tags": "psilocybin", "topic_tags": "Depression,Microdosing,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Case Report,Safety,Toxicity,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.48620/94398", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.48620/94398", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.48620/94398", "source_url": "https://doi.org/10.48620/94398", "doi": "10.48620/94398", "pmid": "", "publication_date": "2026-01-20", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 334, "title": "Psychological Therapy Quantity and Depressive Symptom Reduction in Psychedelic-Assisted Therapy", "authors": "Gianluca Andri Florineth, Isabell Klima, Anna Laura Boeker, Polina Catzeflis, Alexander Wopfner, Niklaus Denier, Tobias Bracht, Kristina Adorjan, Mario Pfammatter, Felix Müller, Leila Maria Soravia", "journal": "JAMA Network Open", "publication_date": "2026-01-20", "publication_year": 2026, "doi": "10.1001/jamanetworkopen.2025.54843", "pubmed_id": "41563753", "openalex_id": "https://openalex.org/W7125277592", "source_url": "https://doi.org/10.1001/jamanetworkopen.2025.54843", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Microdosing,Clinical Trial,Meta-Analysis,Systematic Review,Review Article,Case Report,Safety,Toxicity,Drug Interactions", "study_type": "Meta-Analysis", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41563753", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1001/jamanetworkopen.2025.54843", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41563753", "source_url": "https://doi.org/10.1001/jamanetworkopen.2025.54843", "doi": "10.1001/jamanetworkopen.2025.54843", "pmid": "41563753", "publication_date": "2026-01-20", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 251, "title": "Early response to psilocybin in adults with treatment-resistant depression as a predictor for antidepressant efficacy", "authors": "Zoe Doyle, Noah Chisamore, Erica Kaczmarek, Danica E. Johnson, Ryan M. Brudner, Geneva Weiglein, Marc G. Blainey, Jordan Bawks, Jeremy Riva-Cambrin, Rickinder Sethi, Roger S. McIntyre, Joshua D. Rosenblat", "journal": "General Hospital Psychiatry", "publication_date": "2026-01-18", "publication_year": 2026, "doi": "10.1016/j.genhosppsych.2026.01.001", "pubmed_id": "41581334", "openalex_id": "https://openalex.org/W7124833468", "source_url": "https://doi.org/10.1016/j.genhosppsych.2026.01.001", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Treatment-Resistant Depression,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41581334", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41581334", "source_url": "https://doi.org/10.1016/j.genhosppsych.2026.01.001", "doi": "10.1016/j.genhosppsych.2026.01.001", "pmid": "41581334", "publication_date": "2026-01-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1993, "title": "Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Symptoms of Anxiety and Depression: Safety and Efficacy Outcomes of a Phase 1/2 Study", "authors": "Anthony L. Back, Bonnie A. McGregor, Leslie Lazar Thorn, Kelsey K. Baker, T. Gooley, Mendel Kaelen, Kalin Harvey, John M. Guy, Susanna Myers, Juliana Pérez, Peter Thompson, Lindsay Billingsley, Cheryl Sesnon", "journal": "Psychedelic Medicine", "publication_date": "2026-01-17", "publication_year": 2026, "doi": "10.1177/28314425251413856", "pubmed_id": null, "openalex_id": "https://openalex.org/W7124682544", "source_url": "https://doi.org/10.1177/28314425251413856", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Observational Study,Cancer Patients,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.1177/28314425251413856", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/28314425251413856", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/28314425251413856", "source_url": "https://doi.org/10.1177/28314425251413856", "doi": "10.1177/28314425251413856", "pmid": "", "publication_date": "2026-01-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 198, "title": "Bridging the reporting gap: Application of the ReSPCT guidelines in psilocybin clinical trial protocols", "authors": "Damian Świeczkowski, Aleksander Kwaśny, Krzysztof Sadko, Wiesław Jerzy Cubała", "journal": "European Neuropsychopharmacology", "publication_date": "2026-01-15", "publication_year": 2026, "doi": "10.1016/j.euroneuro.2025.112746", "pubmed_id": "41546918", "openalex_id": "https://openalex.org/W7124418318", "source_url": "https://doi.org/10.1016/j.euroneuro.2025.112746", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41546918", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41546918", "source_url": "https://doi.org/10.1016/j.euroneuro.2025.112746", "doi": "10.1016/j.euroneuro.2025.112746", "pmid": "41546918", "publication_date": "2026-01-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3029, "title": "Psilocybin for Treatment-Resistant OCD: A Randomized Controlled Trial", "authors": "", "journal": "PsyArXiv", "publication_date": "2026-01-14", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/atfum_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,OCD,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/atfum_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/atfum_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/atfum_v1", "source_url": "https://osf.io/preprints/psyarxiv/atfum_v1", "doi": "", "pmid": "", "publication_date": "2026-01-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 184, "title": "The Psychological Support Model in Psilocybin Research: Psychotherapy in Disguise?", "authors": "Celia Faye Jacobsen, Dea Siggaard Stenbæk, Stig Poulsen, Sophia Armand", "journal": "Psychiatric Research and Clinical Practice", "publication_date": "2026-01-13", "publication_year": 2026, "doi": "10.1176/appi.prcp.20250113", "pubmed_id": "42022021", "openalex_id": "https://openalex.org/W7123730053", "source_url": "https://doi.org/10.1176/appi.prcp.20250113", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Emotional Processing,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:42022021", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.prcp.20250113", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42022021", "source_url": "https://doi.org/10.1176/appi.prcp.20250113", "doi": "10.1176/appi.prcp.20250113", "pmid": "42022021", "publication_date": "2026-01-13", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3532, "title": "A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant Depression", "authors": "COMPASS Pathways", "journal": "ClinicalTrials.gov", "publication_date": "2026-01-11", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05711940", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05711940", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05711940", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05711940", "source_url": "https://clinicaltrials.gov/study/NCT05711940", "doi": "", "pmid": "", "publication_date": "2026-01-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 266, "title": "Sense-making around psilocybin in UK women experiencing cancer-related existential distress: An Interpretative Phenomenological Analysis", "authors": "Zaynab Khan, Sterre Weaver, Rachael V. Dando, Anne Katrin Schlag, Joanna; id_orcid 0000-0002-2717-9739 Neill, Verity; id_orcid 0000-0002-9876-250X Wainwright", "journal": "Research Explorer (The University of Manchester)", "publication_date": "2026-01-08", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7128133091", "source_url": "https://research.manchester.ac.uk/en/publications/6f070f13-96c6-4cc4-9e40-f2837bdb79b3", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Aging,Clinical Trial,Cancer Patients", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "https://research.manchester.ac.uk/en/publications/6f070f13-96c6-4cc4-9e40-f2837bdb79b3", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://research.manchester.ac.uk/en/publications/6f070f13-96c6-4cc4-9e40-f2837bdb79b3", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://research.manchester.ac.uk/en/publications/6f070f13-96c6-4cc4-9e40-f2837bdb79b3", "source_url": "https://research.manchester.ac.uk/en/publications/6f070f13-96c6-4cc4-9e40-f2837bdb79b3", "doi": "", "pmid": "", "publication_date": "2026-01-08", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 291, "title": "Psilocybin and Bipolar Depression: Promise and Prudence", "authors": "Matheus G. Marques, Liliana Patarroyo-Rodríguez, Balwinder Singh", "journal": "CNS Drugs", "publication_date": "2026-01-03", "publication_year": 2026, "doi": "10.1007/s40263-025-01255-8", "pubmed_id": "41485178", "openalex_id": "https://openalex.org/W7118127068", "source_url": "https://doi.org/10.1007/s40263-025-01255-8", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Pharmacology,Clinical Trial,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41485178", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41485178", "source_url": "https://doi.org/10.1007/s40263-025-01255-8", "doi": "10.1007/s40263-025-01255-8", "pmid": "41485178", "publication_date": "2026-01-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 336, "title": "The effects of psilocybin on psychological distress in cancer patients: a systematic review and meta-analysis", "authors": "Reza Moshfeghinia, Sara Mostafavi, Kimia Jazi, Amir Reza Ghasemi, Yasamin Khosravaninezhad, Santhosshi Narayanan, Jamshid Ahmadi, Mehdi Pasalar", "journal": "BMC Psychology", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1186/s40359-025-03935-y", "pubmed_id": "41484687", "openalex_id": "https://openalex.org/W7118088637", "source_url": "https://doi.org/10.1186/s40359-025-03935-y", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Wellbeing,Emotional Processing,Spirituality,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Cancer Patients,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41484687", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1186/s40359-025-03935-y", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41484687", "source_url": "https://doi.org/10.1186/s40359-025-03935-y", "doi": "10.1186/s40359-025-03935-y", "pmid": "41484687", "publication_date": "2026-01-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4179, "title": "Psychedelics and Mental Health: Psilocybin and Depression. A Sistematic Review", "authors": "Marta Gómez Álvarez, Javier Calleja-Conde, Víctor Echeverry-Alzate", "journal": "Open Science Framework", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.17605/osf.io/yu3n9", "pubmed_id": null, "openalex_id": "https://openalex.org/W7162447643", "source_url": "https://doi.org/10.17605/osf.io/yu3n9", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.17605/osf.io/yu3n9", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.17605/osf.io/yu3n9", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.17605/osf.io/yu3n9", "source_url": "https://doi.org/10.17605/osf.io/yu3n9", "doi": "10.17605/osf.io/yu3n9", "pmid": "", "publication_date": "2025-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4178, "title": "Symptom-level antidepressant response to psilocybin: exploratory outcomes comparing psilocybin treatment to niacin", "authors": "E. Lopez, J O Lundberg, F. Hieronymus, M. Beckman, H. Yngwe, C.J. Ekman, M. Tiger, N. Edvall", "journal": "Neuroscience Applied", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1016/j.nsa.2026.106904", "pubmed_id": null, "openalex_id": "https://openalex.org/W7161898772", "source_url": "https://doi.org/10.1016/j.nsa.2026.106904", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Pharmacology,Clinical Trial,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2026.106904", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2026.106904", "source_url": "https://doi.org/10.1016/j.nsa.2026.106904", "doi": "10.1016/j.nsa.2026.106904", "pmid": "", "publication_date": "2025-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4175, "title": "Cost-Effectiveness of Psilocybin-Assisted Therapy (PAT) for Patients with Treatment-Resistant Depression", "authors": "Yosr Ziadi, Taehwan Park", "journal": "Open MIND", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.17605/osf.io/nrt59", "pubmed_id": null, "openalex_id": "https://openalex.org/W7161800164", "source_url": "https://osf.io/nrt59", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.17605/osf.io/nrt59", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://osf.io/nrt59", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.17605/osf.io/nrt59", "source_url": "https://osf.io/nrt59", "doi": "10.17605/osf.io/nrt59", "pmid": "", "publication_date": "2025-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4171, "title": "Psychedelic-assisted psychotherapy: Clarifying the role of the \"psychotherapy\"", "authors": "Stefan Jerotić, Olga Čolović, Nađa Marić", "journal": "Medicinska istrazivanja", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.5937/medi0-62051", "pubmed_id": null, "openalex_id": "https://openalex.org/W7130417929", "source_url": "https://doi.org/10.5937/medi0-62051", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Review Article,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.5937/medi0-62051", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5937/medi0-62051", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5937/medi0-62051", "source_url": "https://doi.org/10.5937/medi0-62051", "doi": "10.5937/medi0-62051", "pmid": "", "publication_date": "2025-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4164, "title": "Facing Mortality Together: A Constructivist Grounded Theory Analysis of Group Psilocybin Therapy Among Older Long-Term AIDS Survivor Gay Men", "authors": "Hannah Whitmore, Maria Mangini, Heather Leutwyler, Brian Anderson", "journal": "Palliative Medicine Reports", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1177/26892820251401798", "pubmed_id": null, "openalex_id": "https://openalex.org/W7125776111", "source_url": "https://doi.org/10.1177/26892820251401798", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Emotional Processing,Clinical Trial,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.1177/26892820251401798", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/26892820251401798", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/26892820251401798", "source_url": "https://doi.org/10.1177/26892820251401798", "doi": "10.1177/26892820251401798", "pmid": "", "publication_date": "2025-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4163, "title": "Psilocybin-Therapie vorteilhaft für Stimmungsstörungen von Parkinsonkranken", "authors": "", "journal": "Fortschritte der Neurologie · Psychiatrie", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1055/a-2700-8978", "pubmed_id": null, "openalex_id": "https://openalex.org/W7124268562", "source_url": "https://doi.org/10.1055/a-2700-8978", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.1055/a-2700-8978", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1055/a-2700-8978", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1055/a-2700-8978", "source_url": "https://doi.org/10.1055/a-2700-8978", "doi": "10.1055/a-2700-8978", "pmid": "", "publication_date": "2025-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4158, "title": "Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE): Results of a randomized active placebo-controlled trial", "authors": "L.J. Mertens, M. Koslowski, F. Betzler, M. Brand, R. Evens, L. Krätner, A. Jungaberle, H. Jungaberle, T. Majić, C.N. Schmitz, A. Ströhle, D. Scharf, M. Spangemacher, M. Wolff, Z. Assadi, B. Scharif, L. Becher, L.V. Färber, N. Kirchen, E. Kulakova, L. Kunz, A. Meijer, B. Rohrmoser, S. Wellek, M. Berger, G. Gründer", "journal": "Neuroscience Applied", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1016/j.nsa.2025.105779", "pubmed_id": null, "openalex_id": "https://openalex.org/W7118005769", "source_url": "https://doi.org/10.1016/j.nsa.2025.105779", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2025.105779", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2025.105779", "source_url": "https://doi.org/10.1016/j.nsa.2025.105779", "doi": "10.1016/j.nsa.2025.105779", "pmid": "", "publication_date": "2025-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4157, "title": "The impact of COMP360 psilocybin on anhedonia: post-hoc analyses from a phase IIb randomised controlled trial", "authors": "L. Marwood, M. Young, J. Chai-Rees, S. Mistry, S. Maxwell, G.M. Goodwin", "journal": "Neuroscience Applied", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1016/j.nsa.2025.106572", "pubmed_id": null, "openalex_id": "https://openalex.org/W7118005328", "source_url": "https://doi.org/10.1016/j.nsa.2025.106572", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Clinical Trial,Randomized Controlled Trial,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2025.106572", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2025.106572", "source_url": "https://doi.org/10.1016/j.nsa.2025.106572", "doi": "10.1016/j.nsa.2025.106572", "pmid": "", "publication_date": "2025-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4155, "title": "An open-label study of single-dose COMP360 psilocybin for post-traumatic stress disorder: safety, tolerability, and secondary efficacy outcomes", "authors": "N. Mcgowan, J. Rucker, R. Yehuda, M. Agrawal, H. Simmons, S. Das, G. Goodwin", "journal": "Neuroscience Applied", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1016/j.nsa.2025.106821", "pubmed_id": null, "openalex_id": "https://openalex.org/W7117964120", "source_url": "https://doi.org/10.1016/j.nsa.2025.106821", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Chronic Pain,Pharmacology,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2025.106821", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2025.106821", "source_url": "https://doi.org/10.1016/j.nsa.2025.106821", "doi": "10.1016/j.nsa.2025.106821", "pmid": "", "publication_date": "2025-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4152, "title": "Psilocybin Treatment for Refractory Depression: A Clinical Review", "authors": "Jensen, Hailey A", "journal": "Digital Commons - Gardner-Webb University (Gardner-Webb University)", "publication_date": "2025-12-31", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7110564344", "source_url": "https://digitalcommons.gardner-webb.edu/pa-department-journal-of-medical-science/63", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "https://digitalcommons.gardner-webb.edu/pa-department-journal-of-medical-science/63", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://digitalcommons.gardner-webb.edu/pa-department-journal-of-medical-science/63", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://digitalcommons.gardner-webb.edu/pa-department-journal-of-medical-science/63", "source_url": "https://digitalcommons.gardner-webb.edu/pa-department-journal-of-medical-science/63", "doi": "", "pmid": "", "publication_date": "2025-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 347, "title": "Pharmacological Management of Anxiety in End-of-Life Care: A Systematic Review of Benzodiazepines, Opioids, and Psilocybin", "authors": "Brunno Freitas da Costa, Paula Hartmann, Daniel Pagnin", "journal": "Human Psychopharmacology Clinical and Experimental", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1002/hup.70032", "pubmed_id": "41502021", "openalex_id": "https://openalex.org/W7118595574", "source_url": "https://doi.org/10.1002/hup.70032", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Clinical Trial,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41502021", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/hup.70032", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41502021", "source_url": "https://doi.org/10.1002/hup.70032", "doi": "10.1002/hup.70032", "pmid": "41502021", "publication_date": "2025-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 340, "title": "New Antidepressant Development in the Treatment of Depression.", "authors": "Spiti A, Caldirola D, Perna G.", "journal": null, "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1007/978-981-95-6872-7_23", "pubmed_id": "42036580", "openalex_id": null, "source_url": "https://doi.org/10.1007/978-981-95-6872-7_23", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Receptor Pharmacology,Biomarkers,Clinical Trial,Animal Study,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:42036580", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/978-981-95-6872-7_23", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42036580", "source_url": "https://doi.org/10.1007/978-981-95-6872-7_23", "doi": "10.1007/978-981-95-6872-7_23", "pmid": "42036580", "publication_date": "2025-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 329, "title": "From trials to clinics: investigators’ perspectives on translating psychedelic research into clinical care", "authors": "Joshua Mitchell, Logan Neitzke-Spruill, David S. Mathai, Jill O. Robinson, Zuzana Kavan, Lynnette A Averil, Amy L McGuire", "journal": "Translational Behavioral Medicine", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1093/tbm/ibag027", "pubmed_id": "42152689", "openalex_id": "https://openalex.org/W7161692886", "source_url": "https://doi.org/10.1093/tbm/ibag027", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Chronic Pain,Pharmacology,Clinical Trial,Treatment-Resistant Depression,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:42152689", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/tbm/ibag027", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42152689", "source_url": "https://doi.org/10.1093/tbm/ibag027", "doi": "10.1093/tbm/ibag027", "pmid": "42152689", "publication_date": "2025-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 143, "title": "The effects of psilocybin on time perception in humans: A comparative analysis of subjective and objective measures", "authors": "Petr Scholle, Štěpán Wenke, Tereza Nekovářová, Yulia Zaytseva, Filip Tylš, Martin Brunovský, Jiřı́ Horáček, Veronika Andrashko, Vlastimil Koudelka, Michaela Viktorinová, Vojtěch Viktorin, Kateřina Hájková, Martin Kuchař, T. Páleníček", "journal": "Journal of Psychopharmacology", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1177/02698811251389552", "pubmed_id": "41479142", "openalex_id": "https://openalex.org/W7118000985", "source_url": "https://doi.org/10.1177/02698811251389552", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Consciousness,Clinical Trial,Healthy Volunteers", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41479142", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/02698811251389552", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41479142", "source_url": "https://doi.org/10.1177/02698811251389552", "doi": "10.1177/02698811251389552", "pmid": "41479142", "publication_date": "2025-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3464, "title": "Microdosing Psychedelics to Improve Mood", "authors": "Rotem Petranker", "journal": "ClinicalTrials.gov", "publication_date": "2025-12-29", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05259943", "substance_tags": "psilocybin", "topic_tags": "Depression,Microdosing,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05259943", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05259943", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05259943", "source_url": "https://clinicaltrials.gov/study/NCT05259943", "doi": "", "pmid": "", "publication_date": "2025-12-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 199, "title": "Psilocybin Production With Genetically Modified Aspergillus nidulans Under Pressurized Conditions", "authors": "Sophie Weiser, Sidney Jung, Bettina Bardl, Johann E. Kufs, Slavica Janevska, Vito Valiante, Dirk Hoffmeister, Lars Regestein", "journal": "Biotechnology and Bioengineering", "publication_date": "2025-12-29", "publication_year": 2025, "doi": "10.1002/bit.70137", "pubmed_id": "41467547", "openalex_id": "https://openalex.org/W7117540352", "source_url": "https://doi.org/10.1002/bit.70137", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41467547", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/bit.70137", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41467547", "source_url": "https://doi.org/10.1002/bit.70137", "doi": "10.1002/bit.70137", "pmid": "41467547", "publication_date": "2025-12-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3017, "title": "Psilocybin as a Serotonergic Therapy in Epilepsy: Narrative Review of Therapeutic Potentials and Seizure Risks", "authors": "Miguel Benjamín Cervera-Sánchez, Daniel San-Juan, Roberto Díaz-Peregrino, Evelin Zulema Camacho-Castillo, Sthefany Anahi Bringas-Ortiz, Christian Padilla-Cabezutd", "journal": null, "publication_date": "2025-12-28", "publication_year": 2025, "doi": "10.22541/au.176701186.65064859/v1", "pubmed_id": null, "openalex_id": "https://openalex.org/W7117461912", "source_url": "https://doi.org/10.22541/au.176701186.65064859/v1", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Chronic Pain,Receptor Pharmacology,Clinical Trial,Review Article,Observational Study,Animal Study,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 11:03:45", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.22541/au.176701186.65064859/v1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.22541/au.176701186.65064859/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.22541/au.176701186.65064859/v1", "source_url": "https://doi.org/10.22541/au.176701186.65064859/v1", "doi": "10.22541/au.176701186.65064859/v1", "pmid": "", "publication_date": "2025-12-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 377, "title": "Efficacy and Safety of Psychedelics in Mental Disorder Cases: An Umbrella Review of Meta-Analyses of Randomized Controlled Trials", "authors": "Monika Dominiak, Adam Gędek, Szymon Modrzejewski, Agnieszka Permoda-Osip, Anna Zofia Antosik", "journal": "Journal of Clinical Medicine", "publication_date": "2025-12-28", "publication_year": 2025, "doi": "10.3390/jcm15010253", "pubmed_id": "41517502", "openalex_id": "https://openalex.org/W7117705718", "source_url": "https://doi.org/10.3390/jcm15010253", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Review Article,Safety,Adverse Events,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41517502", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/jcm15010253", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41517502", "source_url": "https://doi.org/10.3390/jcm15010253", "doi": "10.3390/jcm15010253", "pmid": "41517502", "publication_date": "2025-12-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 200, "title": "Comparing single- and repeat-dose psilocybin with active placebo for migraine prevention in an exploratory randomized controlled clinical trial", "authors": "Emmanuelle A. D. Schindler, Christopher Gottschalk, Brian Pittman, Deepak D'Souza", "journal": "Headache The Journal of Head and Face Pain", "publication_date": "2025-12-28", "publication_year": 2025, "doi": "10.1111/head.70024", "pubmed_id": "41459830", "openalex_id": "https://openalex.org/W7117472148", "source_url": "https://doi.org/10.1111/head.70024", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Headache / Migraine,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41459830", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/head.70024", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41459830", "source_url": "https://doi.org/10.1111/head.70024", "doi": "10.1111/head.70024", "pmid": "41459830", "publication_date": "2025-12-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4189, "title": "A Systematic Review of the efficacy, safety, and Tolerability of Psychedelics in the Treatment of post-traumatic Stress Disorder", "authors": "Manasicha Wongpaiboon, Jackson L. Shelton, Eric Delgado Rendon, Maddison Vail", "journal": "Current Treatment Options in Psychiatry", "publication_date": "2025-12-25", "publication_year": 2025, "doi": "10.1007/s40501-025-00373-w", "pubmed_id": null, "openalex_id": "https://openalex.org/W7117327267", "source_url": "https://doi.org/10.1007/s40501-025-00373-w", "substance_tags": "psilocybin", "topic_tags": "PTSD,Pharmacology,Clinical Trial,Meta-Analysis,Systematic Review,Review Article,Safety,Toxicity", "study_type": "Meta-Analysis", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 06:34:37", "bibtex": null, "source_record_id": "DOI:10.1007/s40501-025-00373-w", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1007/s40501-025-00373-w", "source_url": "https://doi.org/10.1007/s40501-025-00373-w", "doi": "10.1007/s40501-025-00373-w", "pmid": "", "publication_date": "2025-12-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3043, "title": "Psilocybin decreases reward-seeking behavior accompanied by increased activity of parvalbumin neurons with perineuronal nets in the medial prefrontal cortex", "authors": "Houff J, Williams A, Allen O, Gisabella B, Pantazopoulos H, Del Arco A.", "journal": "bioRxiv", "publication_date": "2025-12-25", "publication_year": 2025, "doi": "10.64898/2025.12.22.696123", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.64898/2025.12.22.696123", "substance_tags": "psilocybin", "topic_tags": "Addiction,Receptor Pharmacology,Biomarkers,Clinical Trial", "study_type": "Clinical Trial", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.64898/2025.12.22.696123", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.64898/2025.12.22.696123", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.64898/2025.12.22.696123", "source_url": "https://doi.org/10.64898/2025.12.22.696123", "doi": "10.64898/2025.12.22.696123", "pmid": "", "publication_date": "2025-12-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 378, "title": "Knowledge, perceptions, and use of psychedelics for mental health among autistic adults: An online survey", "authors": "Sahba Afsharnia, Vivian Liang, Yona Lunsky, A Orsini, Ami Tint, Hsiang-yuan Lin", "journal": "PLOS mental health.", "publication_date": "2025-12-25", "publication_year": 2025, "doi": "10.1371/journal.pmen.0000514", "pubmed_id": "41662127", "openalex_id": "https://openalex.org/W7117295770", "source_url": "https://doi.org/10.1371/journal.pmen.0000514", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Chronic Pain,Clinical Trial,Observational Study,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41662127", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1371/journal.pmen.0000514", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41662127", "source_url": "https://doi.org/10.1371/journal.pmen.0000514", "doi": "10.1371/journal.pmen.0000514", "pmid": "41662127", "publication_date": "2025-12-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3055, "title": "A Randomised, Triple-Blind, Dose-Finding Study of the Impact of Psilocybin on Motor Function in Healthy Participants", "authors": "Bhagavan C, Carter O, Nielsen G, Berlowitz D, Issak S, Braat S, Zaloumis S, Attard Z, Oliver G, Mayne D, Rucker J, Butler M, Dandash O, Bryson A, Kanaan RA.", "journal": "medRxiv", "publication_date": "2025-12-22", "publication_year": 2025, "doi": "10.64898/2025.12.22.25342874", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.64898/2025.12.22.25342874", "substance_tags": "psilocybin", "topic_tags": "Headache / Migraine,Consciousness,Clinical Trial,Review Article,Healthy Volunteers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.64898/2025.12.22.25342874", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.64898/2025.12.22.25342874", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.64898/2025.12.22.25342874", "source_url": "https://doi.org/10.64898/2025.12.22.25342874", "doi": "10.64898/2025.12.22.25342874", "pmid": "", "publication_date": "2025-12-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1990, "title": "Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Anxiety and Depression: A Rite of Passage Facilitation Model for a Phase 1/2 Study", "authors": "Anthony L. Back, Bonnie A. McGregor, Lindsay Billingsley, Dianna Blom, George Callan, Susanna Myers, John Guy, Sameet Kumar, Melissa Layer, Jackie Levin, Juliana Pérez, Peter Thompson, Kathy Salmonson, Joseph Whinney, Leslie Lazar Thorn", "journal": "Psychedelic Medicine", "publication_date": "2025-12-22", "publication_year": 2025, "doi": "10.1177/28314425251404460", "pubmed_id": null, "openalex_id": "https://openalex.org/W7116873484", "source_url": "https://doi.org/10.1177/28314425251404460", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Cancer Patients,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.1177/28314425251404460", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/28314425251404460", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/28314425251404460", "source_url": "https://doi.org/10.1177/28314425251404460", "doi": "10.1177/28314425251404460", "pmid": "", "publication_date": "2025-12-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 380, "title": "Psychedelics as a Therapeutic Opportunity or Threat: A Narrative Review", "authors": "Paweł Liszka, Agata Ogórek, Klaudia M Olejnik-Chlewicka, Konrad Puchalski, Marta Zasiadła, Klaudia M Patrzykąt, Jakub Perediatkiewicz, Wojciech Urbański, Paweł M Łuczak, Jakub Brodowski", "journal": "Cureus", "publication_date": "2025-12-22", "publication_year": 2025, "doi": "10.7759/cureus.99942", "pubmed_id": "41583322", "openalex_id": "https://openalex.org/W7116864166", "source_url": "https://doi.org/10.7759/cureus.99942", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Pharmacology,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Cancer Patients,Treatment-Resistant Depression,Safety,Toxicity,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41583322", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.7759/cureus.99942", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41583322", "source_url": "https://doi.org/10.7759/cureus.99942", "doi": "10.7759/cureus.99942", "pmid": "41583322", "publication_date": "2025-12-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3585, "title": "Effects of Psilocybin on Speech Fluency, Struggle, and Brain Activity in People Who Stutter", "authors": "NYU Langone Health", "journal": "ClinicalTrials.gov", "publication_date": "2025-12-21", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07296328", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Wellbeing,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07296328", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07296328", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07296328", "source_url": "https://clinicaltrials.gov/study/NCT07296328", "doi": "", "pmid": "", "publication_date": "2025-12-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 388, "title": "The CAnadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT): A Multi-Phase Program Overview.", "authors": "Carlson LE, Richardson H, Shore R, Albertyn CP, Balneaves LG, Bates A, Burnell M, Chochinov HM, Clements D, Deleemans J, Horlock H, Mathews J, McKenzie M, Savard C, Soares CN, Tu W, Williams M", "journal": "Current oncology (Toronto, Ont.)", "publication_date": "2025-12-21", "publication_year": 2025, "doi": "10.3390/curroncol33010007", "pubmed_id": "41590327", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41590327/", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Randomized Controlled Trial,Cancer Patients,Healthcare Workers", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:20:35", "bibtex": null, "source_record_id": "PMID:41590327", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41590327/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41590327", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41590327/", "doi": "10.3390/curroncol33010007", "pmid": "41590327", "publication_date": "2025-12-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4196, "title": "From fungi to pharmacy: Applied technologies in psilocybin production and its therapeutic applications", "authors": "Qinqing Chen, Peiyuan Chen, Tao Wei, Sunita Chamyuang, Bai-Xiong Chen", "journal": "Creative Science", "publication_date": "2025-12-18", "publication_year": 2025, "doi": "10.55674/cs.v18i1.264689", "pubmed_id": null, "openalex_id": "https://openalex.org/W7116104340", "source_url": "https://doi.org/10.55674/cs.v18i1.264689", "substance_tags": "psilocybin,psilocin", "topic_tags": "Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.55674/cs.v18i1.264689", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.55674/cs.v18i1.264689", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.55674/cs.v18i1.264689", "source_url": "https://doi.org/10.55674/cs.v18i1.264689", "doi": "10.55674/cs.v18i1.264689", "pmid": "", "publication_date": "2025-12-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3521, "title": "A Phase III, Multicentre, Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Treatment-resistant Depression", "authors": "COMPASS Pathways", "journal": "ClinicalTrials.gov", "publication_date": "2025-12-17", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05624268", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05624268", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05624268", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05624268", "source_url": "https://clinicaltrials.gov/study/NCT05624268", "doi": "", "pmid": "", "publication_date": "2025-12-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 392, "title": "Psilocybin reporting in media (PRiMe) for the treatment of depression", "authors": "Gurjot Brar, T. R. JUN. BURKE, Andrew Gribben, Colm Harrington, Guillaume Thuery, John R. Kelly", "journal": "Irish Journal of Psychological Medicine", "publication_date": "2025-12-17", "publication_year": 2025, "doi": "10.1017/ipm.2025.10142", "pubmed_id": "41410115", "openalex_id": "https://openalex.org/W4417453981", "source_url": "https://doi.org/10.1017/ipm.2025.10142", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41410115", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1017/ipm.2025.10142", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41410115", "source_url": "https://doi.org/10.1017/ipm.2025.10142", "doi": "10.1017/ipm.2025.10142", "pmid": "41410115", "publication_date": "2025-12-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 353, "title": "Psilocybin-assisted therapy for individuals with palliative care needs: A systematic review of safety and efficacy.", "authors": "Matos ARS, Silva AC, Rego L, Fernandes R, Gonçalves S.", "journal": null, "publication_date": "2025-12-17", "publication_year": 2025, "doi": "10.1177/02692163251383335", "pubmed_id": "41410211", "openalex_id": null, "source_url": "https://doi.org/10.1177/02692163251383335", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Observational Study,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:41410211", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02692163251383335", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:41410211", "source_url": "https://doi.org/10.1177/02692163251383335", "doi": "10.1177/02692163251383335", "pmid": "41410211", "publication_date": "2025-12-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 294, "title": "Psilocybin in the real world: Regulatory, ethical, and operational challenges in Australia’s clinical landscape", "authors": "Megan Dutton, Paul Schwenn, Jules Mitchell, Per Hoffmann, Neil W. Bailey, Paul B. Fitzgerald, Jim Lagopoulos, Adem Can", "journal": "Australian & New Zealand Journal of Psychiatry", "publication_date": "2025-12-16", "publication_year": 2025, "doi": "10.1177/00048674251398677", "pubmed_id": "41405025", "openalex_id": "https://openalex.org/W4417431364", "source_url": "https://doi.org/10.1177/00048674251398677", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Mechanism of Action,Clinical Trial,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41405025", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/00048674251398677", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41405025", "source_url": "https://doi.org/10.1177/00048674251398677", "doi": "10.1177/00048674251398677", "pmid": "41405025", "publication_date": "2025-12-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4200, "title": "Psychedelic-Assisted Therapy (Pat): A New Frontier in Mental Health Treatment", "authors": "M. H. M. Wickramasekara, G. D. M. C. Gonapaladeniya", "journal": "˜The œjournal of desk research review and analysis.", "publication_date": "2025-12-15", "publication_year": 2025, "doi": "10.4038/jdrra.v3i2.87", "pubmed_id": null, "openalex_id": "https://openalex.org/W7115587785", "source_url": "https://doi.org/10.4038/jdrra.v3i2.87", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Older Adults,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.4038/jdrra.v3i2.87", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.4038/jdrra.v3i2.87", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.4038/jdrra.v3i2.87", "source_url": "https://doi.org/10.4038/jdrra.v3i2.87", "doi": "10.4038/jdrra.v3i2.87", "pmid": "", "publication_date": "2025-12-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3437, "title": "Feasibility Phase 2 Study of Psilocybin-Assisted Therapy for Opioid-Refractory Pain in Patients With Advanced Cancer", "authors": "Yvan Beaussant, MD, MSci", "journal": "ClinicalTrials.gov", "publication_date": "2025-12-15", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06001749", "substance_tags": "psilocybin", "topic_tags": "Addiction,End-of-Life Distress,Chronic Pain,Receptor Pharmacology,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06001749", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06001749", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06001749", "source_url": "https://clinicaltrials.gov/study/NCT06001749", "doi": "", "pmid": "", "publication_date": "2025-12-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 394, "title": "Psilocybin-assisted psychotherapy for treatment-resistant obsessive-compulsive disorder: protocol for an open-label pilot study", "authors": "Nicole Ledwos, Jenna Baer, Muhammad Ishrat Husain, Daniel M. Blumberger, Rachel Patterson, Elizabeth Hollingdrake, Ezmond S.L. Cheung, Colin Hawco, Christoph Zrenner, Brigitte Zrenner, Jamie D. Feusner, Susan L. Rossell, David Castle, Gwyneth Zai", "journal": "BJPsych Open", "publication_date": "2025-12-14", "publication_year": 2025, "doi": "10.1192/bjo.2025.10895", "pubmed_id": "41392767", "openalex_id": "https://openalex.org/W4417362478", "source_url": "https://doi.org/10.1192/bjo.2025.10895", "substance_tags": "psilocybin", "topic_tags": "OCD,Chronic Pain,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Biomarkers,Aging,Clinical Trial,Randomized Controlled Trial,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41392767", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1192/bjo.2025.10895", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41392767", "source_url": "https://doi.org/10.1192/bjo.2025.10895", "doi": "10.1192/bjo.2025.10895", "pmid": "41392767", "publication_date": "2025-12-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4203, "title": "COMPARATIVE EFFICACY AND ACCEPTABILITY OF PSILOCYBIN-KETAMINE AND TYPICAL ANTIDEPRESSANTS FOR MAJOR DEPRESSIVE DISORDER MANAGEMENT: A NETWORK META-ANALYSIS", "authors": "Pedro Rodrigues, Weliton Rodrigues dos Santos Júnior, Ivan de Sousa Araújo, Leonardo Maia Leony, Fernanda Adélia Almeida Custódio Pires Gomes, Tairone Matos de Lima Junior, Luís Felipe Freitas Moreira, Rafael Telles Santana, Manoel Carlos Matos Santos, R. Silva", "journal": null, "publication_date": "2025-12-10", "publication_year": 2025, "doi": "10.55905/edicon.978-65-83115-47-8_8", "pubmed_id": null, "openalex_id": "https://openalex.org/W4417258517", "source_url": "https://doi.org/10.55905/edicon.978-65-83115-47-8_8", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Observational Study", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.55905/edicon.978-65-83115-47-8_8", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.55905/edicon.978-65-83115-47-8_8", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.55905/edicon.978-65-83115-47-8_8", "source_url": "https://doi.org/10.55905/edicon.978-65-83115-47-8_8", "doi": "10.55905/edicon.978-65-83115-47-8_8", "pmid": "", "publication_date": "2025-12-10", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3048, "title": "Real-World Psilocybin Therapy for Treatment-Resistant Depression: a Retrospective Observational Study", "authors": "Jungwirth J, Westenhöfer S, Aicher H, Provaznikova B, Kronenberg G, Seifritz E, Prinz S, Olbrich S.", "journal": "Research Square", "publication_date": "2025-12-09", "publication_year": 2025, "doi": "10.21203/rs.3.rs-8079137/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-8079137/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-8079137/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-8079137/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-8079137/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-8079137/v1", "doi": "10.21203/rs.3.rs-8079137/v1", "pmid": "", "publication_date": "2025-12-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 399, "title": "Acute and post-dosing effects of single-dose psilocybin for obsessive-compulsive disorder in a randomized, double-blind, placebo-controlled trial: an interpretative phenomenological analysis", "authors": "T. H. W. Ching, B. Stahnke, S. Shnayder, G. Agin-Liebes, T. G. Adams, L. Amoroso, O. Baiz, A. Belser, C. Bohner, M. Burke, E. D’Amico, G. DePalmer, J. Eilbott, G. Fram, R. Grazioplene, J. Hokanson, A. Jankovsky, S. A. Kichuk, B. Martins, P. Purohit, H. Schaer, Y. P. Sierra, C. Witherow, C. Pittenger, B. Kelmendi", "journal": "Frontiers in Psychiatry", "publication_date": "2025-12-09", "publication_year": 2025, "doi": "10.3389/fpsyt.2025.1726818", "pubmed_id": "41450831", "openalex_id": "https://openalex.org/W7113899315", "source_url": "https://doi.org/10.3389/fpsyt.2025.1726818", "substance_tags": "psilocybin", "topic_tags": "OCD,Chronic Pain,Mechanism of Action,Emotional Processing,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41450831", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2025.1726818", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41450831", "source_url": "https://doi.org/10.3389/fpsyt.2025.1726818", "doi": "10.3389/fpsyt.2025.1726818", "pmid": "41450831", "publication_date": "2025-12-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 352, "title": "Stepping back into life: How Psychedelic Assisted Psychotherapy transforms the way of life of the terminally ill", "authors": "Justin Dwyer, Robert B. Johnston, Clare O’Callaghan, Margaret Ross", "journal": "General Hospital Psychiatry", "publication_date": "2025-12-09", "publication_year": 2025, "doi": "10.1016/j.genhosppsych.2025.12.002", "pubmed_id": "41418682", "openalex_id": "https://openalex.org/W4417184349", "source_url": "https://doi.org/10.1016/j.genhosppsych.2025.12.002", "substance_tags": "psilocybin", "topic_tags": "Anxiety,End-of-Life Distress,Chronic Pain,Clinical Trial,Review Article,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 06:34:37", "bibtex": null, "source_record_id": "PMID:41418682", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41418682", "source_url": "https://doi.org/10.1016/j.genhosppsych.2025.12.002", "doi": "10.1016/j.genhosppsych.2025.12.002", "pmid": "41418682", "publication_date": "2025-12-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3040, "title": "Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacy: A Scoping Review", "authors": "Suspène J, Huet S, Berteina-Raboin S, Benyamina A, Baril P, Morisset-Lopez S, Serreau R.", "journal": "Qeios", "publication_date": "2025-12-08", "publication_year": 2025, "doi": "10.32388/xcfsag.2", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.32388/xcfsag.2", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.32388/xcfsag.2", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.32388/xcfsag.2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.32388/xcfsag.2", "source_url": "https://doi.org/10.32388/xcfsag.2", "doi": "10.32388/xcfsag.2", "pmid": "", "publication_date": "2025-12-08", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 354, "title": "Psilocybin in late-life mental health: Addressing depression, loneliness, and existential anxiety", "authors": "Gerasimos Konstantinou, Joshua D. Rosenblat, Sarah Hales, Muhammad Ishrat Husain, Daniel M. Blumberger", "journal": "General Hospital Psychiatry", "publication_date": "2025-12-08", "publication_year": 2025, "doi": "10.1016/j.genhosppsych.2025.12.005", "pubmed_id": "41401486", "openalex_id": "https://openalex.org/W4417166023", "source_url": "https://doi.org/10.1016/j.genhosppsych.2025.12.005", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Neuroplasticity,Pharmacology,Mechanism of Action,Default Mode Network,Aging,Clinical Trial,Review Article,Safety,Toxicity,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41401486", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.genhosppsych.2025.12.005", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41401486", "source_url": "https://doi.org/10.1016/j.genhosppsych.2025.12.005", "doi": "10.1016/j.genhosppsych.2025.12.005", "pmid": "41401486", "publication_date": "2025-12-08", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 256, "title": "The Relationship Between Participant Pretreatment Clinical Presentation and the Quality of Psilocybin Experience", "authors": "Namik Kirlić, Merve Atli, Sunil Mistry, Michael Gold, Guy M. Goodwin", "journal": "Journal of Clinical Psychopharmacology", "publication_date": "2025-12-08", "publication_year": 2025, "doi": "10.1097/jcp.0000000000002119", "pubmed_id": "41362124", "openalex_id": "https://openalex.org/W4417148678", "source_url": "https://doi.org/10.1097/jcp.0000000000002119", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Mechanism of Action,Consciousness,Personality Change,Emotional Processing,Clinical Trial,Treatment-Resistant Depression,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41362124", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1097/jcp.0000000000002119", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41362124", "source_url": "https://doi.org/10.1097/jcp.0000000000002119", "doi": "10.1097/jcp.0000000000002119", "pmid": "41362124", "publication_date": "2025-12-08", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 296, "title": "Disengaged: A systematic review of community engagement in psychedelic-assisted therapy research.", "authors": "Reid MR, Song J, Boehnke KF, Buchanan NT, Aday JS.", "journal": null, "publication_date": "2025-12-06", "publication_year": 2025, "doi": "10.1016/j.neubiorev.2025.106516", "pubmed_id": "41365426", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.neubiorev.2025.106516", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Aging,Clinical Trial,Systematic Review,Review Article", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:41365426", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.neubiorev.2025.106516", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:41365426", "source_url": "https://doi.org/10.1016/j.neubiorev.2025.106516", "doi": "10.1016/j.neubiorev.2025.106516", "pmid": "41365426", "publication_date": "2025-12-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3513, "title": "A Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Effects of Psilocybin-assisted Psychotherapy on Psychiatric and Existential Distress in Advanced Cancer", "authors": "NYU Langone Health", "journal": "ClinicalTrials.gov", "publication_date": "2025-12-03", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05398484", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05398484", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05398484", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05398484", "source_url": "https://clinicaltrials.gov/study/NCT05398484", "doi": "", "pmid": "", "publication_date": "2025-12-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4212, "title": "Magic Mushrooms as Medicine: What the United States Can Learn from Jamaica’s Unregulated Psilocybin Industry as FDA Approval Nears", "authors": "Spohn, Kyle", "journal": "eYLS (Yale Law School)", "publication_date": "2025-12-01", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7112471464", "source_url": "https://repository.law.miami.edu/umialr/vol57/iss1/7", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "https://repository.law.miami.edu/umialr/vol57/iss1/7", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://repository.law.miami.edu/umialr/vol57/iss1/7", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://repository.law.miami.edu/umialr/vol57/iss1/7", "source_url": "https://repository.law.miami.edu/umialr/vol57/iss1/7", "doi": "", "pmid": "", "publication_date": "2025-12-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4215, "title": "Meaning and Purpose Therapy Modified for Psilocybin (P-MaP): A Treatment Model for Palliative Care Patients", "authors": "Philip Garrity, Alicia Danforth, Brian Anderson, Jason M. Thompson", "journal": "Journal of Health Service Psychology", "publication_date": "2025-11-30", "publication_year": 2025, "doi": "10.1007/s42843-025-00145-3", "pubmed_id": null, "openalex_id": "https://openalex.org/W7118121099", "source_url": "https://doi.org/10.1007/s42843-025-00145-3", "substance_tags": "psilocybin", "topic_tags": "End-of-Life Distress,Chronic Pain,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.1007/s42843-025-00145-3", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1007/s42843-025-00145-3", "source_url": "https://doi.org/10.1007/s42843-025-00145-3", "doi": "10.1007/s42843-025-00145-3", "pmid": "", "publication_date": "2025-11-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4213, "title": "Persistent Altered States: Psychological Treatment of Psychedelic Adverse Effects", "authors": "Bjørn Holmøy, Kristoffer Andreas Aamodt Andersen", "journal": "Tidsskrift for Norsk psykologforening", "publication_date": "2025-11-30", "publication_year": 2025, "doi": "10.52734/hgsn7664", "pubmed_id": null, "openalex_id": "https://openalex.org/W4416844791", "source_url": "https://doi.org/10.52734/hgsn7664", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Clinical Trial,Review Article,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 06:34:38", "bibtex": null, "source_record_id": "DOI:10.52734/hgsn7664", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.52734/hgsn7664", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.52734/hgsn7664", "source_url": "https://doi.org/10.52734/hgsn7664", "doi": "10.52734/hgsn7664", "pmid": "", "publication_date": "2025-11-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 401, "title": "Investigational psilocybin treatment for post-traumatic stress disorder: a qualitative study of participant experience, trauma engagement, and differences from standard treatment", "authors": "Nadav Liam Modlin, Victoria Williamson, Guy M. Goodwin, Ekaterina Malievskaia, Merve Atli, Zsofia Elek, Alice Gaillard, Don Koelpin, Anthony J. Cleare, Manish Agrawal, Rachel Yehuda, Namik Kirlić, James Rucker", "journal": "EClinicalMedicine", "publication_date": "2025-11-30", "publication_year": 2025, "doi": "10.1016/j.eclinm.2025.103692", "pubmed_id": "41497513", "openalex_id": "https://openalex.org/W4417031290", "source_url": "https://doi.org/10.1016/j.eclinm.2025.103692", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Chronic Pain,Mechanism of Action,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41497513", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.eclinm.2025.103692", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41497513", "source_url": "https://doi.org/10.1016/j.eclinm.2025.103692", "doi": "10.1016/j.eclinm.2025.103692", "pmid": "41497513", "publication_date": "2025-11-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3681, "title": "Assessing the Safety, Tolerability, and Efficacy of Psilocybin Therapy Followed by Accelerated Intermittent Theta Burst (aiTBS) Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment-Resistant Major Depressive Disorder", "authors": "University of Texas at Austin", "journal": "ClinicalTrials.gov", "publication_date": "2025-11-25", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06132178", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Biomarkers,Aging,Clinical Trial,Safety,Inflammation", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06132178", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06132178", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06132178", "source_url": "https://clinicaltrials.gov/study/NCT06132178", "doi": "", "pmid": "", "publication_date": "2025-11-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 421, "title": "A comparative assessment of the antidepressant efficacy of ketamine, psilocybin, and fluoxetine in a chronic stress model", "authors": "Małgorzata Domżalska, Joanna Kwiatkowska, Iwona Cichoń, Ewa Sokołowska", "journal": "Scientific Reports", "publication_date": "2025-11-25", "publication_year": 2025, "doi": "10.1038/s41598-025-29642-7", "pubmed_id": "41290975", "openalex_id": "https://openalex.org/W4416669801", "source_url": "https://doi.org/10.1038/s41598-025-29642-7", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41290975", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41598-025-29642-7", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41290975", "source_url": "https://doi.org/10.1038/s41598-025-29642-7", "doi": "10.1038/s41598-025-29642-7", "pmid": "41290975", "publication_date": "2025-11-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 297, "title": "New treatments for OCD? Evidence for cannabinoids and psychedelics.", "authors": "Van Ameringen M, Patel V, Patterson B, Hopkinson P, Rahat M.", "journal": null, "publication_date": "2025-11-25", "publication_year": 2025, "doi": "10.1016/j.jpsychires.2025.11.021", "pubmed_id": "41317726", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jpsychires.2025.11.021", "substance_tags": "psilocybin", "topic_tags": "OCD,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Review Article,Case Report,Observational Study", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:41317726", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jpsychires.2025.11.021", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:41317726", "source_url": "https://doi.org/10.1016/j.jpsychires.2025.11.021", "doi": "10.1016/j.jpsychires.2025.11.021", "pmid": "41317726", "publication_date": "2025-11-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3700, "title": "Pragmatic Trial of Psilocybin Therapy in Palliative Care (PT2PC): A Multicenter Triple-blind Phase 2 Randomized Controlled Trial of Psilocybin Therapy for Demoralized Adults Near the End of Life", "authors": "Charles S. Grob, M.D.", "journal": "ClinicalTrials.gov", "publication_date": "2025-11-24", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05403086", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05403086", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05403086", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05403086", "source_url": "https://clinicaltrials.gov/study/NCT05403086", "doi": "", "pmid": "", "publication_date": "2025-11-24", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 423, "title": "Best practices for first psychedelic experiences: harm reduction advice from the psychedelic community", "authors": "Daniel J. Kruger, Gina Mersereau, Ashley F. Sullivan, Julie Barron, Moss Herberholz, Niloufar Pouyan, Jacob S. Aday, Kevin F. Boehnke", "journal": "Harm Reduction Journal", "publication_date": "2025-11-24", "publication_year": 2025, "doi": "10.1186/s12954-025-01337-2", "pubmed_id": "41291774", "openalex_id": "https://openalex.org/W4416671509", "source_url": "https://doi.org/10.1186/s12954-025-01337-2", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Observational Study,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41291774", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1186/s12954-025-01337-2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41291774", "source_url": "https://doi.org/10.1186/s12954-025-01337-2", "doi": "10.1186/s12954-025-01337-2", "pmid": "41291774", "publication_date": "2025-11-24", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3042, "title": "Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacy: A Scoping Review", "authors": "Suspène J, Huet S, Berteina-Raboin S, Benyamina A, Baril P, Morisset-Lopez S, Serreau R.", "journal": "Qeios", "publication_date": "2025-11-20", "publication_year": 2025, "doi": "10.32388/xcfsag", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.32388/xcfsag", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.32388/xcfsag", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.32388/xcfsag", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.32388/xcfsag", "source_url": "https://doi.org/10.32388/xcfsag", "doi": "10.32388/xcfsag", "pmid": "", "publication_date": "2025-11-20", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 425, "title": "Psilocybin and Chronic Pain: A New Perspective for Future Pain Therapists?", "authors": "Silvia Natoli, Arturo Cuomo, Maurizio Marchesini, Livio Luongo, Giuliano Lo Bianco, Vittorio Guardamagna, Shigeki Yamaguchi", "journal": "Medical Sciences", "publication_date": "2025-11-19", "publication_year": 2025, "doi": "10.3390/medsci13040277", "pubmed_id": "41283278", "openalex_id": "https://openalex.org/W4416407616", "source_url": "https://doi.org/10.3390/medsci13040277", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Resilience,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Review Article,Animal Study,Safety,Toxicity,Inflammation", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41283278", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/medsci13040277", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41283278", "source_url": "https://doi.org/10.3390/medsci13040277", "doi": "10.3390/medsci13040277", "pmid": "41283278", "publication_date": "2025-11-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3548, "title": "A Double-blind, Phase II Feasibility Study to Assess the Safety and Efficacy of Psilocybin Microdosing Combined With Psychotherapy in Treatment-resistant Depression", "authors": "Beersheva Mental Health Center", "journal": "ClinicalTrials.gov", "publication_date": "2025-11-18", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07183748", "substance_tags": "psilocybin", "topic_tags": "Depression,Biomarkers,Microdosing,Clinical Trial,Treatment-Resistant Depression,Safety,Inflammation", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07183748", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07183748", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07183748", "source_url": "https://clinicaltrials.gov/study/NCT07183748", "doi": "", "pmid": "", "publication_date": "2025-11-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3454, "title": "Open Label, Phase 2 Study for Evaluating the Feasibility, Safety and Efficacy of Psychotherapy Assisted Psilocybin for Treatment of Severe Obsessive Compulsive Disorder (OCD) in Drug and/or Psychotherapy Resistant Patients.", "authors": "Beersheva Mental Health Center", "journal": "ClinicalTrials.gov", "publication_date": "2025-11-18", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04882839", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,OCD,End-of-Life Distress,Headache / Migraine,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Consciousness,Emotional Processing,Spirituality,Clinical Trial,Case Report,Animal Study,Cancer Patients,Safety,Adverse Events,Toxicity,Drug Interactions", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04882839", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04882839", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04882839", "source_url": "https://clinicaltrials.gov/study/NCT04882839", "doi": "", "pmid": "", "publication_date": "2025-11-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3058, "title": "Microdosing Psilocybin for Major Depressive Disorder: Study Protocol for a Phase II Double-Blind Placebo-Controlled Randomized Partial Crossover Trial", "authors": "", "journal": "PsyArXiv", "publication_date": "2025-11-15", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/hmnsw_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Microdosing,Wellbeing,Creativity,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/hmnsw_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/hmnsw_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/hmnsw_v1", "source_url": "https://osf.io/preprints/psyarxiv/hmnsw_v1", "doi": "", "pmid": "", "publication_date": "2025-11-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 436, "title": "Negative affective bias in depression following treatment with psilocybin or escitalopram - a secondary analysis from a randomized trial", "authors": "Marieke Martens, Bruna Giribaldi Cunha, David Erritzøe, David Nutt, Robin Carhart-Harris, Catherine J. Harmer", "journal": "Translational Psychiatry", "publication_date": "2025-11-12", "publication_year": 2025, "doi": "10.1038/s41398-025-03693-w", "pubmed_id": "41257994", "openalex_id": "https://openalex.org/W4416593366", "source_url": "https://doi.org/10.1038/s41398-025-03693-w", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Mechanism of Action,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Meta-Analysis", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:41257994", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41398-025-03693-w", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41257994", "source_url": "https://doi.org/10.1038/s41398-025-03693-w", "doi": "10.1038/s41398-025-03693-w", "pmid": "41257994", "publication_date": "2025-11-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 408, "title": "Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis.", "authors": "Højlund M, Kafali HY, Kırmızı B, Fusar-Poli P, Correll CU, Cortese S, Sabé M, Fiedorowicz J, Saraf G, Zein J, Berk M, Husain MI, Rosenblat JD, Rubaiyat R, Corace K, Wong S, Hatcher S, Kaluzienski M, Yatham LN, Cipriani A, Gosling CJ, Carhart-Harris R, Tanuseputro P, Myran DT, Fabiano N, Moher D, Mayo LM, Nicholls SG, White T, Prisco M, Radua J, Vieta E, Ladha KS, Katz J, Veroniki AA, Solmi M.", "journal": null, "publication_date": "2025-11-06", "publication_year": 2025, "doi": "10.1016/j.euroneuro.2025.09.011", "pubmed_id": "41205366", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.euroneuro.2025.09.011", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:41205366", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.euroneuro.2025.09.011", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:41205366", "source_url": "https://doi.org/10.1016/j.euroneuro.2025.09.011", "doi": "10.1016/j.euroneuro.2025.09.011", "pmid": "41205366", "publication_date": "2025-11-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4247, "title": "Classic psychedelics may treat depressive disorders, but more evidence and legislative changes are required", "authors": "Aisling McGuigan", "journal": "Drugs & Therapy Perspectives", "publication_date": "2025-11-04", "publication_year": 2025, "doi": "10.1007/s40267-025-01199-5", "pubmed_id": null, "openalex_id": "https://openalex.org/W4415932492", "source_url": "https://doi.org/10.1007/s40267-025-01199-5", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 06:34:38", "bibtex": null, "source_record_id": "DOI:10.1007/s40267-025-01199-5", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1007/s40267-025-01199-5", "source_url": "https://doi.org/10.1007/s40267-025-01199-5", "doi": "10.1007/s40267-025-01199-5", "pmid": "", "publication_date": "2025-11-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3489, "title": "A Phase 1/2 Study of a Group Model of Psilocybin-Assisted Therapy for Cancer-Related Anxiety in Patients With Metastatic Cancer", "authors": "University of Washington", "journal": "ClinicalTrials.gov", "publication_date": "2025-11-04", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05847686", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Clinical Trial,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05847686", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05847686", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05847686", "source_url": "https://clinicaltrials.gov/study/NCT05847686", "doi": "", "pmid": "", "publication_date": "2025-11-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 357, "title": "Psilocybin Outside the Clinic", "authors": "Kent E. Hutchison, Jake F. Hooper, Hollis C. Karoly", "journal": "JAMA Psychiatry", "publication_date": "2025-11-04", "publication_year": 2025, "doi": "10.1001/jamapsychiatry.2025.3038", "pubmed_id": "41191341", "openalex_id": "https://openalex.org/W4415929140", "source_url": "https://doi.org/10.1001/jamapsychiatry.2025.3038", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Review Article,Safety,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:41191341", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1001/jamapsychiatry.2025.3038", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41191341", "source_url": "https://doi.org/10.1001/jamapsychiatry.2025.3038", "doi": "10.1001/jamapsychiatry.2025.3038", "pmid": "41191341", "publication_date": "2025-11-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 448, "title": "Psilocybin-assisted physiotherapy for refractory motor functional neurological disorder: protocol for a randomised dose-comparison pilot study", "authors": "Chiranth Bhagavan, Alexander Bryson, Olivia Carter, Glenn Nielsen, David J. Berlowitz, Sara Issak, Sabine Braat, Sophie Zaloumis, Zachary Attard, Dina Eleftheriadis, Georgina Oliver, Deanne Mayne, Greg Roebuck, James Rucker, Matthew Butler, Richard Kanaan", "journal": "Acta Neuropsychiatrica", "publication_date": "2025-11-03", "publication_year": 2025, "doi": "10.1017/neu.2025.10042", "pubmed_id": "41186141", "openalex_id": "https://openalex.org/W4415851344", "source_url": "https://doi.org/10.1017/neu.2025.10042", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Brain Imaging,Aging,Personality Change,Clinical Trial,Randomized Controlled Trial,Observational Study,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:41186141", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1017/neu.2025.10042", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41186141", "source_url": "https://doi.org/10.1017/neu.2025.10042", "doi": "10.1017/neu.2025.10042", "pmid": "41186141", "publication_date": "2025-11-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 271, "title": "Microdosing psilocybin and its effect on creativity: Lessons learned from three double-blind placebo controlled longitudinal trials", "authors": "Luisa Prochazkova, Josephine Marschall, Michiel van Elk, Ben David Rifkin, Neil R Schon, Donatella Fiacchino, George Fejer, Martin Kuchař, Bernhard Hommel", "journal": "Neuropharmacology", "publication_date": "2025-11-01", "publication_year": 2025, "doi": "10.1016/j.neuropharm.2025.110732", "pubmed_id": "41187880", "openalex_id": "https://openalex.org/W4415775160", "source_url": "https://doi.org/10.1016/j.neuropharm.2025.110732", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Pharmacology,Microdosing,Creativity,Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:41187880", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41187880", "source_url": "https://doi.org/10.1016/j.neuropharm.2025.110732", "doi": "10.1016/j.neuropharm.2025.110732", "pmid": "41187880", "publication_date": "2025-11-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 449, "title": "Reporting of side-effects in clinical trials of psilocybin-assisted psychotherapy for psychiatric conditions: systematic review", "authors": "Jonathon Marinis, Sarah Clarke, Alexandre A. Guerin, Adam J. Guastella, Gillinder Bedi", "journal": "BJPsych Open", "publication_date": "2025-10-31", "publication_year": 2025, "doi": "10.1192/bjo.2025.10847", "pubmed_id": "41178084", "openalex_id": "https://openalex.org/W4415782096", "source_url": "https://doi.org/10.1192/bjo.2025.10847", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:41178084", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1192/bjo.2025.10847", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41178084", "source_url": "https://doi.org/10.1192/bjo.2025.10847", "doi": "10.1192/bjo.2025.10847", "pmid": "41178084", "publication_date": "2025-10-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4256, "title": "Use of psilocybin for chronic pain: a scoping review with current evidence and prospection of literature and technology for future applications", "authors": "André Leão Dantas, Lara Moreira Jalles Milani, Saulo Gabriel Moreira Falci, João Américo da Silveira, Cristina Pereira Isolan, Lia Dietrich", "journal": "Caderno Pedagógico", "publication_date": "2025-10-30", "publication_year": 2025, "doi": "10.54033/cadpedv22n12-345", "pubmed_id": null, "openalex_id": "https://openalex.org/W4415830103", "source_url": "https://doi.org/10.54033/cadpedv22n12-345", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Neuroplasticity,Pharmacology,Receptor Pharmacology,Microdosing,Clinical Trial,Randomized Controlled Trial,Review Article,Animal Study,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.54033/cadpedv22n12-345", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.54033/cadpedv22n12-345", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.54033/cadpedv22n12-345", "source_url": "https://doi.org/10.54033/cadpedv22n12-345", "doi": "10.54033/cadpedv22n12-345", "pmid": "", "publication_date": "2025-10-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 466, "title": "Psychedelics and ketamine/esketamine in depressive disorders: biological mechanisms and associated neuroimaging and clinical changes.", "authors": "d'Andrea G, Chiappini S, Ciavoni L, Tucci R, Martino F, Semeraro FM, Di Battista D, Mosca A, Miuli A, Di Carlo F, Russo M, Di Petta G, Fornaro M, Pettorruso M, Sensi SL, Martinotti G.", "journal": null, "publication_date": "2025-10-30", "publication_year": 2025, "doi": "10.1038/s41398-025-03654-3", "pubmed_id": "41173871", "openalex_id": null, "source_url": "https://doi.org/10.1038/s41398-025-03654-3", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Aging,Emotional Processing,Clinical Trial,Systematic Review,Review Article,Observational Study,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:41173871", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1038/s41398-025-03654-3", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:41173871", "source_url": "https://doi.org/10.1038/s41398-025-03654-3", "doi": "10.1038/s41398-025-03654-3", "pmid": "41173871", "publication_date": "2025-10-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 306, "title": "Psilocybin use in bipolar disorder: A comprehensive review.", "authors": "Do A, Cloutier L, Hébert-Tremblay L, Thauvin C.", "journal": null, "publication_date": "2025-10-30", "publication_year": 2025, "doi": "10.1016/j.jad.2025.120485", "pubmed_id": "41177271", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jad.2025.120485", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Clinical Trial,Review Article,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:41177271", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jad.2025.120485", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:41177271", "source_url": "https://doi.org/10.1016/j.jad.2025.120485", "doi": "10.1016/j.jad.2025.120485", "pmid": "41177271", "publication_date": "2025-10-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3597, "title": "A Wellcome Leap for the Opioid Crisis: Can the 5HT2A Agonist Psilocybin Improve Brain, Behavioral, and Clinical Outcomes in Opioid Use Disorder (OUD)?", "authors": "Anna Rose Childress, Ph.D.", "journal": "ClinicalTrials.gov", "publication_date": "2025-10-28", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06786325", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,OCD,Receptor Pharmacology,Consciousness,Biomarkers,Emotional Processing,Spirituality,Mystical Experience,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06786325", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06786325", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06786325", "source_url": "https://clinicaltrials.gov/study/NCT06786325", "doi": "", "pmid": "", "publication_date": "2025-10-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4259, "title": "Psilocybin's effects on obsessive-compulsive behaviors: A systematic review of preclinical and clinical evidence", "authors": "James J Gattuso, Bilgenur Bezcioglu, Carey Wilson, Kato Havaux, Anthony J. Hannan, Thibault Renoir", "journal": "Psychedelics.", "publication_date": "2025-10-27", "publication_year": 2025, "doi": "10.61373/pp025i.0044", "pubmed_id": null, "openalex_id": "https://openalex.org/W4415615338", "source_url": "https://doi.org/10.61373/pp025i.0044", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,OCD,Chronic Pain,Neuroplasticity,Brain Imaging,Pharmacology,Biomarkers,Aging,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Animal Study,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.61373/pp025i.0044", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.61373/pp025i.0044", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.61373/pp025i.0044", "source_url": "https://doi.org/10.61373/pp025i.0044", "doi": "10.61373/pp025i.0044", "pmid": "", "publication_date": "2025-10-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 467, "title": "Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) therapy for patients with advanced cancer: protocol for a multi-method feasibility trial", "authors": "Candice Richardson, Cindy Chan, Emily Macgregor, Crystal Hare, Breffni Hannon, SarahRose Black, Evan E. Schneider, Daniel Z. Buchman, Stella Wang, Valeria E. Rac, Lusine Abrahamyan, Ella Huszti, Rinat Nissim, Madeline Li, Camilla Zimmermann, Emma Hapke, Daniel M. Rosenbaum, Sarah Hales", "journal": "Pilot and Feasibility Studies", "publication_date": "2025-10-27", "publication_year": 2025, "doi": "10.1186/s40814-025-01706-5", "pubmed_id": "41152967", "openalex_id": "https://openalex.org/W4415616586", "source_url": "https://doi.org/10.1186/s40814-025-01706-5", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:41152967", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1186/s40814-025-01706-5", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41152967", "source_url": "https://doi.org/10.1186/s40814-025-01706-5", "doi": "10.1186/s40814-025-01706-5", "pmid": "41152967", "publication_date": "2025-10-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 468, "title": "Provider perspectives on challenges in treatment during psychedelic therapy", "authors": "David A. Bender, Sandeep M. Nayak, Joshua S. Siegel, David J. Hellerstein, Barış Erçal, Eric J. Lenze", "journal": "Psychopharmacology", "publication_date": "2025-10-26", "publication_year": 2025, "doi": "10.1007/s00213-025-06907-7", "pubmed_id": "41139739", "openalex_id": "https://openalex.org/W4415564957", "source_url": "https://doi.org/10.1007/s00213-025-06907-7", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Clinical Trial,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 06:34:38", "bibtex": null, "source_record_id": "PMID:41139739", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41139739", "source_url": "https://doi.org/10.1007/s00213-025-06907-7", "doi": "10.1007/s00213-025-06907-7", "pmid": "41139739", "publication_date": "2025-10-26", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 470, "title": "A Systematic Review and Meta-Analysis Investigating the Efficacy of Various Psychedelic Drugs for the Treatment of Substance Use Disorder.", "authors": "Keighley EE, Abo Hamza E, Bedewy DA, Nalla S, Moustafa AA.", "journal": null, "publication_date": "2025-10-22", "publication_year": 2025, "doi": "10.3390/healthcare13212668", "pubmed_id": "41228035", "openalex_id": null, "source_url": "https://doi.org/10.3390/healthcare13212668", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Meta-Analysis,Systematic Review,Review Article", "study_type": "Meta-Analysis", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:41228035", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/healthcare13212668", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:41228035", "source_url": "https://doi.org/10.3390/healthcare13212668", "doi": "10.3390/healthcare13212668", "pmid": "41228035", "publication_date": "2025-10-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 391, "title": "Adverse event reporting and management in psilocybin therapy clinical trials: A systematic review to guide clinical and research protocol development.", "authors": "Bukovsky D, Amaev A, Song J, Kyte S, Carmona-Torres E, Ueno F, Deluca V, Strafella AP, Husain MI, Graff-Guerrero A, Gerretsen P.", "journal": null, "publication_date": "2025-10-22", "publication_year": 2025, "doi": "10.1016/j.pnpbp.2025.111541", "pubmed_id": "41138900", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.pnpbp.2025.111541", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Headache / Migraine,Clinical Trial,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:41138900", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.pnpbp.2025.111541", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:41138900", "source_url": "https://doi.org/10.1016/j.pnpbp.2025.111541", "doi": "10.1016/j.pnpbp.2025.111541", "pmid": "41138900", "publication_date": "2025-10-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 148, "title": "Landscape analysis of pre-registered clinical trials involving classical psychedelics.", "authors": "Uyar A, Forbrich L, Lueken U, Evens R.", "journal": null, "publication_date": "2025-10-20", "publication_year": 2025, "doi": "10.1177/02698811251371690", "pubmed_id": "41121524", "openalex_id": null, "source_url": "https://doi.org/10.1177/02698811251371690", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:41121524", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02698811251371690", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:41121524", "source_url": "https://doi.org/10.1177/02698811251371690", "doi": "10.1177/02698811251371690", "pmid": "41121524", "publication_date": "2025-10-20", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4262, "title": "Is there more to magic mushrooms than psilocybin?", "authors": "special to C EN Mara Johnson-Groh", "journal": "C&EN Global Enterprise", "publication_date": "2025-10-19", "publication_year": 2025, "doi": "10.1021/cen-10322-feature2", "pubmed_id": null, "openalex_id": "https://openalex.org/W4416285937", "source_url": "https://doi.org/10.1021/cen-10322-feature2", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Addiction,OCD,Receptor Pharmacology,Clinical Trial,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1021/cen-10322-feature2", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1021/cen-10322-feature2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1021/cen-10322-feature2", "source_url": "https://doi.org/10.1021/cen-10322-feature2", "doi": "10.1021/cen-10322-feature2", "pmid": "", "publication_date": "2025-10-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3050, "title": "Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacity: A Scoping Review", "authors": "Suspene J, Huet S, Berteina-Raboin S, Benyamina A, Baril P, Morisset-Lopez S, Serreau R.", "journal": "Preprints.org", "publication_date": "2025-10-16", "publication_year": 2025, "doi": "10.20944/preprints202510.1355.v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.20944/preprints202510.1355.v1", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.20944/preprints202510.1355.v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.20944/preprints202510.1355.v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.20944/preprints202510.1355.v1", "source_url": "https://doi.org/10.20944/preprints202510.1355.v1", "doi": "10.20944/preprints202510.1355.v1", "pmid": "", "publication_date": "2025-10-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 310, "title": "Contemplating versus having used psychedelics in bipolar disorder - What makes the difference?", "authors": "Vale LN, Ibrahim M, Fávaro-Pereira L, Soares JC, Meyer TD.", "journal": null, "publication_date": "2025-10-16", "publication_year": 2025, "doi": "10.1016/j.jad.2025.120437", "pubmed_id": "41109422", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jad.2025.120437", "substance_tags": "psilocybin", "topic_tags": "Personality Change,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:41109422", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jad.2025.120437", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:41109422", "source_url": "https://doi.org/10.1016/j.jad.2025.120437", "doi": "10.1016/j.jad.2025.120437", "pmid": "41109422", "publication_date": "2025-10-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 309, "title": "Cognitive and subjective effects of psilocybin microdosing: Results from two double-blind placebo-controlled longitudinal trials", "authors": "Luisa Prochazkova, Josephine Marschall, Dominique P. Lippelt, Neil R Schon, Martin Kuchař, Bernhard Hommel", "journal": "Neuropharmacology", "publication_date": "2025-10-16", "publication_year": 2025, "doi": "10.1016/j.neuropharm.2025.110722", "pubmed_id": "41110634", "openalex_id": "https://openalex.org/W4415356003", "source_url": "https://doi.org/10.1016/j.neuropharm.2025.110722", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Microdosing,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:41110634", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41110634", "source_url": "https://doi.org/10.1016/j.neuropharm.2025.110722", "doi": "10.1016/j.neuropharm.2025.110722", "pmid": "41110634", "publication_date": "2025-10-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 473, "title": "Biological markers of treatment response to serotonergic psychedelic therapies: a systematic review.", "authors": "Wong S, Jones BDM, Thiyagarajah MT, Sabbah SG, Thompson C, Solmi M, Umer M, Zrenner C, Voineskos D, Rosenblat JD, Mulsant BH, Blumberger DM, Husain MI.", "journal": null, "publication_date": "2025-10-15", "publication_year": 2025, "doi": "10.1177/20451253251384513", "pubmed_id": "41122434", "openalex_id": null, "source_url": "https://doi.org/10.1177/20451253251384513", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Biomarkers,Aging,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:41122434", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/20451253251384513", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:41122434", "source_url": "https://doi.org/10.1177/20451253251384513", "doi": "10.1177/20451253251384513", "pmid": "41122434", "publication_date": "2025-10-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 359, "title": "Mind the gap! Addressing unresolved aspects of abuse potential evaluation and scheduling of classic and novel psychedelic drugs", "authors": "David J. Heal, Jane Gosden, Sharon L. Smith", "journal": "Journal of Psychopharmacology", "publication_date": "2025-10-15", "publication_year": 2025, "doi": "10.1177/02698811251382147", "pubmed_id": "41099474", "openalex_id": "https://openalex.org/W4415246143", "source_url": "https://doi.org/10.1177/02698811251382147", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Safety,Toxicity,Abuse Liability", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:41099474", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/02698811251382147", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41099474", "source_url": "https://doi.org/10.1177/02698811251382147", "doi": "10.1177/02698811251382147", "pmid": "41099474", "publication_date": "2025-10-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 358, "title": "A novel psychedelic 5-HT2A receptor agonist GM-2505: The pharmacokinetic, safety, and pharmacodynamic profile from a randomized trial healthy volunteer", "authors": "Gerard J. Marek, Soma Makai-Bölöni, Daniel Umbricht, Edward P. Christian, Jason Winters, Dino Dvořák, Shane Raines, Zoë A. Hughes, Eric W. Austin, Adam K. Klein, William Leong, Fas J. Krol, Anne J. van der Graaf, Maria J. Juachon, Marije E. Otto, Laura Borghans, Gabriël E. Jacobs, Andrew C. Kruegel, Jonathan Sporn", "journal": "Journal of Psychopharmacology", "publication_date": "2025-10-15", "publication_year": 2025, "doi": "10.1177/02698811251378512", "pubmed_id": "41099491", "openalex_id": "https://openalex.org/W4415246252", "source_url": "https://doi.org/10.1177/02698811251378512", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Pharmacology,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Healthy Volunteers,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:41099491", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/02698811251378512", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41099491", "source_url": "https://doi.org/10.1177/02698811251378512", "doi": "10.1177/02698811251378512", "pmid": "41099491", "publication_date": "2025-10-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3640, "title": "A Phase 1 Study of a Second Psilocybin Group Retreat for Partial Responders With Anxiety Associated With Metastatic Cancer", "authors": "University of Washington", "journal": "ClinicalTrials.gov", "publication_date": "2025-10-13", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06644170", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Receptor Pharmacology,Wellbeing,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06644170", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06644170", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06644170", "source_url": "https://clinicaltrials.gov/study/NCT06644170", "doi": "", "pmid": "", "publication_date": "2025-10-13", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4271, "title": "Control group improvement lower in psilocybin trials for depression", "authors": "", "journal": "The Brown University Psychopharmacology Update", "publication_date": "2025-10-09", "publication_year": 2025, "doi": "10.1002/pu.31371", "pubmed_id": null, "openalex_id": "https://openalex.org/W4415055785", "source_url": "https://doi.org/10.1002/pu.31371", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1002/pu.31371", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/pu.31371", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/pu.31371", "source_url": "https://doi.org/10.1002/pu.31371", "doi": "10.1002/pu.31371", "pmid": "", "publication_date": "2025-10-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3575, "title": "Efficacy of Psilocybin and Trazodone Combination in Treatment-resistant Depression: a Randomized Controlled Proof-of-concept Study (PSILOTRAZ)", "authors": "Centre Hospitalier St Anne", "journal": "ClinicalTrials.gov", "publication_date": "2025-10-06", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07210112", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07210112", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07210112", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07210112", "source_url": "https://clinicaltrials.gov/study/NCT07210112", "doi": "", "pmid": "", "publication_date": "2025-10-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4275, "title": "Neurobiological and Therapeutic Potential of Psilocybin in Psychiatric Disorders", "authors": "M Loganathan, A Saravanakumar, P. Parthiban, G Anandharaj, S Gobika, D Dharshana, Mohamed Safir Ali", "journal": "Journal of Pharma Insights and Research.", "publication_date": "2025-10-04", "publication_year": 2025, "doi": "10.69613/thv1dn30", "pubmed_id": null, "openalex_id": "https://openalex.org/W4416779935", "source_url": "https://doi.org/10.69613/thv1dn30", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,End-of-Life Distress,Chronic Pain,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Clinical Trial,Treatment-Resistant Depression,Healthcare Workers,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.69613/thv1dn30", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.69613/thv1dn30", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.69613/thv1dn30", "source_url": "https://doi.org/10.69613/thv1dn30", "doi": "10.69613/thv1dn30", "pmid": "", "publication_date": "2025-10-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4276, "title": "Legal and Regulatory Barriers to Medical Psilocybin Use: An International Overview", "authors": "Mohamad Chweikh", "journal": null, "publication_date": "2025-10-01", "publication_year": 2025, "doi": "10.31219/osf.io/dy5cu_v1", "pubmed_id": null, "openalex_id": "https://openalex.org/W4414761184", "source_url": "https://doi.org/10.31219/osf.io/dy5cu_v1", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.31219/osf.io/dy5cu_v1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.31219/osf.io/dy5cu_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.31219/osf.io/dy5cu_v1", "source_url": "https://doi.org/10.31219/osf.io/dy5cu_v1", "doi": "10.31219/osf.io/dy5cu_v1", "pmid": "", "publication_date": "2025-10-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4283, "title": "3642 Down the rabbit hole: case reports of a hallucinogen-induced disorder of neuroperception", "authors": "Anneliese McConnell, Wei He, Harry McConnell, Sandro Sprendei, Paul F. Sowman", "journal": null, "publication_date": "2025-09-30", "publication_year": 2025, "doi": "10.1136/bmjno-2025-anzan.170", "pubmed_id": null, "openalex_id": "https://openalex.org/W4415496150", "source_url": "https://doi.org/10.1136/bmjno-2025-anzan.170", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Microdosing,Clinical Trial,Systematic Review,Review Article,Case Report,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1136/bmjno-2025-anzan.170", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1136/bmjno-2025-anzan.170", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1136/bmjno-2025-anzan.170", "source_url": "https://doi.org/10.1136/bmjno-2025-anzan.170", "doi": "10.1136/bmjno-2025-anzan.170", "pmid": "", "publication_date": "2025-09-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 485, "title": "[Role of psychedelics in psychiatry: a true therapeutic revolution or a trend?]", "authors": "Michel Sabé, Federico Seragnoli, Louise Penzenstadler, Gabriel Thorens", "journal": "PubMed", "publication_date": "2025-09-30", "publication_year": 2025, "doi": null, "pubmed_id": "41575100", "openalex_id": "https://openalex.org/W7125566383", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41575100", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,End-of-Life Distress,Consciousness,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:41575100", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41575100", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41575100", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41575100", "doi": "", "pmid": "41575100", "publication_date": "2025-09-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4287, "title": "Meditation, psychedelics, and brain connectivity: A randomized controlled resting-state fMRI study of N,N-dimethyltryptamine and harmine in a meditation retreat", "authors": "Egger, Klemens, Meling, Daniel, Polat, Firuze, Seifritz, Erich, Avram, Mihai, Scheidegger, Milan", "journal": "Universität Zürich, ZORA", "publication_date": "2025-09-28", "publication_year": 2025, "doi": "10.5167/uzh-280470", "pubmed_id": null, "openalex_id": "https://openalex.org/W7106223303", "source_url": "https://doi.org/10.5167/uzh-280470", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Brain Imaging,Mechanism of Action,Default Mode Network,Aging,Wellbeing,Emotional Processing,Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.5167/uzh-280470", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5167/uzh-280470", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5167/uzh-280470", "source_url": "https://doi.org/10.5167/uzh-280470", "doi": "10.5167/uzh-280470", "pmid": "", "publication_date": "2025-09-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 508, "title": "Ethical issues with psychedelic-assisted treatments in psychiatry: A systematic scoping review.", "authors": "Caporuscio C, Poppe C, Gieselmann A, Repantis D.", "journal": null, "publication_date": "2025-09-28", "publication_year": 2025, "doi": "10.1017/s0033291725101761", "pubmed_id": "41017267", "openalex_id": null, "source_url": "https://doi.org/10.1017/s0033291725101761", "substance_tags": "psilocybin", "topic_tags": "Wellbeing,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:41017267", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1017/s0033291725101761", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:41017267", "source_url": "https://doi.org/10.1017/s0033291725101761", "doi": "10.1017/s0033291725101761", "pmid": "41017267", "publication_date": "2025-09-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3507, "title": "An Exploratory Study of Feasibility, Efficacy, and Mechanisms of Mindfulness-Assisted Psychedelic Therapy", "authors": "University of Southern California", "journal": "ClinicalTrials.gov", "publication_date": "2025-09-25", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06233344", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Mechanism of Action,Biomarkers,Spirituality,Clinical Trial,Observational Study,Safety,Adverse Events,Inflammation", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06233344", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06233344", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06233344", "source_url": "https://clinicaltrials.gov/study/NCT06233344", "doi": "", "pmid": "", "publication_date": "2025-09-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3262, "title": "“So many relationships in the room”: Participant perspectives on the affordances and challenges of co-therapy in psychedelic assisted therapy", "authors": "", "journal": "PsyArXiv", "publication_date": "2025-09-25", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/4cn5r_v1", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Clinical Trial,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/4cn5r_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/4cn5r_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/4cn5r_v1", "source_url": "https://osf.io/preprints/psyarxiv/4cn5r_v1", "doi": "", "pmid": "", "publication_date": "2025-09-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3588, "title": "Observational Pilot Study to Explore the Social and Health Impacts of a New Model of Care in Oregon: Psilocybin Services on Alcoholism", "authors": "Healing Advocacy Fund", "journal": "ClinicalTrials.gov", "publication_date": "2025-09-23", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07189988", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Wellbeing,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07189988", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07189988", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07189988", "source_url": "https://clinicaltrials.gov/study/NCT07189988", "doi": "", "pmid": "", "publication_date": "2025-09-23", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 248, "title": "Innovative Pharmacological Approaches to Eating Disorder Treatment.", "authors": "Keshen A, Touyz S, Lacroix E, Hay P, McElroy SL.", "journal": null, "publication_date": "2025-09-23", "publication_year": 2025, "doi": "10.1016/j.psc.2025.08.014", "pubmed_id": "41708265", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.psc.2025.08.014", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:41708265", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.psc.2025.08.014", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:41708265", "source_url": "https://doi.org/10.1016/j.psc.2025.08.014", "doi": "10.1016/j.psc.2025.08.014", "pmid": "41708265", "publication_date": "2025-09-23", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4290, "title": "With great power comes great responsibility: Promise and caution in the new psychedelic renaissance", "authors": "Matthew Halma, R. Levy, Joseph Varón", "journal": "Brain Disorders", "publication_date": "2025-09-22", "publication_year": 2025, "doi": "10.1016/j.dscb.2025.100286", "pubmed_id": null, "openalex_id": "https://openalex.org/W4414440106", "source_url": "https://doi.org/10.1016/j.dscb.2025.100286", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Consciousness,Aging,Clinical Trial,Review Article,Treatment-Resistant Depression,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1016/j.dscb.2025.100286", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.dscb.2025.100286", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.dscb.2025.100286", "source_url": "https://doi.org/10.1016/j.dscb.2025.100286", "doi": "10.1016/j.dscb.2025.100286", "pmid": "", "publication_date": "2025-09-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 509, "title": "Psilocybin-assisted psychotherapy for methamphetamine use disorder: A pilot open-label safety and feasibility study", "authors": "Elizabeth Knock, Krista J. Siefried, Gillinder Bedi, Steven M. Albert, Richard O. Day, Nadine Ezard, Margaret Ross, Paul Liknaitzky, Jonathan Brett", "journal": "Addiction", "publication_date": "2025-09-19", "publication_year": 2025, "doi": "10.1111/add.70187", "pubmed_id": "40974259", "openalex_id": "https://openalex.org/W4414374510", "source_url": "https://doi.org/10.1111/add.70187", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Headache / Migraine,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40974259", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/add.70187", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40974259", "source_url": "https://doi.org/10.1111/add.70187", "doi": "10.1111/add.70187", "pmid": "40974259", "publication_date": "2025-09-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4292, "title": "S1 Appendix - Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trial", "authors": "Benjamin R. Lewis (22279166), John Hendrick (22279169), Kevin Byrne (1610821), Madeleine Odette (22279172), Chaorong Wu (8444343), Eric L. Garland (4666660)", "journal": "Figshare", "publication_date": "2025-09-18", "publication_year": 2025, "doi": "10.1371/journal.pmed.1004519.s001", "pubmed_id": null, "openalex_id": "https://openalex.org/W7110952270", "source_url": "https://figshare.com/articles/journal_contribution/S1_Appendix_-_Psilocybin-assisted_group_psychotherapy_and_mindfulness-based_stress_reduction_for_frontline_healthcare_provider_COVID-19-related_depression_and_burnout_A_randomized_controlled_trial/30170132", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1371/journal.pmed.1004519.s001", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://figshare.com/articles/journal_contribution/S1_Appendix_-_Psilocybin-assisted_group_psychotherapy_and_mindfulness-based_stress_reduction_for_frontline_healthcare_provider_COVID-19-related_depression_and_burnout_A_randomized_controlled_trial/30170132", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1371/journal.pmed.1004519.s001", "source_url": "https://figshare.com/articles/journal_contribution/S1_Appendix_-_Psilocybin-assisted_group_psychotherapy_and_mindfulness-based_stress_reduction_for_frontline_healthcare_provider_COVID-19-related_depression_and_burnout_A_randomized_controlled_trial/30170132", "doi": "10.1371/journal.pmed.1004519.s001", "pmid": "", "publication_date": "2025-09-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 512, "title": "Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trial", "authors": "Benjamin R. Lewis, John Hendrick, Kevin Byrne, Madeleine Odette, Chaorong Wu, Eric L. Garland", "journal": "PLoS Medicine", "publication_date": "2025-09-18", "publication_year": 2025, "doi": "10.1371/journal.pmed.1004519", "pubmed_id": "40972137", "openalex_id": "https://openalex.org/W4414366251", "source_url": "https://doi.org/10.1371/journal.pmed.1004519", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Observational Study,Healthcare Workers,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40972137", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1371/journal.pmed.1004519", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40972137", "source_url": "https://doi.org/10.1371/journal.pmed.1004519", "doi": "10.1371/journal.pmed.1004519", "pmid": "40972137", "publication_date": "2025-09-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 511, "title": "Evolution and Comparative Analysis of Clinical Trials on Psilocybin in the Treatment of Psychopathologies: Trends in the EU and the US", "authors": "Anastasia Calin, Ana Flavia Burlec, Cornelia Mircea, Irina Macovei, Monica Hăncianu, Andreia Corciovă", "journal": "Journal of Clinical Medicine", "publication_date": "2025-09-18", "publication_year": 2025, "doi": "10.3390/jcm14186613", "pubmed_id": "41010814", "openalex_id": "https://openalex.org/W4414341779", "source_url": "https://doi.org/10.3390/jcm14186613", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:41010814", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/jcm14186613", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41010814", "source_url": "https://doi.org/10.3390/jcm14186613", "doi": "10.3390/jcm14186613", "pmid": "41010814", "publication_date": "2025-09-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3709, "title": "PRoMiSS: Psilocybin and the Role of Music in Set and Setting", "authors": "Johns Hopkins University", "journal": "ClinicalTrials.gov", "publication_date": "2025-09-17", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07180108", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Consciousness,Wellbeing,Emotional Processing,Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07180108", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07180108", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07180108", "source_url": "https://clinicaltrials.gov/study/NCT07180108", "doi": "", "pmid": "", "publication_date": "2025-09-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4293, "title": "Efficacy of Psychedelics Therapy Across Psychiatric Disorders: An Umbrella Review of Meta-Analyses", "authors": "Lopez, Alissa A, Salloum, Ihsan, Lopez-Alvarenga, Juan C", "journal": "ScholarWorks @ UTRGV (The University of Texas Rio Grande Valley)", "publication_date": "2025-09-16", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7110568410", "source_url": "https://scholarworks.utrgv.edu/colloquium/2025/talks/1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Clinical Trial,Meta-Analysis,Systematic Review,Review Article,Toxicity", "study_type": "Meta-Analysis", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "https://scholarworks.utrgv.edu/colloquium/2025/talks/1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://scholarworks.utrgv.edu/colloquium/2025/talks/1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://scholarworks.utrgv.edu/colloquium/2025/talks/1", "source_url": "https://scholarworks.utrgv.edu/colloquium/2025/talks/1", "doi": "", "pmid": "", "publication_date": "2025-09-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 487, "title": "Dynamic myocardial injury and variable hallucination latency in Psilocybe keralensis poisoning: a molecularly confirmed case series from China", "authors": "Zhifan He, Rui Tang, Min Feng, Xiaohui Li, Changhong Zhang, Jing Li", "journal": "Clinical Toxicology", "publication_date": "2025-09-14", "publication_year": 2025, "doi": "10.1080/15563650.2025.2552438", "pubmed_id": "40948398", "openalex_id": "https://openalex.org/W4414167818", "source_url": "https://doi.org/10.1080/15563650.2025.2552438", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Case Report,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40948398", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/15563650.2025.2552438", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40948398", "source_url": "https://doi.org/10.1080/15563650.2025.2552438", "doi": "10.1080/15563650.2025.2552438", "pmid": "40948398", "publication_date": "2025-09-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 476, "title": "Psilocybin Enhances Cued Fear Extinction and Extinction Recall in Stress-Naïve, Acutely Stressed, and Chronically Stressed Mice", "authors": "John A. Razidlo, Noelle Cataldo, Cody J. Wenthur", "journal": "ACS Pharmacology & Translational Science", "publication_date": "2025-09-10", "publication_year": 2025, "doi": "10.1021/acsptsci.5c00462", "pubmed_id": "41244305", "openalex_id": "https://openalex.org/W4414130775", "source_url": "https://doi.org/10.1021/acsptsci.5c00462", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:41244305", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1021/acsptsci.5c00462", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41244305", "source_url": "https://doi.org/10.1021/acsptsci.5c00462", "doi": "10.1021/acsptsci.5c00462", "pmid": "41244305", "publication_date": "2025-09-10", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3699, "title": "Measurement of Serum Cytokine Levels in Samples Collected as Part of a Clinical Trial of Psilocybin for Treatment-resistant Depression.", "authors": "King's College London", "journal": "ClinicalTrials.gov", "publication_date": "2025-09-09", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07164755", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Biomarkers,Clinical Trial,Animal Study,In Vitro Study,Treatment-Resistant Depression,Safety,Inflammation,Immune Function", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07164755", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07164755", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07164755", "source_url": "https://clinicaltrials.gov/study/NCT07164755", "doi": "", "pmid": "", "publication_date": "2025-09-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 522, "title": "Psychedelics and mental health: reimagining care through science, insight, and compassion", "authors": "Georgios Mikellides, Marios Kyriazis", "journal": "Frontiers in Pharmacology", "publication_date": "2025-09-02", "publication_year": 2025, "doi": "10.3389/fphar.2025.1649929", "pubmed_id": "40969944", "openalex_id": "https://openalex.org/W4413961399", "source_url": "https://doi.org/10.3389/fphar.2025.1649929", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,OCD,End-of-Life Distress,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Aging,Wellbeing,Emotional Processing,Spirituality,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Review Article,Treatment-Resistant Depression,Safety,Adverse Events,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40969944", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fphar.2025.1649929", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40969944", "source_url": "https://doi.org/10.3389/fphar.2025.1649929", "doi": "10.3389/fphar.2025.1649929", "pmid": "40969944", "publication_date": "2025-09-02", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3571, "title": "Effect of Psilocybin Only and Psilocybin Assisted Cognitive Behavioral Therapy in the Management of Major Depressive Disorder and Associated Metabolic, Immune, Inflammatory, Neuroplasticity and Electrical Activity Markers: a Randomized Controlled Trial", "authors": "Khyber Medical University Peshawar", "journal": "ClinicalTrials.gov", "publication_date": "2025-09-01", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06746441", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Neuroplasticity,Brain Imaging,Biomarkers,Clinical Trial,Randomized Controlled Trial,Inflammation,Immune Function", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06746441", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06746441", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06746441", "source_url": "https://clinicaltrials.gov/study/NCT06746441", "doi": "", "pmid": "", "publication_date": "2025-09-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4304, "title": "PSYCHEDELICS IN PSYCHIATRY - OVERVIEW OF PSILOCYBIN RESEARCH", "authors": "Anna Blazhkova, Magdalena Czaja, Hanna Sitka, Sven Solisch, Anna Susłow, Ewa Szczęsna", "journal": "International Journal of Innovative Technologies in Social Science", "publication_date": "2025-08-31", "publication_year": 2025, "doi": "10.31435/ijitss.3(47).2025.3650", "pubmed_id": null, "openalex_id": "https://openalex.org/W4413888032", "source_url": "https://doi.org/10.31435/ijitss.3(47).2025.3650", "substance_tags": "psilocybin", "topic_tags": "Depression,Eating Disorders,Neuroplasticity,Mechanism of Action,Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.31435/ijitss.3(47).2025.3650", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.31435/ijitss.3(47).2025.3650", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.31435/ijitss.3(47).2025.3650", "source_url": "https://doi.org/10.31435/ijitss.3(47).2025.3650", "doi": "10.31435/ijitss.3(47).2025.3650", "pmid": "", "publication_date": "2025-08-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4303, "title": "A lexicon for psychedelic research and treatment", "authors": "David Nutt, David Erritzøe, Anne Katrin Schlag, David Luke, Deborah C. Mash, Hiroyuki Uchida, Jacob S. Aday, James Rucker, Liliana Galindo, Mark Sweeney, Matthew X. Lowe, Oliver Davis, Plinio Ferreira, Rayyan Zafar, Robin Carhart-Harris, Tadeusz Hawrot, Joanna C. Neill", "journal": "Drug Science Policy and Law", "publication_date": "2025-08-31", "publication_year": 2025, "doi": "10.1177/20503245251380511", "pubmed_id": null, "openalex_id": "https://openalex.org/W4414407628", "source_url": "https://doi.org/10.1177/20503245251380511", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Microdosing,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1177/20503245251380511", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/20503245251380511", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/20503245251380511", "source_url": "https://doi.org/10.1177/20503245251380511", "doi": "10.1177/20503245251380511", "pmid": "", "publication_date": "2025-08-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 483, "title": "Psilocybin with psychotherapeutic support for treatment-resistant depression: a pilot clinical trial", "authors": "Sally Meikle, Olivia Carter, Paul Liknaitzky, Lauren Johansen, Ravi Iyer, Nigel Strauss, M.L. Williams, David Castle, Susan L. Rossell", "journal": "Therapeutic Advances in Psychopharmacology", "publication_date": "2025-08-31", "publication_year": 2025, "doi": "10.1177/20451253251377187", "pubmed_id": "41050149", "openalex_id": "https://openalex.org/W4414745551", "source_url": "https://doi.org/10.1177/20451253251377187", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Spirituality,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:41050149", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/20451253251377187", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41050149", "source_url": "https://doi.org/10.1177/20451253251377187", "doi": "10.1177/20451253251377187", "pmid": "41050149", "publication_date": "2025-08-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 361, "title": "Investigating the safety and tolerability of single-dose psilocybin for post-traumatic stress disorder: A nonrandomized open-label clinical trial", "authors": "Niall M. McGowan, James Rucker, Rachel Yehuda, Manish Agrawal, Nadav Liam Modlin, Hollie Simmons, Agata Tofil-Kaluza, Shriya Das, Guy M. Goodwin", "journal": "Journal of Psychopharmacology", "publication_date": "2025-08-28", "publication_year": 2025, "doi": "10.1177/02698811251362390", "pubmed_id": "40883964", "openalex_id": "https://openalex.org/W4413839750", "source_url": "https://doi.org/10.1177/02698811251362390", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Chronic Pain,Headache / Migraine,Pharmacology,Clinical Trial,Treatment-Resistant Depression,Healthcare Workers,Safety,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40883964", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/02698811251362390", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40883964", "source_url": "https://doi.org/10.1177/02698811251362390", "doi": "10.1177/02698811251362390", "pmid": "40883964", "publication_date": "2025-08-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3485, "title": "A Phase 2 Single-site, Double-blind, Placebo-controlled, Randomized Clinical Trial With an Open-label Extension Phase to Examine the Safety, Subjective Experiences, Acute Effects, and Suitability of Psilocybin Combined With Psychological Support (Psi-PS) for Military Veterans and First Responders With Co-occurring Alcohol Use Disorder (AUD) and Posttraumatic Stress Disorder (PTSD)", "authors": "Nathan Brashares Sackett", "journal": "ClinicalTrials.gov", "publication_date": "2025-08-27", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06853912", "substance_tags": "psilocybin", "topic_tags": "PTSD,Addiction,Clinical Trial,Veterans,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06853912", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06853912", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06853912", "source_url": "https://clinicaltrials.gov/study/NCT06853912", "doi": "", "pmid": "", "publication_date": "2025-08-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 558, "title": "Overview and Specificity of Psilocybin Use in the Treatment of Mental Disorders: A Scientometric Analysis.", "authors": "Fernandes-Nascimento MH, Viana-Ferreira K, Negrão AB.", "journal": null, "publication_date": "2025-08-27", "publication_year": 2025, "doi": "10.1089/psymed.2024.0031", "pubmed_id": "40933206", "openalex_id": null, "source_url": "https://doi.org/10.1089/psymed.2024.0031", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:40933206", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1089/psymed.2024.0031", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40933206", "source_url": "https://doi.org/10.1089/psymed.2024.0031", "doi": "10.1089/psymed.2024.0031", "pmid": "40933206", "publication_date": "2025-08-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4312, "title": "Psychedelic minimalism: the case against music in psychedelic therapy settings", "authors": "Samir A Nader", "journal": "Frontiers in Psychiatry", "publication_date": "2025-08-25", "publication_year": 2025, "doi": "10.3389/fpsyt.2025.1652568", "pubmed_id": "40933801", "openalex_id": "https://openalex.org/W4413614435", "source_url": "https://doi.org/10.3389/fpsyt.2025.1652568", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Consciousness,Personality Change,Emotional Processing,Clinical Trial,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40933801", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2025.1652568", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40933801", "source_url": "https://doi.org/10.3389/fpsyt.2025.1652568", "doi": "10.3389/fpsyt.2025.1652568", "pmid": "40933801", "publication_date": "2025-08-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4314, "title": "“To Have the Encounter with Our Own Finiteness in that Existential Way”: Descriptions of Existential Experience in Patients with Cancer and Major Depression Participating in Psilocybin-Assisted Group Therapy", "authors": "Elise C. Tarbi, Skye A. Miner, Kabir Nigam, Zachary Sager, Justin J. Sanders, Michael Ljuslin, Benjamin Guérin, Kimberly Roddy, James A. Tulsky, Manish Agrawal, Yvan Beaussant", "journal": "Psychedelic Medicine", "publication_date": "2025-08-24", "publication_year": 2025, "doi": "10.1177/28314425251370303", "pubmed_id": null, "openalex_id": "https://openalex.org/W4414955208", "source_url": "https://doi.org/10.1177/28314425251370303", "substance_tags": "psilocybin", "topic_tags": "Depression,Spirituality,Clinical Trial,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1177/28314425251370303", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/28314425251370303", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/28314425251370303", "source_url": "https://doi.org/10.1177/28314425251370303", "doi": "10.1177/28314425251370303", "pmid": "", "publication_date": "2025-08-24", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 560, "title": "Psychedelic Therapy, Positive Emotional Experiences, and the Central Role of Self-Compassion", "authors": "Zeifman R, Danias G, Agin-Liebes G, Pagni B, Kettner H, Bhat V, Ross S, Erritzoe D, Carhart-Harris R.", "journal": "Research Square", "publication_date": "2025-08-21", "publication_year": 2025, "doi": "10.21203/rs.3.rs-7420529/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-7420529/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Emotional Processing,Mystical Experience,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-7420529/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-7420529/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-7420529/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-7420529/v1", "doi": "10.21203/rs.3.rs-7420529/v1", "pmid": "", "publication_date": "2025-08-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 561, "title": "Psychedelics and the Serotonin Hypothesis of Eating Disorders.", "authors": "Bilenker D, Avena NM.", "journal": null, "publication_date": "2025-08-20", "publication_year": 2025, "doi": "10.3390/brainsci15080893", "pubmed_id": "40867224", "openalex_id": null, "source_url": "https://doi.org/10.3390/brainsci15080893", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Neuroplasticity,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Animal Study,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:40867224", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/brainsci15080893", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40867224", "source_url": "https://doi.org/10.3390/brainsci15080893", "doi": "10.3390/brainsci15080893", "pmid": "40867224", "publication_date": "2025-08-20", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3466, "title": "A Phase II, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of COMP360 in Participants With Recurrent Major Depressive Disorder", "authors": "COMPASS Pathways", "journal": "ClinicalTrials.gov", "publication_date": "2025-08-18", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05733546", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05733546", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05733546", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05733546", "source_url": "https://clinicaltrials.gov/study/NCT05733546", "doi": "", "pmid": "", "publication_date": "2025-08-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 418, "title": "Exploring the therapeutic potential of psychedelics in treating substance use disorders.", "authors": "Li Y, Li H, Wang H, Wang X.", "journal": null, "publication_date": "2025-08-18", "publication_year": 2025, "doi": "10.1038/s41380-025-03168-w", "pubmed_id": "40830580", "openalex_id": null, "source_url": "https://doi.org/10.1038/s41380-025-03168-w", "substance_tags": "psilocybin", "topic_tags": "Addiction,Neuroplasticity,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:40830580", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1038/s41380-025-03168-w", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40830580", "source_url": "https://doi.org/10.1038/s41380-025-03168-w", "doi": "10.1038/s41380-025-03168-w", "pmid": "40830580", "publication_date": "2025-08-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3070, "title": "Psilocybin treatment for symptoms of depression: a living systematic review, meta-analysis, and data resource", "authors": "Singleton SP, Sevchik BL, Lahey A, Cuijpers P, Harrer M, Jones MT, Nayak SM, Strain EC, Vandekar SN, Dworkin RH, Scott JC, Satterthwaite TD.", "journal": "medRxiv", "publication_date": "2025-08-15", "publication_year": 2025, "doi": "10.1101/2025.08.13.25333530", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2025.08.13.25333530", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.1101/2025.08.13.25333530", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2025.08.13.25333530", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2025.08.13.25333530", "source_url": "https://doi.org/10.1101/2025.08.13.25333530", "doi": "10.1101/2025.08.13.25333530", "pmid": "", "publication_date": "2025-08-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 598, "title": "Perspectives on Trauma Treatment, Self-Management Strategies, and Attitudes Toward Psychedelic Therapies in Individuals with Psychological Trauma Symptoms", "authors": "Nadav Liam Modlin, Jessica L. Maples-Keller, Maria Sarang, Lucie Siebenaler, Carolina Maggio, Susannah Pick, Victoria Williamson, Anthony J. Cleare, James Rucker", "journal": "Psychiatry and Clinical Psychopharmacology", "publication_date": "2025-08-13", "publication_year": 2025, "doi": "10.5152/pcp.2025.24934", "pubmed_id": "40864832", "openalex_id": "https://openalex.org/W4413381444", "source_url": "https://doi.org/10.5152/pcp.2025.24934", "substance_tags": "psilocybin", "topic_tags": "PTSD,Receptor Pharmacology,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40864832", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5152/pcp.2025.24934", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40864832", "source_url": "https://doi.org/10.5152/pcp.2025.24934", "doi": "10.5152/pcp.2025.24934", "pmid": "40864832", "publication_date": "2025-08-13", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 364, "title": "Toward Standardized Products Containing Biomass of Psilocybe Cubensis Fungi", "authors": "Kimberley Foster, Isaac Morrison, Shemar Daniel, Johann M.R. Antoine, Babumon M. Thankappan, Winston De La Haye, Marshall Tyler, Charles N. Grant, Rupika Delgoda", "journal": "Journal of AOAC International", "publication_date": "2025-08-12", "publication_year": 2025, "doi": "10.1093/jaoacint/qsaf072", "pubmed_id": "40802522", "openalex_id": "https://openalex.org/W4413116294", "source_url": "https://doi.org/10.1093/jaoacint/qsaf072", "substance_tags": "psilocybin,psilocin", "topic_tags": "Wellbeing,Clinical Trial,Healthcare Workers,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40802522", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/jaoacint/qsaf072", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40802522", "source_url": "https://doi.org/10.1093/jaoacint/qsaf072", "doi": "10.1093/jaoacint/qsaf072", "pmid": "40802522", "publication_date": "2025-08-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 530, "title": "Psilocybin-assisted psychotherapy for depression and anxiety associated with life threatening illness: A phase 2b randomized controlled trial", "authors": "Margaret Ross, Ravi Iyer, M.L. Williams, Mark Boughey, Clare O’Callaghan, Richard Hiscock, Justin Dwyer", "journal": "General Hospital Psychiatry", "publication_date": "2025-08-11", "publication_year": 2025, "doi": "10.1016/j.genhosppsych.2025.08.001", "pubmed_id": "40858059", "openalex_id": "https://openalex.org/W4413190735", "source_url": "https://doi.org/10.1016/j.genhosppsych.2025.08.001", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Wellbeing,Spirituality,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40858059", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.genhosppsych.2025.08.001", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40858059", "source_url": "https://doi.org/10.1016/j.genhosppsych.2025.08.001", "doi": "10.1016/j.genhosppsych.2025.08.001", "pmid": "40858059", "publication_date": "2025-08-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 567, "title": "Psychedelic-Assisted Therapy: Potential Benefits and Challenges in Mental Health Treatment.", "authors": "Silczuk A, Madejek RJ, Koweszko T, Mularczyk-Tomczewska P, Adamska E, Gujski M, Szulc A.", "journal": null, "publication_date": "2025-08-08", "publication_year": 2025, "doi": "10.12659/msm.948302", "pubmed_id": "40781763", "openalex_id": null, "source_url": "https://doi.org/10.12659/msm.948302", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,OCD,Neuroplasticity,Mechanism of Action,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:40781763", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.12659/msm.948302", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40781763", "source_url": "https://doi.org/10.12659/msm.948302", "doi": "10.12659/msm.948302", "pmid": "40781763", "publication_date": "2025-08-08", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4316, "title": "Intersecting Psychedelic Pharmacology and Gut-Brain Axis Signaling in Neurodegenerative Disorders", "authors": "Harsha S. Krishna", "journal": "JUNIOR RESEARCHERS", "publication_date": "2025-08-07", "publication_year": 2025, "doi": "10.52340/jr.2025.03.03.09", "pubmed_id": null, "openalex_id": "https://openalex.org/W4413142010", "source_url": "https://doi.org/10.52340/jr.2025.03.03.09", "substance_tags": "psilocybin", "topic_tags": "Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Microbiome,Inflammation,Immune Function", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.52340/jr.2025.03.03.09", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.52340/jr.2025.03.03.09", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.52340/jr.2025.03.03.09", "source_url": "https://doi.org/10.52340/jr.2025.03.03.09", "doi": "10.52340/jr.2025.03.03.09", "pmid": "", "publication_date": "2025-08-07", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 576, "title": "Latent Classes of Lifetime Use of Seven Hallucinogens in the United States", "authors": "Meredith C. Meacham, Maha N. Mian, Ralph C. Wang, Allison R. Coker, B. Anderson, Juan Carlos C. Montoy", "journal": "Journal of Psychoactive Drugs", "publication_date": "2025-08-03", "publication_year": 2025, "doi": "10.1080/02791072.2025.2537040", "pubmed_id": "40760833", "openalex_id": "https://openalex.org/W4412950224", "source_url": "https://doi.org/10.1080/02791072.2025.2537040", "substance_tags": "psilocybin", "topic_tags": "Receptor Pharmacology,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40760833", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/02791072.2025.2537040", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40760833", "source_url": "https://doi.org/10.1080/02791072.2025.2537040", "doi": "10.1080/02791072.2025.2537040", "pmid": "40760833", "publication_date": "2025-08-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 575, "title": "Therapeutic and legal aspects of psilocybin in cancer-related depression", "authors": "Małgorzata Wierzbicka, Renata Kopczyk, Aleksandra Gerlach, Joanna Rymaszewska", "journal": "Frontiers in Psychiatry", "publication_date": "2025-08-03", "publication_year": 2025, "doi": "10.3389/fpsyt.2025.1591864", "pubmed_id": "40831528", "openalex_id": "https://openalex.org/W4412939048", "source_url": "https://doi.org/10.3389/fpsyt.2025.1591864", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Observational Study,Cancer Patients,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40831528", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2025.1591864", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40831528", "source_url": "https://doi.org/10.3389/fpsyt.2025.1591864", "doi": "10.3389/fpsyt.2025.1591864", "pmid": "40831528", "publication_date": "2025-08-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4335, "title": "577. CLINICAL EVIDENCE AND APPLICATIONS OF PSYCHEDELICS FOR MENTAL ILLNESSES", "authors": "Hiroe Tani", "journal": "The International Journal of Neuropsychopharmacology", "publication_date": "2025-07-31", "publication_year": 2025, "doi": "10.1093/ijnp/pyaf052.377", "pubmed_id": null, "openalex_id": "https://openalex.org/W4413284846", "source_url": "https://doi.org/10.1093/ijnp/pyaf052.377", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,End-of-Life Distress,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1093/ijnp/pyaf052.377", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/ijnp/pyaf052.377", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1093/ijnp/pyaf052.377", "source_url": "https://doi.org/10.1093/ijnp/pyaf052.377", "doi": "10.1093/ijnp/pyaf052.377", "pmid": "", "publication_date": "2025-07-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3235, "title": "229. PSILOCYBIN WITH PSYCHOTHERAPEUTIC SUPPORT FOR TREATMENT-RESISTANT DEPRESSION: A PILOT CLINICAL TRIAL", "authors": "", "journal": null, "publication_date": "2025-07-31", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC12359778", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC12359778", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC12359778", "source_url": "https://europepmc.org/article/PMC/PMC12359778", "doi": "", "pmid": "", "publication_date": "2025-07-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 580, "title": "Psilocybin as Transformative Fast-Acting Antidepressant: Pharmacological Properties and Molecular Mechanisms.", "authors": "Adebo M, Bonnet M, Laouej O, Defaix C, McGowan JC, Butlen-Ducuing F, David DJ, Poupon E, Tritschler L, Gardier AM.", "journal": null, "publication_date": "2025-07-31", "publication_year": 2025, "doi": "10.1111/fcp.70038", "pubmed_id": "40670864", "openalex_id": null, "source_url": "https://doi.org/10.1111/fcp.70038", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Animal Study", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:40670864", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1111/fcp.70038", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40670864", "source_url": "https://doi.org/10.1111/fcp.70038", "doi": "10.1111/fcp.70038", "pmid": "40670864", "publication_date": "2025-07-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4342, "title": "Preparing Social Work for Psychedelic-Assisted Therapy", "authors": "Heidi Allen, B. Stott", "journal": "Social Work", "publication_date": "2025-07-29", "publication_year": 2025, "doi": "10.1093/sw/swaf031", "pubmed_id": "40803340", "openalex_id": "https://openalex.org/W4413116433", "source_url": "https://doi.org/10.1093/sw/swaf031", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40803340", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/sw/swaf031", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40803340", "source_url": "https://doi.org/10.1093/sw/swaf031", "doi": "10.1093/sw/swaf031", "pmid": "40803340", "publication_date": "2025-07-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 73, "title": "Meaning-Centered Psychotherapy for Psilocybin-Assisted Therapy Among Patients with Advanced Cancer and Depression: Rationale and Preliminary Evaluation of MCP-PSIL.", "authors": "Rosa WE, Napolitano S, McAndrew N, Jenkins B, Lichtenthal WG, Applebaum AJ, Breitbart W, Agrawal M.", "journal": null, "publication_date": "2025-07-29", "publication_year": 2025, "doi": "10.1177/28314425251363983", "pubmed_id": "42311441", "openalex_id": null, "source_url": "https://doi.org/10.1177/28314425251363983", "substance_tags": "psilocybin", "topic_tags": "Depression,Aging,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:42311441", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/28314425251363983", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42311441", "source_url": "https://doi.org/10.1177/28314425251363983", "doi": "10.1177/28314425251363983", "pmid": "42311441", "publication_date": "2025-07-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 599, "title": "Psilocybin in the treatment of eating disorders: a systematic review of the literature and registered clinical trials.", "authors": "Bevione F, Lacidogna MC, Lavalle R, Abbate Daga G, Preti A.", "journal": null, "publication_date": "2025-07-28", "publication_year": 2025, "doi": "10.1007/s40519-025-01771-y", "pubmed_id": "40730892", "openalex_id": null, "source_url": "https://doi.org/10.1007/s40519-025-01771-y", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Case Report,Observational Study,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:40730892", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s40519-025-01771-y", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40730892", "source_url": "https://doi.org/10.1007/s40519-025-01771-y", "doi": "10.1007/s40519-025-01771-y", "pmid": "40730892", "publication_date": "2025-07-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3691, "title": "Outpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder: a Randomized Double-blind Trial", "authors": "Johns Hopkins University", "journal": "ClinicalTrials.gov", "publication_date": "2025-07-27", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06067737", "substance_tags": "psilocybin", "topic_tags": "Addiction,Pharmacology,Clinical Trial,Randomized Controlled Trial,Healthy Volunteers,Healthcare Workers,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06067737", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06067737", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06067737", "source_url": "https://clinicaltrials.gov/study/NCT06067737", "doi": "", "pmid": "", "publication_date": "2025-07-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3424, "title": "Modulation of Serotonin Pathways Using Psilocybin in Adults With and Without Autism Spectrum Disorder (ASD)", "authors": "King's College London", "journal": "ClinicalTrials.gov", "publication_date": "2025-07-27", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05651126", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05651126", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05651126", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05651126", "source_url": "https://clinicaltrials.gov/study/NCT05651126", "doi": "", "pmid": "", "publication_date": "2025-07-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3648, "title": "Mechanistic Studies of Psilocybin in Headache Disorders", "authors": "Yale University", "journal": "ClinicalTrials.gov", "publication_date": "2025-07-23", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06464367", "substance_tags": "psilocybin", "topic_tags": "Headache / Migraine,Neuroplasticity,Brain Imaging,Biomarkers,Clinical Trial,Inflammation", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06464367", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06464367", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06464367", "source_url": "https://clinicaltrials.gov/study/NCT06464367", "doi": "", "pmid": "", "publication_date": "2025-07-23", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 602, "title": "Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial", "authors": "Amandine Luquiens, Dahbia Belahda, Carine Graux, Noe Igounenc, Chris Serrand, Paul A. Rochefort, Thibault Mura, Felix Sergent", "journal": "Addiction", "publication_date": "2025-07-23", "publication_year": 2025, "doi": "10.1111/add.70152", "pubmed_id": "40702912", "openalex_id": "https://openalex.org/W4412642858", "source_url": "https://doi.org/10.1111/add.70152", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40702912", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/add.70152", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40702912", "source_url": "https://doi.org/10.1111/add.70152", "doi": "10.1111/add.70152", "pmid": "40702912", "publication_date": "2025-07-23", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 601, "title": "Psychedelic use in individuals living with eating disorders or disordered eating: findings from the international MED-FED survey", "authors": "Sarah-Catherine Rodan, Noah Meez, Sophie Lloyd-Hurwitz, Miguel A. Bedoya-Pérez, Anastasia Suraev, Natasha Sommer, Kayla Greenstien, Sarah Maguire, Iain S. McGregor", "journal": "Journal of Eating Disorders", "publication_date": "2025-07-23", "publication_year": 2025, "doi": "10.1186/s40337-025-01328-5", "pubmed_id": "40708053", "openalex_id": "https://openalex.org/W4412645629", "source_url": "https://doi.org/10.1186/s40337-025-01328-5", "substance_tags": "psilocybin", "topic_tags": "PTSD,Eating Disorders,Microdosing,Clinical Trial,Observational Study,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40708053", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1186/s40337-025-01328-5", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40708053", "source_url": "https://doi.org/10.1186/s40337-025-01328-5", "doi": "10.1186/s40337-025-01328-5", "pmid": "40708053", "publication_date": "2025-07-23", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3633, "title": "The Safety, Feasibility, and Acceptability of Psilocybin Combined With Multidisciplinary Palliative Care in Demoralized Cancer Survivors With Chronic Pain (P-PC)", "authors": "Emory University", "journal": "ClinicalTrials.gov", "publication_date": "2025-07-22", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05506982", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Mystical Experience,Clinical Trial,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05506982", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05506982", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05506982", "source_url": "https://clinicaltrials.gov/study/NCT05506982", "doi": "", "pmid": "", "publication_date": "2025-07-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3581, "title": "Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and Suicidality", "authors": "The University of Texas Health Science Center, Houston", "journal": "ClinicalTrials.gov", "publication_date": "2025-07-17", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06706232", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06706232", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06706232", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06706232", "source_url": "https://clinicaltrials.gov/study/NCT06706232", "doi": "", "pmid": "", "publication_date": "2025-07-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 395, "title": "Mapping psilocybin therapy: A systematic review of therapeutic frameworks, adaptations, and standardization across contemporary clinical trials.", "authors": "Kittur ME, Burgos M LA, Jones BDM, Blumberger DM, Mulsant BH, Rosenblat JD, Husain MI.", "journal": null, "publication_date": "2025-07-17", "publication_year": 2025, "doi": "10.1016/j.jad.2025.119952", "pubmed_id": "40684956", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jad.2025.119952", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,OCD,Eating Disorders,Mechanism of Action,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:40684956", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jad.2025.119952", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40684956", "source_url": "https://doi.org/10.1016/j.jad.2025.119952", "doi": "10.1016/j.jad.2025.119952", "pmid": "40684956", "publication_date": "2025-07-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 494, "title": "Informed Consent Documents from Psychedelic Clinical Trials: A Descriptive Ethical Analysis", "authors": "Katherine Cheung, Caleigh Propes, Marianna Graziosi, Kyle Patch, David B. Yaden", "journal": "AJOB Empirical Bioethics", "publication_date": "2025-07-15", "publication_year": 2025, "doi": "10.1080/23294515.2025.2526339", "pubmed_id": "40668936", "openalex_id": "https://openalex.org/W4412488390", "source_url": "https://doi.org/10.1080/23294515.2025.2526339", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Consciousness,Clinical Trial,Review Article,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40668936", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/23294515.2025.2526339", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40668936", "source_url": "https://doi.org/10.1080/23294515.2025.2526339", "doi": "10.1080/23294515.2025.2526339", "pmid": "40668936", "publication_date": "2025-07-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 608, "title": "Females in Psychedelic Research: A Perspective for Advancing Research and Practice.", "authors": "Cohen ZZ, Blest-Hopley G", "journal": "ACS pharmacology & translational science", "publication_date": "2025-07-10", "publication_year": 2025, "doi": "10.1021/acsptsci.5c00255", "pubmed_id": "40672681", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40672681/", "substance_tags": "psilocybin", "topic_tags": "Neuroplasticity,Pharmacology,Receptor Pharmacology,Clinical Trial,Observational Study,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:20:35", "bibtex": null, "source_record_id": "PMID:40672681", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40672681/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40672681", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40672681/", "doi": "10.1021/acsptsci.5c00255", "pmid": "40672681", "publication_date": "2025-07-10", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 537, "title": "Unequal representation? A cross-sectional analysis of age, sex, race, and ethnicity in clinical trials of classic psychedelics", "authors": "Damian Świeczkowski, Aleksander Kwaśny, Patrycja Ciurkowska, Michał Pruc, Łukasz Szarpak, Wiesław Jerzy Cubała", "journal": "Journal of Psychopharmacology", "publication_date": "2025-07-10", "publication_year": 2025, "doi": "10.1177/02698811251353250", "pubmed_id": "40643096", "openalex_id": "https://openalex.org/W4412197020", "source_url": "https://doi.org/10.1177/02698811251353250", "substance_tags": "psilocybin,psilocin", "topic_tags": "Chronic Pain,Aging,Clinical Trial,Review Article,Healthy Volunteers,Older Adults,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40643096", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/02698811251353250", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40643096", "source_url": "https://doi.org/10.1177/02698811251353250", "doi": "10.1177/02698811251353250", "pmid": "40643096", "publication_date": "2025-07-10", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 538, "title": "Psychedelics for Alcohol Use Disorder: A Narrative Review with Candidate Mechanisms of Action.", "authors": "Miller EA, Capone C, Eaton E, Swift RM, Haass-Koffler CL.", "journal": null, "publication_date": "2025-07-09", "publication_year": 2025, "doi": "10.1007/s40263-025-01199-z", "pubmed_id": "40640527", "openalex_id": null, "source_url": "https://doi.org/10.1007/s40263-025-01199-z", "substance_tags": "psilocybin", "topic_tags": "Addiction,Neuroplasticity,Mechanism of Action,Clinical Trial,Review Article,Observational Study", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:40640527", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s40263-025-01199-z", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40640527", "source_url": "https://doi.org/10.1007/s40263-025-01199-z", "doi": "10.1007/s40263-025-01199-z", "pmid": "40640527", "publication_date": "2025-07-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3313, "title": "Clinical Psychedelic Therapy Research Involving Adolescents: Protocol for a Scoping Review of Intervention Studies", "authors": "Khaleel Rajwani, Melanie Almonte, F. Feroz, Jamila Hokanson, Edward Jacobs, Julian Savulescu, Ilina Singh, David B. Yaden, Brian D. Earp", "journal": "Wellcome Open Research", "publication_date": "2025-07-07", "publication_year": 2025, "doi": "10.12688/wellcomeopenres.24181.1", "pubmed_id": null, "openalex_id": "https://openalex.org/W4414213011", "source_url": "https://doi.org/10.12688/wellcomeopenres.24181.1", "substance_tags": "psilocybin", "topic_tags": "Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Observational Study,Adolescents", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 11:03:50", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.12688/wellcomeopenres.24181.1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.12688/wellcomeopenres.24181.1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.12688/wellcomeopenres.24181.1", "source_url": "https://doi.org/10.12688/wellcomeopenres.24181.1", "doi": "10.12688/wellcomeopenres.24181.1", "pmid": "", "publication_date": "2025-07-07", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 461, "title": "Unraveling the policies, legislations, and regulations of psychedelics in Australia, Canada, Netherlands, New Zealand, and India.", "authors": "Joga R, Yerram S, Patnam JD, Choudhary KK, Varpe P, Raghuvanshi RS, Srivastava S.", "journal": null, "publication_date": "2025-07-07", "publication_year": 2025, "doi": "10.1016/j.healthpol.2025.105392", "pubmed_id": "40694950", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.healthpol.2025.105392", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Clinical Trial,Review Article,Treatment-Resistant Depression,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:40694950", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.healthpol.2025.105392", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40694950", "source_url": "https://doi.org/10.1016/j.healthpol.2025.105392", "doi": "10.1016/j.healthpol.2025.105392", "pmid": "40694950", "publication_date": "2025-07-07", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3216, "title": "Accurate and Interpretable Prediction of Antidepressant Treatment Response from Receptor-informed Neuroimaging", "authors": "Tolle HM, Luppi AI, Lawn T, Roseman L, Nutt D, Carhart-Harris RL, Mediano PAM.", "journal": "bioRxiv", "publication_date": "2025-07-02", "publication_year": 2025, "doi": "10.1101/2025.07.02.662710", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2025.07.02.662710", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Biomarkers,Aging,Clinical Trial", "study_type": "Clinical Trial", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "DOI:10.1101/2025.07.02.662710", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2025.07.02.662710", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2025.07.02.662710", "source_url": "https://doi.org/10.1101/2025.07.02.662710", "doi": "10.1101/2025.07.02.662710", "pmid": "", "publication_date": "2025-07-02", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 497, "title": "Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge study", "authors": "Luca Pellegrini, Naomi Fineberg, Sorcha O'Connor, Ana Maria Frota Lisbôa Pereira de Souza, Kate Godfrey, Sara Reed, Joseph Peill, Mairead Healy, Cyrus Rohani-Shukla, Hakjun Lee, Robin Carhart-Harris, Trevor W. Robbins, David Nutt, David Erritzøe", "journal": "Comprehensive Psychiatry", "publication_date": "2025-07-01", "publication_year": 2025, "doi": "10.1016/j.comppsych.2025.152619", "pubmed_id": "40618640", "openalex_id": "https://openalex.org/W4411969620", "source_url": "https://doi.org/10.1016/j.comppsych.2025.152619", "substance_tags": "psilocybin", "topic_tags": "Depression,OCD,Chronic Pain,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Healthcare Workers,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40618640", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.comppsych.2025.152619", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40618640", "source_url": "https://doi.org/10.1016/j.comppsych.2025.152619", "doi": "10.1016/j.comppsych.2025.152619", "pmid": "40618640", "publication_date": "2025-07-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 640, "title": "Disentangling the acute subjective effects of classic psychedelics from their enduring therapeutic properties.", "authors": "Atiq MA, Baker MR, Voort JLV, Vargas MV, Choi DS", "journal": "Psychopharmacology", "publication_date": "2025-06-30", "publication_year": 2025, "doi": "10.1007/s00213-024-06599-5", "pubmed_id": "38743110", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38743110/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Receptor Pharmacology,Mystical Experience,Clinical Trial,Review Article,Animal Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:20:35", "bibtex": null, "source_record_id": "PMID:38743110", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38743110/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38743110", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38743110/", "doi": "10.1007/s00213-024-06599-5", "pmid": "38743110", "publication_date": "2025-06-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 618, "title": "Control Group Outcomes in Trials of Psilocybin, SSRIs, or Esketamine for Depression: A Meta-Analysis.", "authors": "Hieronymus F, López E, Werin Sjögren H, Lundberg J.", "journal": null, "publication_date": "2025-06-30", "publication_year": 2025, "doi": "10.1001/jamanetworkopen.2025.24119", "pubmed_id": "40736734", "openalex_id": null, "source_url": "https://doi.org/10.1001/jamanetworkopen.2025.24119", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:40736734", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1001/jamanetworkopen.2025.24119", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40736734", "source_url": "https://doi.org/10.1001/jamanetworkopen.2025.24119", "doi": "10.1001/jamanetworkopen.2025.24119", "pmid": "40736734", "publication_date": "2025-06-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4356, "title": "Increasing the Evaluation and Reporting Rigor of Psychotherapy Interventions in Treatments Involving Psychedelics", "authors": "Mathieu Fradet", "journal": "Psychoactives", "publication_date": "2025-06-28", "publication_year": 2025, "doi": "10.3390/psychoactives4030021", "pubmed_id": null, "openalex_id": "https://openalex.org/W4411824807", "source_url": "https://doi.org/10.3390/psychoactives4030021", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.3390/psychoactives4030021", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/psychoactives4030021", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3390/psychoactives4030021", "source_url": "https://doi.org/10.3390/psychoactives4030021", "doi": "10.3390/psychoactives4030021", "pmid": "", "publication_date": "2025-06-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 645, "title": "A Scoping Review of Research in Naturalistic Studies with Psychedelics.", "authors": "Carvalho LC, Encantado J, Kettner H, Timmermann C, Veiga D, Teixeira PJ.", "journal": null, "publication_date": "2025-06-27", "publication_year": 2025, "doi": "10.1080/02791072.2025.2520221", "pubmed_id": "40581772", "openalex_id": null, "source_url": "https://doi.org/10.1080/02791072.2025.2520221", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Review Article,Observational Study", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:40581772", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/02791072.2025.2520221", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40581772", "source_url": "https://doi.org/10.1080/02791072.2025.2520221", "doi": "10.1080/02791072.2025.2520221", "pmid": "40581772", "publication_date": "2025-06-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 649, "title": "The Clinical Applications of Psilocybin Therapies and Post-COVID Syndrome: A Comprehensive Narrative Review.", "authors": "Mathew A, Dongre R, Kim SH, Turner J, Mathew A, Cherryholmes E, Mehrinfar M, Kamprath S.", "journal": null, "publication_date": "2025-06-23", "publication_year": 2025, "doi": "10.7759/cureus.86659", "pubmed_id": "40718283", "openalex_id": null, "source_url": "https://doi.org/10.7759/cureus.86659", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Wellbeing,Clinical Trial,Review Article,In Vitro Study", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:40718283", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.7759/cureus.86659", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40718283", "source_url": "https://doi.org/10.7759/cureus.86659", "doi": "10.7759/cureus.86659", "pmid": "40718283", "publication_date": "2025-06-23", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 150, "title": "The Music for Subanesthetic Infusions of Ketamine randomised clinical trial: ketamine as a psychedelic treatment for highly refractory depression", "authors": "Kyle T. Greenway, Nicolas Garel, Lê-Anh Dinh-Williams, Julien Thibault Lévesque, Mendel Kaelen, Vincent Dagenais-Beaulé, Sara de la Salle, David Erritzøe, Karl Looper, Gustavo Turecki, Soham Rej, Stéphane Richard-Devantoy", "journal": "The British Journal of Psychiatry", "publication_date": "2025-06-17", "publication_year": 2025, "doi": "10.1192/bjp.2025.102", "pubmed_id": "40528492", "openalex_id": "https://openalex.org/W4411430663", "source_url": "https://doi.org/10.1192/bjp.2025.102", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Personality Change,Emotional Processing,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Healthcare Workers,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40528492", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1192/bjp.2025.102", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40528492", "source_url": "https://doi.org/10.1192/bjp.2025.102", "doi": "10.1192/bjp.2025.102", "pmid": "40528492", "publication_date": "2025-06-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 654, "title": "Long-term benefits of single-dose psilocybin in depressed patients with cancer", "authors": "Manish Agrawal, Kim Roddy, Betsy Jenkins, Celia Leeks, Ezekiel Emanuel", "journal": "Cancer", "publication_date": "2025-06-14", "publication_year": 2025, "doi": "10.1002/cncr.35889", "pubmed_id": "40518804", "openalex_id": "https://openalex.org/W4411327114", "source_url": "https://doi.org/10.1002/cncr.35889", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Clinical Trial,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40518804", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/cncr.35889", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40518804", "source_url": "https://doi.org/10.1002/cncr.35889", "doi": "10.1002/cncr.35889", "pmid": "40518804", "publication_date": "2025-06-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 656, "title": "Evaluation of behavioural and neurochemical effects of psilocybin in mice subjected to chronic unpredictable mild stress", "authors": "Ines Erkizia-Santamaría, Igor Horrillo, Nerea Martínez-Álvarez, Daniel Pérez-Martínez, Guadalupe Rivero, Amaia M. Erdozain, J. Javier Meana, Jorge E. Ortega", "journal": "Translational Psychiatry", "publication_date": "2025-06-13", "publication_year": 2025, "doi": "10.1038/s41398-025-03421-4", "pubmed_id": "40517150", "openalex_id": "https://openalex.org/W4411302754", "source_url": "https://doi.org/10.1038/s41398-025-03421-4", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Animal Study,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40517150", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41398-025-03421-4", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40517150", "source_url": "https://doi.org/10.1038/s41398-025-03421-4", "doi": "10.1038/s41398-025-03421-4", "pmid": "40517150", "publication_date": "2025-06-13", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3611, "title": "A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of MLS101 (Psilocybin) in Healthy Participants", "authors": "MycoMedica Life Sciences PBC", "journal": "ClinicalTrials.gov", "publication_date": "2025-06-11", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06643637", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Microdosing,Clinical Trial,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06643637", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06643637", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06643637", "source_url": "https://clinicaltrials.gov/study/NCT06643637", "doi": "", "pmid": "", "publication_date": "2025-06-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4363, "title": "Stephen Ross: Psychedelic-assisted therapies for difficult-to-treat psychiatric and medical disorders", "authors": "Stephen Ross", "journal": "Psychedelics.", "publication_date": "2025-06-09", "publication_year": 2025, "doi": "10.61373/pp025k.0017", "pubmed_id": null, "openalex_id": "https://openalex.org/W4411182514", "source_url": "https://doi.org/10.61373/pp025k.0017", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Clinical Trial,Adolescents,Cancer Patients,Genomics,Inflammation", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.61373/pp025k.0017", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.61373/pp025k.0017", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.61373/pp025k.0017", "source_url": "https://doi.org/10.61373/pp025k.0017", "doi": "10.61373/pp025k.0017", "pmid": "", "publication_date": "2025-06-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 433, "title": "Long-term outcomes of single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - 12-month data from an open-label pilot study", "authors": "Sara Ellis, Catherine Bostian, Anna J. Donnelly, Wendy Feng, Katherine Eisen, Melanie Lean, Elizabeth Conlan, Michael J. Ostacher, Scott T. Aaronson, Trisha Suppes", "journal": "Journal of Affective Disorders", "publication_date": "2025-06-08", "publication_year": 2025, "doi": "10.1016/j.jad.2025.119655", "pubmed_id": "40499827", "openalex_id": "https://openalex.org/W4411137642", "source_url": "https://doi.org/10.1016/j.jad.2025.119655", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Treatment-Resistant Depression,Veterans,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40499827", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40499827", "source_url": "https://doi.org/10.1016/j.jad.2025.119655", "doi": "10.1016/j.jad.2025.119655", "pmid": "40499827", "publication_date": "2025-06-08", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 664, "title": "Enhanced meaning in life following psychedelic use: converging evidence from controlled and naturalistic studies", "authors": "William Roseby, Hannes Kettner, Leor Roseman, Meg J. Spriggs, Taylor Lyons, Joe Peill, Bruna Giribaldi, David Erritzøe, David Nutt, Robin Carhart-Harris", "journal": "Frontiers in Psychology", "publication_date": "2025-06-05", "publication_year": 2025, "doi": "10.3389/fpsyg.2025.1580663", "pubmed_id": "40547590", "openalex_id": "https://openalex.org/W4411107182", "source_url": "https://doi.org/10.3389/fpsyg.2025.1580663", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Mechanism of Action,Wellbeing,Emotional Processing,Mystical Experience,Clinical Trial,Observational Study,Healthy Volunteers,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40547590", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyg.2025.1580663", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40547590", "source_url": "https://doi.org/10.3389/fpsyg.2025.1580663", "doi": "10.3389/fpsyg.2025.1580663", "pmid": "40547590", "publication_date": "2025-06-05", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 652, "title": "Classic Psychedelics in Pain Modulation: Mechanisms, Clinical Evidence, and Future Perspectives.", "authors": "Czopek A, Jończyk J, Fryc M, Kluzik D, Zagórska A.", "journal": null, "publication_date": "2025-06-05", "publication_year": 2025, "doi": "10.1021/acschemneuro.5c00152", "pubmed_id": "40474592", "openalex_id": null, "source_url": "https://doi.org/10.1021/acschemneuro.5c00152", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Headache / Migraine,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Review Article,Animal Study,Safety,Inflammation", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:40474592", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1021/acschemneuro.5c00152", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40474592", "source_url": "https://doi.org/10.1021/acschemneuro.5c00152", "doi": "10.1021/acschemneuro.5c00152", "pmid": "40474592", "publication_date": "2025-06-05", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3672, "title": "Low-Income Group Psilocybin Assisted Therapy for Depression: A Feasibility Study", "authors": "Matthew Hicks", "journal": "ClinicalTrials.gov", "publication_date": "2025-06-04", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06372197", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Consciousness,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06372197", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06372197", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06372197", "source_url": "https://clinicaltrials.gov/study/NCT06372197", "doi": "", "pmid": "", "publication_date": "2025-06-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3480, "title": "Optimizing Microdosing and Meditation", "authors": "National University of Natural Medicine", "journal": "ClinicalTrials.gov", "publication_date": "2025-06-04", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06560658", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Consciousness,Microdosing,Wellbeing,Clinical Trial,Review Article,Observational Study,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06560658", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06560658", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06560658", "source_url": "https://clinicaltrials.gov/study/NCT06560658", "doi": "", "pmid": "", "publication_date": "2025-06-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 666, "title": "Psilocybin’s acute and persistent brain effects: a precision imaging drug trial", "authors": "Subha Subramanian, Travis Rick Reneau, Demetrius Perry, Ravi V. Chacko, Timothy O. Laumann, Karin Flavin, Christine Horan, Julia Schweiger, Nicholas V. Metcalf, Eric J. Lenze, Abraham Z. Snyder, Nico U.F. Dosenbach, Ginger E. Nicol, Joshua S. Siegel", "journal": "Scientific Data", "publication_date": "2025-06-04", "publication_year": 2025, "doi": "10.1038/s41597-025-05189-0", "pubmed_id": "40473634", "openalex_id": "https://openalex.org/W4411071772", "source_url": "https://doi.org/10.1038/s41597-025-05189-0", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Pharmacology,Receptor Pharmacology,Aging,Clinical Trial,Healthy Volunteers", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40473634", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41597-025-05189-0", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40473634", "source_url": "https://doi.org/10.1038/s41597-025-05189-0", "doi": "10.1038/s41597-025-05189-0", "pmid": "40473634", "publication_date": "2025-06-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 587, "title": "Neurocognitive effects of psilocybin: A systematic and comprehensive review of neuroimaging studies in humans.", "authors": "Berkovitch L, Fauvel B, Preller KH, Gaillard R.", "journal": null, "publication_date": "2025-05-30", "publication_year": 2025, "doi": "10.1016/j.neubiorev.2025.106239", "pubmed_id": "40456393", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.neubiorev.2025.106239", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Default Mode Network,Aging,Personality Change,Emotional Processing,Clinical Trial,Systematic Review,Review Article,Healthy Volunteers", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:40456393", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.neubiorev.2025.106239", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40456393", "source_url": "https://doi.org/10.1016/j.neubiorev.2025.106239", "doi": "10.1016/j.neubiorev.2025.106239", "pmid": "40456393", "publication_date": "2025-05-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3069, "title": "Understanding the Psychological Effects of Psilocybin and 3,4-Methylenedioxymethamphetamine in a Non-Clinical Population", "authors": "Fitzgerald PB, Webb SL, Denning NC, Dowie T, Schweickle MM, Modak A, Chan G, Knight J, Waldron M, Gainsford K, Hawkes H, Zammit S, Sutanto NC, Fitzgibbon BM, Bailey NW.", "journal": "medRxiv", "publication_date": "2025-05-28", "publication_year": 2025, "doi": "10.1101/2025.05.28.25328532", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2025.05.28.25328532", "substance_tags": "psilocybin", "topic_tags": "Personality Change,Mystical Experience,Clinical Trial,Adverse Events", "study_type": "Clinical Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.1101/2025.05.28.25328532", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2025.05.28.25328532", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2025.05.28.25328532", "source_url": "https://doi.org/10.1101/2025.05.28.25328532", "doi": "10.1101/2025.05.28.25328532", "pmid": "", "publication_date": "2025-05-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 659, "title": "The Selective Serotonin 5-HT2A Receptor Agonist (S)-3-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)piperidine (LPH-5) Induces Persistent and Robust Antidepressant-Like Effects in Rodents", "authors": "Anders A. Jensen, Cláudia R. Cecchi, Meghan Hibicke, Astrid H. Bach, Erik Kaadt, Emil Märcher-Rørsted, Charles D. Nichols, Betina Elfving, Jesper L. Kristensen", "journal": "ACS Pharmacology & Translational Science", "publication_date": "2025-05-28", "publication_year": 2025, "doi": "10.1021/acsptsci.5c00208", "pubmed_id": "40534669", "openalex_id": "https://openalex.org/W4410859687", "source_url": "https://doi.org/10.1021/acsptsci.5c00208", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40534669", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1021/acsptsci.5c00208", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40534669", "source_url": "https://doi.org/10.1021/acsptsci.5c00208", "doi": "10.1021/acsptsci.5c00208", "pmid": "40534669", "publication_date": "2025-05-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 689, "title": "The Potential Role of Psilocybin in Traumatic Brain Injury Recovery: A Narrative Review.", "authors": "Palmer C, Ferber AT, Greenwald BD.", "journal": null, "publication_date": "2025-05-25", "publication_year": 2025, "doi": "10.3390/brainsci15060572", "pubmed_id": "40563744", "openalex_id": null, "source_url": "https://doi.org/10.3390/brainsci15060572", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Neuroplasticity,Clinical Trial,Review Article,Inflammation", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:40563744", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/brainsci15060572", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40563744", "source_url": "https://doi.org/10.3390/brainsci15060572", "doi": "10.3390/brainsci15060572", "pmid": "40563744", "publication_date": "2025-05-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 881, "title": "Clinical pharmacology.", "authors": "Vogt SB, Liechti ME.", "journal": null, "publication_date": "2025-05-22", "publication_year": 2025, "doi": "10.1016/bs.irn.2025.02.003", "pubmed_id": "40541320", "openalex_id": null, "source_url": "https://doi.org/10.1016/bs.irn.2025.02.003", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:40541320", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/bs.irn.2025.02.003", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40541320", "source_url": "https://doi.org/10.1016/bs.irn.2025.02.003", "doi": "10.1016/bs.irn.2025.02.003", "pmid": "40541320", "publication_date": "2025-05-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 588, "title": "Lessons learned from the regulatory alignment in ketamine, esketamine and arketamine clinical trials: A cross-sectional analysis of protocols from ClinicalTrials.gov.", "authors": "Swieczkowski D, Kwaśny A, Sadko K, Pruc M, Gaca Z, Szarpak L, Cubała WJ.", "journal": null, "publication_date": "2025-05-21", "publication_year": 2025, "doi": "10.1016/j.psychres.2025.116559", "pubmed_id": "40440859", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.psychres.2025.116559", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:40440859", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.psychres.2025.116559", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40440859", "source_url": "https://doi.org/10.1016/j.psychres.2025.116559", "doi": "10.1016/j.psychres.2025.116559", "pmid": "40440859", "publication_date": "2025-05-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 885, "title": "Serotonergic psychedelics for depression: A comprehensive overview.", "authors": "Wingert AM, Agnorelli C, Peill J, Reed S, Nutt DJ, Erritzoe D.", "journal": null, "publication_date": "2025-05-13", "publication_year": 2025, "doi": "10.1016/bs.irn.2025.04.009", "pubmed_id": "40541312", "openalex_id": null, "source_url": "https://doi.org/10.1016/bs.irn.2025.04.009", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:40541312", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/bs.irn.2025.04.009", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40541312", "source_url": "https://doi.org/10.1016/bs.irn.2025.04.009", "doi": "10.1016/bs.irn.2025.04.009", "pmid": "40541312", "publication_date": "2025-05-13", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3426, "title": "A Phase 2a, Placebo-Controlled Randomized, Double-Blind Trial to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Psilocybin Oral Solution in Adults With Generalized Anxiety Disorder", "authors": "Queen's University", "journal": "ClinicalTrials.gov", "publication_date": "2025-05-12", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06969170", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Brain Imaging,Clinical Trial,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06969170", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06969170", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06969170", "source_url": "https://clinicaltrials.gov/study/NCT06969170", "doi": "", "pmid": "", "publication_date": "2025-05-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 546, "title": "Set and setting of psychedelics for therapeutic use in psychiatry: A systematic review.", "authors": "Estric C, Duron T, Kabani S, Lopez-Castroman J.", "journal": null, "publication_date": "2025-05-11", "publication_year": 2025, "doi": "10.1177/02698811251338214", "pubmed_id": "40353492", "openalex_id": null, "source_url": "https://doi.org/10.1177/02698811251338214", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:40353492", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02698811251338214", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40353492", "source_url": "https://doi.org/10.1177/02698811251338214", "doi": "10.1177/02698811251338214", "pmid": "40353492", "publication_date": "2025-05-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 629, "title": "Non-hallucinogenic psychedelics for mood and anxiety disorders: A systematic review.", "authors": "Chen MJQ, Chen-Li D, Chisamore N, Husain MI, Di Vincenzo JD, Mansur RB, Phan L, Johnson D, McIntyre RS, Rosenblat JD.", "journal": null, "publication_date": "2025-05-07", "publication_year": 2025, "doi": "10.1016/j.psychres.2025.116532", "pubmed_id": "40354769", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.psychres.2025.116532", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Consciousness,Clinical Trial,Systematic Review,Review Article,Case Report", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:40354769", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.psychres.2025.116532", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40354769", "source_url": "https://doi.org/10.1016/j.psychres.2025.116532", "doi": "10.1016/j.psychres.2025.116532", "pmid": "40354769", "publication_date": "2025-05-07", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 706, "title": "Divergent Effects of Psilocybin for 2 Patients Participating in a Psilocybin-assisted Cognitive Behavioral Therapy Trial for Major Depressive Disorder.", "authors": "Weintraub MJ, Miklowitz DJ, Jeffrey JK.", "journal": null, "publication_date": "2025-04-30", "publication_year": 2025, "doi": "10.1097/pra.0000000000000853", "pubmed_id": "40440674", "openalex_id": null, "source_url": "https://doi.org/10.1097/pra.0000000000000853", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:40440674", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1097/pra.0000000000000853", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40440674", "source_url": "https://doi.org/10.1097/pra.0000000000000853", "doi": "10.1097/pra.0000000000000853", "pmid": "40440674", "publication_date": "2025-04-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4382, "title": "The benefits and harm of psychedelics in the treatment of patients with mental health and substance abuse disorders: an integrative literature review", "authors": "Saara Susan Sevander, Marja-Liisa Rissanen", "journal": null, "publication_date": "2025-04-29", "publication_year": 2025, "doi": "10.59476/hesdia.v0i1.700", "pubmed_id": null, "openalex_id": "https://openalex.org/W4411419984", "source_url": "https://doi.org/10.59476/hesdia.v0i1.700", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Receptor Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.59476/hesdia.v0i1.700", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.59476/hesdia.v0i1.700", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.59476/hesdia.v0i1.700", "source_url": "https://doi.org/10.59476/hesdia.v0i1.700", "doi": "10.59476/hesdia.v0i1.700", "pmid": "", "publication_date": "2025-04-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4386, "title": "Psilocybin-assisted therapy shows range of benefits in cancer patients", "authors": "", "journal": "The Brown University Psychopharmacology Update", "publication_date": "2025-04-28", "publication_year": 2025, "doi": "10.1002/pu.31316", "pubmed_id": null, "openalex_id": "https://openalex.org/W4409945764", "source_url": "https://doi.org/10.1002/pu.31316", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Receptor Pharmacology,Clinical Trial,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1002/pu.31316", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/pu.31316", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/pu.31316", "source_url": "https://doi.org/10.1002/pu.31316", "doi": "10.1002/pu.31316", "pmid": "", "publication_date": "2025-04-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3591, "title": "Treatment With Psilocybin for Chronic Neuropathic Pain and Depression (TRANSCEND): An Open-Label Clinical Trial", "authors": "Centre for Addiction and Mental Health", "journal": "ClinicalTrials.gov", "publication_date": "2025-04-24", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06518720", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06518720", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06518720", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06518720", "source_url": "https://clinicaltrials.gov/study/NCT06518720", "doi": "", "pmid": "", "publication_date": "2025-04-24", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 732, "title": "[Treatment with psychedelics: potential benefits in Parkinson's disease].", "authors": "Louise Penzenstadler, Sandra Baudois, Alma Lingenberg, Sabina Catalano Chiuvé, Emilie Tomkova, Vanessa Fleury", "journal": "PubMed", "publication_date": "2025-04-22", "publication_year": 2025, "doi": "10.53738/revmed.2025.21.915.47180", "pubmed_id": "40275842", "openalex_id": "https://openalex.org/W4409833807", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40275842", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Neuroplasticity,Receptor Pharmacology,Clinical Trial,Safety,Inflammation", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40275842", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40275842", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40275842", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40275842", "doi": "10.53738/revmed.2025.21.915.47180", "pmid": "40275842", "publication_date": "2025-04-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 626, "title": "5-HT2A receptors: Pharmacology and functional selectivity.", "authors": "Cummins BR, Billac GB, Nichols DE, Nichols CD.", "journal": null, "publication_date": "2025-04-22", "publication_year": 2025, "doi": "10.1016/j.pharmr.2025.100059", "pubmed_id": "40418878", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.pharmr.2025.100059", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Drug Interactions", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:40418878", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.pharmr.2025.100059", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40418878", "source_url": "https://doi.org/10.1016/j.pharmr.2025.100059", "doi": "10.1016/j.pharmr.2025.100059", "pmid": "40418878", "publication_date": "2025-04-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 708, "title": "Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: a phase 2a clinical trial in treatment-resistant depression.", "authors": "Falchi-Carvalho M, Palhano-Fontes F, Wießner I, Barros H, Bolcont R, Laborde S, Ruschi B Silva S, Montanini D, C Barbosa D, Teixeira E, Florence-Vilela R, Almeida R, K A de Macedo R, Arichelle F, J Pantrigo É, V Costa-Macedo J, da Cruz Nunes JA, de Araújo Costa Neto LA, Nunes Ferreira LF, Dantas Corrêa L, da Costa Bezerra RB, Arcoverde E, Galvão-Coelho N, B Araujo D.", "journal": null, "publication_date": "2025-04-21", "publication_year": 2025, "doi": "10.1038/s41386-025-02091-6", "pubmed_id": "40258990", "openalex_id": null, "source_url": "https://doi.org/10.1038/s41386-025-02091-6", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events,Drug Interactions", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:40258990", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1038/s41386-025-02091-6", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40258990", "source_url": "https://doi.org/10.1038/s41386-025-02091-6", "doi": "10.1038/s41386-025-02091-6", "pmid": "40258990", "publication_date": "2025-04-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 884, "title": "Psychedelics and substance use disorder treatment.", "authors": "DuPont CM, Johnson MW.", "journal": null, "publication_date": "2025-04-20", "publication_year": 2025, "doi": "10.1016/bs.irn.2025.03.005", "pubmed_id": "40541314", "openalex_id": null, "source_url": "https://doi.org/10.1016/bs.irn.2025.03.005", "substance_tags": "psilocybin", "topic_tags": "Addiction,Emotional Processing,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:40541314", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/bs.irn.2025.03.005", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40541314", "source_url": "https://doi.org/10.1016/bs.irn.2025.03.005", "doi": "10.1016/bs.irn.2025.03.005", "pmid": "40541314", "publication_date": "2025-04-20", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 736, "title": "Development of a PBPK model of psilocybin/psilocin from Psilocybe cubensis (magic mushroom) in mice, rats, and humans", "authors": "Nilubon Thaoboonruang, Ornrat Lohitnavy, Kimheang Ya, Manupat Lohitnavy", "journal": "Scientific Reports", "publication_date": "2025-04-20", "publication_year": 2025, "doi": "10.1038/s41598-025-98202-w", "pubmed_id": "40258947", "openalex_id": "https://openalex.org/W4409623005", "source_url": "https://doi.org/10.1038/s41598-025-98202-w", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Pharmacology,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40258947", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41598-025-98202-w", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40258947", "source_url": "https://doi.org/10.1038/s41598-025-98202-w", "doi": "10.1038/s41598-025-98202-w", "pmid": "40258947", "publication_date": "2025-04-20", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 737, "title": "Comparative Efficacy and Functional Outcomes of Psychedelic-Assisted Therapies in Treatment-Resistant Depression: A Systematic Review of Recent Clinical Trials.", "authors": "Mimms C, Sotelo K, Khaliq AS.", "journal": null, "publication_date": "2025-04-17", "publication_year": 2025, "doi": "10.7759/cureus.82532", "pubmed_id": "40385821", "openalex_id": null, "source_url": "https://doi.org/10.7759/cureus.82532", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:40385821", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.7759/cureus.82532", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40385821", "source_url": "https://doi.org/10.7759/cureus.82532", "doi": "10.7759/cureus.82532", "pmid": "40385821", "publication_date": "2025-04-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 633, "title": "Regulatory Alignment of Psilocybin Clinical Trials in Major Depressive Disorder on ClinicalTrials.gov: A Cross-Sectional Analysis", "authors": "Damian Świeczkowski, Aleksander Kwaśny, Michał Pruc, Zuzanna Gaca, Łukasz Szarpak, Wiesław Jerzy Cubała", "journal": "Pharmacopsychiatry", "publication_date": "2025-04-16", "publication_year": 2025, "doi": "10.1055/a-2529-7029", "pubmed_id": "40245934", "openalex_id": "https://openalex.org/W4409534321", "source_url": "https://doi.org/10.1055/a-2529-7029", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Treatment-Resistant Depression,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40245934", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1055/a-2529-7029", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40245934", "source_url": "https://doi.org/10.1055/a-2529-7029", "doi": "10.1055/a-2529-7029", "pmid": "40245934", "publication_date": "2025-04-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3465, "title": "A Phase 2a, Open-label, Pilot Study to Assess the Safety and Efficacy of Psilocybin Administration in Concert With Psychotherapy Among Adult Patients With Fibromyalgia", "authors": "Kevin Boehnke", "journal": "ClinicalTrials.gov", "publication_date": "2025-04-15", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05128162", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Mechanism of Action,Clinical Trial,Review Article,Cancer Patients,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05128162", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05128162", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05128162", "source_url": "https://clinicaltrials.gov/study/NCT05128162", "doi": "", "pmid": "", "publication_date": "2025-04-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 677, "title": "Efficacy and safety of psilocybin for the treatment of substance use disorders: A systematic review.", "authors": "Meshkat S, Malik G, Zeifman RJ, Swainson J, Balachandra K, Reichelt AC, Zhang Y, Burback L, Winkler O, Greenshaw A, Vermetten E, Mayo LM, Tanguay R, Jetly R, Bhat V.", "journal": null, "publication_date": "2025-04-14", "publication_year": 2025, "doi": "10.1016/j.neubiorev.2025.106163", "pubmed_id": "40245969", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.neubiorev.2025.106163", "substance_tags": "psilocybin", "topic_tags": "Addiction,Brain Imaging,Aging,Microdosing,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Observational Study,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:40245969", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.neubiorev.2025.106163", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40245969", "source_url": "https://doi.org/10.1016/j.neubiorev.2025.106163", "doi": "10.1016/j.neubiorev.2025.106163", "pmid": "40245969", "publication_date": "2025-04-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 678, "title": "Exploring psilocybin's role in mental health and palliative medicine: a path to improved well-being.", "authors": "Umbacia MA, Leon MX, Quintero JM, Castro LM, Paez V, Dodd S, Bustos RH.", "journal": null, "publication_date": "2025-04-09", "publication_year": 2025, "doi": "10.1080/14728214.2025.2488786", "pubmed_id": "40178229", "openalex_id": null, "source_url": "https://doi.org/10.1080/14728214.2025.2488786", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Mechanism of Action,Receptor Pharmacology,Wellbeing,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:40178229", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/14728214.2025.2488786", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40178229", "source_url": "https://doi.org/10.1080/14728214.2025.2488786", "doi": "10.1080/14728214.2025.2488786", "pmid": "40178229", "publication_date": "2025-04-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4400, "title": "187. Changes in Symptoms of Anhedonia With Psilocybin-Assisted Psychotherapy: A Secondary Analysis of a Randomized Clinical Trial for Treatment-Resistant Depression", "authors": "Erica Kaczmarek, Nelson B. Rodrigues, Noah Chisamore, Zoe Doyle, Roger S. McIntyre, Rodrigo B. Mansur, Joshua D. Rosenblat", "journal": "Biological Psychiatry", "publication_date": "2025-04-08", "publication_year": 2025, "doi": "10.1016/j.biopsych.2025.02.424", "pubmed_id": null, "openalex_id": "https://openalex.org/W4409281325", "source_url": "https://doi.org/10.1016/j.biopsych.2025.02.424", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1016/j.biopsych.2025.02.424", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.biopsych.2025.02.424", "source_url": "https://doi.org/10.1016/j.biopsych.2025.02.424", "doi": "10.1016/j.biopsych.2025.02.424", "pmid": "", "publication_date": "2025-04-08", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3446, "title": "Psilocybin-assisted Interpersonal Therapy for Depression", "authors": "University of Otago", "journal": "ClinicalTrials.gov", "publication_date": "2025-04-08", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05581797", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Emotional Processing,Clinical Trial,Review Article,Treatment-Resistant Depression,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05581797", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05581797", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05581797", "source_url": "https://clinicaltrials.gov/study/NCT05581797", "doi": "", "pmid": "", "publication_date": "2025-04-08", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 745, "title": "The Emergence of Psilocybin in Psychiatry and Neuroscience.", "authors": "Omidian H, Omidian A.", "journal": null, "publication_date": "2025-04-08", "publication_year": 2025, "doi": "10.3390/ph18040555", "pubmed_id": "40283990", "openalex_id": null, "source_url": "https://doi.org/10.3390/ph18040555", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Pharmacology,Mechanism of Action,Clinical Trial,Review Article,Cancer Patients,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:40283990", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/ph18040555", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40283990", "source_url": "https://doi.org/10.3390/ph18040555", "doi": "10.3390/ph18040555", "pmid": "40283990", "publication_date": "2025-04-08", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 693, "title": "In Vitro Psilocybin Synthesis by Co-Immobilized Enzymes", "authors": "Tim Schäfer, Alexander M. Sherwood, Thomas A. Kirkland, Thomas Krüger, Jakob Worbs, Olaf Kniemeyer, Markus Gressler, Dirk Hoffmeister", "journal": "Chemistry - A European Journal", "publication_date": "2025-04-08", "publication_year": 2025, "doi": "10.1002/chem.202501037", "pubmed_id": "40202903", "openalex_id": "https://openalex.org/W4409288174", "source_url": "https://doi.org/10.1002/chem.202501037", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Clinical Trial,In Vitro Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40202903", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/chem.202501037", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40202903", "source_url": "https://doi.org/10.1002/chem.202501037", "doi": "10.1002/chem.202501037", "pmid": "40202903", "publication_date": "2025-04-08", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4404, "title": "Harnessing neuroplasticity with psychoplastogens: the essential role of psychotherapy in psychedelic treatment optimization", "authors": "Jennifer Jones", "journal": "Frontiers in Psychiatry", "publication_date": "2025-04-07", "publication_year": 2025, "doi": "10.3389/fpsyt.2025.1565852", "pubmed_id": "40264517", "openalex_id": "https://openalex.org/W4409274889", "source_url": "https://doi.org/10.3389/fpsyt.2025.1565852", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Eating Disorders,Chronic Pain,Neuroplasticity,Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Aging,Emotional Processing,Psychological Flexibility,Clinical Trial,Review Article,Animal Study,Veterans,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40264517", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2025.1565852", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40264517", "source_url": "https://doi.org/10.3389/fpsyt.2025.1565852", "doi": "10.3389/fpsyt.2025.1565852", "pmid": "40264517", "publication_date": "2025-04-07", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4405, "title": "Psilocybin’s Effects on Headache Frequency are Not Related to Acute Psychedelic Effects or Measures of Mental Health: Secondary Analysis of Clinical Trials in Migraine and Cluster Headache (P7-12.001)", "authors": "Emmanuelle A. D. Schindler, Christopher Gottschalk, Deepak Cyril D’Souza", "journal": "Neurology", "publication_date": "2025-04-06", "publication_year": 2025, "doi": "10.1212/wnl.0000000000210945", "pubmed_id": null, "openalex_id": "https://openalex.org/W4409228190", "source_url": "https://doi.org/10.1212/wnl.0000000000210945", "substance_tags": "psilocybin", "topic_tags": "Headache / Migraine,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1212/wnl.0000000000210945", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1212/wnl.0000000000210945", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1212/wnl.0000000000210945", "source_url": "https://doi.org/10.1212/wnl.0000000000210945", "doi": "10.1212/wnl.0000000000210945", "pmid": "", "publication_date": "2025-04-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 886, "title": "Potential therapeutic effects of psychedelics in small doses: Is there a role for microdosing in psychiatry?", "authors": "Totomanova I, Haijen ECHM, Hurks PPM, Ramaekers JG, Kuypers KPC.", "journal": null, "publication_date": "2025-04-01", "publication_year": 2025, "doi": "10.1016/bs.irn.2025.03.002", "pubmed_id": "40541311", "openalex_id": null, "source_url": "https://doi.org/10.1016/bs.irn.2025.03.002", "substance_tags": "psilocybin", "topic_tags": "Depression,OCD,Chronic Pain,Pharmacology,Microdosing,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:40541311", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/bs.irn.2025.03.002", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40541311", "source_url": "https://doi.org/10.1016/bs.irn.2025.03.002", "doi": "10.1016/bs.irn.2025.03.002", "pmid": "40541311", "publication_date": "2025-04-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4421, "title": "Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trial", "authors": "Nathalie M. Rieser, Raoul Bitar, Simon Halm, Christina Rossgoderer, Ladina P Gubser, Maeva Thévenaz, Yara Kreis, Robin von Rotz, Carlos Nordt, Monika Visentini, Flora Moujaes, Etna Engeli, Andres Ort, Erich Seifritz, Franz Xaver Vollenweider, Marcus Herdener, Katrin H. Preller", "journal": "Universität Zürich, ZORA", "publication_date": "2025-03-31", "publication_year": 2025, "doi": "10.5167/uzh-284304", "pubmed_id": null, "openalex_id": "https://openalex.org/W7127080333", "source_url": "https://doi.org/10.5167/uzh-284304", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Randomized Controlled Trial,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.5167/uzh-284304", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5167/uzh-284304", "source_url": "https://doi.org/10.5167/uzh-284304", "doi": "10.5167/uzh-284304", "pmid": "", "publication_date": "2025-03-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4420, "title": "Selective outcome reporting and non-reporting in trials of psychedelic drugs for mental disorders", "authors": "Ioana A. Cristea, G Tomei, Jazmín Freddi, A. Bonessio", "journal": "European Psychiatry", "publication_date": "2025-03-31", "publication_year": 2025, "doi": "10.1192/j.eurpsy.2025.393", "pubmed_id": null, "openalex_id": "https://openalex.org/W4414208490", "source_url": "https://doi.org/10.1192/j.eurpsy.2025.393", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Randomized Controlled Trial,Review Article,Observational Study,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1192/j.eurpsy.2025.393", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1192/j.eurpsy.2025.393", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1192/j.eurpsy.2025.393", "source_url": "https://doi.org/10.1192/j.eurpsy.2025.393", "doi": "10.1192/j.eurpsy.2025.393", "pmid": "", "publication_date": "2025-03-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 754, "title": "Psilocybin Dispensaries and Online Health Claims in Canada", "authors": "Jenna Matsukubo, Sarah Dickson, Jennifer Xiao, Erik Loewen Friesen, Marco Solmi, Jess G. Fiedorowicz, Benedikt Fischer, Daniel T. Myran", "journal": "JAMA Network Open", "publication_date": "2025-03-31", "publication_year": 2025, "doi": "10.1001/jamanetworkopen.2025.2853", "pubmed_id": "40168023", "openalex_id": "https://openalex.org/W4409086968", "source_url": "https://doi.org/10.1001/jamanetworkopen.2025.2853", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Microdosing,Clinical Trial,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40168023", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1001/jamanetworkopen.2025.2853", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40168023", "source_url": "https://doi.org/10.1001/jamanetworkopen.2025.2853", "doi": "10.1001/jamanetworkopen.2025.2853", "pmid": "40168023", "publication_date": "2025-03-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 739, "title": "Psilocybin-Assisted suppoRtive psychoTherapy IN the treatment of prolonged Grief (PARTING) trial: protocol for an open-label pilot trial for cancer-related bereavement", "authors": "Vanessa L. Beesley, Tom Kennedy, Fiona Maccallum, Margaret Ross, Renee Harvey, Susan L. Rossell, Jerome Sarris, Daniel Perkins, Rachel Ε. Neale, James Bennett-Levy, Shevaugn Johnson, Hanna Beebe, Natalie Roset, Jörg Strobel, Stephen Parker", "journal": "BMJ Open", "publication_date": "2025-03-31", "publication_year": 2025, "doi": "10.1136/bmjopen-2024-095992", "pubmed_id": "40233965", "openalex_id": "https://openalex.org/W4409449177", "source_url": "https://doi.org/10.1136/bmjopen-2024-095992", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Aging,Psychological Flexibility,Clinical Trial,Review Article,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40233965", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1136/bmjopen-2024-095992", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40233965", "source_url": "https://doi.org/10.1136/bmjopen-2024-095992", "doi": "10.1136/bmjopen-2024-095992", "pmid": "40233965", "publication_date": "2025-03-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3635, "title": "Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN", "authors": "Unity Health Toronto", "journal": "ClinicalTrials.gov", "publication_date": "2025-03-29", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06731335", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06731335", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06731335", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06731335", "source_url": "https://clinicaltrials.gov/study/NCT06731335", "doi": "", "pmid": "", "publication_date": "2025-03-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 892, "title": "Existing evidence for the use of psychedelics in patients with cancer and other serious illness: A narrative review.", "authors": "Bires J.", "journal": null, "publication_date": "2025-03-25", "publication_year": 2025, "doi": "10.1080/07347332.2025.2482917", "pubmed_id": "40138527", "openalex_id": null, "source_url": "https://doi.org/10.1080/07347332.2025.2482917", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Review Article,Cancer Patients,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:40138527", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/07347332.2025.2482917", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40138527", "source_url": "https://doi.org/10.1080/07347332.2025.2482917", "doi": "10.1080/07347332.2025.2482917", "pmid": "40138527", "publication_date": "2025-03-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 502, "title": "Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study Participation: Comparaison des effets antidépresseurs de la psychothérapie assistée par la psilocybine (PAP) chez les personnes non médicamentées à la sélection initiale et les personnes ayant arrêté les médicaments pour participer à l’étude", "authors": "Noah Chisamore, Erica Kaczmarek, Zoe Doyle, Danica E. Johnson, Geneva Weiglein, Shakila Meshkat, Ryan M. Brudner, Marc G. Blainey, Jeremy Riva-Cambrin, Roger S. McIntyre, Joshua D. Rosenblat", "journal": "The Canadian Journal of Psychiatry", "publication_date": "2025-03-24", "publication_year": 2025, "doi": "10.1177/07067437251328316", "pubmed_id": "40129307", "openalex_id": "https://openalex.org/W4408813813", "source_url": "https://doi.org/10.1177/07067437251328316", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Healthcare Workers,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:40129307", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/07067437251328316", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40129307", "source_url": "https://doi.org/10.1177/07067437251328316", "doi": "10.1177/07067437251328316", "pmid": "40129307", "publication_date": "2025-03-24", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3544, "title": "An 8-week Phase 2 Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of Psilocybin-assisted-psychotherapy in Adults With Cannabis Use Disorder: A Proof-of-Concept Study", "authors": "McMaster University", "journal": "ClinicalTrials.gov", "publication_date": "2025-03-18", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06225232", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06225232", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06225232", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06225232", "source_url": "https://clinicaltrials.gov/study/NCT06225232", "doi": "", "pmid": "", "publication_date": "2025-03-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3457, "title": "Psilocybin in Alcohol Use Disorder With Comorbid Depression", "authors": "Centre Hospitalier Universitaire de Nīmes", "journal": "ClinicalTrials.gov", "publication_date": "2025-03-18", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06235411", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Clinical Trial,Observational Study,Safety,Inflammation,Immune Function", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06235411", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06235411", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06235411", "source_url": "https://clinicaltrials.gov/study/NCT06235411", "doi": "", "pmid": "", "publication_date": "2025-03-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 565, "title": "Current Evidence for the Role of Rapid-Acting Antidepressants in Bipolar Depression: A Perspective and Plan for Action.", "authors": "Repple J, Bayas M, Möser C, Kobayashi NF, Reif A.", "journal": null, "publication_date": "2025-03-07", "publication_year": 2025, "doi": "10.1016/j.biopsych.2025.02.903", "pubmed_id": "40064389", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.biopsych.2025.02.903", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:40064389", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.biopsych.2025.02.903", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40064389", "source_url": "https://doi.org/10.1016/j.biopsych.2025.02.903", "doi": "10.1016/j.biopsych.2025.02.903", "pmid": "40064389", "publication_date": "2025-03-07", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3666, "title": "Acute Effects of 2C-B Compared With MDMA and Psilocybin in Healthy Subjects", "authors": "University Hospital, Basel, Switzerland", "journal": "ClinicalTrials.gov", "publication_date": "2025-03-04", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05523401", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,PTSD,Pharmacology,Receptor Pharmacology,Clinical Trial,In Vitro Study,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05523401", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05523401", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05523401", "source_url": "https://clinicaltrials.gov/study/NCT05523401", "doi": "", "pmid": "", "publication_date": "2025-03-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 788, "title": "Further education in psychedelic-assisted therapy - experiences from Switzerland.", "authors": "Aicher HD, Müller F, Gasser P.", "journal": null, "publication_date": "2025-03-04", "publication_year": 2025, "doi": "10.1186/s12909-025-06871-y", "pubmed_id": "40045361", "openalex_id": null, "source_url": "https://doi.org/10.1186/s12909-025-06871-y", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Consciousness,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:40045361", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1186/s12909-025-06871-y", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40045361", "source_url": "https://doi.org/10.1186/s12909-025-06871-y", "doi": "10.1186/s12909-025-06871-y", "pmid": "40045361", "publication_date": "2025-03-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4433, "title": "Could psilocin rescue chronic, stress-accelerated, transcriptional aging in brain?", "authors": "Craig, Danny R, Blalock, Eric M.", "journal": "UKnowledge (University of Kentucky)", "publication_date": "2025-03-03", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7110662772", "source_url": "https://uknowledge.uky.edu/jpns/vol2/iss1/1", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Cellular Senescence,Resilience,Clinical Trial,Randomized Controlled Trial,Animal Study,Older Adults,Adolescents,Treatment-Resistant Depression,Safety,Drug Interactions,Transcriptomics,Inflammation", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "https://uknowledge.uky.edu/jpns/vol2/iss1/1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://uknowledge.uky.edu/jpns/vol2/iss1/1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://uknowledge.uky.edu/jpns/vol2/iss1/1", "source_url": "https://uknowledge.uky.edu/jpns/vol2/iss1/1", "doi": "", "pmid": "", "publication_date": "2025-03-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4434, "title": "Psilocybin therapy might help frontline pandemic workers", "authors": "", "journal": "The Brown University Psychopharmacology Update", "publication_date": "2025-03-02", "publication_year": 2025, "doi": "10.1002/pu.31292", "pubmed_id": null, "openalex_id": "https://openalex.org/W4408154898", "source_url": "https://doi.org/10.1002/pu.31292", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Pharmacology,Clinical Trial,Healthcare Workers,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.1002/pu.31292", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/pu.31292", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/pu.31292", "source_url": "https://doi.org/10.1002/pu.31292", "doi": "10.1002/pu.31292", "pmid": "", "publication_date": "2025-03-02", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 797, "title": "Psychedelics for Cancer Pain and Associated Psychological Distress: A Narrative Review of a Potential Strategy.", "authors": "Belitzky E, Ravani Carvalho LV, Taylor M, Ortiz CN, Baum L, Fiellin DA, Lustberg MB.", "journal": null, "publication_date": "2025-02-28", "publication_year": 2025, "doi": "10.1002/cam4.70586", "pubmed_id": "40052631", "openalex_id": null, "source_url": "https://doi.org/10.1002/cam4.70586", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Clinical Trial,Review Article,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:40052631", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1002/cam4.70586", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40052631", "source_url": "https://doi.org/10.1002/cam4.70586", "doi": "10.1002/cam4.70586", "pmid": "40052631", "publication_date": "2025-02-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3764, "title": "Sociodemographic and mental-health characteristics of psychedelic-assisted therapy participants: Latent class analysis of a cross-sectional, purposive online sample", "authors": "Petrovitch D, Hosford S, Littlefield AK, Austin-Robillard H.", "journal": "PsyArXiv", "publication_date": "2025-02-27", "publication_year": 2025, "doi": "10.31234/osf.io/26tz7_v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/26tz7_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:19", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/26tz7_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/26tz7_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/26tz7_v1", "source_url": "https://doi.org/10.31234/osf.io/26tz7_v1", "doi": "10.31234/osf.io/26tz7_v1", "pmid": "", "publication_date": "2025-02-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3196, "title": "Sociodemographic and mental-health characteristics of psychedelic-assisted therapy participants: Latent class analysis of a cross-sectional, purposive online sample", "authors": "", "journal": "PsyArXiv", "publication_date": "2025-02-27", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/26tz7_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/26tz7_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/26tz7_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/26tz7_v1", "source_url": "https://osf.io/preprints/psyarxiv/26tz7_v1", "doi": "", "pmid": "", "publication_date": "2025-02-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4436, "title": "Psychedelics are Bringing a new wind to the Pharmacopoeia", "authors": "Michel Bourin", "journal": "Neuroscience and Neurological Surgery", "publication_date": "2025-02-26", "publication_year": 2025, "doi": "10.31579/2578-8868/360", "pubmed_id": null, "openalex_id": "https://openalex.org/W4409567580", "source_url": "https://doi.org/10.31579/2578-8868/360", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.31579/2578-8868/360", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.31579/2578-8868/360", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.31579/2578-8868/360", "source_url": "https://doi.org/10.31579/2578-8868/360", "doi": "10.31579/2578-8868/360", "pmid": "", "publication_date": "2025-02-26", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 815, "title": "A review of psychedelics trials completed in depression, informed by European regulatory perspectives.", "authors": "Silva F, Butlen-Ducuing F, Guizzaro L, Balabanov P.", "journal": null, "publication_date": "2025-02-25", "publication_year": 2025, "doi": "10.1016/j.nsa.2025.105516", "pubmed_id": "40654583", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.nsa.2025.105516", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:40654583", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.nsa.2025.105516", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40654583", "source_url": "https://doi.org/10.1016/j.nsa.2025.105516", "doi": "10.1016/j.nsa.2025.105516", "pmid": "40654583", "publication_date": "2025-02-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 824, "title": "A qualitative analysis of the psychedelic mushroom come-up and come-down", "authors": "Ari Brouwer, Joshua K. Brown, Earth Erowid, Fire Erowid, Sylvia Thyssen, Charles L. Raison, Robin Carhart-Harris", "journal": "npj Mental Health Research", "publication_date": "2025-02-06", "publication_year": 2025, "doi": "10.1038/s44184-024-00095-6", "pubmed_id": "39915687", "openalex_id": "https://openalex.org/W4407207411", "source_url": "https://doi.org/10.1038/s44184-024-00095-6", "substance_tags": "psilocybin", "topic_tags": "Consciousness,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39915687", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s44184-024-00095-6", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39915687", "source_url": "https://doi.org/10.1038/s44184-024-00095-6", "doi": "10.1038/s44184-024-00095-6", "pmid": "39915687", "publication_date": "2025-02-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 826, "title": "Emerging Medications for Treatment-Resistant Depression: A Review with Perspective on Mechanisms and Challenges.", "authors": "Lucido MJ, Dunlop BW.", "journal": null, "publication_date": "2025-02-05", "publication_year": 2025, "doi": "10.3390/brainsci15020161", "pubmed_id": "40002494", "openalex_id": null, "source_url": "https://doi.org/10.3390/brainsci15020161", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression,Inflammation,Immune Function", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:40002494", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/brainsci15020161", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40002494", "source_url": "https://doi.org/10.3390/brainsci15020161", "doi": "10.3390/brainsci15020161", "pmid": "40002494", "publication_date": "2025-02-05", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 825, "title": "The Therapeutic Potential of Psychedelics in Treating Substance Use Disorders: A Review of Clinical Trials.", "authors": "Hogea L, Tabugan DC, Costea I, Albai O, Nussbaum L, Cojocaru A, Corsaro L, Anghel T.", "journal": null, "publication_date": "2025-02-05", "publication_year": 2025, "doi": "10.3390/medicina61020278", "pubmed_id": "40005395", "openalex_id": null, "source_url": "https://doi.org/10.3390/medicina61020278", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Wellbeing,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:40005395", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/medicina61020278", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40005395", "source_url": "https://doi.org/10.3390/medicina61020278", "doi": "10.3390/medicina61020278", "pmid": "40005395", "publication_date": "2025-02-05", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 828, "title": "Psychological Support Approaches in Psychedelic Therapy", "authors": "David A. Bender, Sandeep M. Nayak, Joshua S. Siegel, David J. Hellerstein, Barış Erçal, Eric J. Lenze", "journal": "The Journal of Clinical Psychiatry", "publication_date": "2025-02-04", "publication_year": 2025, "doi": "10.4088/jcp.24m15521", "pubmed_id": "39928849", "openalex_id": "https://openalex.org/W4407154479", "source_url": "https://doi.org/10.4088/jcp.24m15521", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Chronic Pain,Spirituality,Clinical Trial,Observational Study,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39928849", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.4088/jcp.24m15521", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39928849", "source_url": "https://doi.org/10.4088/jcp.24m15521", "doi": "10.4088/jcp.24m15521", "pmid": "39928849", "publication_date": "2025-02-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 827, "title": "Psychedelics assisting therapy, or therapy assisting psychedelics? The importance of psychotherapy in psychedelic-assisted therapy", "authors": "Joseph A. Zamaria, Gisele Fernandes-Osterhold, Jonathan Shedler, Rachel Yehuda", "journal": "Frontiers in Psychology", "publication_date": "2025-02-04", "publication_year": 2025, "doi": "10.3389/fpsyg.2025.1505894", "pubmed_id": "39973948", "openalex_id": "https://openalex.org/W4407181198", "source_url": "https://doi.org/10.3389/fpsyg.2025.1505894", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Consciousness,Emotional Processing,Clinical Trial,Observational Study,Treatment-Resistant Depression,Healthcare Workers,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39973948", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyg.2025.1505894", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39973948", "source_url": "https://doi.org/10.3389/fpsyg.2025.1505894", "doi": "10.3389/fpsyg.2025.1505894", "pmid": "39973948", "publication_date": "2025-02-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 830, "title": "Investigating novel pharmacological strategies for treatment-resistant depression: focus on new mechanisms and approaches.", "authors": "de Miranda AS, C B Toscano E, Venna VR, Graeff FG, Teixeira AL.", "journal": null, "publication_date": "2025-02-02", "publication_year": 2025, "doi": "10.1080/17460441.2025.2460674", "pubmed_id": "39885729", "openalex_id": null, "source_url": "https://doi.org/10.1080/17460441.2025.2460674", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Clinical Trial,Treatment-Resistant Depression,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:39885729", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/17460441.2025.2460674", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39885729", "source_url": "https://doi.org/10.1080/17460441.2025.2460674", "doi": "10.1080/17460441.2025.2460674", "pmid": "39885729", "publication_date": "2025-02-02", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4452, "title": "Clinical Trial Comparing Psilocybin to Nicotine Patch for Tobacco Addiction", "authors": "Matthew Weirick Johnson", "journal": "Drug and Alcohol Dependence", "publication_date": "2025-01-31", "publication_year": 2025, "doi": "10.1016/j.drugalcdep.2024.112187", "pubmed_id": null, "openalex_id": "https://openalex.org/W4407077022", "source_url": "https://doi.org/10.1016/j.drugalcdep.2024.112187", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.1016/j.drugalcdep.2024.112187", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.drugalcdep.2024.112187", "source_url": "https://doi.org/10.1016/j.drugalcdep.2024.112187", "doi": "10.1016/j.drugalcdep.2024.112187", "pmid": "", "publication_date": "2025-01-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 846, "title": "Psychedelic-assisted treatment for substance use disorder: A narrative systematic review.", "authors": "Piper T, Small F, Brown S, Kelleher M, Mitcheson L, Rucker J, Young AH, Marsden J.", "journal": null, "publication_date": "2025-01-29", "publication_year": 2025, "doi": "10.1111/add.16762", "pubmed_id": "39887551", "openalex_id": null, "source_url": "https://doi.org/10.1111/add.16762", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Observational Study,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:39887551", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1111/add.16762", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39887551", "source_url": "https://doi.org/10.1111/add.16762", "doi": "10.1111/add.16762", "pmid": "39887551", "publication_date": "2025-01-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 851, "title": "Down the Rabbit Hole: A Large-Scale Survey of Psychedelic Users’ Patterns of Use and Perceived Effects", "authors": "Carrie Cuttler, Amanda Stueber, Jonathan J. Simone, Leah M. Mayo", "journal": "Journal of Psychoactive Drugs", "publication_date": "2025-01-28", "publication_year": 2025, "doi": "10.1080/02791072.2025.2452226", "pubmed_id": "39878200", "openalex_id": "https://openalex.org/W4406930020", "source_url": "https://doi.org/10.1080/02791072.2025.2452226", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Headache / Migraine,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39878200", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/02791072.2025.2452226", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39878200", "source_url": "https://doi.org/10.1080/02791072.2025.2452226", "doi": "10.1080/02791072.2025.2452226", "pmid": "39878200", "publication_date": "2025-01-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3679, "title": "A Phase II Randomized, Double-blind, Active Placebo-controlled Parallel Group Trial to Examine the Efficacy and Safety of Psilocybin in Treatment-resistant Major Depression", "authors": "Central Institute of Mental Health, Mannheim", "journal": "ClinicalTrials.gov", "publication_date": "2025-01-19", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04670081", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04670081", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04670081", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04670081", "source_url": "https://clinicaltrials.gov/study/NCT04670081", "doi": "", "pmid": "", "publication_date": "2025-01-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 722, "title": "Catalyst for change: Psilocybin's antidepressant mechanisms-A systematic review.", "authors": "Liebnau J, Betzler F, Kerber A.", "journal": null, "publication_date": "2025-01-19", "publication_year": 2025, "doi": "10.1177/02698811241312866", "pubmed_id": "39829391", "openalex_id": null, "source_url": "https://doi.org/10.1177/02698811241312866", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Default Mode Network,Aging,Emotional Processing,Clinical Trial,Meta-Analysis,Systematic Review,Review Article", "study_type": "Meta-Analysis", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:39829391", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02698811241312866", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39829391", "source_url": "https://doi.org/10.1177/02698811241312866", "doi": "10.1177/02698811241312866", "pmid": "39829391", "publication_date": "2025-01-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 854, "title": "Uncovering Psychedelics: From Neural Circuits to Therapeutic Applications.", "authors": "Melani A, Bonaso M, Biso L, Zucchini B, Conversano C, Scarselli M.", "journal": null, "publication_date": "2025-01-18", "publication_year": 2025, "doi": "10.3390/ph18010130", "pubmed_id": "39861191", "openalex_id": null, "source_url": "https://doi.org/10.3390/ph18010130", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Neuroplasticity,Brain Imaging,Mechanism of Action,Default Mode Network,Consciousness,Aging,Emotional Processing,Spirituality,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:39861191", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/ph18010130", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39861191", "source_url": "https://doi.org/10.3390/ph18010130", "doi": "10.3390/ph18010130", "pmid": "39861191", "publication_date": "2025-01-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 550, "title": "A critical evaluation of psilocybin-assisted therapy protocol components from clinical trial patients, facilitators, and caregivers.", "authors": "Roman Palitsky, Jessica L. Maples-Keller, Caroline Peacock, Boadie W. Dunlop, Tanja Mletzko, George H. Grant, Charles L. Raison, Sam Chao, Isabelle Shub, Michal Mendelbaum-Kweller, Liam Smolyar, Deanna M. Kaplan, Barbara O. Rothbaum, Ali John Zarrabi", "journal": "Psychotherapy", "publication_date": "2025-01-12", "publication_year": 2025, "doi": "10.1037/pst0000551", "pubmed_id": "39804360", "openalex_id": "https://openalex.org/W4406306242", "source_url": "https://doi.org/10.1037/pst0000551", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Clinical Trial,Cancer Patients", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39804360", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1037/pst0000551", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39804360", "source_url": "https://doi.org/10.1037/pst0000551", "doi": "10.1037/pst0000551", "pmid": "39804360", "publication_date": "2025-01-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 806, "title": "A systematic review of participant diversity in psychedelic-assisted psychotherapy trials.", "authors": "Haft SL, Downey AE, Raymond-Flesch M, Fernandes-Osterhold G, Bradley ER, O'Donovan A, Woolley J.", "journal": null, "publication_date": "2025-01-09", "publication_year": 2025, "doi": "10.1016/j.psychres.2025.116359", "pubmed_id": "39823947", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.psychres.2025.116359", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:39823947", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.psychres.2025.116359", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39823947", "source_url": "https://doi.org/10.1016/j.psychres.2025.116359", "doi": "10.1016/j.psychres.2025.116359", "pmid": "39823947", "publication_date": "2025-01-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 862, "title": "Neurobiological mechanisms of antidepressant properties of psilocybin: A systematic review of blood biomarkers.", "authors": "Constantino JL, van Dalfsen JH, Massetti S, Kamphuis J, Schoevers RA.", "journal": null, "publication_date": "2025-01-06", "publication_year": 2025, "doi": "10.1016/j.pnpbp.2025.111251", "pubmed_id": "39788410", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.pnpbp.2025.111251", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Biomarkers,Clinical Trial,Systematic Review,Review Article,Animal Study,Healthy Volunteers", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:39788410", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.pnpbp.2025.111251", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39788410", "source_url": "https://doi.org/10.1016/j.pnpbp.2025.111251", "doi": "10.1016/j.pnpbp.2025.111251", "pmid": "39788410", "publication_date": "2025-01-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 863, "title": "Clinical and preclinical evidence of psilocybin as antidepressant. A narrative review.", "authors": "Erkizia-Santamaría I, Horrillo I, Meana JJ, Ortega JE.", "journal": null, "publication_date": "2025-01-05", "publication_year": 2025, "doi": "10.1016/j.pnpbp.2025.111249", "pubmed_id": "39778644", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.pnpbp.2025.111249", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Animal Study,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:39778644", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.pnpbp.2025.111249", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39778644", "source_url": "https://doi.org/10.1016/j.pnpbp.2025.111249", "doi": "10.1016/j.pnpbp.2025.111249", "pmid": "39778644", "publication_date": "2025-01-05", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 807, "title": "Elucidating the Phase I metabolism of psilocin in vitro.", "authors": "Chen J, Wang Z, Yong CY, Goh EML, Moy HY, Chan ECY.", "journal": null, "publication_date": "2025-01-02", "publication_year": 2025, "doi": "10.1007/s00204-024-03952-7", "pubmed_id": "39751877", "openalex_id": "https://openalex.org/W4406036520", "source_url": "https://doi.org/10.1007/s00204-024-03952-7", "substance_tags": "psilocybin,psilocin", "topic_tags": "End-of-Life Distress,Pharmacology,Mechanism of Action,Clinical Trial,In Vitro Study", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:39751877", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s00204-024-03952-7", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39751877", "source_url": "https://doi.org/10.1007/s00204-024-03952-7", "doi": "10.1007/s00204-024-03952-7", "pmid": "39751877", "publication_date": "2025-01-02", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3201, "title": "Perturbing whole-brain models of brain hierarchy: an application for depression following pharmacological treatment", "authors": "Socoró Garrigosa M, Sanz Perl Y, Kringelbach ML, Carhart-Harris R, Vohryzek J, Deco G.", "journal": "bioRxiv", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1101/2025.01.01.631011", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2025.01.01.631011", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Clinical Trial", "study_type": "Clinical Trial", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "DOI:10.1101/2025.01.01.631011", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2025.01.01.631011", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2025.01.01.631011", "source_url": "https://doi.org/10.1101/2025.01.01.631011", "doi": "10.1101/2025.01.01.631011", "pmid": "", "publication_date": "2025-01-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4494, "title": "Comparative Efficacy of Hallucinogens in Treating Mood Disorders Through a Meta-Analysis of Symptom Reduction, Dosage, and Duration", "authors": "Muniz, John Marco D.F.", "journal": "Journal of International Crisis and Risk Communication Research", "publication_date": "2024-12-31", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7112971088", "source_url": "https://stars.library.ucf.edu/hut2024/268", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "https://stars.library.ucf.edu/hut2024/268", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://stars.library.ucf.edu/hut2024/268", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://stars.library.ucf.edu/hut2024/268", "source_url": "https://stars.library.ucf.edu/hut2024/268", "doi": "", "pmid": "", "publication_date": "2024-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4488, "title": "Psilocybin-Assisted Therapy for Trauma-Related Disorders: A Scoping Review of a Depression-Dominated Evidence Base with Implications for Intimate Partner Violence-Related PTSD", "authors": "Hancock, Mackenzie, Shambhu Prasad Adhikari, Getz, Nicole", "journal": "Open Science Framework", "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.17605/osf.io/ar2s4", "pubmed_id": null, "openalex_id": "https://openalex.org/W7106330185", "source_url": "https://doi.org/10.17605/osf.io/ar2s4", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Clinical Trial,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.17605/osf.io/ar2s4", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.17605/osf.io/ar2s4", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.17605/osf.io/ar2s4", "source_url": "https://doi.org/10.17605/osf.io/ar2s4", "doi": "10.17605/osf.io/ar2s4", "pmid": "", "publication_date": "2024-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4484, "title": "Alternative therapy for neurological and psychiatric disorders using psilocybin", "authors": "Henrique Tofoli Vieira Machado, GEOVANA MENDES DE SEIXAS, L. Silva, Mariana Duarte Garcia Brito, Gabriella Assink de Castro", "journal": null, "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.5327/1516-3180.cpn.1123", "pubmed_id": null, "openalex_id": "https://openalex.org/W4417514861", "source_url": "https://doi.org/10.5327/1516-3180.cpn.1123", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Chronic Pain,Mechanism of Action,Wellbeing,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.5327/1516-3180.cpn.1123", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5327/1516-3180.cpn.1123", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5327/1516-3180.cpn.1123", "source_url": "https://doi.org/10.5327/1516-3180.cpn.1123", "doi": "10.5327/1516-3180.cpn.1123", "pmid": "", "publication_date": "2024-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4470, "title": "Supplemental Material for A Critical Evaluation of Psilocybin-Assisted Therapy Protocol Components From Clinical Trial Patients, Facilitators, and Caregivers", "authors": "", "journal": "Psychotherapy", "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.1037/pst0000551.supp", "pubmed_id": null, "openalex_id": "https://openalex.org/W4406217027", "source_url": "https://doi.org/10.1037/pst0000551.supp", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.1037/pst0000551.supp", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1037/pst0000551.supp", "source_url": "https://doi.org/10.1037/pst0000551.supp", "doi": "10.1037/pst0000551.supp", "pmid": "", "publication_date": "2024-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 909, "title": "Practical considerations in the establishment of psychedelic research programs.", "authors": "Barnett BS, Vest MF, Delatte MS, King Iv F, Mauney EE, Coulson AJ, Nayak SM, Hendricks PS, Greer GR, Murnane KS", "journal": "Psychopharmacology", "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.1007/s00213-024-06722-6", "pubmed_id": "39627438", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39627438/", "substance_tags": "psilocybin", "topic_tags": "Aging,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:20:36", "bibtex": null, "source_record_id": "PMID:39627438", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39627438/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39627438", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39627438/", "doi": "10.1007/s00213-024-06722-6", "pmid": "39627438", "publication_date": "2024-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 906, "title": "Compass Psychological Support Model for COMP360 Psilocybin Treatment of Serious Mental Health Conditions", "authors": "Namik Kirlić, Molly Lennard-Jones, Merve Atli, Ekaterina Malievskaia, Nadav Liam Modlin, Stéphanie Knatz Peck, Alice Gaillard, Guy M. Goodwin, Don Koelpin", "journal": "American Journal of Psychiatry", "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.1176/appi.ajp.20230884", "pubmed_id": "39741434", "openalex_id": "https://openalex.org/W4405978092", "source_url": "https://doi.org/10.1176/appi.ajp.20230884", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39741434", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.ajp.20230884", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39741434", "source_url": "https://doi.org/10.1176/appi.ajp.20230884", "doi": "10.1176/appi.ajp.20230884", "pmid": "39741434", "publication_date": "2024-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 904, "title": "Psilocybin: From Psychiatric Pariah to Perceived Panacea.", "authors": "Fonzo GA, Wolfgang AS, Barksdale BR, Krystal JH, Carpenter LL, Kraguljac NV, Grzenda A, McDonald WM, Widge AS, Rodriguez CI, Nemeroff CB.", "journal": null, "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.1176/appi.ajp.20230682", "pubmed_id": "39741437", "openalex_id": null, "source_url": "https://doi.org/10.1176/appi.ajp.20230682", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Eating Disorders,Mechanism of Action,Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:39741437", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1176/appi.ajp.20230682", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39741437", "source_url": "https://doi.org/10.1176/appi.ajp.20230682", "doi": "10.1176/appi.ajp.20230682", "pmid": "39741437", "publication_date": "2024-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 903, "title": "Benefits and Challenges of Ultra-Fast, Short-Acting Psychedelics in the Treatment of Depression.", "authors": "Ramaekers JG, Reckweg JT, Mason NL.", "journal": null, "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.1176/appi.ajp.20230890", "pubmed_id": "39741439", "openalex_id": null, "source_url": "https://doi.org/10.1176/appi.ajp.20230890", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:39741439", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1176/appi.ajp.20230890", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39741439", "source_url": "https://doi.org/10.1176/appi.ajp.20230890", "doi": "10.1176/appi.ajp.20230890", "pmid": "39741439", "publication_date": "2024-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 902, "title": "Single-Dose Psilocybin for Depression With Severe Treatment Resistance: An Open-Label Trial", "authors": "Scott T. Aaronson, Andrew van der Vaart, Tammy Miller, Jeffrey LaPratt, Kimberly Swartz, Audrey Shoultz, Margo Lauterbach, Trisha Suppes, Harold A. Sackeïm", "journal": "American Journal of Psychiatry", "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.1176/appi.ajp.20231063", "pubmed_id": "39741440", "openalex_id": "https://openalex.org/W4405955624", "source_url": "https://doi.org/10.1176/appi.ajp.20231063", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Chronic Pain,Clinical Trial,Treatment-Resistant Depression,Safety,Toxicity,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39741440", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.ajp.20231063", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39741440", "source_url": "https://doi.org/10.1176/appi.ajp.20231063", "doi": "10.1176/appi.ajp.20231063", "pmid": "39741440", "publication_date": "2024-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 900, "title": "Multidimensional Personality Changes Following Psilocybin-Assisted Therapy in Patients With Alcohol Use Disorder: Results From a Double-Blind, Placebo-Controlled Clinical Trial", "authors": "Broc A. Pagni, Richard J. Zeifman, Sarah E. Mennenga, Brennan M. Carrithers, Noam Goldway, Snehal Bhatt, Kelley C. O’Donnell, Stephen Ross, Michael P. Bogenschutz", "journal": "American Journal of Psychiatry", "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.1176/appi.ajp.20230887", "pubmed_id": "39741446", "openalex_id": "https://openalex.org/W4405955644", "source_url": "https://doi.org/10.1176/appi.ajp.20230887", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Chronic Pain,Personality Change,Clinical Trial,Randomized Controlled Trial,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39741446", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.ajp.20230887", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39741446", "source_url": "https://doi.org/10.1176/appi.ajp.20230887", "doi": "10.1176/appi.ajp.20230887", "pmid": "39741446", "publication_date": "2024-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 899, "title": "Exploring Psychedelics Pharmacology: A Scoping Review Charting the Course of Psilocybin Pharmacokinetics.", "authors": "Manzano-Nunez R, Gomez DA, Toledo-Mendoza C, Perez-Otero M, Matilla IL, Prats C, Perez-Lopez E, Pardo H, Díaz-Pellicer P, De La Torre-Fornell R, Aldea AM.", "journal": null, "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.1097/wnf.0000000000000617", "pubmed_id": "39787428", "openalex_id": null, "source_url": "https://doi.org/10.1097/wnf.0000000000000617", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,End-of-Life Distress,Pharmacology,Clinical Trial,Review Article,Healthy Volunteers,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:39787428", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1097/wnf.0000000000000617", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39787428", "source_url": "https://doi.org/10.1097/wnf.0000000000000617", "doi": "10.1097/wnf.0000000000000617", "pmid": "39787428", "publication_date": "2024-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 898, "title": "Psilocybin-Assisted Group Psychotherapy + Mindfulness Based Stress Reduction (MBSR) for Frontline Healthcare Provider COVID-19 Related Depression and Burnout: A Randomized Clinical Trial", "authors": "Lewis BR, Hendrick J, Byrne K, Odette M, Wu C, Garland EL.", "journal": "medRxiv", "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.1101/2024.12.31.24319806", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2024.12.31.24319806", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Observational Study,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.1101/2024.12.31.24319806", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2024.12.31.24319806", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2024.12.31.24319806", "source_url": "https://doi.org/10.1101/2024.12.31.24319806", "doi": "10.1101/2024.12.31.24319806", "pmid": "", "publication_date": "2024-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 883, "title": "Post-traumatic stress disorder in psychedelic research.", "authors": "Bostoen T, Tap S, Breeksema J, Schoevers R", "journal": "International review of neurobiology", "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.1016/bs.irn.2025.02.004", "pubmed_id": "40541315", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40541315/", "substance_tags": "psilocybin", "topic_tags": "PTSD,Mechanism of Action,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:20:36", "bibtex": null, "source_record_id": "PMID:40541315", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40541315/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40541315", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40541315/", "doi": "10.1016/bs.irn.2025.02.004", "pmid": "40541315", "publication_date": "2024-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 597, "title": "Psychedelic Treatment with Psilocybin: Addressing Medical Malpractice Risk and Physicians’ Concerns", "authors": "Katherine Cheung, Maxwell Brodie, Sue-Ling Chang, P. Deschamps, Jean-Sébastien Fallu, Houman Farzin, Johanne Hébert, Jean-François Stephan, Michel Dorval, Yann Joly, for the P3A Study Group", "journal": "The Journal of Law Medicine & Ethics", "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.1017/jme.2025.10109", "pubmed_id": "40739983", "openalex_id": "https://openalex.org/W4412810429", "source_url": "https://doi.org/10.1017/jme.2025.10109", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:40739983", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1017/jme.2025.10109", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40739983", "source_url": "https://doi.org/10.1017/jme.2025.10109", "doi": "10.1017/jme.2025.10109", "pmid": "40739983", "publication_date": "2024-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 435, "title": "The ethical use of therapeutic touch in psychedelic-assisted therapy: a qualitative study of researcher perspectives and experiences.", "authors": "McHerron D, Barber M, Ham R, Liknaitzky P, Carter A, Gardner J", "journal": "Therapeutic advances in psychopharmacology", "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.1177/20451253251377191", "pubmed_id": "41244962", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41244962/", "substance_tags": "psilocybin", "topic_tags": "Aging,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:20:35", "bibtex": null, "source_record_id": "PMID:41244962", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41244962/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41244962", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41244962/", "doi": "10.1177/20451253251377191", "pmid": "41244962", "publication_date": "2024-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5688, "title": "[Psychedelics and pyschodelic-associated psychotherapies - Who is PAP for after all?]", "authors": "Papp N, Gonda X.", "journal": null, "publication_date": "2024-12-30", "publication_year": 2024, "doi": null, "pubmed_id": "42412648", "openalex_id": null, "source_url": "https://europepmc.org/article/MED/42412648", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Emotional Processing,Clinical Trial,Review Article,Animal Study", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-11 19:28:10", "last_checked": "2026-07-11 19:28:10", "bibtex": null, "source_record_id": "PMID:42412648", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/MED/42412648", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42412648", "source_url": "https://europepmc.org/article/MED/42412648", "doi": "", "pmid": "42412648", "publication_date": "2024-12-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4505, "title": "Psychedelic-Assisted Therapy: The Emerging Role of the Psychiatric-Mental Health Nurse", "authors": "Khalaud Naseeb Alhajry, Zahra Mohammed Sukairi, Hamidah Abdullah Lajami, Safiah Anber Bin Ali Ibrahim, Nawal Obaid Alanazi, Eman Ali Alsafwani, Ashwag Saad Hnif Albishi, Nada Naser Alomi, Zahrh Ahmed Ali Al-Hamadah, Anwar Mehdaf Akash Alrowaly", "journal": "Saudi Journal of Medicine and Public Health", "publication_date": "2024-12-30", "publication_year": 2024, "doi": "10.64483/20251153", "pubmed_id": null, "openalex_id": "https://openalex.org/W7104738164", "source_url": "https://doi.org/10.64483/20251153", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,End-of-Life Distress,Chronic Pain,Mechanism of Action,Clinical Trial,Systematic Review,Review Article,Safety,Toxicity", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.64483/20251153", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.64483/20251153", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.64483/20251153", "source_url": "https://doi.org/10.64483/20251153", "doi": "10.64483/20251153", "pmid": "", "publication_date": "2024-12-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4504, "title": "Treatment-Resistant Depression: A Comprehensive Insight of Ketamine Infusion Therapy, Transcranial Magnetic Stimulation (TMS), and Psychedelic-Assisted Psychotherapy", "authors": "Mohammad Ali, Urbah Viqar", "journal": "Annals of Punjab Medical College", "publication_date": "2024-12-30", "publication_year": 2024, "doi": "10.29054/apmc/2024.1658", "pubmed_id": null, "openalex_id": "https://openalex.org/W4408418352", "source_url": "https://doi.org/10.29054/apmc/2024.1658", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Clinical Trial,Systematic Review,Review Article,Case Report,Observational Study,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.29054/apmc/2024.1658", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.29054/apmc/2024.1658", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.29054/apmc/2024.1658", "source_url": "https://doi.org/10.29054/apmc/2024.1658", "doi": "10.29054/apmc/2024.1658", "pmid": "", "publication_date": "2024-12-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 833, "title": "Efficacy and safety of psilocybin in the treatment of Major Depressive Disorder (MDD): A dose-response network meta-analysis of randomized placebo-controlled clinical trials.", "authors": "Swieczkowski D, Kwaśny A, Pruc M, Gaca Z, Szarpak L, Cubała WJ.", "journal": null, "publication_date": "2024-12-22", "publication_year": 2024, "doi": "10.1016/j.psychres.2024.116337", "pubmed_id": "39754904", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.psychres.2024.116337", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:39754904", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.psychres.2024.116337", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39754904", "source_url": "https://doi.org/10.1016/j.psychres.2024.116337", "doi": "10.1016/j.psychres.2024.116337", "pmid": "39754904", "publication_date": "2024-12-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 835, "title": "Therapeutic Potential of MDMA- and Psychedelic-Assisted Psychotherapy for Adolescent Depression and Trauma.", "authors": "Geller J, Whitney E.", "journal": null, "publication_date": "2024-12-18", "publication_year": 2024, "doi": "10.1007/s11920-024-01577-2", "pubmed_id": "39699759", "openalex_id": null, "source_url": "https://doi.org/10.1007/s11920-024-01577-2", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Aging,Clinical Trial,Review Article,Adolescents,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:39699759", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s11920-024-01577-2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39699759", "source_url": "https://doi.org/10.1007/s11920-024-01577-2", "doi": "10.1007/s11920-024-01577-2", "pmid": "39699759", "publication_date": "2024-12-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3101, "title": "Psilocybin causes sex, time, and dose dependent alterations in brain signaling pathways", "authors": "Barnett JH, Todd KT, Benetatos J, Rabichow BE, Gibson KA, Olney KC, Fryer JD.", "journal": "bioRxiv", "publication_date": "2024-12-16", "publication_year": 2024, "doi": "10.1101/2024.12.16.628764", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2024.12.16.628764", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Neurogenesis,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Animal Study,Healthcare Workers,Transcriptomics", "study_type": "Clinical Trial", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.1101/2024.12.16.628764", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2024.12.16.628764", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2024.12.16.628764", "source_url": "https://doi.org/10.1101/2024.12.16.628764", "doi": "10.1101/2024.12.16.628764", "pmid": "", "publication_date": "2024-12-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4508, "title": "Disentangling debate about therapeutic and recreational use of psychedelics", "authors": "Christina M. Andrews, Wayne Hall, Keith Humphreys, John Marsden", "journal": "Addiction", "publication_date": "2024-12-14", "publication_year": 2024, "doi": "10.1111/add.16744", "pubmed_id": "39676069", "openalex_id": "https://openalex.org/W4405412696", "source_url": "https://doi.org/10.1111/add.16744", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Addiction,Clinical Trial,Veterans,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39676069", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/add.16744", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39676069", "source_url": "https://doi.org/10.1111/add.16744", "doi": "10.1111/add.16744", "pmid": "39676069", "publication_date": "2024-12-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 837, "title": "The safety of psilocybin-assisted psychotherapy: A systematic review.", "authors": "Freitas RR, Gotsis ES, Gallo AT, Fitzgibbon BM, Bailey NW, Fitzgerald PB.", "journal": null, "publication_date": "2024-12-12", "publication_year": 2024, "doi": "10.1177/00048674241289024", "pubmed_id": "39670342", "openalex_id": null, "source_url": "https://doi.org/10.1177/00048674241289024", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:39670342", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/00048674241289024", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39670342", "source_url": "https://doi.org/10.1177/00048674241289024", "doi": "10.1177/00048674241289024", "pmid": "39670342", "publication_date": "2024-12-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 781, "title": "Psychedelic use and bipolar disorder - An investigation of recreational use and its impact on mental health.", "authors": "Meyer TD, Ibrahim M, Vale LN, Soares JC.", "journal": null, "publication_date": "2024-12-12", "publication_year": 2024, "doi": "10.1016/j.jad.2024.12.044", "pubmed_id": "39675677", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jad.2024.12.044", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:39675677", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jad.2024.12.044", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39675677", "source_url": "https://doi.org/10.1016/j.jad.2024.12.044", "doi": "10.1016/j.jad.2024.12.044", "pmid": "39675677", "publication_date": "2024-12-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 809, "title": "Treatment Expectancies and Psilocybin vs Escitalopram for Depression", "authors": "Ethan G. Dutcher, Andrew D. Krystal", "journal": "JAMA Psychiatry", "publication_date": "2024-12-09", "publication_year": 2024, "doi": "10.1001/jamapsychiatry.2024.4387", "pubmed_id": "39653344", "openalex_id": "https://openalex.org/W4405172984", "source_url": "https://doi.org/10.1001/jamapsychiatry.2024.4387", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39653344", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1001/jamapsychiatry.2024.4387", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39653344", "source_url": "https://doi.org/10.1001/jamapsychiatry.2024.4387", "doi": "10.1001/jamapsychiatry.2024.4387", "pmid": "39653344", "publication_date": "2024-12-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 928, "title": "Psilocybin-assisted psychotherapy for methamphetamine dependence: a case report involving daily methamphetamine use", "authors": "Jonathan Brett, Elizabeth Knock, Kathy Watson, Steven M. Albert, Krista J. Siefried, Jeffrey Guss", "journal": "Frontiers in Psychiatry", "publication_date": "2024-12-05", "publication_year": 2024, "doi": "10.3389/fpsyt.2024.1490907", "pubmed_id": "39713770", "openalex_id": "https://openalex.org/W4405122998", "source_url": "https://doi.org/10.3389/fpsyt.2024.1490907", "substance_tags": "psilocybin", "topic_tags": "Addiction,Pharmacology,Receptor Pharmacology,Aging,Emotional Processing,Clinical Trial,Case Report,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39713770", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2024.1490907", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39713770", "source_url": "https://doi.org/10.3389/fpsyt.2024.1490907", "doi": "10.3389/fpsyt.2024.1490907", "pmid": "39713770", "publication_date": "2024-12-05", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 936, "title": "Psilocybin Therapy for Clinicians With Symptoms of Depression From Frontline Care During the COVID-19 Pandemic", "authors": "Anthony L. Back, Timara K. Freeman-Young, Ladybird Morgan, Tanmeet Sethi, Kelsey K. Baker, Susanna Myers, Bonnie A. McGregor, Kalin Harvey, Marlene Tai, Austin Kollefrath, Brandon J. Thomas, Dennis Sorta, Mendel Kaelen, Benjamin Kelmendi, Ted Gooley", "journal": "JAMA Network Open", "publication_date": "2024-12-04", "publication_year": 2024, "doi": "10.1001/jamanetworkopen.2024.49026", "pubmed_id": "39636638", "openalex_id": "https://openalex.org/W4405031949", "source_url": "https://doi.org/10.1001/jamanetworkopen.2024.49026", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Healthcare Workers", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39636638", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1001/jamanetworkopen.2024.49026", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39636638", "source_url": "https://doi.org/10.1001/jamanetworkopen.2024.49026", "doi": "10.1001/jamanetworkopen.2024.49026", "pmid": "39636638", "publication_date": "2024-12-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4514, "title": "God hasn’t died, it has merely been encapsulated - Psilocybin and ayahuasca in the psychedelic renaissance: Intersections between religion, indigenous cosmologies, spirituality, and science", "authors": "Juan Scuro", "journal": "Social Compass", "publication_date": "2024-11-30", "publication_year": 2024, "doi": "10.1177/00377686241301923", "pubmed_id": null, "openalex_id": "https://openalex.org/W4405760007", "source_url": "https://doi.org/10.1177/00377686241301923", "substance_tags": "psilocybin", "topic_tags": "Spirituality,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.1177/00377686241301923", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/00377686241301923", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/00377686241301923", "source_url": "https://doi.org/10.1177/00377686241301923", "doi": "10.1177/00377686241301923", "pmid": "", "publication_date": "2024-11-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 922, "title": "Psilocybin as a Disease-Modifying Drug-A Salutogenic Approach in Psychiatry.", "authors": "Spangemacher M, Mertens LJ, Färber LV, Jungaberle A, Jungaberle H, Gründer G.", "journal": null, "publication_date": "2024-11-30", "publication_year": 2024, "doi": "10.3238/arztebl.m2024.0224", "pubmed_id": "39628414", "openalex_id": null, "source_url": "https://doi.org/10.3238/arztebl.m2024.0224", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Review Article", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:39628414", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3238/arztebl.m2024.0224", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39628414", "source_url": "https://doi.org/10.3238/arztebl.m2024.0224", "doi": "10.3238/arztebl.m2024.0224", "pmid": "39628414", "publication_date": "2024-11-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 811, "title": "Reconsidering evidence for psychedelic-induced psychosis: an overview of reviews, a systematic review, and meta-analysis of human studies.", "authors": "Sabé M, Sulstarova A, Glangetas A, De Pieri M, Mallet L, Curtis L, Richard-Lepouriel H, Penzenstadler L, Seragnoli F, Thorens G, Zullino D, Preller K, Böge K, Leucht S, Correll CU, Solmi M, Kaiser S, Kirschner M.", "journal": null, "publication_date": "2024-11-26", "publication_year": 2024, "doi": "10.1038/s41380-024-02800-5", "pubmed_id": "39592825", "openalex_id": null, "source_url": "https://doi.org/10.1038/s41380-024-02800-5", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:39592825", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1038/s41380-024-02800-5", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39592825", "source_url": "https://doi.org/10.1038/s41380-024-02800-5", "doi": "10.1038/s41380-024-02800-5", "pmid": "39592825", "publication_date": "2024-11-26", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 795, "title": "Participants’ Experience of Psychedelic Integration Groups and Processes: A Qualitative Thematic Analysis", "authors": "Nadav Liam Modlin, Tyler McPhee, Nira Zazon, Maria Sarang, Rebecca Hignett, Susannah Pick, Anthony J. Cleare, Victoria Williamson, James Rucker", "journal": "Psychedelic Medicine", "publication_date": "2024-11-25", "publication_year": 2024, "doi": "10.1089/psymed.2024.0027", "pubmed_id": "40337755", "openalex_id": "https://openalex.org/W4404743266", "source_url": "https://doi.org/10.1089/psymed.2024.0027", "substance_tags": "psilocybin", "topic_tags": "Aging,Clinical Trial,Observational Study,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:40337755", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1089/psymed.2024.0027", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40337755", "source_url": "https://doi.org/10.1089/psymed.2024.0027", "doi": "10.1089/psymed.2024.0027", "pmid": "40337755", "publication_date": "2024-11-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 796, "title": "Psilocybin-Assisted Therapy May Enhance Conservation Values in Patients with Alcohol Use Disorder", "authors": "Noah D. Gold, Broc A. Pagni, Petros Petridis, Michael P. Bogenschutz", "journal": "Psychedelic Medicine", "publication_date": "2024-11-24", "publication_year": 2024, "doi": "10.1089/psymed.2024.0030", "pubmed_id": "40337752", "openalex_id": "https://openalex.org/W4404701866", "source_url": "https://doi.org/10.1089/psymed.2024.0030", "substance_tags": "psilocybin", "topic_tags": "Addiction,Pharmacology,Consciousness,Personality Change,Mystical Experience,Clinical Trial,Observational Study,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:40337752", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1089/psymed.2024.0030", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40337752", "source_url": "https://doi.org/10.1089/psymed.2024.0030", "doi": "10.1089/psymed.2024.0030", "pmid": "40337752", "publication_date": "2024-11-24", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3488, "title": "Psilocybin Treatment in Obsessive-Compulsive Disorder: a Preliminary Efficacy Study and Exploratory Investigation of Neural Correlates.", "authors": "Yale University", "journal": "ClinicalTrials.gov", "publication_date": "2024-11-19", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT03356483", "substance_tags": "psilocybin", "topic_tags": "OCD,Brain Imaging,Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT03356483", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT03356483", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT03356483", "source_url": "https://clinicaltrials.gov/study/NCT03356483", "doi": "", "pmid": "", "publication_date": "2024-11-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3512, "title": "A Phase 2a Safety and Feasibility Study Evaluating Psilocybin (TRP-8802) Administration in Concert With Psychotherapy in the Treatment of Binge Eating Disorder", "authors": "TRYP Therapeutics", "journal": "ClinicalTrials.gov", "publication_date": "2024-11-18", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05035927", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Eating Disorders,Pharmacology,Clinical Trial,Cancer Patients,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05035927", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05035927", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05035927", "source_url": "https://clinicaltrials.gov/study/NCT05035927", "doi": "", "pmid": "", "publication_date": "2024-11-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 970, "title": "Preliminary Evidence of Sleep Improvements Following Psilocybin Administration, and their Involvement in Antidepressant Therapeutic Action.", "authors": "Reid MJ, Kettner H, Blanken TF, Weiss B, Carhart-Harris R.", "journal": null, "publication_date": "2024-11-12", "publication_year": 2024, "doi": "10.1007/s11920-024-01539-8", "pubmed_id": "39532819", "openalex_id": null, "source_url": "https://doi.org/10.1007/s11920-024-01539-8", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Drug Interactions", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:39532819", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s11920-024-01539-8", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39532819", "source_url": "https://doi.org/10.1007/s11920-024-01539-8", "doi": "10.1007/s11920-024-01539-8", "pmid": "39532819", "publication_date": "2024-11-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4523, "title": "Psychedelic treatment for anorexia nervosa: A first-hand view of how psilocybin treatment did and did not help", "authors": "Stéphanie Knatz Peck, Hannah M. Fisher, Jessie Kim, Samantha Shao, Julie Trim, Walter H. Kaye", "journal": "Psychedelics.", "publication_date": "2024-11-06", "publication_year": 2024, "doi": "10.61373/pp024e.0034", "pubmed_id": null, "openalex_id": "https://openalex.org/W4404961618", "source_url": "https://doi.org/10.61373/pp024e.0034", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.61373/pp024e.0034", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.61373/pp024e.0034", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.61373/pp024e.0034", "source_url": "https://doi.org/10.61373/pp024e.0034", "doi": "10.61373/pp024e.0034", "pmid": "", "publication_date": "2024-11-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3134, "title": "Preliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: An open-label, pilot clinical trial", "authors": "Aday JS, McAfee J, Conroy DA, Hosanagar A, Tarnal V, Weston C, Scott K, Horowitz D, Harte SE, Pouyan N, Glynos NG, Baker AK, Guss J, Davis AK, Burgess HJ, Mashour GA, Clauw DJ, Boehnke KF.", "journal": "PsyArXiv", "publication_date": "2024-11-03", "publication_year": 2024, "doi": "10.31234/osf.io/j8zb5", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/j8zb5", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Chronic Pain,Headache / Migraine,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/j8zb5", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/j8zb5", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/j8zb5", "source_url": "https://doi.org/10.31234/osf.io/j8zb5", "doi": "10.31234/osf.io/j8zb5", "pmid": "", "publication_date": "2024-11-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 776, "title": "Preliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: An open-label, pilot clinical trial", "authors": "", "journal": "PsyArXiv", "publication_date": "2024-11-03", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/j8zb5_v1", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Chronic Pain,Headache / Migraine,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/j8zb5_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/j8zb5_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/j8zb5_v1", "source_url": "https://osf.io/preprints/psyarxiv/j8zb5_v1", "doi": "", "pmid": "", "publication_date": "2024-11-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5670, "title": "Worsening suicidal ideation and prolonged adverse event following psilocybin administration in a clinical setting: case report and thematic analysis of one participant's experience", "authors": "Mourad Wahba, Caroline Hayes, Maartje Kletter, R. Hamish McAllister-Williams", "journal": "BJPsych Open", "publication_date": "2024-10-31", "publication_year": 2024, "doi": "10.1192/bjo.2024.768", "pubmed_id": "39654264", "openalex_id": "https://openalex.org/W4405215942", "source_url": "https://doi.org/10.1192/bjo.2024.768", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Pharmacology,Clinical Trial,Case Report,Treatment-Resistant Depression,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 07:00:34", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39654264", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1192/bjo.2024.768", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39654264", "source_url": "https://doi.org/10.1192/bjo.2024.768", "doi": "10.1192/bjo.2024.768", "pmid": "39654264", "publication_date": "2024-10-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 927, "title": "Worsening suicidal ideation and prolonged adverse event following psilocybin administration in a clinical setting: case report and thematic analysis of one participant's experience", "authors": "Mourad Wahba, Caroline Hayes, Maartje Kletter, R. Hamish McAllister-Williams", "journal": "BJPsych Open", "publication_date": "2024-10-31", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7139416359", "source_url": "https://doi.org/10.1192/bjo.2024.768", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Pharmacology,Clinical Trial,Case Report,Treatment-Resistant Depression,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 06:34:42", "bibtex": null, "source_record_id": "https://doi.org/10.1192/bjo.2024.768", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1192/bjo.2024.768", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://doi.org/10.1192/bjo.2024.768", "source_url": "https://doi.org/10.1192/bjo.2024.768", "doi": "", "pmid": "", "publication_date": "2024-10-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3136, "title": "Personal Psychedelic Experience as a Training Qualification for Facilitators: A Thematic Analysis of Qualitative Interviews with Psilocybin Experts", "authors": "Luoma JB, Wilson-Poe A, Pertl K, Hoffman K, Bazinet A, Stauffer C, McCarty D, Korthuis P.", "journal": "PsyArXiv", "publication_date": "2024-10-30", "publication_year": 2024, "doi": "10.31234/osf.io/dwhcu_v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/dwhcu_v1", "substance_tags": "psilocybin", "topic_tags": "Wellbeing,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/dwhcu_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/dwhcu_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/dwhcu_v1", "source_url": "https://doi.org/10.31234/osf.io/dwhcu_v1", "doi": "10.31234/osf.io/dwhcu_v1", "pmid": "", "publication_date": "2024-10-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 551, "title": "Personal Psychedelic Experience as a Training Qualification for Facilitators: A Thematic Analysis of Qualitative Interviews with Psilocybin Experts", "authors": "", "journal": "PsyArXiv", "publication_date": "2024-10-30", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/dwhcu_v1", "substance_tags": "psilocybin", "topic_tags": "Wellbeing,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/dwhcu_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/dwhcu_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/dwhcu_v1", "source_url": "https://osf.io/preprints/psyarxiv/dwhcu_v1", "doi": "", "pmid": "", "publication_date": "2024-10-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 371, "title": "Psilocybin for major depressive disorder: An updated systematic review and meta-analysis of randomized clinical trials", "authors": "Sepehr Aghajanian, Arman Shafiee, Samira Parvizi Omran, Aida Rezaei Nejad, Kyana Jafarabady, Omid Kohandel Gargari, Shahryar Rajai Firouzabadi, Ida Mohammadi, Touran Bahrami Babaheidari, Mahmood Bakhtiyari", "journal": "Journal of Psychopharmacology", "publication_date": "2024-10-30", "publication_year": 2024, "doi": "10.1177/02698811241287542", "pubmed_id": "39480198", "openalex_id": "https://openalex.org/W4403943147", "source_url": "https://doi.org/10.1177/02698811241287542", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39480198", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/02698811241287542", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39480198", "source_url": "https://doi.org/10.1177/02698811241287542", "doi": "10.1177/02698811241287542", "pmid": "39480198", "publication_date": "2024-10-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3584, "title": "A Registered Clinical Trial of PEX010-Assisted Therapy for Stimulant Use Disorder: A Safety, Feasibility and Efficacy Study", "authors": "Filament Health Corp.", "journal": "ClinicalTrials.gov", "publication_date": "2024-10-29", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06666010", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06666010", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06666010", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06666010", "source_url": "https://clinicaltrials.gov/study/NCT06666010", "doi": "", "pmid": "", "publication_date": "2024-10-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 986, "title": "A narrative exploration of psilocybin's potential in mental health.", "authors": "Min H, Park SY, Park J, Na S, Lee HS, Kim T, Ham J, Park YT.", "journal": null, "publication_date": "2024-10-29", "publication_year": 2024, "doi": "10.3389/fpsyt.2024.1429373", "pubmed_id": "39540010", "openalex_id": null, "source_url": "https://doi.org/10.3389/fpsyt.2024.1429373", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Clinical Trial,Review Article,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:39540010", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2024.1429373", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39540010", "source_url": "https://doi.org/10.3389/fpsyt.2024.1429373", "doi": "10.3389/fpsyt.2024.1429373", "pmid": "39540010", "publication_date": "2024-10-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4531, "title": "“The mushroom was more alive and vibrant”: Patient reports of synthetic versus organic forms of psilocybin", "authors": "Pamela Kryskow, Paul Stamets, Joseph La Torre, Kathy Sattler, Vivian W. L. Tsang, Monnica T. Williams", "journal": "Journal of Psychedelic Studies", "publication_date": "2024-10-28", "publication_year": 2024, "doi": "10.1556/2054.2024.00379", "pubmed_id": null, "openalex_id": "https://openalex.org/W4403860154", "source_url": "https://doi.org/10.1556/2054.2024.00379", "substance_tags": "psilocybin", "topic_tags": "Emotional Processing,Mystical Experience,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2024.00379", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2024.00379", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2024.00379", "source_url": "https://doi.org/10.1556/2054.2024.00379", "doi": "10.1556/2054.2024.00379", "pmid": "", "publication_date": "2024-10-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3644, "title": "Psilocybin vs Escitalopram for Major Depressive Disorder: Comparative Mechanisms", "authors": "Imperial College London", "journal": "ClinicalTrials.gov", "publication_date": "2024-10-23", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT03429075", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT03429075", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT03429075", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT03429075", "source_url": "https://clinicaltrials.gov/study/NCT03429075", "doi": "", "pmid": "", "publication_date": "2024-10-23", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 989, "title": "Expert recommendations for Germany's integration of psychedelic-assisted therapy.", "authors": "Perez Rosal SR, La Torre JT, Birnkammer S, Chernoloz O, Williams MT, Faber SC.", "journal": null, "publication_date": "2024-10-23", "publication_year": 2024, "doi": "10.1186/s12909-024-06141-3", "pubmed_id": "39443907", "openalex_id": null, "source_url": "https://doi.org/10.1186/s12909-024-06141-3", "substance_tags": "psilocybin", "topic_tags": "PTSD,Mechanism of Action,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:39443907", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1186/s12909-024-06141-3", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39443907", "source_url": "https://doi.org/10.1186/s12909-024-06141-3", "doi": "10.1186/s12909-024-06141-3", "pmid": "39443907", "publication_date": "2024-10-23", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3453, "title": "Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression: An Emotional-Processing fMRI Pilot Study", "authors": "University Health Network, Toronto", "journal": "ClinicalTrials.gov", "publication_date": "2024-10-17", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06506019", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Consciousness,Aging,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Healthy Volunteers,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06506019", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06506019", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06506019", "source_url": "https://clinicaltrials.gov/study/NCT06506019", "doi": "", "pmid": "", "publication_date": "2024-10-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 954, "title": "Moving psychedelic-assisted therapies from promising research into routine clinical practice: Lessons from the field of implementation science", "authors": "Danielle R. Adams, Heidi Allen, Ginger E. Nicol, Leopoldo J. Cabassa", "journal": "Translational Behavioral Medicine", "publication_date": "2024-10-16", "publication_year": 2024, "doi": "10.1093/tbm/ibae053", "pubmed_id": "39419768", "openalex_id": "https://openalex.org/W4403502370", "source_url": "https://doi.org/10.1093/tbm/ibae053", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Mechanism of Action,Clinical Trial,Veterans,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39419768", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/tbm/ibae053", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39419768", "source_url": "https://doi.org/10.1093/tbm/ibae053", "doi": "10.1093/tbm/ibae053", "pmid": "39419768", "publication_date": "2024-10-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 957, "title": "Expanding the Therapeutic Horizons of Psilocybin in Mental Health.", "authors": "Kargbo RB.", "journal": null, "publication_date": "2024-10-14", "publication_year": 2024, "doi": "10.1021/acsmedchemlett.4c00488", "pubmed_id": "39563826", "openalex_id": null, "source_url": "https://doi.org/10.1021/acsmedchemlett.4c00488", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Wellbeing,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:39563826", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1021/acsmedchemlett.4c00488", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39563826", "source_url": "https://doi.org/10.1021/acsmedchemlett.4c00488", "doi": "10.1021/acsmedchemlett.4c00488", "pmid": "39563826", "publication_date": "2024-10-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4540, "title": "Plain Language Summary Publication: Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: Results from an open-label phase Ib ascending dose study", "authors": "James Rucker, Matthew Butler, Sadie Hambleton, Catherine Bird, Mathieu Seynaeve, Sanjay Cheema, Kete Campbell-Coker, Carolina Maggio, Fiona Dunbar, Giorgio Lambru, Manjit Matharu", "journal": "Headache The Journal of Head and Face Pain", "publication_date": "2024-10-08", "publication_year": 2024, "doi": "10.1111/head.14846", "pubmed_id": "39382331", "openalex_id": "https://openalex.org/W4403248178", "source_url": "https://doi.org/10.1111/head.14846", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Headache / Migraine,Pharmacology,Mechanism of Action,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39382331", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/head.14846", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39382331", "source_url": "https://doi.org/10.1111/head.14846", "doi": "10.1111/head.14846", "pmid": "39382331", "publication_date": "2024-10-08", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3469, "title": "A Phase 1 Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MLS101 (psilocybin) in Healthy Participants", "authors": "MycoMedica Life Sciences PBC", "journal": "ClinicalTrials.gov", "publication_date": "2024-10-08", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06326606", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Microdosing,Clinical Trial,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06326606", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06326606", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06326606", "source_url": "https://clinicaltrials.gov/study/NCT06326606", "doi": "", "pmid": "", "publication_date": "2024-10-08", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4545, "title": "PR012/#955 Psilocybin assisted psychotherapy for patients with ovarian caner: a subset analysis of a randomized, double-blind, placebo-controlled, phase II clinical trial", "authors": "Daniel Spinosa, Stacy M. Fischer, Richard J. Zeifman, Carolyn Lefkowits, Petros Petridis, Stephen Ross", "journal": "International Journal of Gynecological Cancer", "publication_date": "2024-09-30", "publication_year": 2024, "doi": "10.1136/ijgc-2024-igcs.54", "pubmed_id": null, "openalex_id": "https://openalex.org/W4405447055", "source_url": "https://doi.org/10.1136/ijgc-2024-igcs.54", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.1136/ijgc-2024-igcs.54", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1136/ijgc-2024-igcs.54", "source_url": "https://doi.org/10.1136/ijgc-2024-igcs.54", "doi": "10.1136/ijgc-2024-igcs.54", "pmid": "", "publication_date": "2024-09-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1000, "title": "Artificial intelligence and psychedelic medicine.", "authors": "Sarris J, Halman A, Urokohara A, Lehrner M, Perkins D", "journal": "Annals of the New York Academy of Sciences", "publication_date": "2024-09-30", "publication_year": 2024, "doi": "10.1111/nyas.15229", "pubmed_id": "39308441", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39308441/", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:36", "bibtex": null, "source_record_id": "PMID:39308441", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39308441/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39308441", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39308441/", "doi": "10.1111/nyas.15229", "pmid": "39308441", "publication_date": "2024-09-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1016, "title": "Psilocybin increases optimistic engagement over time: computational modelling of behaviour in rats", "authors": "Elizabeth L. Fisher, Ryan Smith, Kyna-Anne Conn, Andrew W. Corcoran, Laura K Milton, Jakob Hohwy, Claire J. Foldi", "journal": "Translational Psychiatry", "publication_date": "2024-09-29", "publication_year": 2024, "doi": "10.1038/s41398-024-03103-7", "pubmed_id": "39349428", "openalex_id": "https://openalex.org/W4402975017", "source_url": "https://doi.org/10.1038/s41398-024-03103-7", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39349428", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41398-024-03103-7", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39349428", "source_url": "https://doi.org/10.1038/s41398-024-03103-7", "doi": "10.1038/s41398-024-03103-7", "pmid": "39349428", "publication_date": "2024-09-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3546, "title": "The Effects of Psilocybin on Shared Experience in Film Processing", "authors": "Western University, Canada", "journal": "ClinicalTrials.gov", "publication_date": "2024-09-26", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06529939", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Consciousness,Aging,Clinical Trial,Healthy Volunteers", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06529939", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06529939", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06529939", "source_url": "https://clinicaltrials.gov/study/NCT06529939", "doi": "", "pmid": "", "publication_date": "2024-09-26", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 859, "title": "Single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - A first-in-kind open-label pilot study", "authors": "Sara Ellis, Catherine Bostian, Wendy Feng, E. Grace Fischer, Garrett Schwartz, Katherine Eisen, Melanie Lean, Elizabeth Conlan, Michael J. Ostacher, Scott T. Aaronson, Trisha Suppes", "journal": "Journal of Affective Disorders", "publication_date": "2024-09-26", "publication_year": 2024, "doi": "10.1016/j.jad.2024.09.133", "pubmed_id": "39343309", "openalex_id": "https://openalex.org/W4402912774", "source_url": "https://doi.org/10.1016/j.jad.2024.09.133", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Treatment-Resistant Depression,Veterans,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39343309", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39343309", "source_url": "https://doi.org/10.1016/j.jad.2024.09.133", "doi": "10.1016/j.jad.2024.09.133", "pmid": "39343309", "publication_date": "2024-09-26", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 997, "title": "Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial", "authors": "David Erritzøe, Tommaso Barba, Kyle T. Greenway, Roberta Murphy, Jonny Martell, Bruna Giribaldi, Christopher Timmermann, Ashleigh Murphy-Beiner, Michelle Baker Jones, David Nutt, Brandon Weiss, Robin Carhart-Harris", "journal": "EClinicalMedicine", "publication_date": "2024-09-22", "publication_year": 2024, "doi": "10.1016/j.eclinm.2024.102799", "pubmed_id": "39764567", "openalex_id": "https://openalex.org/W4402747955", "source_url": "https://doi.org/10.1016/j.eclinm.2024.102799", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Observational Study,Safety,Contraindications", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39764567", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.eclinm.2024.102799", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39764567", "source_url": "https://doi.org/10.1016/j.eclinm.2024.102799", "doi": "10.1016/j.eclinm.2024.102799", "pmid": "39764567", "publication_date": "2024-09-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 974, "title": "Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: results from an open-label phase Ib ascending dose study", "authors": "James Rucker, Matthew Butler, Sadie Hambleton, Catherine Bird, Mathieu Seynaeve, Sanjay Cheema, Kete Campbell-Coker, Carolina Maggio, Fiona Dunbar, Giorgio Lambru, Manjit Matharu", "journal": "Headache The Journal of Head and Face Pain", "publication_date": "2024-09-19", "publication_year": 2024, "doi": "10.1111/head.14837", "pubmed_id": "39301810", "openalex_id": "https://openalex.org/W4402697828", "source_url": "https://doi.org/10.1111/head.14837", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Headache / Migraine,Pharmacology,Receptor Pharmacology,Consciousness,Clinical Trial,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39301810", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/head.14837", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39301810", "source_url": "https://doi.org/10.1111/head.14837", "doi": "10.1111/head.14837", "pmid": "39301810", "publication_date": "2024-09-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1018, "title": "Psychedelic research at a crossroads.", "authors": "Armstrong SB, Davis AK.", "journal": null, "publication_date": "2024-09-18", "publication_year": 2024, "doi": "10.1126/science.adt1024", "pubmed_id": "39298596", "openalex_id": null, "source_url": "https://doi.org/10.1126/science.adt1024", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Consciousness,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:39298596", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1126/science.adt1024", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39298596", "source_url": "https://doi.org/10.1126/science.adt1024", "doi": "10.1126/science.adt1024", "pmid": "39298596", "publication_date": "2024-09-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4551, "title": "Use of Psilocybin in the Treatment of Mental Disorders: Systematic Review of Clinal Trials", "authors": "Danielle B Rodrigues", "journal": "Journal of Complementary Medicine & Alternative Healthcare", "publication_date": "2024-09-16", "publication_year": 2024, "doi": "10.19080/jcmah.2024.13.555852", "pubmed_id": null, "openalex_id": "https://openalex.org/W4408545862", "source_url": "https://doi.org/10.19080/jcmah.2024.13.555852", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Clinical Trial,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.19080/jcmah.2024.13.555852", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.19080/jcmah.2024.13.555852", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.19080/jcmah.2024.13.555852", "source_url": "https://doi.org/10.19080/jcmah.2024.13.555852", "doi": "10.19080/jcmah.2024.13.555852", "pmid": "", "publication_date": "2024-09-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 950, "title": "New frontiers in the biosynthesis of psychoactive specialized metabolites.", "authors": "Li G, Facchini PJ.", "journal": null, "publication_date": "2024-09-15", "publication_year": 2024, "doi": "10.1016/j.pbi.2024.102626", "pubmed_id": "39288539", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.pbi.2024.102626", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:39288539", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.pbi.2024.102626", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39288539", "source_url": "https://doi.org/10.1016/j.pbi.2024.102626", "doi": "10.1016/j.pbi.2024.102626", "pmid": "39288539", "publication_date": "2024-09-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 553, "title": "Pharmacokinetics of Psilocybin, a Tryptamine Alkaloid in Magic Mushroom (Psilocybe cubensis): A Systematic Review.", "authors": "Thaoboonruang N, Lohitnavy M, Lohitnavy O.", "journal": null, "publication_date": "2024-09-09", "publication_year": 2024, "doi": "10.1080/02791072.2024.2399128", "pubmed_id": "39257234", "openalex_id": null, "source_url": "https://doi.org/10.1080/02791072.2024.2399128", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Pharmacology,Clinical Trial,Systematic Review,Review Article,In Vitro Study", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:39257234", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/02791072.2024.2399128", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39257234", "source_url": "https://doi.org/10.1080/02791072.2024.2399128", "doi": "10.1080/02791072.2024.2399128", "pmid": "39257234", "publication_date": "2024-09-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 867, "title": "The immunomodulatory effects of classical psychedelics: A systematic review of preclinical studies.", "authors": "Low ZXB, Ng WS, Lim ESY, Goh BH, Kumari Y.", "journal": null, "publication_date": "2024-09-06", "publication_year": 2024, "doi": "10.1016/j.pnpbp.2024.111139", "pubmed_id": "39251080", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.pnpbp.2024.111139", "substance_tags": "psilocybin,psilocin", "topic_tags": "Biomarkers,Clinical Trial,Systematic Review,Review Article,Animal Study,In Vitro Study,Safety,Inflammation,Immune Function", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:39251080", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.pnpbp.2024.111139", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39251080", "source_url": "https://doi.org/10.1016/j.pnpbp.2024.111139", "doi": "10.1016/j.pnpbp.2024.111139", "pmid": "39251080", "publication_date": "2024-09-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4556, "title": "Usage of Psilocybin to Treat Huntington's Disease: A Research Protocol", "authors": "Cynthia Duan, Navid Farkhondehpay, Viana Safa, Emma Yuan", "journal": "Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal", "publication_date": "2024-09-04", "publication_year": 2024, "doi": "10.26685/urncst.644", "pubmed_id": null, "openalex_id": "https://openalex.org/W4402270940", "source_url": "http://dx.doi.org/10.26685/urncst.644", "substance_tags": "psilocybin", "topic_tags": "Neuroplasticity,Biomarkers,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.26685/urncst.644", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.26685/urncst.644", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.26685/urncst.644", "source_url": "http://dx.doi.org/10.26685/urncst.644", "doi": "10.26685/urncst.644", "pmid": "", "publication_date": "2024-09-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1026, "title": "Understanding Psychedelic-Assisted Psychotherapy Providers' Perspective and Insights: A Qualitative Analysis.", "authors": "Smith CL, Sackett N, Stark BC, Dinh V, Romesburg EW, Roll J", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2024-08-31", "publication_year": 2024, "doi": "10.1089/psymed.2023.0074", "pubmed_id": "40051684", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40051684/", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:36", "bibtex": null, "source_record_id": "PMID:40051684", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40051684/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40051684", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40051684/", "doi": "10.1089/psymed.2023.0074", "pmid": "40051684", "publication_date": "2024-08-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1003, "title": "The role of psilocybin in depressive disorders.", "authors": "Najib J.", "journal": null, "publication_date": "2024-08-27", "publication_year": 2024, "doi": "10.1080/03007995.2024.2396536", "pubmed_id": "39177339", "openalex_id": null, "source_url": "https://doi.org/10.1080/03007995.2024.2396536", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:39177339", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/03007995.2024.2396536", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39177339", "source_url": "https://doi.org/10.1080/03007995.2024.2396536", "doi": "10.1080/03007995.2024.2396536", "pmid": "39177339", "publication_date": "2024-08-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3141, "title": "The phenomenology of psilocybin’s experience mediates subsequent persistent psychological effects independently of sex, previous experience or setting", "authors": "Klučková T, Nikolič M, Tylš F, Viktorin V, Vejmola Č, Viktorinová M, Bravermanová A, Androvičová R, Andrashko V, Korčák J, Zach P, Hájková K, Kuchař M, Balíková M, Brunovský M, Horáček J, Páleníček T.", "journal": "medRxiv", "publication_date": "2024-08-25", "publication_year": 2024, "doi": "10.1101/2024.08.26.24311611", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2024.08.26.24311611", "substance_tags": "psilocybin,psilocin", "topic_tags": "Anxiety,Brain Imaging,Consciousness,Emotional Processing,Clinical Trial,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.1101/2024.08.26.24311611", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2024.08.26.24311611", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2024.08.26.24311611", "source_url": "https://doi.org/10.1101/2024.08.26.24311611", "doi": "10.1101/2024.08.26.24311611", "pmid": "", "publication_date": "2024-08-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3075, "title": "­­­­Single-Dose Psilocybin Therapy for Alcohol Use Disorder: Pharmacokinetics, Feasibility, Safety, and Efficacy in an Open-Label Study", "authors": "Jensen ME, Stenbæk DS, Messell CD, Poulsen ED, Varga TV, Fisher PM, Nielsen MKK, Johansen SS, Volkow ND, Knudsen GM, Fink-Jensen A.", "journal": "Research Square", "publication_date": "2024-08-22", "publication_year": 2024, "doi": "10.21203/rs.3.rs-4947184/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-4947184/v1", "substance_tags": "psilocybin,psilocin", "topic_tags": "Addiction,Pharmacology,Receptor Pharmacology,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-4947184/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-4947184/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-4947184/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-4947184/v1", "doi": "10.21203/rs.3.rs-4947184/v1", "pmid": "", "publication_date": "2024-08-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 923, "title": "Classic psychedelics and the treatment for alcoholism.", "authors": "Lodetti G, de Bitencourt RM, Rico EP.", "journal": null, "publication_date": "2024-08-22", "publication_year": 2024, "doi": "10.1016/j.pnpbp.2024.111129", "pubmed_id": "39181308", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.pnpbp.2024.111129", "substance_tags": "psilocybin", "topic_tags": "Addiction,Neuroplasticity,Aging,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:39181308", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.pnpbp.2024.111129", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39181308", "source_url": "https://doi.org/10.1016/j.pnpbp.2024.111129", "doi": "10.1016/j.pnpbp.2024.111129", "pmid": "39181308", "publication_date": "2024-08-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1049, "title": "Comparative oral monotherapy of psilocybin, lysergic acid diethylamide, 3,4-methylenedioxymethamphetamine, ayahuasca, and escitalopram for depressive symptoms: systematic review and Bayesian network meta-analysis.", "authors": "Hsu TW, Tsai CK, Kao YC, Thompson T, Carvalho AF, Yang FC, Tseng PT, Hsu CW, Yu CL, Tu YK, Liang CS.", "journal": null, "publication_date": "2024-08-20", "publication_year": 2024, "doi": "10.1136/bmj-2023-078607", "pubmed_id": "39168500", "openalex_id": null, "source_url": "https://doi.org/10.1136/bmj-2023-078607", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:39168500", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1136/bmj-2023-078607", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39168500", "source_url": "https://doi.org/10.1136/bmj-2023-078607", "doi": "10.1136/bmj-2023-078607", "pmid": "39168500", "publication_date": "2024-08-20", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1021, "title": "Current Trends in Psychedelic Science: Integrating Modified Lysergic Acid Derivatives and Psilocybin in Modern Medicine.", "authors": "Kargbo RB.", "journal": null, "publication_date": "2024-08-20", "publication_year": 2024, "doi": "10.1021/acsmedchemlett.4c00414", "pubmed_id": "39291015", "openalex_id": null, "source_url": "https://doi.org/10.1021/acsmedchemlett.4c00414", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Mechanism of Action,Emotional Processing,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:39291015", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1021/acsmedchemlett.4c00414", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39291015", "source_url": "https://doi.org/10.1021/acsmedchemlett.4c00414", "doi": "10.1021/acsmedchemlett.4c00414", "pmid": "39291015", "publication_date": "2024-08-20", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3268, "title": "A virtual clinical trial of psychedelics to treat patients with disorders of consciousness", "authors": "Alnagger NL, Cardone P, Martial C, Sanz Perl Y, Mindlin I, Sitt JD, Roseman L, Carhart-Harris R, Nutt D, Mallaroni P, Mason NL, Ramaekers JG, Bonhomme V, Laureys S, Deco G, Gosseries O, Nunez P, Annen J.", "journal": "bioRxiv", "publication_date": "2024-08-18", "publication_year": 2024, "doi": "10.1101/2024.08.16.608251", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2024.08.16.608251", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Consciousness,Aging,Clinical Trial", "study_type": "Clinical Trial", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "DOI:10.1101/2024.08.16.608251", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2024.08.16.608251", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2024.08.16.608251", "source_url": "https://doi.org/10.1101/2024.08.16.608251", "doi": "10.1101/2024.08.16.608251", "pmid": "", "publication_date": "2024-08-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1051, "title": "Comparison between Single-Dose and Two-Dose Psilocybin Administration in the Treatment of Major Depression: A Systematic Review and Meta-Analysis of Current Clinical Trials.", "authors": "Salvetti G, Saccenti D, Moro AS, Lamanna J, Ferro M.", "journal": null, "publication_date": "2024-08-17", "publication_year": 2024, "doi": "10.3390/brainsci14080829", "pubmed_id": "39199520", "openalex_id": null, "source_url": "https://doi.org/10.3390/brainsci14080829", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression", "study_type": "Meta-Analysis", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:39199520", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/brainsci14080829", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39199520", "source_url": "https://doi.org/10.3390/brainsci14080829", "doi": "10.3390/brainsci14080829", "pmid": "39199520", "publication_date": "2024-08-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 980, "title": "Psilocybin-assisted psychotherapy for existential distress: practical considerations for therapeutic application-a review.", "authors": "Kim A, Halton B, Shah A, Seecof OM, Ross S.", "journal": null, "publication_date": "2024-08-15", "publication_year": 2024, "doi": "10.21037/apm-24-35", "pubmed_id": "39168642", "openalex_id": null, "source_url": "https://doi.org/10.21037/apm-24-35", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Pharmacology,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:39168642", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21037/apm-24-35", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39168642", "source_url": "https://doi.org/10.21037/apm-24-35", "doi": "10.21037/apm-24-35", "pmid": "39168642", "publication_date": "2024-08-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3428, "title": "A24-Week, Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Clinical Trial to Evaluate Efficacy and Safety of Psilocybin-Assisted Psychotherapy in Adults With Alcohol Use Disorder (AUD)", "authors": "Clairvoyant Therapeutics", "journal": "ClinicalTrials.gov", "publication_date": "2024-08-14", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05646303", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05646303", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05646303", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05646303", "source_url": "https://clinicaltrials.gov/study/NCT05646303", "doi": "", "pmid": "", "publication_date": "2024-08-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1053, "title": "The association between diverse psychological protocols and the efficacy of psilocybin-assisted therapy for clinical depressive symptoms: a Bayesian meta-analysis.", "authors": "Chen MH, Cheng SL, Kao YC, Tseng PT, Hsu CW, Yu CL, Yang FC, Thompson T, Hsu TW, Liang CS.", "journal": null, "publication_date": "2024-08-12", "publication_year": 2024, "doi": "10.3389/fpsyt.2024.1439347", "pubmed_id": "39193583", "openalex_id": null, "source_url": "https://doi.org/10.3389/fpsyt.2024.1439347", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Meta-Analysis,Review Article", "study_type": "Meta-Analysis", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:39193583", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2024.1439347", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39193583", "source_url": "https://doi.org/10.3389/fpsyt.2024.1439347", "doi": "10.3389/fpsyt.2024.1439347", "pmid": "39193583", "publication_date": "2024-08-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 842, "title": "A clinical research perspective on the regulation of medical and non-medical use of psychedelic drugs", "authors": "Michael P. Bogenschutz", "journal": "Addiction", "publication_date": "2024-08-11", "publication_year": 2024, "doi": "10.1111/add.16647", "pubmed_id": "39129581", "openalex_id": "https://openalex.org/W4401521492", "source_url": "https://doi.org/10.1111/add.16647", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Chronic Pain,Receptor Pharmacology,Consciousness,Clinical Trial,Review Article,Treatment-Resistant Depression,Healthcare Workers,Safety,Adverse Events,Toxicity,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:39129581", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/add.16647", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39129581", "source_url": "https://doi.org/10.1111/add.16647", "doi": "10.1111/add.16647", "pmid": "39129581", "publication_date": "2024-08-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3438, "title": "Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder: Feasibility, Clinical Efficacy & (Neuro)Cognitive Mechanisms", "authors": "Brugmann University Hospital", "journal": "ClinicalTrials.gov", "publication_date": "2024-08-06", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06160232", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Neuroplasticity,Mechanism of Action,Biomarkers,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06160232", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06160232", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06160232", "source_url": "https://clinicaltrials.gov/study/NCT06160232", "doi": "", "pmid": "", "publication_date": "2024-08-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4572, "title": "Different hierarchical reconfigurations in the brain by psilocybin and escitalopram for depression", "authors": "Gustavo Deco, Yonatan Sanz Perl, Samuel Johnson, Niamh Bourke, Robin Carhart-Harris, Morten L. Kringelbach", "journal": "Nature Mental Health", "publication_date": "2024-08-04", "publication_year": 2024, "doi": "10.1038/s44220-024-00298-y", "pubmed_id": null, "openalex_id": "https://openalex.org/W4401339608", "source_url": "https://doi.org/10.1038/s44220-024-00298-y", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Brain Imaging,Mechanism of Action,Aging,Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.1038/s44220-024-00298-y", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s44220-024-00298-y", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1038/s44220-024-00298-y", "source_url": "https://doi.org/10.1038/s44220-024-00298-y", "doi": "10.1038/s44220-024-00298-y", "pmid": "", "publication_date": "2024-08-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1055, "title": "Psilocybin-assisted therapy and HIV-related shame", "authors": "Nicky J. Mehtani, Mallory O. Johnson, Peter S. Hendricks, Jennifer Mitchell, B. Anderson", "journal": "Scientific Reports", "publication_date": "2024-08-01", "publication_year": 2024, "doi": "10.1038/s41598-024-68908-4", "pubmed_id": "39095420", "openalex_id": "https://openalex.org/W4401257064", "source_url": "https://doi.org/10.1038/s41598-024-68908-4", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:39095420", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41598-024-68908-4", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39095420", "source_url": "https://doi.org/10.1038/s41598-024-68908-4", "doi": "10.1038/s41598-024-68908-4", "pmid": "39095420", "publication_date": "2024-08-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1065, "title": "Psychedelic-assisted psychotherapy: where is the psychotherapy research?", "authors": "Aday JS, Horton D, Fernandes-Osterhold G, O'Donovan A, Bradley ER, Rosen RC, Woolley JD", "journal": "Psychopharmacology", "publication_date": "2024-07-31", "publication_year": 2024, "doi": "10.1007/s00213-024-06620-x", "pubmed_id": "38782821", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38782821/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:36", "bibtex": null, "source_record_id": "PMID:38782821", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38782821/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38782821", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38782821/", "doi": "10.1007/s00213-024-06620-x", "pmid": "38782821", "publication_date": "2024-07-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1074, "title": "Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapy", "authors": "Sara de la Salle, Hannes Kettner, Julien Thibault Lévesque, Nicolas Garel, Shannon Dames, Ryan Patchett-Marble, Soham Rej, Sara G. Gloeckler, David Erritzøe, Robin Carhart-Harris, Kyle T. Greenway", "journal": "Scientific Reports", "publication_date": "2024-07-16", "publication_year": 2024, "doi": "10.1038/s41598-024-66817-0", "pubmed_id": "39019922", "openalex_id": "https://openalex.org/W4400737202", "source_url": "https://doi.org/10.1038/s41598-024-66817-0", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Mechanism of Action,Wellbeing,Spirituality,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:39019922", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41598-024-66817-0", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39019922", "source_url": "https://doi.org/10.1038/s41598-024-66817-0", "doi": "10.1038/s41598-024-66817-0", "pmid": "39019922", "publication_date": "2024-07-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1076, "title": "Serotoninergic antidepressants combination in psilocybin-assisted psychotherapy: a case report", "authors": "André Do, Vanessa Michaud, Jean-François Stephan, Miltiadis Moreau, Élise Benoît, Felix-Antoine Berubé, Antoine Bibaud-De Serres, Alain Taillefer, Philippe Vincent", "journal": "Frontiers in Psychiatry", "publication_date": "2024-07-15", "publication_year": 2024, "doi": "10.3389/fpsyt.2024.1394962", "pubmed_id": "39086732", "openalex_id": "https://openalex.org/W4400695899", "source_url": "https://doi.org/10.3389/fpsyt.2024.1394962", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Pharmacology,Receptor Pharmacology,Clinical Trial,Case Report,Safety,Adverse Events,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:39086732", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2024.1394962", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39086732", "source_url": "https://doi.org/10.3389/fpsyt.2024.1394962", "doi": "10.3389/fpsyt.2024.1394962", "pmid": "39086732", "publication_date": "2024-07-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4587, "title": "Assessment of psychedelic--induced states: Norwegian translation and adaptation of the revised Mystical Experience Questionnaire (MEQ-30)", "authors": "Kristoffer Andreas Aamodt Andersen, Bjørn Holmøy, Lowan H. Stewart", "journal": "Journal of Psychedelic Studies", "publication_date": "2024-07-11", "publication_year": 2024, "doi": "10.1556/2054.2024.00346", "pubmed_id": null, "openalex_id": "https://openalex.org/W4400581008", "source_url": "https://doi.org/10.1556/2054.2024.00346", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Consciousness,Mystical Experience,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2024.00346", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2024.00346", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2024.00346", "source_url": "https://doi.org/10.1556/2054.2024.00346", "doi": "10.1556/2054.2024.00346", "pmid": "", "publication_date": "2024-07-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4590, "title": "Psilocybin in the Management of Substance Use Disorders: A Summary ofCurrent Evidence", "authors": "Hussein El Bourji, Aziz Farhat, Zahi Hamdan, Ritvij Satodiya, Rashmi Shukla, Samer El Hayek", "journal": "Current Psychopharmacologye", "publication_date": "2024-07-03", "publication_year": 2024, "doi": "10.2174/0122115560288779240628043307", "pubmed_id": null, "openalex_id": "https://openalex.org/W4400323479", "source_url": "https://doi.org/10.2174/0122115560288779240628043307", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Review Article", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.2174/0122115560288779240628043307", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.2174/0122115560288779240628043307", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.2174/0122115560288779240628043307", "source_url": "https://doi.org/10.2174/0122115560288779240628043307", "doi": "10.2174/0122115560288779240628043307", "pmid": "", "publication_date": "2024-07-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2993, "title": "Psilocybin Therapy for Females With Anorexia Nervosa: A Phase 1, Open-Label Feasibility Study", "authors": "Stéphanie Knatz Peck, Samantha Shao, Tessa Gruen, Kevin H. Yang, Alexandra Babakanian, Julie Trim, Daphna M. Finn, Walter H. Kaye", "journal": "FOCUS The Journal of Lifelong Learning in Psychiatry", "publication_date": "2024-06-30", "publication_year": 2024, "doi": "10.1176/appi.focus.24022013", "pubmed_id": "38988455", "openalex_id": "https://openalex.org/W4400572892", "source_url": "http://dx.doi.org/10.1176/appi.focus.24022013", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Pharmacology,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 07:01:03", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38988455", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1176/appi.focus.24022013", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38988455", "source_url": "http://dx.doi.org/10.1176/appi.focus.24022013", "doi": "10.1176/appi.focus.24022013", "pmid": "38988455", "publication_date": "2024-06-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1079, "title": "The Black Book of Psychotropic Dosing and Monitoring.", "authors": "DeBattista C, Schatzberg AF.", "journal": null, "publication_date": "2024-06-30", "publication_year": 2024, "doi": "10.64719/pb.4493", "pubmed_id": "38993656", "openalex_id": null, "source_url": "https://doi.org/10.64719/pb.4493", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Headache / Migraine,Brain Imaging,Pharmacology,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:07", "bibtex": null, "source_record_id": "PMID:38993656", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.64719/pb.4493", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38993656", "source_url": "https://doi.org/10.64719/pb.4493", "doi": "10.64719/pb.4493", "pmid": "38993656", "publication_date": "2024-06-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 812, "title": "Striking Long Term Beneficial Effects of Single Dose Psilocybin and Psychedelic Mushroom Extract in the SAPAP3 Rodent Model of OCD-Like Excessive Self-Grooming", "authors": "Brownstien M, Lazar M, Botvinnik A, Shevakh C, Blakolmer K, Lerer L, Lifschytz T, Lerer B.", "journal": "bioRxiv", "publication_date": "2024-06-28", "publication_year": 2024, "doi": "10.1101/2024.06.25.600634", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2024.06.25.600634", "substance_tags": "psilocybin", "topic_tags": "Anxiety,OCD,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Animal Study,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.1101/2024.06.25.600634", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2024.06.25.600634", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2024.06.25.600634", "source_url": "https://doi.org/10.1101/2024.06.25.600634", "doi": "10.1101/2024.06.25.600634", "pmid": "", "publication_date": "2024-06-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1100, "title": "Race and ethnicity moderate the associations between lifetime psilocybin use and past year hypertension", "authors": "Grant Jones, Jocelyn A. Ricard, Matthew K. Nock", "journal": "Frontiers in Psychiatry", "publication_date": "2024-06-23", "publication_year": 2024, "doi": "10.3389/fpsyt.2024.1169686", "pubmed_id": "38979507", "openalex_id": "https://openalex.org/W4399977372", "source_url": "https://doi.org/10.3389/fpsyt.2024.1169686", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Observational Study,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38979507", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2024.1169686", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38979507", "source_url": "https://doi.org/10.3389/fpsyt.2024.1169686", "doi": "10.3389/fpsyt.2024.1169686", "pmid": "38979507", "publication_date": "2024-06-23", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1062, "title": "The cyclical revival of psychedelics in psychiatric treatment.", "authors": "Appiani FJ, Caroff SN.", "journal": null, "publication_date": "2024-06-19", "publication_year": 2024, "doi": "10.1080/03007995.2024.2368725", "pubmed_id": "38880945", "openalex_id": null, "source_url": "https://doi.org/10.1080/03007995.2024.2368725", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:38880945", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/03007995.2024.2368725", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38880945", "source_url": "https://doi.org/10.1080/03007995.2024.2368725", "doi": "10.1080/03007995.2024.2368725", "pmid": "38880945", "publication_date": "2024-06-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1061, "title": "Developing the Open Psychedelic Evaluation Nexus consensus measures for assessment of supervised psilocybin services: An e-Delphi study", "authors": "P. Todd Korthuis, Kim Hoffman, Adrianne R. Wilson-Poe, Jason B. Luoma, Alissa Bazinet, Kellie Pertl, David L. Morgan, Ryan Cook, Sarann Bielavitz, Renae Myers, R. Cameron Wolf, Dennis McCarty, Christopher S. Stauffer", "journal": "Journal of Psychopharmacology", "publication_date": "2024-06-17", "publication_year": 2024, "doi": "10.1177/02698811241257839", "pubmed_id": "38888164", "openalex_id": "https://openalex.org/W4399780176", "source_url": "https://doi.org/10.1177/02698811241257839", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Wellbeing,Clinical Trial,Observational Study,Safety,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38888164", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/02698811241257839", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38888164", "source_url": "https://doi.org/10.1177/02698811241257839", "doi": "10.1177/02698811241257839", "pmid": "38888164", "publication_date": "2024-06-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1107, "title": "Licit use of illicit drugs for treating depression: the pill and the process.", "authors": "Torrado Pacheco A, Moghaddam B.", "journal": null, "publication_date": "2024-06-16", "publication_year": 2024, "doi": "10.1172/jci180217", "pubmed_id": "40047885", "openalex_id": null, "source_url": "https://doi.org/10.1172/jci180217", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Clinical Trial,Review Article,Animal Study,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:40047885", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1172/jci180217", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40047885", "source_url": "https://doi.org/10.1172/jci180217", "doi": "10.1172/jci180217", "pmid": "40047885", "publication_date": "2024-06-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1106, "title": "A Plea for Nuance: Should People with a Family History of Bipolar Disorder Be Excluded from Clinical Trials of Psilocybin Therapy?", "authors": "Downey AE, Bradley ER, Lerche AS, O'Donovan A, Krystal AD, Woolley J.", "journal": null, "publication_date": "2024-06-16", "publication_year": 2024, "doi": "10.1089/psymed.2023.0051", "pubmed_id": "40051581", "openalex_id": null, "source_url": "https://doi.org/10.1089/psymed.2023.0051", "substance_tags": "psilocybin", "topic_tags": "Aging,Clinical Trial,Review Article,Observational Study,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:40051581", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1089/psymed.2023.0051", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40051581", "source_url": "https://doi.org/10.1089/psymed.2023.0051", "doi": "10.1089/psymed.2023.0051", "pmid": "40051581", "publication_date": "2024-06-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1037, "title": "Commentary on Darkeet al.: Expanded psychedelic access requires new safety monitoring systems", "authors": "P. Todd Korthuis, Adrianne R. Wilson-Poe, Joshua C. Black, Andrew A. Monte", "journal": "Addiction", "publication_date": "2024-06-16", "publication_year": 2024, "doi": "10.1111/add.16589", "pubmed_id": "38881433", "openalex_id": "https://openalex.org/W4399750332", "source_url": "http://dx.doi.org/10.1111/add.16589", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Aging,Spirituality,Clinical Trial,Review Article,Adolescents,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38881433", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1111/add.16589", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38881433", "source_url": "http://dx.doi.org/10.1111/add.16589", "doi": "10.1111/add.16589", "pmid": "38881433", "publication_date": "2024-06-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4605, "title": "Psychedelics’ Use as Medicine Hits Significant Roadblock", "authors": "Linda M. Richmond", "journal": "Psychiatric News", "publication_date": "2024-06-11", "publication_year": 2024, "doi": "10.1176/appi.pn.2024.07.7.54", "pubmed_id": null, "openalex_id": "https://openalex.org/W4399577191", "source_url": "https://doi.org/10.1176/appi.pn.2024.07.7.54", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Pharmacology,Mechanism of Action,Aging,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2024.07.7.54", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2024.07.7.54", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2024.07.7.54", "source_url": "https://doi.org/10.1176/appi.pn.2024.07.7.54", "doi": "10.1176/appi.pn.2024.07.7.54", "pmid": "", "publication_date": "2024-06-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1110, "title": "Unlocking the healing power of psilocybin: an overview of the role of psilocybin therapy in major depressive disorder, obsessive-compulsive disorder and substance use disorder", "authors": "Sandra Szafoni, Piotr Gręblowski, Klaudia Grabowska, Gniewko Więckiewicz", "journal": "Frontiers in Psychiatry", "publication_date": "2024-06-10", "publication_year": 2024, "doi": "10.3389/fpsyt.2024.1406888", "pubmed_id": "38919636", "openalex_id": "https://openalex.org/W4399572299", "source_url": "https://doi.org/10.3389/fpsyt.2024.1406888", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,OCD,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38919636", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2024.1406888", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38919636", "source_url": "https://doi.org/10.3389/fpsyt.2024.1406888", "doi": "10.3389/fpsyt.2024.1406888", "pmid": "38919636", "publication_date": "2024-06-10", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3791, "title": "Who believes psychedelic-assisted therapies work? Risky cannabis use and other factors are associated with positive treatment-outcome expectancies", "authors": "Petrovitch D, Mitchell SM, Van Allen J, Littlefield AK.", "journal": "PsyArXiv", "publication_date": "2024-06-09", "publication_year": 2024, "doi": "10.31234/osf.io/adnpg", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/adnpg", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:22", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/adnpg", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/adnpg", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/adnpg", "source_url": "https://doi.org/10.31234/osf.io/adnpg", "doi": "10.31234/osf.io/adnpg", "pmid": "", "publication_date": "2024-06-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3445, "title": "A Multi-centre, Double-blinded, Placebo-controlled, Randomised, Phase II Clinical Trial for Psilocybin-assisted Therapy for Alcohol Use Disorder", "authors": "University of Sydney", "journal": "ClinicalTrials.gov", "publication_date": "2024-06-09", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06444243", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Wellbeing,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06444243", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06444243", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06444243", "source_url": "https://clinicaltrials.gov/study/NCT06444243", "doi": "", "pmid": "", "publication_date": "2024-06-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3355, "title": "Who believes psychedelic-assisted therapies work? Risky cannabis use and other factors are associated with positive treatment-outcome expectancies", "authors": "", "journal": "PsyArXiv", "publication_date": "2024-06-09", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/adnpg_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Pharmacology,Clinical Trial,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/adnpg_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/adnpg_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/adnpg_v1", "source_url": "https://osf.io/preprints/psyarxiv/adnpg_v1", "doi": "", "pmid": "", "publication_date": "2024-06-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1064, "title": "Protocols and practices in psilocybin assisted psychotherapy for depression: A systematic review.", "authors": "Chisamore N, Johnson D, Chen MJQ, Offman H, Chen-Li D, Kaczmarek ES, Doyle Z, McIntyre RS, Rosenblat JD.", "journal": null, "publication_date": "2024-05-30", "publication_year": 2024, "doi": "10.1016/j.jpsychires.2024.05.051", "pubmed_id": "38850581", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jpsychires.2024.05.051", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:38850581", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jpsychires.2024.05.051", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38850581", "source_url": "https://doi.org/10.1016/j.jpsychires.2024.05.051", "doi": "10.1016/j.jpsychires.2024.05.051", "pmid": "38850581", "publication_date": "2024-05-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3277, "title": "On serotonin, psychedelics, entactogens and psychoplastogens in depression, anxiety, post-traumatic stress, and related disorders.", "authors": "Hoyer D.", "journal": "Authorea Preprints", "publication_date": "2024-05-22", "publication_year": 2024, "doi": "10.22541/au.171648613.31141136/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.22541/au.171648613.31141136/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Neuroplasticity,Receptor Pharmacology,Clinical Trial,Treatment-Resistant Depression,Inflammation,Immune Function", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "DOI:10.22541/au.171648613.31141136/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.22541/au.171648613.31141136/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.22541/au.171648613.31141136/v1", "source_url": "https://doi.org/10.22541/au.171648613.31141136/v1", "doi": "10.22541/au.171648613.31141136/v1", "pmid": "", "publication_date": "2024-05-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 939, "title": "Narrative review of the potential for psychedelics to treat Prolonged Grief Disorder.", "authors": "Ehrenkranz R, Agrawal M, Penberthy JK, Yaden DB.", "journal": null, "publication_date": "2024-05-22", "publication_year": 2024, "doi": "10.1080/09540261.2024.2357668", "pubmed_id": "39980217", "openalex_id": null, "source_url": "https://doi.org/10.1080/09540261.2024.2357668", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Mystical Experience,Clinical Trial,Review Article,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:39980217", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/09540261.2024.2357668", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39980217", "source_url": "https://doi.org/10.1080/09540261.2024.2357668", "doi": "10.1080/09540261.2024.2357668", "pmid": "39980217", "publication_date": "2024-05-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3118, "title": "Psilocybin increases optimistic engagement over time: computational modelling of behavior in rats", "authors": "Fisher EL, Smith R, Corcoran AW, Milton LK, Conn K, Hohwy J, Foldi CJ.", "journal": "bioRxiv", "publication_date": "2024-05-16", "publication_year": 2024, "doi": "10.1101/2024.05.16.594614", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2024.05.16.594614", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial", "study_type": "Clinical Trial", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.1101/2024.05.16.594614", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2024.05.16.594614", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2024.05.16.594614", "source_url": "https://doi.org/10.1101/2024.05.16.594614", "doi": "10.1101/2024.05.16.594614", "pmid": "", "publication_date": "2024-05-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1104, "title": "RE104: Synthesis and Activity of a Novel Serotonergic Psychedelic Prodrug of 4-Hydroxy-N,N-diisopropyltryptamine", "authors": "Nathan Bryson, Robert Alexander, Aviva Asnis-Alibozek, Michael Ehlers", "journal": "ACS Chemical Neuroscience", "publication_date": "2024-05-16", "publication_year": 2024, "doi": "10.1021/acschemneuro.4c00058", "pubmed_id": "38758589", "openalex_id": "https://openalex.org/W4396988535", "source_url": "https://doi.org/10.1021/acschemneuro.4c00058", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38758589", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1021/acschemneuro.4c00058", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38758589", "source_url": "https://doi.org/10.1021/acschemneuro.4c00058", "doi": "10.1021/acschemneuro.4c00058", "pmid": "38758589", "publication_date": "2024-05-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4623, "title": "Psychedelic renaissance: A renewed focus on the clinical utility of hallucinogens", "authors": "Shunichiro Ikeda, Toshihiko Kinoshita", "journal": "Psychiatry and Clinical Neurosciences Reports", "publication_date": "2024-05-15", "publication_year": 2024, "doi": "10.1002/pcn5.196", "pubmed_id": null, "openalex_id": "https://openalex.org/W4397013596", "source_url": "https://doi.org/10.1002/pcn5.196", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Receptor Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety,Inflammation", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.1002/pcn5.196", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/pcn5.196", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/pcn5.196", "source_url": "https://doi.org/10.1002/pcn5.196", "doi": "10.1002/pcn5.196", "pmid": "", "publication_date": "2024-05-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 952, "title": "Clinical Research Trials of Psychedelic-Assisted Therapy in Adolescents Aged 16 to 17 Years: Rationale Balanced With Caution.", "authors": "Jeffrey JK, Weintraub MJ, Grob CS.", "journal": null, "publication_date": "2024-05-08", "publication_year": 2024, "doi": "10.1016/j.jaac.2024.03.021", "pubmed_id": "38734406", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jaac.2024.03.021", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Clinical Trial,Adolescents,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:38734406", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jaac.2024.03.021", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38734406", "source_url": "https://doi.org/10.1016/j.jaac.2024.03.021", "doi": "10.1016/j.jaac.2024.03.021", "pmid": "38734406", "publication_date": "2024-05-08", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 934, "title": "Evolving Guidelines for the Use of Touch During a Clinical Trial of Group Psilocybin-Assisted Therapy", "authors": "Anthony L. Back, Susanna Myers, John Guy, Juliana Pérez, Leslie Lazar Thorn, Bonnie A. McGregor", "journal": "Psychedelic Medicine", "publication_date": "2024-05-07", "publication_year": 2024, "doi": "10.1089/psymed.2023.0069", "pubmed_id": "40051480", "openalex_id": "https://openalex.org/W4396720923", "source_url": "https://doi.org/10.1089/psymed.2023.0069", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:40051480", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1089/psymed.2023.0069", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40051480", "source_url": "https://doi.org/10.1089/psymed.2023.0069", "doi": "10.1089/psymed.2023.0069", "pmid": "40051480", "publication_date": "2024-05-07", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3632, "title": "Mechanisms Supporting Psilocybin-assisted Psychotherapy for Alcohol Use Disorder: A Randomized, Controlled Clinical Trial", "authors": "University of Calgary", "journal": "ClinicalTrials.gov", "publication_date": "2024-05-06", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05995769", "substance_tags": "psilocybin", "topic_tags": "Addiction,Brain Imaging,Mechanism of Action,Aging,Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05995769", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05995769", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05995769", "source_url": "https://clinicaltrials.gov/study/NCT05995769", "doi": "", "pmid": "", "publication_date": "2024-05-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1093, "title": "What is needed for the roll-out of psychedelic treatments?", "authors": "Stephen N. Xenakis, Scott Shannon", "journal": "Current Opinion in Psychiatry", "publication_date": "2024-05-06", "publication_year": 2024, "doi": "10.1097/yco.0000000000000946", "pubmed_id": "38726805", "openalex_id": "https://openalex.org/W4396803137", "source_url": "https://doi.org/10.1097/yco.0000000000000946", "substance_tags": "psilocybin", "topic_tags": "PTSD,Chronic Pain,Pharmacology,Clinical Trial,Review Article,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38726805", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1097/yco.0000000000000946", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38726805", "source_url": "https://doi.org/10.1097/yco.0000000000000946", "doi": "10.1097/yco.0000000000000946", "pmid": "38726805", "publication_date": "2024-05-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1139, "title": "EXPRESSION OF CONCERN: Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis", "authors": "British Medical Journal Publishing Group", "journal": "BMJ", "publication_date": "2024-05-03", "publication_year": 2024, "doi": "10.1136/bmj.q1025", "pubmed_id": "38704154", "openalex_id": "https://openalex.org/W4396634501", "source_url": "https://doi.org/10.1136/bmj.q1025", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Meta-Analysis,Systematic Review,Review Article", "study_type": "Meta-Analysis", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38704154", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1136/bmj.q1025", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38704154", "source_url": "https://doi.org/10.1136/bmj.q1025", "doi": "10.1136/bmj.q1025", "pmid": "38704154", "publication_date": "2024-05-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4631, "title": "Efficacy of Psilocybin in the Treatment of Substance and Alcohol Use Disorders", "authors": "Hanna Brancaccio", "journal": null, "publication_date": "2024-05-01", "publication_year": 2024, "doi": "10.31986/issn.2689-0690_rdw.stratford_research_day.149_2024", "pubmed_id": null, "openalex_id": "https://openalex.org/W4401380403", "source_url": "http://dx.doi.org/10.31986/issn.2689-0690_rdw.stratford_research_day.149_2024", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Microdosing,Clinical Trial,Review Article,Animal Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.31986/issn.2689-0690_rdw.stratford_research_day.149_2024", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.31986/issn.2689-0690_rdw.stratford_research_day.149_2024", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.31986/issn.2689-0690_rdw.stratford_research_day.149_2024", "source_url": "http://dx.doi.org/10.31986/issn.2689-0690_rdw.stratford_research_day.149_2024", "doi": "10.31986/issn.2689-0690_rdw.stratford_research_day.149_2024", "pmid": "", "publication_date": "2024-05-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1103, "title": "At the Forefront: Social Workers’ Role in Psilocybin Treatment for Depression and Substance Misuse", "authors": "Claire Parker, Bethany Wood", "journal": "Social Work", "publication_date": "2024-05-01", "publication_year": 2024, "doi": "10.1093/sw/swae019", "pubmed_id": "38697188", "openalex_id": "https://openalex.org/W4396599639", "source_url": "http://dx.doi.org/10.1093/sw/swae019", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38697188", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1093/sw/swae019", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38697188", "source_url": "http://dx.doi.org/10.1093/sw/swae019", "doi": "10.1093/sw/swae019", "pmid": "38697188", "publication_date": "2024-05-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4633, "title": "From Venerable Cultural Practices to Modern Psychological Solutions: Enter Entheogens into Mainstream Medicine", "authors": "Nicholas A Kerna, Kevin D. Pruitt, N.D. Victor Carsrud, Kyle Kadivi, Dabeluchi C. Ngwu, Hilary M. Holets, John V. Flores, Ijeoma Nnake, Cornelius I. Azi, Joseph Anderson, Fatimah A. Olunlade, Uzoamaka Nwokorie", "journal": "European Journal of Arts Humanities and Social Sciences", "publication_date": "2024-04-30", "publication_year": 2024, "doi": "10.59324/ejahss.2024.1(3).10", "pubmed_id": null, "openalex_id": "https://openalex.org/W4399259513", "source_url": "https://doi.org/10.59324/ejahss.2024.1(3).10", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Chronic Pain,Headache / Migraine,Mechanism of Action,Receptor Pharmacology,Spirituality,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.59324/ejahss.2024.1(3).10", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.59324/ejahss.2024.1(3).10", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.59324/ejahss.2024.1(3).10", "source_url": "https://doi.org/10.59324/ejahss.2024.1(3).10", "doi": "10.59324/ejahss.2024.1(3).10", "pmid": "", "publication_date": "2024-04-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1142, "title": "Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis.", "authors": "Metaxa AM, Clarke M.", "journal": null, "publication_date": "2024-04-30", "publication_year": 2024, "doi": "10.1136/bmj-2023-078084", "pubmed_id": "38692686", "openalex_id": null, "source_url": "https://doi.org/10.1136/bmj-2023-078084", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Healthcare Workers,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:38692686", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1136/bmj-2023-078084", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38692686", "source_url": "https://doi.org/10.1136/bmj-2023-078084", "doi": "10.1136/bmj-2023-078084", "pmid": "38692686", "publication_date": "2024-04-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1158, "title": "In vitro and in vivo metabolism of psilocybin’s active metabolite psilocin", "authors": "Jan Thomann, Karolina E. Kolaczynska, Oliver V Stoeckmann, Deborah Rudin, Patrick Vizeli, Marius C. Hoener, Christopher R. Pryce, Franz X. Vollenweider, Matthias E. Liechti, Urs Duthaler", "journal": "Frontiers in Pharmacology", "publication_date": "2024-04-28", "publication_year": 2024, "doi": "10.3389/fphar.2024.1391689", "pubmed_id": "38741590", "openalex_id": "https://openalex.org/W4396224564", "source_url": "https://doi.org/10.3389/fphar.2024.1391689", "substance_tags": "psilocybin,psilocin", "topic_tags": "Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Animal Study,In Vitro Study,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38741590", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fphar.2024.1391689", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38741590", "source_url": "https://doi.org/10.3389/fphar.2024.1391689", "doi": "10.3389/fphar.2024.1391689", "pmid": "38741590", "publication_date": "2024-04-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1013, "title": "Psilocybin restrains activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms", "authors": "Kyna-Anne Conn, Laura K Milton, Kaixin Huang, Hermany Munguba, Janika Ruuska, M. B. Lemus, Erin Greaves, Jihane Homman-Ludiye, Brian J. Oldfield, Claire J. Foldi", "journal": "Molecular Psychiatry", "publication_date": "2024-04-26", "publication_year": 2024, "doi": "10.1038/s41380-024-02575-9", "pubmed_id": "38678087", "openalex_id": "https://openalex.org/W4395688958", "source_url": "https://doi.org/10.1038/s41380-024-02575-9", "substance_tags": "psilocybin", "topic_tags": "Depression,Eating Disorders,Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38678087", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41380-024-02575-9", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38678087", "source_url": "https://doi.org/10.1038/s41380-024-02575-9", "doi": "10.1038/s41380-024-02575-9", "pmid": "38678087", "publication_date": "2024-04-26", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1161, "title": "The ‘PSILAUT’ protocol: an experimental medicine study of autistic differences in the function of brain serotonin targets of psilocybin", "authors": "Tobias P. Whelan, Eileen Daly, Nicolaas A.J. Puts, Paula Smith, Carrie Allison, Simon Baron-Cohen, Ekaterina Malievskaia, Declan Murphy, Gráinne McAlonan", "journal": "BMC Psychiatry", "publication_date": "2024-04-24", "publication_year": 2024, "doi": "10.1186/s12888-024-05768-2", "pubmed_id": "38658877", "openalex_id": "https://openalex.org/W4395462414", "source_url": "https://doi.org/10.1186/s12888-024-05768-2", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38658877", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1186/s12888-024-05768-2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38658877", "source_url": "https://doi.org/10.1186/s12888-024-05768-2", "doi": "10.1186/s12888-024-05768-2", "pmid": "38658877", "publication_date": "2024-04-24", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1162, "title": "Psilocybin therapy and anorexia nervosa: a narrative review of safety considerations for researchers and clinicians.", "authors": "Downey AE, Chaphekar AV, Woolley J, Raymond-Flesch M.", "journal": null, "publication_date": "2024-04-23", "publication_year": 2024, "doi": "10.1186/s40337-024-01005-z", "pubmed_id": "38659049", "openalex_id": null, "source_url": "https://doi.org/10.1186/s40337-024-01005-z", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Headache / Migraine,Clinical Trial,Review Article,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:38659049", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1186/s40337-024-01005-z", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38659049", "source_url": "https://doi.org/10.1186/s40337-024-01005-z", "doi": "10.1186/s40337-024-01005-z", "pmid": "38659049", "publication_date": "2024-04-23", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4638, "title": "MedCheck: Psilocybin for Depression, LSD for Anxiety, Donanemab, LSD, and More", "authors": "Terri D’Arrigo", "journal": "Psychiatric News", "publication_date": "2024-04-22", "publication_year": 2024, "doi": "10.1176/appi.pn.2024.05.5.1", "pubmed_id": null, "openalex_id": "https://openalex.org/W4395032120", "source_url": "http://dx.doi.org/10.1176/appi.pn.2024.05.5.1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2024.05.5.1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1176/appi.pn.2024.05.5.1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2024.05.5.1", "source_url": "http://dx.doi.org/10.1176/appi.pn.2024.05.5.1", "doi": "10.1176/appi.pn.2024.05.5.1", "pmid": "", "publication_date": "2024-04-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3366, "title": "The selective 5-HT2A receptor agonist LPH-5 induces persistent and robust antidepressant-like effects in rodents", "authors": "Jensen AA, Cecchi CR, Hibicke M, Bach AH, Kaadt E, Märcher-Rørsted E, Nichols CD, Elfving B, Kristensen JL.", "journal": "bioRxiv", "publication_date": "2024-04-21", "publication_year": 2024, "doi": "10.1101/2024.04.19.590212", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2024.04.19.590212", "substance_tags": "psilocybin", "topic_tags": "Receptor Pharmacology,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "DOI:10.1101/2024.04.19.590212", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2024.04.19.590212", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2024.04.19.590212", "source_url": "https://doi.org/10.1101/2024.04.19.590212", "doi": "10.1101/2024.04.19.590212", "pmid": "", "publication_date": "2024-04-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1138, "title": "Discovery and Structure-Activity Relationships of 2,5-Dimethoxyphenylpiperidines as Selective Serotonin 5-HT2A Receptor Agonists", "authors": "Emil Märcher-Rørsted, Anders A. Jensen, Gints Šmits, Karla Frydenvang, Jesper L. Kristensen", "journal": "Journal of Medicinal Chemistry", "publication_date": "2024-04-21", "publication_year": 2024, "doi": "10.1021/acs.jmedchem.4c00082", "pubmed_id": "38648420", "openalex_id": "https://openalex.org/W4394993604", "source_url": "https://doi.org/10.1021/acs.jmedchem.4c00082", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Receptor Pharmacology,Clinical Trial,In Vitro Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38648420", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1021/acs.jmedchem.4c00082", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38648420", "source_url": "https://doi.org/10.1021/acs.jmedchem.4c00082", "doi": "10.1021/acs.jmedchem.4c00082", "pmid": "38648420", "publication_date": "2024-04-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3434, "title": "The Effect of Psilocybin on MDD Symptom Severity and Synaptic Density - A Single Dose Randomized, Double Blind, Placebo- Controlled Phase 2 Positron Emission Tomography Study", "authors": "Section for Affective Disorders; Northern Stockholm Psychiatry", "journal": "ClinicalTrials.gov", "publication_date": "2024-04-18", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04630964", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Brain Imaging,Aging,Clinical Trial,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04630964", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04630964", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04630964", "source_url": "https://clinicaltrials.gov/study/NCT04630964", "doi": "", "pmid": "", "publication_date": "2024-04-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1040, "title": "Emerging drugs in phase II and III clinical development for the treatment of alcohol use disorder.", "authors": "Köhne S, Hillemacher T, Glahn A, Bach P.", "journal": null, "publication_date": "2024-04-17", "publication_year": 2024, "doi": "10.1080/14728214.2024.2342951", "pubmed_id": "38606899", "openalex_id": null, "source_url": "https://doi.org/10.1080/14728214.2024.2342951", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:38606899", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/14728214.2024.2342951", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38606899", "source_url": "https://doi.org/10.1080/14728214.2024.2342951", "doi": "10.1080/14728214.2024.2342951", "pmid": "38606899", "publication_date": "2024-04-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1166, "title": "Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial", "authors": "Jordan Sloshower, Richard J. Zeifman, Jeffrey Guss, Robert Krause, Hamideh Safi-Aghdam, Surbhi Pathania, Brian Pittman, Deepak Cyril D’Souza", "journal": "Scientific Reports", "publication_date": "2024-04-16", "publication_year": 2024, "doi": "10.1038/s41598-024-58318-x", "pubmed_id": "38632313", "openalex_id": "https://openalex.org/W4394886406", "source_url": "https://doi.org/10.1038/s41598-024-58318-x", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Receptor Pharmacology,Psychological Flexibility,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38632313", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41598-024-58318-x", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38632313", "source_url": "https://doi.org/10.1038/s41598-024-58318-x", "doi": "10.1038/s41598-024-58318-x", "pmid": "38632313", "publication_date": "2024-04-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4640, "title": "Psychedelic therapists, pharma collaborate on clinical trial", "authors": "Valerie A. Canady", "journal": "Mental Health Weekly", "publication_date": "2024-04-12", "publication_year": 2024, "doi": "10.1002/mhw.34009", "pubmed_id": null, "openalex_id": "https://openalex.org/W4394786197", "source_url": "https://doi.org/10.1002/mhw.34009", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.1002/mhw.34009", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/mhw.34009", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/mhw.34009", "source_url": "https://doi.org/10.1002/mhw.34009", "doi": "10.1002/mhw.34009", "pmid": "", "publication_date": "2024-04-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4642, "title": "Who will staff the psychedelic resurgence?", "authors": "Erika Dyck", "journal": "Open Access Government", "publication_date": "2024-04-08", "publication_year": 2024, "doi": "10.56367/oag-042-10690", "pubmed_id": null, "openalex_id": "https://openalex.org/W4394904988", "source_url": "http://dx.doi.org/10.56367/oag-042-10690", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.56367/oag-042-10690", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.56367/oag-042-10690", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.56367/oag-042-10690", "source_url": "http://dx.doi.org/10.56367/oag-042-10690", "doi": "10.56367/oag-042-10690", "pmid": "", "publication_date": "2024-04-08", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3726, "title": "[Psychedelic psychiatry].", "authors": "López E, Yngwe H, Beckman M, Tiger M, Hieronymus F, Lundberg J.", "journal": null, "publication_date": "2024-04-03", "publication_year": 2024, "doi": null, "pubmed_id": "38572715", "openalex_id": null, "source_url": "https://europepmc.org/article/MED/38572715", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Receptor Pharmacology,Clinical Trial,Review Article,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:08:41", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:38572715", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/MED/38572715", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38572715", "source_url": "https://europepmc.org/article/MED/38572715", "doi": "", "pmid": "38572715", "publication_date": "2024-04-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1170, "title": "The psychedelic call: analysis of Australian Poisons Information Centre calls associated with classic psychedelics", "authors": "Rachael Wilkes, Darren M. Roberts, Paul Liknaitzky, Jonathan Brett", "journal": "Clinical Toxicology", "publication_date": "2024-04-01", "publication_year": 2024, "doi": "10.1080/15563650.2024.2346612", "pubmed_id": "38753585", "openalex_id": "https://openalex.org/W4396977515", "source_url": "https://doi.org/10.1080/15563650.2024.2346612", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Observational Study,Healthcare Workers,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38753585", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/15563650.2024.2346612", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38753585", "source_url": "https://doi.org/10.1080/15563650.2024.2346612", "doi": "10.1080/15563650.2024.2346612", "pmid": "38753585", "publication_date": "2024-04-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4658, "title": "Current situation regarding psychedelics and magic mushroom in Korea", "authors": "J. S. Seo", "journal": "European Psychiatry", "publication_date": "2024-03-31", "publication_year": 2024, "doi": "10.1192/j.eurpsy.2024.1695", "pubmed_id": null, "openalex_id": "https://openalex.org/W4401921810", "source_url": "http://dx.doi.org/10.1192/j.eurpsy.2024.1695", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Clinical Trial,Review Article,Cancer Patients,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.1192/j.eurpsy.2024.1695", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1192/j.eurpsy.2024.1695", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1192/j.eurpsy.2024.1695", "source_url": "http://dx.doi.org/10.1192/j.eurpsy.2024.1695", "doi": "10.1192/j.eurpsy.2024.1695", "pmid": "", "publication_date": "2024-03-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4646, "title": "Microdosing psychedelics in the treatment of ADHD and comorbid disorders", "authors": "Kim P. C. Kuypers", "journal": "European Psychiatry", "publication_date": "2024-03-31", "publication_year": 2024, "doi": "10.1192/j.eurpsy.2024.44", "pubmed_id": null, "openalex_id": "https://openalex.org/W4401920710", "source_url": "https://doi.org/10.1192/j.eurpsy.2024.44", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Neuroplasticity,Default Mode Network,Microdosing,Personality Change,Emotional Processing,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.1192/j.eurpsy.2024.44", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1192/j.eurpsy.2024.44", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1192/j.eurpsy.2024.44", "source_url": "https://doi.org/10.1192/j.eurpsy.2024.44", "doi": "10.1192/j.eurpsy.2024.44", "pmid": "", "publication_date": "2024-03-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1172, "title": "Acute Adverse Effects of Therapeutic Doses of Psilocybin: A Systematic Review and Meta-Analysis.", "authors": "Yerubandi A, Thomas JE, Bhuiya NMMA, Harrington C, Villa Zapata L, Caballero J.", "journal": null, "publication_date": "2024-03-31", "publication_year": 2024, "doi": "10.1001/jamanetworkopen.2024.5960", "pubmed_id": "38598236", "openalex_id": null, "source_url": "https://doi.org/10.1001/jamanetworkopen.2024.5960", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:38598236", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1001/jamanetworkopen.2024.5960", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38598236", "source_url": "https://doi.org/10.1001/jamanetworkopen.2024.5960", "doi": "10.1001/jamanetworkopen.2024.5960", "pmid": "38598236", "publication_date": "2024-03-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1167, "title": "The Promise of Therapeutic Psilocybin: An Evaluation of the 134 Clinical Trials, 54 Potential Indications, and 0 Marketing Approvals on ClinicalTrials.gov", "authors": "Sarah A. Norring, Michael G. Spigarelli", "journal": "Drug Design Development and Therapy", "publication_date": "2024-03-31", "publication_year": 2024, "doi": "10.2147/dddt.s443177", "pubmed_id": "38618282", "openalex_id": "https://openalex.org/W4394684735", "source_url": "https://doi.org/10.2147/dddt.s443177", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Clinical Trial,Observational Study,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38618282", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.2147/dddt.s443177", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38618282", "source_url": "https://doi.org/10.2147/dddt.s443177", "doi": "10.2147/dddt.s443177", "pmid": "38618282", "publication_date": "2024-03-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4660, "title": "MedCheck; Psilocybin, Roluperidone, Latozinemab, Lacosamide", "authors": "Terri D’Arrigo", "journal": "Psychiatric News", "publication_date": "2024-03-25", "publication_year": 2024, "doi": "10.1176/appi.pn.2024.04.4.1", "pubmed_id": null, "openalex_id": "https://openalex.org/W4393210403", "source_url": "http://dx.doi.org/10.1176/appi.pn.2024.04.4.1", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Pharmacology,Clinical Trial,Review Article,Safety,Immune Function", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2024.04.4.1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1176/appi.pn.2024.04.4.1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2024.04.4.1", "source_url": "http://dx.doi.org/10.1176/appi.pn.2024.04.4.1", "doi": "10.1176/appi.pn.2024.04.4.1", "pmid": "", "publication_date": "2024-03-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1148, "title": "Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression", "authors": "David Erritzøe, Tommaso Barba, Meg J. Spriggs, Fernando E. Rosas, David Nutt, Robin Carhart-Harris", "journal": "Journal of Psychopharmacology", "publication_date": "2024-03-21", "publication_year": 2024, "doi": "10.1177/02698811241237870", "pubmed_id": "38520045", "openalex_id": "https://openalex.org/W4393118291", "source_url": "https://doi.org/10.1177/02698811241237870", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Receptor Pharmacology,Wellbeing,Clinical Trial,Safety,Toxicity,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38520045", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/02698811241237870", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38520045", "source_url": "https://doi.org/10.1177/02698811241237870", "doi": "10.1177/02698811241237870", "pmid": "38520045", "publication_date": "2024-03-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4663, "title": "Psychedelic Renaissance: Evidence and Culture", "authors": "Adrian Preda", "journal": "Psychiatric News", "publication_date": "2024-03-20", "publication_year": 2024, "doi": "10.1176/appi.pn.2024.04.4.39", "pubmed_id": null, "openalex_id": "https://openalex.org/W4393030764", "source_url": "http://dx.doi.org/10.1176/appi.pn.2024.04.4.39", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Neuroplasticity,Emotional Processing,Spirituality,Clinical Trial,Animal Study,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2024.04.4.39", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1176/appi.pn.2024.04.4.39", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2024.04.4.39", "source_url": "http://dx.doi.org/10.1176/appi.pn.2024.04.4.39", "doi": "10.1176/appi.pn.2024.04.4.39", "pmid": "", "publication_date": "2024-03-20", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4664, "title": "Psychedelic drugs and the law: What’s next?", "authors": "Ben Seal", "journal": "Knowable Magazine", "publication_date": "2024-03-13", "publication_year": 2024, "doi": "10.1146/knowable-031424-2", "pubmed_id": null, "openalex_id": "https://openalex.org/W4392794286", "source_url": "http://dx.doi.org/10.1146/knowable-031424-2", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Chronic Pain,Mechanism of Action,Receptor Pharmacology,Spirituality,Clinical Trial,Systematic Review,Review Article,Cancer Patients,Safety", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.1146/knowable-031424-2", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1146/knowable-031424-2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1146/knowable-031424-2", "source_url": "http://dx.doi.org/10.1146/knowable-031424-2", "doi": "10.1146/knowable-031424-2", "pmid": "", "publication_date": "2024-03-13", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1199, "title": "The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder", "authors": "Adam W. Levin, Rafael Lancelotta, Nathan D. Sepeda, Natalie Gukasyan, Sandeep M. Nayak, Theodore L. Wagener, Frederick S. Barrett, Roland R. Griffiths, Alan K. Davis", "journal": "PLoS ONE", "publication_date": "2024-03-13", "publication_year": 2024, "doi": "10.1371/journal.pone.0300501", "pubmed_id": "38483940", "openalex_id": "https://openalex.org/W4392797453", "source_url": "https://doi.org/10.1371/journal.pone.0300501", "substance_tags": "psilocybin", "topic_tags": "Depression,Mystical Experience,Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38483940", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1371/journal.pone.0300501", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38483940", "source_url": "https://doi.org/10.1371/journal.pone.0300501", "doi": "10.1371/journal.pone.0300501", "pmid": "38483940", "publication_date": "2024-03-13", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4667, "title": "Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive Disorder", "authors": "Brandon Weiss, Leor Roseman, Bruna Giribaldi, David Nutt, Robin Carhart-Harris, David Erritzøe", "journal": "International Journal of Mental Health and Addiction", "publication_date": "2024-03-06", "publication_year": 2024, "doi": "10.1007/s11469-024-01253-9", "pubmed_id": null, "openalex_id": "https://openalex.org/W4392550813", "source_url": "https://doi.org/10.1007/s11469-024-01253-9", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Mystical Experience,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.1007/s11469-024-01253-9", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1007/s11469-024-01253-9", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1007/s11469-024-01253-9", "source_url": "https://doi.org/10.1007/s11469-024-01253-9", "doi": "10.1007/s11469-024-01253-9", "pmid": "", "publication_date": "2024-03-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1210, "title": "Psychedelic Therapy: A Primer for Primary Care Clinicians-Historical Perspective and Overview", "authors": "Burton J. Tabaac, Kenneth Shinozuka, Alejandro Arenas, Bryce D. Beutler, Kirsten Cherian, Viviana D. Evans, Chelsey Fasano, Owen S. Muir", "journal": "American Journal of Therapeutics", "publication_date": "2024-02-29", "publication_year": 2024, "doi": "10.1097/mjt.0000000000001727", "pubmed_id": "38518266", "openalex_id": "https://openalex.org/W4393098943", "source_url": "https://doi.org/10.1097/mjt.0000000000001727", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Chronic Pain,Pharmacology,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Healthcare Workers,Adverse Events,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38518266", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1097/mjt.0000000000001727", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38518266", "source_url": "https://doi.org/10.1097/mjt.0000000000001727", "doi": "10.1097/mjt.0000000000001727", "pmid": "38518266", "publication_date": "2024-02-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1209, "title": "Psychedelic Therapy: A Primer for Primary Care Clinicians-Psilocybin", "authors": "Burton J. Tabaac, Kenneth Shinozuka, Alejandro Arenas, Bryce D. Beutler, Kirsten Cherian, Viviana D. Evans, Chelsey Fasano, Owen S. Muir", "journal": "American Journal of Therapeutics", "publication_date": "2024-02-29", "publication_year": 2024, "doi": "10.1097/mjt.0000000000001724", "pubmed_id": "38518269", "openalex_id": "https://openalex.org/W4393098899", "source_url": "https://doi.org/10.1097/mjt.0000000000001724", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Chronic Pain,Headache / Migraine,Pharmacology,Receptor Pharmacology,Consciousness,Clinical Trial,Review Article,Treatment-Resistant Depression,Healthcare Workers,Safety,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38518269", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1097/mjt.0000000000001724", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38518269", "source_url": "https://doi.org/10.1097/mjt.0000000000001724", "doi": "10.1097/mjt.0000000000001724", "pmid": "38518269", "publication_date": "2024-02-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1105, "title": "Impact of Psilocybin on Peripheral Cytokine Production", "authors": "Dana DiRenzo, Frederick S. Barrett, Jamie Perin, Erika Darrah, Lisa Christopher-Stine, Roland R. Griffiths", "journal": "Psychedelic Medicine", "publication_date": "2024-02-27", "publication_year": 2024, "doi": "10.1089/psymed.2023.0039", "pubmed_id": "40051582", "openalex_id": "https://openalex.org/W4392242985", "source_url": "https://doi.org/10.1089/psymed.2023.0039", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Pharmacology,Clinical Trial,Randomized Controlled Trial,Toxicity,Inflammation,Immune Function", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:40051582", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1089/psymed.2023.0039", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40051582", "source_url": "https://doi.org/10.1089/psymed.2023.0039", "doi": "10.1089/psymed.2023.0039", "pmid": "40051582", "publication_date": "2024-02-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 594, "title": "Are \"mystical experiences\" essential for antidepressant actions of ketamine and the classic psychedelics?", "authors": "Hashimoto K.", "journal": null, "publication_date": "2024-02-26", "publication_year": 2024, "doi": "10.1007/s00406-024-01770-7", "pubmed_id": "38411629", "openalex_id": null, "source_url": "https://doi.org/10.1007/s00406-024-01770-7", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Mystical Experience,Clinical Trial,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:38411629", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s00406-024-01770-7", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38411629", "source_url": "https://doi.org/10.1007/s00406-024-01770-7", "doi": "10.1007/s00406-024-01770-7", "pmid": "38411629", "publication_date": "2024-02-26", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3282, "title": "The Temporal Trajectory of the Psychedelic Mushroom Experience Mimics the Narrative Arc of the Hero’s Journey", "authors": "Brouwer A, Brown JK, Erowid E, Erowid F, Thyssen S, Raison CL, Carhart-Harris RL.", "journal": "Research Square", "publication_date": "2024-02-22", "publication_year": 2024, "doi": "10.21203/rs.3.rs-3941205/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-3941205/v1", "substance_tags": "psilocybin", "topic_tags": "Consciousness,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-3941205/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-3941205/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-3941205/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-3941205/v1", "doi": "10.21203/rs.3.rs-3941205/v1", "pmid": "", "publication_date": "2024-02-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1150, "title": "Expectancy Effects in Psychedelic Trials", "authors": "Balázs Szigeti, Boris D. Heifets", "journal": "Biological Psychiatry Cognitive Neuroscience and Neuroimaging", "publication_date": "2024-02-19", "publication_year": 2024, "doi": "10.1016/j.bpsc.2024.02.004", "pubmed_id": "38387698", "openalex_id": "https://openalex.org/W4391953134", "source_url": "https://doi.org/10.1016/j.bpsc.2024.02.004", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 06:34:44", "bibtex": null, "source_record_id": "PMID:38387698", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38387698", "source_url": "https://doi.org/10.1016/j.bpsc.2024.02.004", "doi": "10.1016/j.bpsc.2024.02.004", "pmid": "38387698", "publication_date": "2024-02-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1225, "title": "Efficacy and acceptability of psilocybin for primary or secondary depression: A systematic review and meta-analysis of randomized controlled trials.", "authors": "Fang S, Yang X, Zhang W.", "journal": null, "publication_date": "2024-02-14", "publication_year": 2024, "doi": "10.3389/fpsyt.2024.1359088", "pubmed_id": "38426002", "openalex_id": null, "source_url": "https://doi.org/10.3389/fpsyt.2024.1359088", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:38426002", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2024.1359088", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38426002", "source_url": "https://doi.org/10.3389/fpsyt.2024.1359088", "doi": "10.3389/fpsyt.2024.1359088", "pmid": "38426002", "publication_date": "2024-02-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1204, "title": "Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin", "authors": "Joshua D. Rosenblat, Shakila Meshkat, Zoe Doyle, Erica Kaczmarek, Ryan M. Brudner, Kevin Kratiuk, Rodrigo B. Mansur, Christian Schulz, Rickinder Sethi, Amanda Abate, Shaun Ali, Jordan Bawks, Marc G. Blainey, Elisa Brietzke, Victoria Cronin, Jessica Danilewitz, Shalini Dhawan, Anthony Di Fonzo, M. Di Fonzo, Pawel Drzadzewski, William Dunlop, Hajnalka Fiszter, Fabiano A. Gomes, Smrita Grewal, Marisa Leon-Carlyle, Marilyn McCallum, Niki Mofidi, Hilary Offman, Jeremy Riva-Cambrin, Joel E. Schmidt, Mark E. Smolkin, Joan M. Quinn, Andrea Zumrova, Michelle Marlborough, Roger S. McIntyre", "journal": "Med", "publication_date": "2024-02-13", "publication_year": 2024, "doi": "10.1016/j.medj.2024.01.005", "pubmed_id": "38359838", "openalex_id": "https://openalex.org/W4391810199", "source_url": "https://doi.org/10.1016/j.medj.2024.01.005", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38359838", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38359838", "source_url": "https://doi.org/10.1016/j.medj.2024.01.005", "doi": "10.1016/j.medj.2024.01.005", "pmid": "38359838", "publication_date": "2024-02-13", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1232, "title": "Psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder: an fMRI pilot study", "authors": "Broc A. Pagni, Petros Petridis, Samantha K. Podrebarac, Jack Grinband, Eric D. Claus, Michael P. Bogenschutz", "journal": "Scientific Reports", "publication_date": "2024-02-06", "publication_year": 2024, "doi": "10.1038/s41598-024-52967-8", "pubmed_id": "38326432", "openalex_id": "https://openalex.org/W4391617258", "source_url": "https://doi.org/10.1038/s41598-024-52967-8", "substance_tags": "psilocybin", "topic_tags": "Addiction,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Emotional Processing,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38326432", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41598-024-52967-8", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38326432", "source_url": "https://doi.org/10.1038/s41598-024-52967-8", "doi": "10.1038/s41598-024-52967-8", "pmid": "38326432", "publication_date": "2024-02-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1231, "title": "Psychedelics and sexual functioning: a mixed-methods study", "authors": "Tommaso Barba, Hannes Kettner, Caterina Radu, Joseph Peill, Leor Roseman, David Nutt, David Erritzøe, Robin Carhart-Harris, Bruna Giribaldi", "journal": "Scientific Reports", "publication_date": "2024-02-06", "publication_year": 2024, "doi": "10.1038/s41598-023-49817-4", "pubmed_id": "38326446", "openalex_id": "https://openalex.org/W4391630740", "source_url": "https://doi.org/10.1038/s41598-023-49817-4", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Wellbeing,Clinical Trial,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38326446", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41598-023-49817-4", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38326446", "source_url": "https://doi.org/10.1038/s41598-023-49817-4", "doi": "10.1038/s41598-023-49817-4", "pmid": "38326446", "publication_date": "2024-02-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1235, "title": "Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: a qualitative study", "authors": "Joost J. Breeksema, Alistair Niemeijer, Erwin Krediet, T.L. Karsten, Jeanine Kamphuis, Eric Vermetten, Wim van den Brink, Robert A. Schoevers", "journal": "Scientific Reports", "publication_date": "2024-02-04", "publication_year": 2024, "doi": "10.1038/s41598-024-53188-9", "pubmed_id": "38316896", "openalex_id": "https://openalex.org/W4391540455", "source_url": "https://doi.org/10.1038/s41598-024-53188-9", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Aging,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38316896", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41598-024-53188-9", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38316896", "source_url": "https://doi.org/10.1038/s41598-024-53188-9", "doi": "10.1038/s41598-024-53188-9", "pmid": "38316896", "publication_date": "2024-02-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4677, "title": "Ketamine-assisted psychotherapy, psychedelic methodologies, and the impregnable value of the subjective-a new and evolving approach", "authors": "Phil Wolfson, Gita Vaid", "journal": "Frontiers in Psychiatry", "publication_date": "2024-01-31", "publication_year": 2024, "doi": "10.3389/fpsyt.2024.1209419", "pubmed_id": "38362026", "openalex_id": "https://openalex.org/W4391444130", "source_url": "https://doi.org/10.3389/fpsyt.2024.1209419", "substance_tags": "psilocybin", "topic_tags": "Depression,Consciousness,Clinical Trial,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 06:34:44", "bibtex": null, "source_record_id": "PMID:38362026", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2024.1209419", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38362026", "source_url": "https://doi.org/10.3389/fpsyt.2024.1209419", "doi": "10.3389/fpsyt.2024.1209419", "pmid": "38362026", "publication_date": "2024-01-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1247, "title": "The development of psilocybin therapy for treatment-resistant depression: an update.", "authors": "Borissova A, Rucker JJ.", "journal": null, "publication_date": "2024-01-31", "publication_year": 2024, "doi": "10.1192/bjb.2023.25", "pubmed_id": "37357767", "openalex_id": null, "source_url": "https://doi.org/10.1192/bjb.2023.25", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Aging,Clinical Trial,Randomized Controlled Trial,Healthy Volunteers,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:37357767", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1192/bjb.2023.25", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37357767", "source_url": "https://doi.org/10.1192/bjb.2023.25", "doi": "10.1192/bjb.2023.25", "pmid": "37357767", "publication_date": "2024-01-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4681, "title": "Psilocybin-assisted psychotherapy for cancer patients", "authors": "Houman Farzin", "journal": "International Journal of Whole Person Care", "publication_date": "2024-01-28", "publication_year": 2024, "doi": "10.26443/ijwpc.v11i1.390", "pubmed_id": null, "openalex_id": "https://openalex.org/W4391329406", "source_url": "http://dx.doi.org/10.26443/ijwpc.v11i1.390", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Consciousness,Spirituality,Clinical Trial,Case Report,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.26443/ijwpc.v11i1.390", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.26443/ijwpc.v11i1.390", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.26443/ijwpc.v11i1.390", "source_url": "http://dx.doi.org/10.26443/ijwpc.v11i1.390", "doi": "10.26443/ijwpc.v11i1.390", "pmid": "", "publication_date": "2024-01-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1272, "title": "Older adults in psychedelic-assisted therapy trials: A systematic review.", "authors": "Bouchet L, Sager Z, Yrondi A, Nigam KB, Anderson BT, Ross S, Petridis PD, Beaussant Y.", "journal": null, "publication_date": "2024-01-18", "publication_year": 2024, "doi": "10.1177/02698811231215420", "pubmed_id": "38240068", "openalex_id": null, "source_url": "https://doi.org/10.1177/02698811231215420", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Aging,Clinical Trial,Systematic Review,Review Article,Older Adults,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:38240068", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02698811231215420", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38240068", "source_url": "https://doi.org/10.1177/02698811231215420", "doi": "10.1177/02698811231215420", "pmid": "38240068", "publication_date": "2024-01-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1257, "title": "Knowledge gaps in psychedelic medicalisation: Clinical studies and regulatory aspects.", "authors": "E-Wen McCulloch D, Liechti ME, Kuypers KP, Nutt D, Lundberg J, Stenbæk DS, Goodwin GM, Gründer G, Butlen-Ducuing F, Haberkamp M, Thirstrup S, Knudsen GM.", "journal": null, "publication_date": "2024-01-10", "publication_year": 2024, "doi": "10.1016/j.nsa.2024.103938", "pubmed_id": "40656112", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.nsa.2024.103938", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:40656112", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.nsa.2024.103938", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40656112", "source_url": "https://doi.org/10.1016/j.nsa.2024.103938", "doi": "10.1016/j.nsa.2024.103938", "pmid": "40656112", "publication_date": "2024-01-10", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1261, "title": "Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings", "authors": "Terence H. W. Ching, Lucia Amoroso, Calvin Bohner, Elizabeth J. D’Amico, Jeffrey Eilbott, Tara Entezar, Madison Fitzpatrick, Geena Fram, Rachael Grazioplene, Jamila Hokanson, Anastasia Jankovsky, Stephen A. Kichuk, Bradford Martins, Prerana Patel, Henry Schaer, Sarah Shnayder, Chelsea Witherow, Christopher Pittenger, Benjamin Kelmendi", "journal": "Frontiers in Psychiatry", "publication_date": "2024-01-08", "publication_year": 2024, "doi": "10.3389/fpsyt.2023.1278823", "pubmed_id": "38264632", "openalex_id": "https://openalex.org/W4390753253", "source_url": "https://doi.org/10.3389/fpsyt.2023.1278823", "substance_tags": "psilocybin", "topic_tags": "OCD,Chronic Pain,Pharmacology,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:38264632", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2023.1278823", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38264632", "source_url": "https://doi.org/10.3389/fpsyt.2023.1278823", "doi": "10.3389/fpsyt.2023.1278823", "pmid": "38264632", "publication_date": "2024-01-08", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3623, "title": "Safety and Tolerability of Psilocybin in Post-Traumatic Stress Disorder", "authors": "Johns Hopkins University", "journal": "ClinicalTrials.gov", "publication_date": "2024-01-04", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05562973", "substance_tags": "psilocybin", "topic_tags": "PTSD,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05562973", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05562973", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05562973", "source_url": "https://clinicaltrials.gov/study/NCT05562973", "doi": "", "pmid": "", "publication_date": "2024-01-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1097, "title": "Neural Mechanisms of Resting-State Networks and the Amygdala Underlying the Cognitive and Emotional Effects of Psilocybin", "authors": "Devon Stoliker, Leonardo Novelli, Franz X. Vollenweider, Gary F. Egan, Katrin H. Preller, Adeel Razi", "journal": "Biological Psychiatry", "publication_date": "2024-01-04", "publication_year": 2024, "doi": "10.1016/j.biopsych.2024.01.002", "pubmed_id": "38185235", "openalex_id": "https://openalex.org/W4390629750", "source_url": "https://doi.org/10.1016/j.biopsych.2024.01.002", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Mechanism of Action,Default Mode Network,Emotional Processing,Clinical Trial,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:38185235", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.biopsych.2024.01.002", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38185235", "source_url": "https://doi.org/10.1016/j.biopsych.2024.01.002", "doi": "10.1016/j.biopsych.2024.01.002", "pmid": "38185235", "publication_date": "2024-01-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3174, "title": "Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder: Protocol for a Double-Blind, Randomized, Placebo-Controlled, 7-month Parallel-Group Phase II Superiority Trial", "authors": "Vanderijst L, Hever F, Buot A, Dauré C, Benoit J, Hanak C, Veeser J, Morgiève M, Campanella S, Kornreich C, Mallet L, Leys C, Noël X.", "journal": "Research Square", "publication_date": "2024-01-03", "publication_year": 2024, "doi": "10.21203/rs.3.rs-3829237/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-3829237/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Neuroplasticity,Mechanism of Action,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-3829237/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-3829237/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-3829237/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-3829237/v1", "doi": "10.21203/rs.3.rs-3829237/v1", "pmid": "", "publication_date": "2024-01-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4700, "title": "Psychedelics: The New Kid on the Block", "authors": "Prosenjit Ghosh, Avinash Desousa", "journal": "Annals of Indian Psychiatry", "publication_date": "2023-12-31", "publication_year": 2023, "doi": "10.4103/aip.aip_195_23", "pubmed_id": null, "openalex_id": "https://openalex.org/W4392949566", "source_url": "https://doi.org/10.4103/aip.aip_195_23", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Eating Disorders,End-of-Life Distress,Chronic Pain,Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Consciousness,Aging,Clinical Trial,Randomized Controlled Trial,Healthy Volunteers,Adolescents,Cancer Patients,Treatment-Resistant Depression,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.4103/aip.aip_195_23", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.4103/aip.aip_195_23", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.4103/aip.aip_195_23", "source_url": "https://doi.org/10.4103/aip.aip_195_23", "doi": "10.4103/aip.aip_195_23", "pmid": "", "publication_date": "2023-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1289, "title": "When the Trial Ends: The Case for Post-Trial Provisions in Clinical Psychedelic Research.", "authors": "Jacobs E, Murphy-Beiner A, Rouiller I, Nutt D, Spriggs MJ", "journal": "Neuroethics", "publication_date": "2023-12-31", "publication_year": 2023, "doi": "10.1007/s12152-023-09536-z", "pubmed_id": "37942467", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37942467/", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:37", "bibtex": null, "source_record_id": "PMID:37942467", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37942467/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37942467", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37942467/", "doi": "10.1007/s12152-023-09536-z", "pmid": "37942467", "publication_date": "2023-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1273, "title": "CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivity", "authors": "M. Madsen, Anja Sofie Petersen, Dea Siggaard Stenbæk, Inger Marie Sørensen, Harald Schiønning, Tobias Fjeld, Charlotte H. Nykjær, Sara Marie Ulv Larsen, Maria Zofia Grzywacz, Tobias Mathiesen, Ida L. Klausen, Oliver Overgaard-Hansen, Kristoffer Brendstrup-Brix, Kristían Línnet, Sys Stybe Johansen, Patrick M. Fisher, Rigmor Jensen, Gitte M. Knudsen", "journal": "Headache The Journal of Head and Face Pain", "publication_date": "2023-12-31", "publication_year": 2023, "doi": "10.1111/head.14656", "pubmed_id": "38238974", "openalex_id": "https://openalex.org/W4391036082", "source_url": "https://doi.org/10.1111/head.14656", "substance_tags": "psilocybin", "topic_tags": "Headache / Migraine,Brain Imaging,Mechanism of Action,Aging,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:38238974", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/head.14656", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38238974", "source_url": "https://doi.org/10.1111/head.14656", "doi": "10.1111/head.14656", "pmid": "38238974", "publication_date": "2023-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1271, "title": "The Psychedelic Future of Post-Traumatic Stress Disorder Treatment.", "authors": "Zaretsky TG, Jagodnik KM, Barsic R, Antonio JH, Bonanno PA, MacLeod C, Pierce C, Carney H, Morrison MT, Saylor C, Danias G, Lepow L, Yehuda R.", "journal": null, "publication_date": "2023-12-31", "publication_year": 2023, "doi": "10.2174/1570159x22666231027111147", "pubmed_id": "38284341", "openalex_id": null, "source_url": "https://doi.org/10.2174/1570159x22666231027111147", "substance_tags": "psilocybin", "topic_tags": "PTSD,Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:38284341", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.2174/1570159x22666231027111147", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38284341", "source_url": "https://doi.org/10.2174/1570159x22666231027111147", "doi": "10.2174/1570159x22666231027111147", "pmid": "38284341", "publication_date": "2023-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1187, "title": "Commentary: Evidence-Informed Recommendation to Achieve Approximate Parity in the Allowed Number of Doses for Common Psychedelics.", "authors": "Thomas KL, Jesse R, Mehtani NJ, Mitchell JM, Anderson BT", "journal": "Journal of psychoactive drugs", "publication_date": "2023-12-31", "publication_year": 2023, "doi": "10.1080/02791072.2023.2201244", "pubmed_id": "37061961", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37061961/", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:37", "bibtex": null, "source_record_id": "PMID:37061961", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37061961/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37061961", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37061961/", "doi": "10.1080/02791072.2023.2201244", "pmid": "37061961", "publication_date": "2023-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5702, "title": "Psilocybin Therapy for Depression: A Review of Current Molecular Knowledge", "authors": "Verheijen Marcha C.T.", "journal": "Journal of the Netherlands Society of Toxicology", "publication_date": "2023-12-30", "publication_year": 2023, "doi": "10.61833/jnst.2024.0002", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.61833/jnst.2024.0002", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety,Inflammation", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-11 19:28:11", "last_checked": "2026-07-11 19:28:11", "bibtex": null, "source_record_id": "DOI:10.61833/jnst.2024.0002", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.61833/jnst.2024.0002", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.61833/jnst.2024.0002", "source_url": "https://doi.org/10.61833/jnst.2024.0002", "doi": "10.61833/jnst.2024.0002", "pmid": "", "publication_date": "2023-12-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3780, "title": "Psychedelic Therapy: A Primer for Primary Care Clinicians - Part I. Historical Perspective and Overview", "authors": "Tabaac BJ, Shinozuka K, Arenas A, Beutler BD, Cherian K, Evans VD, Fasano C, Muir OS.", "journal": "PsyArXiv", "publication_date": "2023-12-25", "publication_year": 2023, "doi": "10.31234/osf.io/byms6", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/byms6", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Receptor Pharmacology,Clinical Trial,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:21", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/byms6", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/byms6", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/byms6", "source_url": "https://doi.org/10.31234/osf.io/byms6", "doi": "10.31234/osf.io/byms6", "pmid": "", "publication_date": "2023-12-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3751, "title": "Psychedelic Therapy: A Primer for Primary Care Clinicians - Part IV. Psilocybin", "authors": "Tabaac BJ, Shinozuka K, Arenas A, Beutler BD, Cherian K, Evans VD, Fasano C, Muir OS.", "journal": "PsyArXiv", "publication_date": "2023-12-25", "publication_year": 2023, "doi": "10.31234/osf.io/a8xwk", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/a8xwk", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Pharmacology,Receptor Pharmacology,Consciousness,Clinical Trial,Review Article,Treatment-Resistant Depression,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:18", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/a8xwk", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/a8xwk", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/a8xwk", "source_url": "https://doi.org/10.31234/osf.io/a8xwk", "doi": "10.31234/osf.io/a8xwk", "pmid": "", "publication_date": "2023-12-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3293, "title": "Psychedelic Therapy: A Primer for Primary Care Clinicians - Part I. Historical Perspective and Overview", "authors": "", "journal": "PsyArXiv", "publication_date": "2023-12-25", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/byms6_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Receptor Pharmacology,Clinical Trial,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:50", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/byms6_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/byms6_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/byms6_v1", "source_url": "https://osf.io/preprints/psyarxiv/byms6_v1", "doi": "", "pmid": "", "publication_date": "2023-12-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3133, "title": "Psychedelic Therapy: A Primer for Primary Care Clinicians - Part IV. Psilocybin", "authors": "", "journal": "PsyArXiv", "publication_date": "2023-12-25", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/a8xwk_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Pharmacology,Receptor Pharmacology,Consciousness,Clinical Trial,Review Article,Treatment-Resistant Depression,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/a8xwk_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/a8xwk_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/a8xwk_v1", "source_url": "https://osf.io/preprints/psyarxiv/a8xwk_v1", "doi": "", "pmid": "", "publication_date": "2023-12-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1324, "title": "Potential use of psilocybin drugs in the treatment of depression.", "authors": "Śladowska K, Kawalec P, Brzostek T, Pilc A.", "journal": null, "publication_date": "2023-12-25", "publication_year": 2023, "doi": "10.1080/14728214.2023.2264180", "pubmed_id": "37817501", "openalex_id": null, "source_url": "https://doi.org/10.1080/14728214.2023.2264180", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:37817501", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/14728214.2023.2264180", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37817501", "source_url": "https://doi.org/10.1080/14728214.2023.2264180", "doi": "10.1080/14728214.2023.2264180", "pmid": "37817501", "publication_date": "2023-12-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4725, "title": "Application of psilocybin in mental health disorders", "authors": "Jingxuan Chen", "journal": "Theoretical and Natural Science", "publication_date": "2023-12-19", "publication_year": 2023, "doi": "10.54254/2753-8818/21/20230859", "pubmed_id": null, "openalex_id": "https://openalex.org/W4390006951", "source_url": "https://doi.org/10.54254/2753-8818/21/20230859", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.54254/2753-8818/21/20230859", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.54254/2753-8818/21/20230859", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.54254/2753-8818/21/20230859", "source_url": "https://doi.org/10.54254/2753-8818/21/20230859", "doi": "10.54254/2753-8818/21/20230859", "pmid": "", "publication_date": "2023-12-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1281, "title": "Set and setting predict psychopathology, wellbeing and meaningfulness of psychedelic experiences: a correlational study", "authors": "Lucas F. Borkel, Jaime Rojas-Hernández, Luis Alberto Henríquez-Hernández, Ángelo Santana, Domingo Jesús Quintana Hernández", "journal": "Expert Review of Clinical Pharmacology", "publication_date": "2023-12-17", "publication_year": 2023, "doi": "10.1080/17512433.2023.2295997", "pubmed_id": "38108102", "openalex_id": "https://openalex.org/W4389900041", "source_url": "https://doi.org/10.1080/17512433.2023.2295997", "substance_tags": "psilocybin", "topic_tags": "Addiction,Chronic Pain,Wellbeing,Personality Change,Clinical Trial,Observational Study,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:38108102", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/17512433.2023.2295997", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38108102", "source_url": "https://doi.org/10.1080/17512433.2023.2295997", "doi": "10.1080/17512433.2023.2295997", "pmid": "38108102", "publication_date": "2023-12-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1183, "title": "Acceptability of psilocybin-assisted group therapy in patients with cancer and major depressive disorder: Qualitative analysis", "authors": "Yvan Beaussant, Elise C. Tarbi, Kabir Nigam, Skye A. Miner, Zachary Sager, Justin J. Sanders, Michael Ljuslin, Benjamin Guérin, Paul Thambi, James A. Tulsky, Manish Agrawal", "journal": "Cancer", "publication_date": "2023-12-17", "publication_year": 2023, "doi": "10.1002/cncr.35024", "pubmed_id": "38105653", "openalex_id": "https://openalex.org/W4389895437", "source_url": "https://doi.org/10.1002/cncr.35024", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Aging,Clinical Trial,Cancer Patients,Safety,Toxicity,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:38105653", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/cncr.35024", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38105653", "source_url": "https://doi.org/10.1002/cncr.35024", "doi": "10.1002/cncr.35024", "pmid": "38105653", "publication_date": "2023-12-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1181, "title": "Psilocybin-assisted group therapy in patients with cancer diagnosed with a major depressive disorder", "authors": "Manish Agrawal, William A. Richards, Yvan Beaussant, Sarah Shnayder, Rezvan Ameli, Kimberly Roddy, Norma Stevens, Brian D. Richards, Nick Schor, Heather Honstein, Betsy Jenkins, Mark Bates, Paul Thambi", "journal": "Cancer", "publication_date": "2023-12-17", "publication_year": 2023, "doi": "10.1002/cncr.35010", "pubmed_id": "38105655", "openalex_id": "https://openalex.org/W4389900078", "source_url": "https://doi.org/10.1002/cncr.35010", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Headache / Migraine,Clinical Trial,Observational Study,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:38105655", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/cncr.35010", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38105655", "source_url": "https://doi.org/10.1002/cncr.35010", "doi": "10.1002/cncr.35010", "pmid": "38105655", "publication_date": "2023-12-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1306, "title": "Psilocybin-induced default mode network hypoconnectivity is blunted in alcohol-dependent rats", "authors": "Jonathan Reinwald, Christian N. Schmitz, Ivan Skorodumov, Martin Kuchař, Wolfgang Weber-Fahr, Rainer Spanagel, Marcus W. Meinhardt", "journal": "Translational Psychiatry", "publication_date": "2023-12-13", "publication_year": 2023, "doi": "10.1038/s41398-023-02690-1", "pubmed_id": "38097569", "openalex_id": "https://openalex.org/W4389728826", "source_url": "https://doi.org/10.1038/s41398-023-02690-1", "substance_tags": "psilocybin", "topic_tags": "Addiction,Brain Imaging,Pharmacology,Receptor Pharmacology,Default Mode Network,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:38097569", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41398-023-02690-1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38097569", "source_url": "https://doi.org/10.1038/s41398-023-02690-1", "doi": "10.1038/s41398-023-02690-1", "pmid": "38097569", "publication_date": "2023-12-13", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3152, "title": "Psilocybin prevents activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms", "authors": "Conn K, Milton L, Huang K, Munguba H, Ruuska J, Lemus M, Greaves E, Homman-Ludiye J, Oldfield B, Foldi C.", "journal": "bioRxiv", "publication_date": "2023-12-12", "publication_year": 2023, "doi": "10.1101/2023.12.12.571374", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2023.12.12.571374", "substance_tags": "psilocybin", "topic_tags": "Depression,Eating Disorders,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.1101/2023.12.12.571374", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2023.12.12.571374", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2023.12.12.571374", "source_url": "https://doi.org/10.1101/2023.12.12.571374", "doi": "10.1101/2023.12.12.571374", "pmid": "", "publication_date": "2023-12-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1308, "title": "A Systematic Review of Reporting Practices in Psychedelic Clinical Trials: Psychological Support, Therapy, and Psychosocial Interventions.", "authors": "Brennan W, Kelman AR, Belser AB.", "journal": null, "publication_date": "2023-12-12", "publication_year": 2023, "doi": "10.1089/psymed.2023.0007", "pubmed_id": "40046864", "openalex_id": null, "source_url": "https://doi.org/10.1089/psymed.2023.0007", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:40046864", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1089/psymed.2023.0007", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40046864", "source_url": "https://doi.org/10.1089/psymed.2023.0007", "doi": "10.1089/psymed.2023.0007", "pmid": "40046864", "publication_date": "2023-12-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4726, "title": "Psychotropics: A scientific, regulatory, and public view on the medicinal uses of cannabinoids and psilocybin", "authors": "Ivana Turek", "journal": "Medical Writing", "publication_date": "2023-12-10", "publication_year": 2023, "doi": "10.56012/tsen2260", "pubmed_id": null, "openalex_id": "https://openalex.org/W4389763815", "source_url": "http://dx.doi.org/10.56012/tsen2260", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.56012/tsen2260", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.56012/tsen2260", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.56012/tsen2260", "source_url": "http://dx.doi.org/10.56012/tsen2260", "doi": "10.56012/tsen2260", "pmid": "", "publication_date": "2023-12-10", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1260, "title": "Serotonin 2A Receptor (5-HT2AR) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants.", "authors": "Duan W, Cao D, Wang S, Cheng J.", "journal": null, "publication_date": "2023-11-29", "publication_year": 2023, "doi": "10.1021/acs.chemrev.3c00375", "pubmed_id": "38033123", "openalex_id": null, "source_url": "https://doi.org/10.1021/acs.chemrev.3c00375", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:38033123", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1021/acs.chemrev.3c00375", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38033123", "source_url": "https://doi.org/10.1021/acs.chemrev.3c00375", "doi": "10.1021/acs.chemrev.3c00375", "pmid": "38033123", "publication_date": "2023-11-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1127, "title": "Current Understanding on Psilocybin for Major Depressive Disorder: A Review Focusing on Clinical Trials.", "authors": "Wang SM, Kim S, Choi WS, Lim HK, Woo YS, Pae CU, Bahk WM.", "journal": null, "publication_date": "2023-11-29", "publication_year": 2023, "doi": "10.9758/cpn.23.1134", "pubmed_id": "38627070", "openalex_id": null, "source_url": "https://doi.org/10.9758/cpn.23.1134", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Default Mode Network,Clinical Trial,Randomized Controlled Trial,Review Article,Cancer Patients,Treatment-Resistant Depression,Safety,Inflammation", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:38627070", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.9758/cpn.23.1134", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38627070", "source_url": "https://doi.org/10.9758/cpn.23.1134", "doi": "10.9758/cpn.23.1134", "pmid": "38627070", "publication_date": "2023-11-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4733, "title": "Altered stakes: Identifying gaps in the informed consent process for psychedelic-assisted therapy trials", "authors": "Tahlia R. Harrison", "journal": "Journal of Psychedelic Studies", "publication_date": "2023-11-19", "publication_year": 2023, "doi": "10.1556/2054.2023.00267", "pubmed_id": null, "openalex_id": "https://openalex.org/W4388822593", "source_url": "https://doi.org/10.1556/2054.2023.00267", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2023.00267", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2023.00267", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2023.00267", "source_url": "https://doi.org/10.1556/2054.2023.00267", "doi": "10.1556/2054.2023.00267", "pmid": "", "publication_date": "2023-11-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4735, "title": "Psychedelic Integration: Psychotherapy for non-ordinary states of consciousness", "authors": "Danelle Jones", "journal": "Journal of Psychedelic Studies", "publication_date": "2023-11-15", "publication_year": 2023, "doi": "10.1556/2054.2023.00306", "pubmed_id": null, "openalex_id": "https://openalex.org/W4388730617", "source_url": "http://dx.doi.org/10.1556/2054.2023.00306", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Chronic Pain,Consciousness,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2023.00306", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1556/2054.2023.00306", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2023.00306", "source_url": "http://dx.doi.org/10.1556/2054.2023.00306", "doi": "10.1556/2054.2023.00306", "pmid": "", "publication_date": "2023-11-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1285, "title": "Assessment of the acute subjective psychedelic experience: A review of patient-reported outcome measures in clinical research on classical psychedelics.", "authors": "Hovmand OR, Poulsen ED, Arnfred S.", "journal": null, "publication_date": "2023-11-15", "publication_year": 2023, "doi": "10.1177/02698811231200019", "pubmed_id": "37969069", "openalex_id": null, "source_url": "https://doi.org/10.1177/02698811231200019", "substance_tags": "psilocybin", "topic_tags": "Consciousness,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:37969069", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02698811231200019", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37969069", "source_url": "https://doi.org/10.1177/02698811231200019", "doi": "10.1177/02698811231200019", "pmid": "37969069", "publication_date": "2023-11-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1335, "title": "Epidemiology of classic psychedelic substances: results from a Norwegian internet convenience sample", "authors": "Tor-Morten Kvam, Malin V. Uthaug, Kristoffer Andreas Aamodt Andersen, Birk Berggrav Refsum, Paula Aarseth Tunstad, Lowan H. Stewart, Henrik Børsting Jacobsen, Cato Grønnerød", "journal": "Frontiers in Psychiatry", "publication_date": "2023-11-12", "publication_year": 2023, "doi": "10.3389/fpsyt.2023.1287196", "pubmed_id": "38025484", "openalex_id": "https://openalex.org/W4388646562", "source_url": "https://doi.org/10.3389/fpsyt.2023.1287196", "substance_tags": "psilocybin", "topic_tags": "Addiction,Receptor Pharmacology,Clinical Trial,Observational Study,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:38025484", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2023.1287196", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38025484", "source_url": "https://doi.org/10.3389/fpsyt.2023.1287196", "doi": "10.3389/fpsyt.2023.1287196", "pmid": "38025484", "publication_date": "2023-11-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1287, "title": "The psychedelic effects of cannabis: A review of the literature.", "authors": "Wolinsky D, Barrett FS, Vandrey R.", "journal": null, "publication_date": "2023-11-09", "publication_year": 2023, "doi": "10.1177/02698811231209194", "pubmed_id": "37947321", "openalex_id": null, "source_url": "https://doi.org/10.1177/02698811231209194", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Mechanism of Action,Consciousness,Aging,Mystical Experience,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:37947321", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02698811231209194", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37947321", "source_url": "https://doi.org/10.1177/02698811231209194", "doi": "10.1177/02698811231209194", "pmid": "37947321", "publication_date": "2023-11-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1321, "title": "Psychedelic renaissance: Revitalized potential therapies for psychiatric disorders.", "authors": "Rhee TG, Davoudian PA, Sanacora G, Wilkinson ST.", "journal": null, "publication_date": "2023-11-01", "publication_year": 2023, "doi": "10.1016/j.drudis.2023.103818", "pubmed_id": "37925136", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.drudis.2023.103818", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:37925136", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.drudis.2023.103818", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37925136", "source_url": "https://doi.org/10.1016/j.drudis.2023.103818", "doi": "10.1016/j.drudis.2023.103818", "pmid": "37925136", "publication_date": "2023-11-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4744, "title": "Single dose of psilocybin improves depressive symptoms in Phase 2 study", "authors": "", "journal": "The Brown University Psychopharmacology Update", "publication_date": "2023-10-29", "publication_year": 2023, "doi": "10.1002/pu.31093", "pubmed_id": null, "openalex_id": "https://openalex.org/W4388023533", "source_url": "http://dx.doi.org/10.1002/pu.31093", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Clinical Trial,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1002/pu.31093", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1002/pu.31093", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/pu.31093", "source_url": "http://dx.doi.org/10.1002/pu.31093", "doi": "10.1002/pu.31093", "pmid": "", "publication_date": "2023-10-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1069, "title": "The Tolerability and Safety of Psilocybin in Psychiatric and Substance-Dependence Conditions: A Systematic Review.", "authors": "Kaminski D, Reinert JP.", "journal": null, "publication_date": "2023-10-29", "publication_year": 2023, "doi": "10.1177/10600280231205645", "pubmed_id": "37902038", "openalex_id": null, "source_url": "https://doi.org/10.1177/10600280231205645", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Headache / Migraine,Clinical Trial,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:37902038", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/10600280231205645", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37902038", "source_url": "https://doi.org/10.1177/10600280231205645", "doi": "10.1177/10600280231205645", "pmid": "37902038", "publication_date": "2023-10-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1323, "title": "Cardiovascular safety of psychedelic medicine: current status and future directions.", "authors": "Wsół A.", "journal": null, "publication_date": "2023-10-23", "publication_year": 2023, "doi": "10.1007/s43440-023-00539-4", "pubmed_id": "37874530", "openalex_id": null, "source_url": "https://doi.org/10.1007/s43440-023-00539-4", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Receptor Pharmacology,Microdosing,Clinical Trial,Review Article,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:37874530", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s43440-023-00539-4", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37874530", "source_url": "https://doi.org/10.1007/s43440-023-00539-4", "doi": "10.1007/s43440-023-00539-4", "pmid": "37874530", "publication_date": "2023-10-23", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1342, "title": "Psilocybin-assisted therapy for depression: A systematic review and meta-analysis.", "authors": "Haikazian S, Chen-Li DCJ, Johnson DE, Fancy F, Levinta A, Husain MI, Mansur RB, McIntyre RS, Rosenblat JD.", "journal": null, "publication_date": "2023-10-10", "publication_year": 2023, "doi": "10.1016/j.psychres.2023.115531", "pubmed_id": "37844352", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.psychres.2023.115531", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Clinical Trial,Meta-Analysis,Systematic Review,Review Article", "study_type": "Meta-Analysis", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:37844352", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.psychres.2023.115531", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37844352", "source_url": "https://doi.org/10.1016/j.psychres.2023.115531", "doi": "10.1016/j.psychres.2023.115531", "pmid": "37844352", "publication_date": "2023-10-10", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4754, "title": "Psychedelics and Psychotherapy: Is the Whole Greater than the Sum of its Parts?", "authors": "Robert H. Dworkin, Michael McDermott, Sandeep M. Nayak, Eric C. Strain", "journal": "Clinical Pharmacology & Therapeutics", "publication_date": "2023-10-04", "publication_year": 2023, "doi": "10.1002/cpt.3050", "pubmed_id": "37795632", "openalex_id": "https://openalex.org/W4387357883", "source_url": "https://doi.org/10.1002/cpt.3050", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Headache / Migraine,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Consciousness,Microdosing,Wellbeing,Clinical Trial,Healthcare Workers,Safety,Adverse Events,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37795632", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/cpt.3050", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37795632", "source_url": "https://doi.org/10.1002/cpt.3050", "doi": "10.1002/cpt.3050", "pmid": "37795632", "publication_date": "2023-10-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1360, "title": "An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1)", "authors": "C Donegan, Dimitri Daldegan-Bueno, Rachael L. Sumner, David B Menkes, William J. Evans, Nicholas Hoeh, Frederick Sundram, Lisa Reynolds, Rhys Ponton, Alana Cavadino, Todd Smith, Partha S. Roop, Nathan Allen, Binu Abeysinghe, Darren Svirskis, Anna Forsyth, Mahima Bansal, Suresh Muthukumaraswamy", "journal": "Pilot and Feasibility Studies", "publication_date": "2023-10-04", "publication_year": 2023, "doi": "10.1186/s40814-023-01399-8", "pubmed_id": "37798662", "openalex_id": "https://openalex.org/W4387372869", "source_url": "https://doi.org/10.1186/s40814-023-01399-8", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology,Microdosing,Clinical Trial,Randomized Controlled Trial,Observational Study,Healthy Volunteers,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37798662", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1186/s40814-023-01399-8", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37798662", "source_url": "https://doi.org/10.1186/s40814-023-01399-8", "doi": "10.1186/s40814-023-01399-8", "pmid": "37798662", "publication_date": "2023-10-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4755, "title": "Psilocybin shows promising results in subjects continuing to use an antidepressant", "authors": "", "journal": "The Brown University Psychopharmacology Update", "publication_date": "2023-10-03", "publication_year": 2023, "doi": "10.1002/pu.31089", "pubmed_id": null, "openalex_id": "https://openalex.org/W4387361294", "source_url": "http://dx.doi.org/10.1002/pu.31089", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Receptor Pharmacology,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1002/pu.31089", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1002/pu.31089", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/pu.31089", "source_url": "http://dx.doi.org/10.1002/pu.31089", "doi": "10.1002/pu.31089", "pmid": "", "publication_date": "2023-10-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4758, "title": "6.3 Psilocybin Therapy for the Treatment of Young Adults With Anorexia Nervosa: State of the Research", "authors": "Amanda E. Downey", "journal": "Journal of the American Academy of Child & Adolescent Psychiatry", "publication_date": "2023-09-30", "publication_year": 2023, "doi": "10.1016/j.jaac.2023.07.666", "pubmed_id": null, "openalex_id": "https://openalex.org/W4387494383", "source_url": "https://doi.org/10.1016/j.jaac.2023.07.666", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1016/j.jaac.2023.07.666", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.jaac.2023.07.666", "source_url": "https://doi.org/10.1016/j.jaac.2023.07.666", "doi": "10.1016/j.jaac.2023.07.666", "pmid": "", "publication_date": "2023-09-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1368, "title": "Exploring the Potential Utility of Psychedelic Therapy for Patients With Amyotrophic Lateral Sclerosis.", "authors": "Gold ND, Mallard AJ, Hermann JC, Zeifman RJ, Pagni BA, Bogenschutz MP, Ross S", "journal": "Journal of palliative medicine", "publication_date": "2023-09-30", "publication_year": 2023, "doi": "10.1089/jpm.2022.0604", "pubmed_id": "37167080", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37167080/", "substance_tags": "psilocybin", "topic_tags": "End-of-Life Distress,Mechanism of Action,Spirituality,Clinical Trial,Review Article,Animal Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:38", "bibtex": null, "source_record_id": "PMID:37167080", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37167080/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37167080", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37167080/", "doi": "10.1089/jpm.2022.0604", "pmid": "37167080", "publication_date": "2023-09-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1362, "title": "Use of Psychedelics for Pain: A Scoping Review.", "authors": "Goel A, Rai Y, Sivadas S, Diep C, Clarke H, Shanthanna H, Ladha KS.", "journal": null, "publication_date": "2023-09-30", "publication_year": 2023, "doi": "10.1097/aln.0000000000004673", "pubmed_id": "37698433", "openalex_id": null, "source_url": "https://doi.org/10.1097/aln.0000000000004673", "substance_tags": "psilocybin", "topic_tags": "Addiction,Chronic Pain,Headache / Migraine,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Adverse Events,Inflammation", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:37698433", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1097/aln.0000000000004673", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37698433", "source_url": "https://doi.org/10.1097/aln.0000000000004673", "doi": "10.1097/aln.0000000000004673", "pmid": "37698433", "publication_date": "2023-09-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1359, "title": "Predicting the Intensity of Psychedelic-Induced Mystical and Challenging Experience in a Healthy Population: An Exploratory Post-Hoc Analysis", "authors": "Kwonmok Ko, Ben Carter, Anthony J. Cleare, James Rucker", "journal": "Neuropsychiatric Disease and Treatment", "publication_date": "2023-09-30", "publication_year": 2023, "doi": "10.2147/ndt.s426193", "pubmed_id": "37818448", "openalex_id": "https://openalex.org/W4387389328", "source_url": "https://doi.org/10.2147/ndt.s426193", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Personality Change,Mystical Experience,Clinical Trial,Healthy Volunteers,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37818448", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.2147/ndt.s426193", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37818448", "source_url": "https://doi.org/10.2147/ndt.s426193", "doi": "10.2147/ndt.s426193", "pmid": "37818448", "publication_date": "2023-09-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1314, "title": "Perceptions of psychedelic-assisted therapy among Black Americans", "authors": "Sierra Carter, Grace Packard, Callan Coghlan, Jamilah R. George, Ashanti J. Brown, Terence H. W. Ching, Jacob Julian, Jessica L. Maples-Keller", "journal": "Journal of Mood and Anxiety Disorders", "publication_date": "2023-09-25", "publication_year": 2023, "doi": "10.1016/j.xjmad.2023.100023", "pubmed_id": "40656968", "openalex_id": "https://openalex.org/W4387063622", "source_url": "https://doi.org/10.1016/j.xjmad.2023.100023", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Receptor Pharmacology,Clinical Trial,Observational Study,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:40656968", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.xjmad.2023.100023", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40656968", "source_url": "https://doi.org/10.1016/j.xjmad.2023.100023", "doi": "10.1016/j.xjmad.2023.100023", "pmid": "40656968", "publication_date": "2023-09-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5704, "title": "Psilocybin-Assisted Therapy: A scoping review of participants’ and facilitators’ experiences in qualitative studies", "authors": "Schuitmaker Nicole", "journal": "Research, Society and Development", "publication_date": "2023-09-22", "publication_year": 2023, "doi": "10.33448/rsd-v12i9.43308", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.33448/rsd-v12i9.43308", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-11 19:28:11", "last_checked": "2026-07-11 19:28:11", "bibtex": null, "source_record_id": "DOI:10.33448/rsd-v12i9.43308", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.33448/rsd-v12i9.43308", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.33448/rsd-v12i9.43308", "source_url": "https://doi.org/10.33448/rsd-v12i9.43308", "doi": "10.33448/rsd-v12i9.43308", "pmid": "", "publication_date": "2023-09-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4764, "title": "Expectancies for Subjective and Antidepressant Effects in Psilocybin Users", "authors": "Mitch Earleywine, Maha N. Mian, Joseph A. De Leo", "journal": "Journal of Humanistic Psychology", "publication_date": "2023-09-21", "publication_year": 2023, "doi": "10.1177/00221678231194798", "pubmed_id": null, "openalex_id": "https://openalex.org/W4386958768", "source_url": "https://doi.org/10.1177/00221678231194798", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Wellbeing,Emotional Processing,Mystical Experience,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1177/00221678231194798", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/00221678231194798", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/00221678231194798", "source_url": "https://doi.org/10.1177/00221678231194798", "doi": "10.1177/00221678231194798", "pmid": "", "publication_date": "2023-09-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3573, "title": "Phase II, Randomized, Double Blind, Placebo Controlled, Parallel Group, Single Center Study of Psilocybin Efficacy and Mechanism in Alcohol Use Disorder", "authors": "University of Zurich", "journal": "ClinicalTrials.gov", "publication_date": "2023-09-20", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04141501", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Receptor Pharmacology,Aging,Emotional Processing,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04141501", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04141501", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04141501", "source_url": "https://clinicaltrials.gov/study/NCT04141501", "doi": "", "pmid": "", "publication_date": "2023-09-20", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1373, "title": "Nature-themed video intervention may improve cardiovascular safety of psilocybin-assisted therapy for alcohol use disorder", "authors": "Keith G. Heinzerling, Karina Sergi, Micah Linton, Rhianna Rich, Brittany Youssef, Inez Bentancourt, Jennifer E. Bramen, Prabha Siddarth, L. Schwartzberg, Daniel F. Kelly", "journal": "Frontiers in Psychiatry", "publication_date": "2023-09-17", "publication_year": 2023, "doi": "10.3389/fpsyt.2023.1215972", "pubmed_id": "37795513", "openalex_id": "https://openalex.org/W4386849390", "source_url": "https://doi.org/10.3389/fpsyt.2023.1215972", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Addiction,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37795513", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2023.1215972", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37795513", "source_url": "https://doi.org/10.3389/fpsyt.2023.1215972", "doi": "10.3389/fpsyt.2023.1215972", "pmid": "37795513", "publication_date": "2023-09-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1201, "title": "American Psychiatrists' Opinions About Classic Hallucinogens and Their Potential Therapeutic Applications: A7-Year Follow-Up Survey", "authors": "Brian S. Barnett, Miranda Arakelian, David S. Beebe, Jared Ontko, Connor Riegal, Willie O. Siu, Jeremy Weleff, Harrison G. Pope", "journal": "Psychedelic Medicine", "publication_date": "2023-09-17", "publication_year": 2023, "doi": "10.1089/psymed.2023.0036", "pubmed_id": "40051760", "openalex_id": "https://openalex.org/W4386824127", "source_url": "https://doi.org/10.1089/psymed.2023.0036", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Chronic Pain,Clinical Trial,Observational Study,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:40051760", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1089/psymed.2023.0036", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40051760", "source_url": "https://doi.org/10.1089/psymed.2023.0036", "doi": "10.1089/psymed.2023.0036", "pmid": "40051760", "publication_date": "2023-09-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4769, "title": "The psychedelic experience and treatment-resistant depression", "authors": "Guy M. Goodwin", "journal": "World Psychiatry", "publication_date": "2023-09-14", "publication_year": 2023, "doi": "10.1002/wps.21140", "pubmed_id": "37713542", "openalex_id": "https://openalex.org/W4386765441", "source_url": "http://dx.doi.org/10.1002/wps.21140", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Consciousness,Personality Change,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Review Article,Healthy Volunteers,Treatment-Resistant Depression,Safety,Adverse Events,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37713542", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1002/wps.21140", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37713542", "source_url": "http://dx.doi.org/10.1002/wps.21140", "doi": "10.1002/wps.21140", "pmid": "37713542", "publication_date": "2023-09-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1358, "title": "Tryptamines and Mental Health: Activating the 5-HT Receptor for Therapeutic Potential.", "authors": "Kargbo RB.", "journal": null, "publication_date": "2023-09-14", "publication_year": 2023, "doi": "10.1021/acsmedchemlett.3c00390", "pubmed_id": "37849550", "openalex_id": null, "source_url": "https://doi.org/10.1021/acsmedchemlett.3c00390", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Receptor Pharmacology,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:37849550", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1021/acsmedchemlett.3c00390", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37849550", "source_url": "https://doi.org/10.1021/acsmedchemlett.3c00390", "doi": "10.1021/acsmedchemlett.3c00390", "pmid": "37849550", "publication_date": "2023-09-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3543, "title": "Phase 1, Open-Label, One-Treatment, Single-Dose, One-Period, Pharmacokinetic Study of Psilocin 4 mg as Its Mucic Acid Salt (L-130) Form, in Healthy Subjects Under Fasted Conditions", "authors": "Lobe Sciences Ltd.", "journal": "ClinicalTrials.gov", "publication_date": "2023-09-12", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06035900", "substance_tags": "psilocybin,psilocin", "topic_tags": "Addiction,Pharmacology,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06035900", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06035900", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06035900", "source_url": "https://clinicaltrials.gov/study/NCT06035900", "doi": "", "pmid": "", "publication_date": "2023-09-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4775, "title": "Classic Psychedelics for the Treatment of Depressive Disorders: An Update for Psychiatrists in Training", "authors": "Lawrence Canale, Dhvanit Raval, Preet Chatha, Katie Penn, Claudia Weber, Catherine Stout, Jeremy Weleff", "journal": "American Journal of Psychiatry Residents Journal", "publication_date": "2023-09-07", "publication_year": 2023, "doi": "10.1176/appi.ajp-rj.2023.190103", "pubmed_id": null, "openalex_id": "https://openalex.org/W4386544759", "source_url": "http://dx.doi.org/10.1176/appi.ajp-rj.2023.190103", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology,Clinical Trial,Treatment-Resistant Depression,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1176/appi.ajp-rj.2023.190103", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1176/appi.ajp-rj.2023.190103", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.ajp-rj.2023.190103", "source_url": "http://dx.doi.org/10.1176/appi.ajp-rj.2023.190103", "doi": "10.1176/appi.ajp-rj.2023.190103", "pmid": "", "publication_date": "2023-09-07", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1364, "title": "Psychedelic-Assisted Therapy in Military and Veterans Healthcare Systems: Clinical, Legal, and Implementation Considerations.", "authors": "Wolfgang AS, Hoge CW.", "journal": null, "publication_date": "2023-09-07", "publication_year": 2023, "doi": "10.1007/s11920-023-01446-4", "pubmed_id": "37682446", "openalex_id": null, "source_url": "https://doi.org/10.1007/s11920-023-01446-4", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Mechanism of Action,Clinical Trial,Review Article,Veterans,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:37682446", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s11920-023-01446-4", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37682446", "source_url": "https://doi.org/10.1007/s11920-023-01446-4", "doi": "10.1007/s11920-023-01446-4", "pmid": "37682446", "publication_date": "2023-09-07", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1309, "title": "Psilocybin-Assisted Cognitive Behavioral Therapy for Adults with Major Depressive Disorder: Rationale and Treatment Development", "authors": "Marc J. Weintraub, Jessica Jeffrey, Charles S. Grob, Megan Ichinose, R. Lindsey Bergman, Ziva D. Cooper, David J. Miklowitz", "journal": "Psychedelic Medicine", "publication_date": "2023-09-05", "publication_year": 2023, "doi": "10.1089/psymed.2023.0018", "pubmed_id": "40046861", "openalex_id": "https://openalex.org/W4386469528", "source_url": "https://doi.org/10.1089/psymed.2023.0018", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Mechanism of Action,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:40046861", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1089/psymed.2023.0018", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40046861", "source_url": "https://doi.org/10.1089/psymed.2023.0018", "doi": "10.1089/psymed.2023.0018", "pmid": "40046861", "publication_date": "2023-09-05", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1375, "title": "Psychedelic Use Among Psychiatric Medication Prescribers: Effects on Well-Being, Depression, Anxiety, and Associations with Patterns of Use, Reported Harms, and Transformative Mental States.", "authors": "Herrmann Z, Levin AW, Cole SP, Slabaugh S, Barnett B, Penn A, Jain R, Raison C, Rajanna B, Jain S", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2023-08-31", "publication_year": 2023, "doi": "10.1089/psymed.2023.0030", "pubmed_id": "40046570", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40046570/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Wellbeing,Resilience,Mystical Experience,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:38", "bibtex": null, "source_record_id": "PMID:40046570", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40046570/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40046570", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40046570/", "doi": "10.1089/psymed.2023.0030", "pmid": "40046570", "publication_date": "2023-08-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1435, "title": "Adapting psychedelic medicine for headache and chronic pain disorders", "authors": "Emmanuelle A. D. Schindler, Peter S. Hendricks", "journal": "Expert Review of Neurotherapeutics", "publication_date": "2023-08-30", "publication_year": 2023, "doi": "10.1080/14737175.2023.2246655", "pubmed_id": "37652000", "openalex_id": "https://openalex.org/W4386317658", "source_url": "https://doi.org/10.1080/14737175.2023.2246655", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Chronic Pain,Headache / Migraine,Mechanism of Action,Clinical Trial,Review Article,Case Report,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37652000", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/14737175.2023.2246655", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37652000", "source_url": "https://doi.org/10.1080/14737175.2023.2246655", "doi": "10.1080/14737175.2023.2246655", "pmid": "37652000", "publication_date": "2023-08-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1387, "title": "Psilocybin history, action and reaction: A narrative clinical review.", "authors": "Sharma P, Nguyen QA, Matthews SJ, Carpenter E, Mathews DB, Patten CA, Hammond CJ.", "journal": null, "publication_date": "2023-08-30", "publication_year": 2023, "doi": "10.1177/02698811231190858", "pubmed_id": "37650489", "openalex_id": null, "source_url": "https://doi.org/10.1177/02698811231190858", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Mechanism of Action,Clinical Trial,Review Article,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:37650489", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02698811231190858", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37650489", "source_url": "https://doi.org/10.1177/02698811231190858", "doi": "10.1177/02698811231190858", "pmid": "37650489", "publication_date": "2023-08-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1379, "title": "Single-Dose Psilocybin Treatment for Major Depressive Disorder", "authors": "Charles L. Raison, Gerard Sanacora, Joshua Woolley, Keith G. Heinzerling, Boadie W. Dunlop, Randall Brown, Rishi Kakar, Michael Hassman, Rupal Trivedi, Reid Robison, Natalie Gukasyan, Sandeep M. Nayak, Xiaojue Hu, Kelley C. O’Donnell, Benjamin Kelmendi, Jordan Sloshower, Andrew Penn, Ellen Bradley, Daniel F. Kelly, Tanja Mletzko, Christopher R. Nicholas, Paul R. Hutson, Gary Tarpley, Malynn Utzinger, Kelsey Lenoch, Kasia Warchol, Theraysa Gapasin, Mike C. Davis, Courtney Nelson-Douthit, Steffanie H Wilson, Carrie Brown, William Linton, Matthew W. Johnson, Stephen Ross, Roland R. Griffiths", "journal": "JAMA", "publication_date": "2023-08-30", "publication_year": 2023, "doi": "10.1001/jama.2023.14530", "pubmed_id": "37651119", "openalex_id": "https://openalex.org/W4386305655", "source_url": "https://doi.org/10.1001/jama.2023.14530", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Clinical Trial,Safety,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37651119", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1001/jama.2023.14530", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37651119", "source_url": "https://doi.org/10.1001/jama.2023.14530", "doi": "10.1001/jama.2023.14530", "pmid": "37651119", "publication_date": "2023-08-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1246, "title": "The changing outlook of psychedelic drugs: The importance of risk assessment and occupational exposure limits", "authors": "Natália Bernardi Videira, Vijayalekshmi Nair, Valérie Paquet, Dean Calhoun", "journal": "Journal of Applied Toxicology", "publication_date": "2023-08-29", "publication_year": 2023, "doi": "10.1002/jat.4533", "pubmed_id": "37646119", "openalex_id": "https://openalex.org/W4386272089", "source_url": "https://doi.org/10.1002/jat.4533", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Clinical Trial,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37646119", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/jat.4533", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37646119", "source_url": "https://doi.org/10.1002/jat.4533", "doi": "10.1002/jat.4533", "pmid": "37646119", "publication_date": "2023-08-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1327, "title": "Developing a Direct Observation Measure of Therapeutic Connection in Psilocybin-Assisted Therapy: A Feasibility Study", "authors": "Robert Gramling, Emily Bennett, Keith Curtis, William A. Richards, Donna M. Rizzo, Francesca Arnoldy, Logan P Hegg, Jon Porter, Heather Honstein, Susanna Pratt, Elise C. Tarbi, Maija Reblin, Paul Thambi, Manish Agrawal", "journal": "Journal of Palliative Medicine", "publication_date": "2023-08-16", "publication_year": 2023, "doi": "10.1089/jpm.2023.0189", "pubmed_id": "37590474", "openalex_id": "https://openalex.org/W4385932674", "source_url": "https://doi.org/10.1089/jpm.2023.0189", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Consciousness,Clinical Trial,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37590474", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1089/jpm.2023.0189", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37590474", "source_url": "https://doi.org/10.1089/jpm.2023.0189", "doi": "10.1089/jpm.2023.0189", "pmid": "37590474", "publication_date": "2023-08-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4786, "title": "Australia Legalizes Psychedelics for Use in Depression, PTSD Therapy", "authors": "Nick Zagorski", "journal": "Psychiatric News", "publication_date": "2023-08-14", "publication_year": 2023, "doi": "10.1176/appi.pn.2023.09.9.20", "pubmed_id": null, "openalex_id": "https://openalex.org/W4385829163", "source_url": "https://doi.org/10.1176/appi.pn.2023.09.9.20", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Mechanism of Action,Consciousness,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2023.09.9.20", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2023.09.9.20", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2023.09.9.20", "source_url": "https://doi.org/10.1176/appi.pn.2023.09.9.20", "doi": "10.1176/appi.pn.2023.09.9.20", "pmid": "", "publication_date": "2023-08-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3618, "title": "A Phase 1, Two-Part Study in Healthy Volunteers to Evaluate The Effect of Psilocybin on Cardiac Repolarization and The Effect of Food on Psilocybin Pharmacokinetics", "authors": "Usona Institute", "journal": "ClinicalTrials.gov", "publication_date": "2023-08-14", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05478278", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Clinical Trial,Healthy Volunteers", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05478278", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05478278", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05478278", "source_url": "https://clinicaltrials.gov/study/NCT05478278", "doi": "", "pmid": "", "publication_date": "2023-08-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4788, "title": "Psilocybin's Emerging Role in Combating Depressive Disorder", "authors": "Anna Jaremek, Joanna Kępa, Norbert Kandefer, Michał Wyszkowski, Aleksandra Grabarczyk, Anna Pawlak, Sylwia Grad, Małgorzata Gregorek, Paweł Gregorek", "journal": "Journal of Education Health and Sport", "publication_date": "2023-08-07", "publication_year": 2023, "doi": "10.12775/jehs.2023.40.01.011", "pubmed_id": null, "openalex_id": "https://openalex.org/W4385658334", "source_url": "https://doi.org/10.12775/jehs.2023.40.01.011", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Neurogenesis,Mechanism of Action,Default Mode Network,Aging,Emotional Processing,Clinical Trial,Review Article,Animal Study,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.12775/jehs.2023.40.01.011", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.12775/jehs.2023.40.01.011", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.12775/jehs.2023.40.01.011", "source_url": "https://doi.org/10.12775/jehs.2023.40.01.011", "doi": "10.12775/jehs.2023.40.01.011", "pmid": "", "publication_date": "2023-08-07", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1349, "title": "“But the reality is it's happening”: A qualitative study of eating disorder providers about psilocybin-assisted psychotherapy", "authors": "Amanda E. Downey, Maxine Boyd, Anita V. Chaphekar, Joshua Woolley, Marissa Raymond-Flesch", "journal": "International Journal of Eating Disorders", "publication_date": "2023-08-07", "publication_year": 2023, "doi": "10.1002/eat.24041", "pubmed_id": "37551650", "openalex_id": "https://openalex.org/W4385664009", "source_url": "https://doi.org/10.1002/eat.24041", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Chronic Pain,Clinical Trial,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37551650", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/eat.24041", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37551650", "source_url": "https://doi.org/10.1002/eat.24041", "doi": "10.1002/eat.24041", "pmid": "37551650", "publication_date": "2023-08-07", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1389, "title": "The Potential of Psychedelics for the Treatment of Episodic Migraine.", "authors": "Schindler EAD.", "journal": null, "publication_date": "2023-08-03", "publication_year": 2023, "doi": "10.1007/s11916-023-01145-y", "pubmed_id": "37540398", "openalex_id": null, "source_url": "https://doi.org/10.1007/s11916-023-01145-y", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Headache / Migraine,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:37540398", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s11916-023-01145-y", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37540398", "source_url": "https://doi.org/10.1007/s11916-023-01145-y", "doi": "10.1007/s11916-023-01145-y", "pmid": "37540398", "publication_date": "2023-08-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1420, "title": "Psychedelic medicines for end-of-life care: Pipeline clinical trial review 2022.", "authors": "Jing X, Hoeh NR, Menkes DB.", "journal": null, "publication_date": "2023-07-31", "publication_year": 2023, "doi": "10.1017/s147895152300069x", "pubmed_id": "37334486", "openalex_id": null, "source_url": "https://doi.org/10.1017/s147895152300069x", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Microdosing,Clinical Trial,Randomized Controlled Trial,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:37334486", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1017/s147895152300069x", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37334486", "source_url": "https://doi.org/10.1017/s147895152300069x", "doi": "10.1017/s147895152300069x", "pmid": "37334486", "publication_date": "2023-07-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1413, "title": "Psychedelic drugs in the treatment of psychiatric disorders.", "authors": "Ibrahim IB, Videbech P, Straszek SPV.", "journal": null, "publication_date": "2023-07-31", "publication_year": 2023, "doi": null, "pubmed_id": "37615227", "openalex_id": null, "source_url": "https://europepmc.org/article/MED/37615227", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Clinical Trial,Randomized Controlled Trial,Review Article,Cancer Patients,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:37615227", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/MED/37615227", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37615227", "source_url": "https://europepmc.org/article/MED/37615227", "doi": "", "pmid": "37615227", "publication_date": "2023-07-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4791, "title": "Med Check: FDA, Anti-Amyloid Beta Vaccine, Clinical Trials of Psychedelics, and Lumryz", "authors": "Terri D’Arrigo", "journal": "Psychiatric News", "publication_date": "2023-07-26", "publication_year": 2023, "doi": "10.1176/appi.pn.2023.08.8.3", "pubmed_id": null, "openalex_id": "https://openalex.org/W4385324763", "source_url": "https://doi.org/10.1176/appi.pn.2023.08.8.3", "substance_tags": "psilocybin", "topic_tags": "Addiction,Receptor Pharmacology,Clinical Trial,Review Article,Observational Study,Safety,Immune Function", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2023.08.8.3", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2023.08.8.3", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2023.08.8.3", "source_url": "https://doi.org/10.1176/appi.pn.2023.08.8.3", "doi": "10.1176/appi.pn.2023.08.8.3", "pmid": "", "publication_date": "2023-07-26", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3519, "title": "The Efficacy and Tolerability of Psilocybin in Participants With Treatment-Resistant Depression: a Phase 2, Randomized Feasibility Study", "authors": "Brain and Cognition Discovery Foundation", "journal": "ClinicalTrials.gov", "publication_date": "2023-07-26", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05029466", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05029466", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05029466", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05029466", "source_url": "https://clinicaltrials.gov/study/NCT05029466", "doi": "", "pmid": "", "publication_date": "2023-07-26", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4792, "title": "Imprinting: expanding the extra-pharmacological model of psychedelic drug action to incorporate delayed influences of sets and settings", "authors": "Nicolas Garel, Julien Thibault Lévesque, Dasha A. Sandra, Justin Lessard-Wajcer, Elizaveta Solomonova, Michael Lifshitz, Stéphane Richard-Devantoy, Kyle T. Greenway", "journal": "Frontiers in Human Neuroscience", "publication_date": "2023-07-17", "publication_year": 2023, "doi": "10.3389/fnhum.2023.1200393", "pubmed_id": "37533588", "openalex_id": "https://openalex.org/W4384695430", "source_url": "https://doi.org/10.3389/fnhum.2023.1200393", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Mystical Experience,Clinical Trial,Review Article,Treatment-Resistant Depression,Healthcare Workers,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 06:34:45", "bibtex": null, "source_record_id": "PMID:37533588", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fnhum.2023.1200393", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37533588", "source_url": "https://doi.org/10.3389/fnhum.2023.1200393", "doi": "10.3389/fnhum.2023.1200393", "pmid": "37533588", "publication_date": "2023-07-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3422, "title": "A Systematic Review of Reporting Practices in Psychedelic Clinical Trials: Psychological Support, Therapy, and Psychosocial Interventions", "authors": "", "journal": "PsyArXiv", "publication_date": "2023-07-17", "publication_year": 2023, "doi": "10.1089/psymed.2023.00071", "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/2ab59_v1", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:04:24", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "DOI:10.1089/psymed.2023.00071", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/2ab59_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.1089/psymed.2023.00071", "source_url": "https://osf.io/preprints/psyarxiv/2ab59_v1", "doi": "10.1089/psymed.2023.00071", "pmid": "", "publication_date": "2023-07-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3380, "title": "A Systematic Review of Reporting Practices in Psychedelic Clinical Trials: Psychological Support, Therapy, and Psychosocial Interventions", "authors": "Brennan B, Kelman A, Belser AB.", "journal": "PsyArXiv", "publication_date": "2023-07-17", "publication_year": 2023, "doi": "10.31234/osf.io/2ab59", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/2ab59", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/2ab59", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/2ab59", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/2ab59", "source_url": "https://doi.org/10.31234/osf.io/2ab59", "doi": "10.31234/osf.io/2ab59", "pmid": "", "publication_date": "2023-07-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1393, "title": "Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication", "authors": "Guy M. Goodwin, Megan Croal, David Feifel, John R. Kelly, Lindsey Marwood, Sunil Mistry, Veronica O’Keane, Stéphanie Knatz Peck, Hollie Simmons, Claudia Sisa, S. C. Stansfield, Joyce Tsai, Sam Williams, Ekaterina Malievskaia", "journal": "Neuropsychopharmacology", "publication_date": "2023-07-12", "publication_year": 2023, "doi": "10.1038/s41386-023-01648-7", "pubmed_id": "37443386", "openalex_id": "https://openalex.org/W4384130479", "source_url": "https://doi.org/10.1038/s41386-023-01648-7", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37443386", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41386-023-01648-7", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37443386", "source_url": "https://doi.org/10.1038/s41386-023-01648-7", "doi": "10.1038/s41386-023-01648-7", "pmid": "37443386", "publication_date": "2023-07-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1438, "title": "Risk of bias in randomized clinical trials on psychedelic medicine: A systematic review.", "authors": "Hovmand OR, Poulsen ED, Arnfred S, Storebø OJ.", "journal": null, "publication_date": "2023-07-03", "publication_year": 2023, "doi": "10.1177/02698811231180276", "pubmed_id": "37403379", "openalex_id": null, "source_url": "https://doi.org/10.1177/02698811231180276", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Healthcare Workers,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:37403379", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02698811231180276", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37403379", "source_url": "https://doi.org/10.1177/02698811231180276", "doi": "10.1177/02698811231180276", "pmid": "37403379", "publication_date": "2023-07-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4799, "title": "Psychedelic drug psilocybin shows promise treating anorexia in early trials", "authors": "Grace Wade", "journal": "The New Scientist", "publication_date": "2023-06-30", "publication_year": 2023, "doi": "10.1016/s0262-4079(23)01394-5", "pubmed_id": null, "openalex_id": "https://openalex.org/W4385336292", "source_url": "https://doi.org/10.1016/s0262-4079(23)01394-5", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1016/s0262-4079(23)01394-5", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/s0262-4079(23)01394-5", "source_url": "https://doi.org/10.1016/s0262-4079(23)01394-5", "doi": "10.1016/s0262-4079(23)01394-5", "pmid": "", "publication_date": "2023-06-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1434, "title": "Assessing potential of psilocybin for depressive disorders.", "authors": "Kozak Z, Johnson MW, Aaronson ST.", "journal": null, "publication_date": "2023-06-30", "publication_year": 2023, "doi": "10.1080/13543784.2023.2273493", "pubmed_id": "37869790", "openalex_id": null, "source_url": "https://doi.org/10.1080/13543784.2023.2273493", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:37869790", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/13543784.2023.2273493", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37869790", "source_url": "https://doi.org/10.1080/13543784.2023.2273493", "doi": "10.1080/13543784.2023.2273493", "pmid": "37869790", "publication_date": "2023-06-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4801, "title": "FDA issues first draft guidance on psychedelic research", "authors": "Valerie A. Canady", "journal": "Mental Health Weekly", "publication_date": "2023-06-29", "publication_year": 2023, "doi": "10.1002/mhw.33697", "pubmed_id": null, "openalex_id": "https://openalex.org/W4382680172", "source_url": "http://dx.doi.org/10.1002/mhw.33697", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1002/mhw.33697", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1002/mhw.33697", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/mhw.33697", "source_url": "http://dx.doi.org/10.1002/mhw.33697", "doi": "10.1002/mhw.33697", "pmid": "", "publication_date": "2023-06-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3538, "title": "Investigating the Therapeutic Effects of Psilocybin in Treatment-Resistant Post-Traumatic Stress Disorder", "authors": "Halucenex Life Sciences Inc.", "journal": "ClinicalTrials.gov", "publication_date": "2023-06-28", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05243329", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Neuroplasticity,Neurogenesis,Receptor Pharmacology,Clinical Trial,Animal Study,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05243329", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05243329", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05243329", "source_url": "https://clinicaltrials.gov/study/NCT05243329", "doi": "", "pmid": "", "publication_date": "2023-06-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1456, "title": "Psychedelic Assisted Psychotherapy preparing your target using psychohistoriography: a Jamaican perspective", "authors": "Winston De La Haye, G Walcott, Jordan Eaton, Jhoelle Beckford, Janelle D. Greene", "journal": "Frontiers in Psychiatry", "publication_date": "2023-06-28", "publication_year": 2023, "doi": "10.3389/fpsyt.2023.1136990", "pubmed_id": "37457761", "openalex_id": "https://openalex.org/W4382602456", "source_url": "https://doi.org/10.3389/fpsyt.2023.1136990", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Personality Change,Mystical Experience,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37457761", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2023.1136990", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37457761", "source_url": "https://doi.org/10.3389/fpsyt.2023.1136990", "doi": "10.3389/fpsyt.2023.1136990", "pmid": "37457761", "publication_date": "2023-06-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4803, "title": "Experts Offer Tips on Talking With Patients About Psychedelics", "authors": "Terri D’Arrigo", "journal": "Psychiatric News", "publication_date": "2023-06-27", "publication_year": 2023, "doi": "10.1176/appi.pn.2023.07.7.51", "pubmed_id": null, "openalex_id": "https://openalex.org/W4382360061", "source_url": "https://doi.org/10.1176/appi.pn.2023.07.7.51", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Clinical Trial,Veterans,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2023.07.7.51", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2023.07.7.51", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2023.07.7.51", "source_url": "https://doi.org/10.1176/appi.pn.2023.07.7.51", "doi": "10.1176/appi.pn.2023.07.7.51", "pmid": "", "publication_date": "2023-06-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1296, "title": "Psilocybin-assisted psychotherapy as a potential treatment for eating disorders: a narrative review of preliminary evidence.", "authors": "Koning E, Brietzke E.", "journal": null, "publication_date": "2023-06-05", "publication_year": 2023, "doi": "10.47626/2237-6089-2022-0597", "pubmed_id": "37126863", "openalex_id": null, "source_url": "https://doi.org/10.47626/2237-6089-2022-0597", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Emotional Processing,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:37126863", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.47626/2237-6089-2022-0597", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37126863", "source_url": "https://doi.org/10.47626/2237-6089-2022-0597", "doi": "10.47626/2237-6089-2022-0597", "pmid": "37126863", "publication_date": "2023-06-05", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4808, "title": "Psilocybin therapy: A novel approach to treating depression", "authors": "Tooba Noor, Areej Shakil, Aimen Waqar Khan, Syeda Mahrukh Fatima Zaidi, Hussain Sohail Rangwala, Burhanuddin Sohail Rangwala", "journal": "International Journal of Surgery Global Health", "publication_date": "2023-06-01", "publication_year": 2023, "doi": "10.1097/gh9.0000000000000175", "pubmed_id": null, "openalex_id": "https://openalex.org/W4379142909", "source_url": "http://dx.doi.org/10.1097/gh9.0000000000000175", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,Headache / Migraine,Brain Imaging,Pharmacology,Receptor Pharmacology,Default Mode Network,Consciousness,Aging,Wellbeing,Emotional Processing,Clinical Trial,Review Article,Adolescents,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1097/gh9.0000000000000175", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1097/gh9.0000000000000175", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1097/gh9.0000000000000175", "source_url": "http://dx.doi.org/10.1097/gh9.0000000000000175", "doi": "10.1097/gh9.0000000000000175", "pmid": "", "publication_date": "2023-06-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1295, "title": "Personality change in a trial of psilocybin therapy v. escitalopram treatment for depression", "authors": "Brandon Weiss, Induni Ginige, Lu Shannon, Bruna Giribaldi, Ashleigh Murphy-Beiner, Roberta Murphy, Michelle Baker-Jones, Jonny Martell, David Nutt, Robin Carhart-Harris, David Erritzøe", "journal": "Psychological Medicine", "publication_date": "2023-06-01", "publication_year": 2023, "doi": "10.1017/s0033291723001514", "pubmed_id": "37264814", "openalex_id": "https://openalex.org/W4379093876", "source_url": "https://doi.org/10.1017/s0033291723001514", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Personality Change,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37264814", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1017/s0033291723001514", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37264814", "source_url": "https://doi.org/10.1017/s0033291723001514", "doi": "10.1017/s0033291723001514", "pmid": "37264814", "publication_date": "2023-06-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3373, "title": "Global species diversity and distribution of the psychedelic fungal genus Panaeolus", "authors": "Strauss D, Ghosh S, Murray Z, Gryzenhout M.", "journal": null, "publication_date": "2023-05-31", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/AGR/IND608043020", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "https://europepmc.org/article/AGR/IND608043020", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/AGR/IND608043020", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/AGR/IND608043020", "source_url": "https://europepmc.org/article/AGR/IND608043020", "doi": "", "pmid": "", "publication_date": "2023-05-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1466, "title": "Examining the Rationale for Studying Psychedelic-Assisted Psychotherapy for the Treatment of Caregiver Distress.", "authors": "Gold ND, Podrebarac SK, White LA, Marini C, Simon NM, Mittelman MS, Ross S, Bogenschutz MP, Petridis PD", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2023-05-31", "publication_year": 2023, "doi": "10.1089/psymed.2022.0011", "pubmed_id": "40046728", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40046728/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Spirituality,Clinical Trial,Review Article,Cancer Patients,Safety,Inflammation", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:38", "bibtex": null, "source_record_id": "PMID:40046728", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40046728/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40046728", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40046728/", "doi": "10.1089/psymed.2022.0011", "pmid": "40046728", "publication_date": "2023-05-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1194, "title": "Ethical considerations for psychedelic-assisted therapy in military clinical settings", "authors": "Scott Hoener, Aaron Wolfgang, David A. Nissan, Edmund G. Howe", "journal": "Journal of Medical Ethics", "publication_date": "2023-05-29", "publication_year": 2023, "doi": "10.1136/jme-2023-108943", "pubmed_id": "37253556", "openalex_id": "https://openalex.org/W4378782490", "source_url": "http://dx.doi.org/10.1136/jme-2023-108943", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37253556", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1136/jme-2023-108943", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37253556", "source_url": "http://dx.doi.org/10.1136/jme-2023-108943", "doi": "10.1136/jme-2023-108943", "pmid": "37253556", "publication_date": "2023-05-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1186, "title": "Evidence versus expectancy: the development of psilocybin therapy", "authors": "James Rucker", "journal": "BJPsych Bulletin", "publication_date": "2023-05-28", "publication_year": 2023, "doi": "10.1192/bjb.2023.28", "pubmed_id": "37246405", "openalex_id": "https://openalex.org/W4378640469", "source_url": "https://doi.org/10.1192/bjb.2023.28", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37246405", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1192/bjb.2023.28", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37246405", "source_url": "https://doi.org/10.1192/bjb.2023.28", "doi": "10.1192/bjb.2023.28", "pmid": "37246405", "publication_date": "2023-05-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1374, "title": "Psychedelics: Threshold of a Therapeutic Revolution.", "authors": "Heal DJ, Smith SL, Belouin SJ, Henningfield JE.", "journal": null, "publication_date": "2023-05-26", "publication_year": 2023, "doi": "10.1016/j.neuropharm.2023.109610", "pubmed_id": "37247807", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.neuropharm.2023.109610", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Eating Disorders,Chronic Pain,Pharmacology,Clinical Trial,Review Article,Cancer Patients,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:37247807", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.neuropharm.2023.109610", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37247807", "source_url": "https://doi.org/10.1016/j.neuropharm.2023.109610", "doi": "10.1016/j.neuropharm.2023.109610", "pmid": "37247807", "publication_date": "2023-05-26", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3219, "title": "Bridging the translational neuroscience gap: Development of the ‘shiftability’ paradigm and an exemplar protocol to capture psilocybin-elicited ‘shift’ in neurobiological mechanisms in autism", "authors": "Whelan TP, Daly E, Puts NA, Malievskaia E, Murphy DG, McAlonan GM.", "journal": "medRxiv", "publication_date": "2023-05-25", "publication_year": 2023, "doi": "10.1101/2023.05.25.23290521", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2023.05.25.23290521", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Receptor Pharmacology,Biomarkers,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "DOI:10.1101/2023.05.25.23290521", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2023.05.25.23290521", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2023.05.25.23290521", "source_url": "https://doi.org/10.1101/2023.05.25.23290521", "doi": "10.1101/2023.05.25.23290521", "pmid": "", "publication_date": "2023-05-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1480, "title": "Acute psilocybin increased cortical activities in rats", "authors": "Junhong Liu, Yuanyuan Wang, Ke Xia, Jinfeng Wu, Danhao Zheng, Aoling Cai, Haitao Yan, Ruibin Su", "journal": "Frontiers in Neuroscience", "publication_date": "2023-05-22", "publication_year": 2023, "doi": "10.3389/fnins.2023.1168911", "pubmed_id": "37287797", "openalex_id": "https://openalex.org/W4378084778", "source_url": "https://doi.org/10.3389/fnins.2023.1168911", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37287797", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fnins.2023.1168911", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37287797", "source_url": "https://doi.org/10.3389/fnins.2023.1168911", "doi": "10.3389/fnins.2023.1168911", "pmid": "37287797", "publication_date": "2023-05-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3683, "title": "Recall of Experience and Conscious Awareness in Psilocybin Treatment of Depression (The RECAP Study): Pilot Phase in Healthy Adult Volunteers", "authors": "University of Wisconsin, Madison", "journal": "ClinicalTrials.gov", "publication_date": "2023-05-18", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04842045", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Clinical Trial,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04842045", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04842045", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04842045", "source_url": "https://clinicaltrials.gov/study/NCT04842045", "doi": "", "pmid": "", "publication_date": "2023-05-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1126, "title": "[Psilocybin-Assisted Treatment of Depression, Anxiety and Substance use Disorders: Neurobiological Basis and Clinical Application].", "authors": "Lasch A, Schweikert T, Dora E, Kolb T, Schurig HL, Walther A.", "journal": null, "publication_date": "2023-05-18", "publication_year": 2023, "doi": "10.1055/a-2046-5202", "pubmed_id": "37207669", "openalex_id": null, "source_url": "https://doi.org/10.1055/a-2046-5202", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Mechanism of Action,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:37207669", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1055/a-2046-5202", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37207669", "source_url": "https://doi.org/10.1055/a-2046-5202", "doi": "10.1055/a-2046-5202", "pmid": "37207669", "publication_date": "2023-05-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3063, "title": "Novel psilocin prodrugs with altered pharmacological properties as candidate therapies for treatment-resistant anxiety disorders", "authors": "Raithatha SA, Hagel JM, Matinkhoo K, Yu L, Press D, Cook SG, Sharma G, D D, Jensen G, Lee JB, Cai C, Gallant J, Bains JS, Tucker JE, Facchini PJ.", "journal": "bioRxiv", "publication_date": "2023-05-17", "publication_year": 2023, "doi": "10.1101/2023.05.16.540994", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2023.05.16.540994", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Pharmacology,Receptor Pharmacology,Biomarkers,Clinical Trial,Animal Study,In Vitro Study,Cancer Patients,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.1101/2023.05.16.540994", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2023.05.16.540994", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2023.05.16.540994", "source_url": "https://doi.org/10.1101/2023.05.16.540994", "doi": "10.1101/2023.05.16.540994", "pmid": "", "publication_date": "2023-05-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1472, "title": "Global species diversity and distribution of the psychedelic fungal genus Panaeolus.", "authors": "Strauss D, Ghosh S, Murray Z, Gryzenhout M.", "journal": null, "publication_date": "2023-05-17", "publication_year": 2023, "doi": "10.1016/j.heliyon.2023.e16338", "pubmed_id": "37274634", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.heliyon.2023.e16338", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:37274634", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.heliyon.2023.e16338", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37274634", "source_url": "https://doi.org/10.1016/j.heliyon.2023.e16338", "doi": "10.1016/j.heliyon.2023.e16338", "pmid": "37274634", "publication_date": "2023-05-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3634, "title": "A Phase 1 Study Comparing the Pharmacokinetics and Safety of Intravenous and Oral Psilocybin", "authors": "University of Wisconsin, Madison", "journal": "ClinicalTrials.gov", "publication_date": "2023-05-14", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05467761", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,Pharmacology,Clinical Trial,Cancer Patients,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05467761", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05467761", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05467761", "source_url": "https://clinicaltrials.gov/study/NCT05467761", "doi": "", "pmid": "", "publication_date": "2023-05-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1497, "title": "Unblinding and demand characteristics in the treatment of depression.", "authors": "Goodwin GM, Croal M, Marwood L, Malievskaia E", "journal": "Journal of affective disorders", "publication_date": "2023-04-30", "publication_year": 2023, "doi": "10.1016/j.jad.2023.02.030", "pubmed_id": "36781142", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36781142/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:38", "bibtex": null, "source_record_id": "PMID:36781142", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36781142/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36781142", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36781142/", "doi": "10.1016/j.jad.2023.02.030", "pmid": "36781142", "publication_date": "2023-04-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1491, "title": "Study protocol of an open-label proof-of-concept trial examining the safety and clinical efficacy of psilocybin-assisted therapy for veterans with PTSD", "authors": "Alan K. Davis, Adam W. Levin, Paul Nagib, Stacey B. Armstrong, Rafael Lancelotta", "journal": "BMJ Open", "publication_date": "2023-04-30", "publication_year": 2023, "doi": "10.1136/bmjopen-2022-068884", "pubmed_id": "37142308", "openalex_id": "https://openalex.org/W4372336620", "source_url": "https://doi.org/10.1136/bmjopen-2022-068884", "substance_tags": "psilocybin", "topic_tags": "Anxiety,PTSD,Chronic Pain,Clinical Trial,Review Article,Veterans,Healthcare Workers,Safety,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37142308", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1136/bmjopen-2022-068884", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37142308", "source_url": "https://doi.org/10.1136/bmjopen-2022-068884", "doi": "10.1136/bmjopen-2022-068884", "pmid": "37142308", "publication_date": "2023-04-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1449, "title": "A critical evaluation of QIDS-SR-16 using data from a trial of psilocybin therapy versus escitalopram treatment for depression", "authors": "Brandon Weiss, David Erritzøe, Bruna Giribaldi, David Nutt, Robin Carhart-Harris", "journal": "Journal of Psychopharmacology", "publication_date": "2023-04-24", "publication_year": 2023, "doi": "10.1177/02698811231167848", "pubmed_id": "37122239", "openalex_id": "https://openalex.org/W4367053025", "source_url": "https://doi.org/10.1177/02698811231167848", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Clinical Trial,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37122239", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/02698811231167848", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37122239", "source_url": "https://doi.org/10.1177/02698811231167848", "doi": "10.1177/02698811231167848", "pmid": "37122239", "publication_date": "2023-04-24", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3176, "title": "A Phase I trial to inform clinical protocols for the safe administration of psilocybin-assisted psychotherapy", "authors": "Bennett JN, Blough MD, Mitchell I, Galloway L, Bains R.", "journal": "medRxiv", "publication_date": "2023-04-18", "publication_year": 2023, "doi": "10.1101/2023.04.12.23288325", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2023.04.12.23288325", "substance_tags": "psilocybin", "topic_tags": "Mystical Experience,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "DOI:10.1101/2023.04.12.23288325", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2023.04.12.23288325", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2023.04.12.23288325", "source_url": "https://doi.org/10.1101/2023.04.12.23288325", "doi": "10.1101/2023.04.12.23288325", "pmid": "", "publication_date": "2023-04-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4826, "title": "Psychedelic Medicine: From Brain Science to Clinical Trials", "authors": "David Nutt", "journal": "Biological Psychiatry", "publication_date": "2023-04-09", "publication_year": 2023, "doi": "10.1016/j.biopsych.2023.02.022", "pubmed_id": null, "openalex_id": "https://openalex.org/W4363673488", "source_url": "http://dx.doi.org/10.1016/j.biopsych.2023.02.022", "substance_tags": "psilocybin", "topic_tags": "Addiction,Brain Imaging,Receptor Pharmacology,Default Mode Network,Aging,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-07-04 06:34:46", "bibtex": null, "source_record_id": "DOI:10.1016/j.biopsych.2023.02.022", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.biopsych.2023.02.022", "source_url": "http://dx.doi.org/10.1016/j.biopsych.2023.02.022", "doi": "10.1016/j.biopsych.2023.02.022", "pmid": "", "publication_date": "2023-04-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1506, "title": "Use of Selective Alternative Therapies for Treatment of OCD.", "authors": "Khan I, Jaura TA, Tukruna A, Arif A, Tebha SS, Nasir S, Mukherjee D, Masroor N, Yosufi A.", "journal": null, "publication_date": "2023-04-04", "publication_year": 2023, "doi": "10.2147/ndt.s403997", "pubmed_id": "37041856", "openalex_id": null, "source_url": "https://doi.org/10.2147/ndt.s403997", "substance_tags": "psilocybin", "topic_tags": "OCD,Mechanism of Action,Clinical Trial,Systematic Review,Review Article,Observational Study,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:37041856", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.2147/ndt.s403997", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37041856", "source_url": "https://doi.org/10.2147/ndt.s403997", "doi": "10.2147/ndt.s403997", "pmid": "37041856", "publication_date": "2023-04-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1424, "title": "Are psychedelic medicines the reset for chronic pain? Preliminary findings and research needs.", "authors": "Zia FZ, Baumann MH, Belouin SJ, Dworkin RH, Ghauri MH, Hendricks PS, Henningfield JE, Lanier RK, Ross S, Berger A.", "journal": null, "publication_date": "2023-04-01", "publication_year": 2023, "doi": "10.1016/j.neuropharm.2023.109528", "pubmed_id": "37015315", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.neuropharm.2023.109528", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Chronic Pain,Pharmacology,Mechanism of Action,Spirituality,Clinical Trial,Safety,Adverse Events,Inflammation", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:37015315", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.neuropharm.2023.109528", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37015315", "source_url": "https://doi.org/10.1016/j.neuropharm.2023.109528", "doi": "10.1016/j.neuropharm.2023.109528", "pmid": "37015315", "publication_date": "2023-04-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1451, "title": "The need for establishing best practices and gold standards in psychedelic medicine.", "authors": "Feduccia A, Agin-Liebes G, Price CM, Grinsell N, Paradise S, Rabin DM.", "journal": null, "publication_date": "2023-03-29", "publication_year": 2023, "doi": "10.1016/j.jad.2023.03.083", "pubmed_id": "37003433", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jad.2023.03.083", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:37003433", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jad.2023.03.083", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37003433", "source_url": "https://doi.org/10.1016/j.jad.2023.03.083", "doi": "10.1016/j.jad.2023.03.083", "pmid": "37003433", "publication_date": "2023-03-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1526, "title": "Psychedelic Targeting of Metabotropic Glutamate Receptor 2 and Its Implications for the Treatment of Alcoholism.", "authors": "Domanegg K, Sommer WH, Meinhardt MW.", "journal": null, "publication_date": "2023-03-21", "publication_year": 2023, "doi": "10.3390/cells12060963", "pubmed_id": "36980303", "openalex_id": null, "source_url": "https://doi.org/10.3390/cells12060963", "substance_tags": "psilocybin", "topic_tags": "Addiction,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Aging,Epigenetics,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:36980303", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/cells12060963", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36980303", "source_url": "https://doi.org/10.3390/cells12060963", "doi": "10.3390/cells12060963", "pmid": "36980303", "publication_date": "2023-03-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1530, "title": "Exploring psilocybin-assisted psychotherapy in the treatment of methamphetamine use disorder.", "authors": "Brett J, Knock E, Korthuis PT, Liknaitzky P, Murnane KS, Nicholas CR, Patterson JC, Stauffer CS.", "journal": null, "publication_date": "2023-03-13", "publication_year": 2023, "doi": "10.3389/fpsyt.2023.1123424", "pubmed_id": "36998623", "openalex_id": null, "source_url": "https://doi.org/10.3389/fpsyt.2023.1123424", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:36998623", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2023.1123424", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36998623", "source_url": "https://doi.org/10.3389/fpsyt.2023.1123424", "doi": "10.3389/fpsyt.2023.1123424", "pmid": "36998623", "publication_date": "2023-03-13", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1465, "title": "Preclinical perspectives on the mechanisms underlying the therapeutic actions of psilocybin in psychiatric disorders.", "authors": "Wulff AB, Nichols CD, Thompson SM.", "journal": null, "publication_date": "2023-03-12", "publication_year": 2023, "doi": "10.1016/j.neuropharm.2023.109504", "pubmed_id": "36921889", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.neuropharm.2023.109504", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Animal Study,Treatment-Resistant Depression,Inflammation", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:36921889", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.neuropharm.2023.109504", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36921889", "source_url": "https://doi.org/10.1016/j.neuropharm.2023.109504", "doi": "10.1016/j.neuropharm.2023.109504", "pmid": "36921889", "publication_date": "2023-03-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3782, "title": "Understanding psychedelic 'mystical experience'-A case example", "authors": "Turkia M.", "journal": "PsyArXiv", "publication_date": "2023-03-09", "publication_year": 2023, "doi": "10.31234/osf.io/dh92g", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/dh92g", "substance_tags": "psilocybin", "topic_tags": "Mystical Experience,Clinical Trial,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:21", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/dh92g", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/dh92g", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/dh92g", "source_url": "https://doi.org/10.31234/osf.io/dh92g", "doi": "10.31234/osf.io/dh92g", "pmid": "", "publication_date": "2023-03-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3767, "title": "Underground small-group therapy of treatment-resistant depression and complex post-traumatic stress disorder (C-PTSD) with psilocybin-A retrospective case study", "authors": "Turkia M.", "journal": "PsyArXiv", "publication_date": "2023-03-09", "publication_year": 2023, "doi": "10.31234/osf.io/t6k9b", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/t6k9b", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:19", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/t6k9b", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/t6k9b", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/t6k9b", "source_url": "https://doi.org/10.31234/osf.io/t6k9b", "doi": "10.31234/osf.io/t6k9b", "pmid": "", "publication_date": "2023-03-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3305, "title": "Understanding psychedelic 'mystical experience'-A case example", "authors": "", "journal": "PsyArXiv", "publication_date": "2023-03-09", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/dh92g_v1", "substance_tags": "psilocybin", "topic_tags": "Anxiety,PTSD,Wellbeing,Personality Change,Mystical Experience,Clinical Trial,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:50", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/dh92g_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/dh92g_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/dh92g_v1", "source_url": "https://osf.io/preprints/psyarxiv/dh92g_v1", "doi": "", "pmid": "", "publication_date": "2023-03-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3207, "title": "Underground small-group therapy of treatment-resistant depression and complex post-traumatic stress disorder (C-PTSD) with psilocybin-A retrospective case study", "authors": "", "journal": "PsyArXiv", "publication_date": "2023-03-09", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/t6k9b_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/t6k9b_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/t6k9b_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/t6k9b_v1", "source_url": "https://osf.io/preprints/psyarxiv/t6k9b_v1", "doi": "", "pmid": "", "publication_date": "2023-03-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4833, "title": "Psychedelics for Medicinal Use: How Will This Alter the Collective Laboratory Consciousness?", "authors": "Steven W. Cotten, Frederick G. Strathmann, Frederick S. Barrett, Laura Labay, James Mullally, Alexander M. Sherwood, Frank Wiegand", "journal": "Clinical Chemistry", "publication_date": "2023-03-06", "publication_year": 2023, "doi": "10.1093/clinchem/hvad016", "pubmed_id": "36881769", "openalex_id": "https://openalex.org/W4323351497", "source_url": "http://dx.doi.org/10.1093/clinchem/hvad016", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Pharmacology,Mechanism of Action,Receptor Pharmacology,Consciousness,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36881769", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1093/clinchem/hvad016", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:36881769", "source_url": "http://dx.doi.org/10.1093/clinchem/hvad016", "doi": "10.1093/clinchem/hvad016", "pmid": "36881769", "publication_date": "2023-03-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1542, "title": "Pharmacotherapies for Treatment-Resistant Depression: How Antipsychotics Fit in the Rapidly Evolving Therapeutic Landscape.", "authors": "Jha MK, Mathew SJ.", "journal": null, "publication_date": "2023-02-28", "publication_year": 2023, "doi": "10.1176/appi.ajp.20230025", "pubmed_id": "36855876", "openalex_id": null, "source_url": "https://doi.org/10.1176/appi.ajp.20230025", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:36855876", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1176/appi.ajp.20230025", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36855876", "source_url": "https://doi.org/10.1176/appi.ajp.20230025", "doi": "10.1176/appi.ajp.20230025", "pmid": "36855876", "publication_date": "2023-02-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1534, "title": "A Single Administration of Psilocybin Persistently Rescues Cognitive Deficits Caused by Adolescent Chronic Restraint Stress Without Long-Term Changes in Synaptic Protein Gene Expression in a Rat Experimental System with Translational Relevance to Depression", "authors": "Meghan Hibicke, Hannah M. Kramer, Charles D. Nichols", "journal": "Psychedelic Medicine", "publication_date": "2023-02-28", "publication_year": 2023, "doi": "10.1089/psymed.2022.0012", "pubmed_id": "40047006", "openalex_id": "https://openalex.org/W4323041020", "source_url": "https://doi.org/10.1089/psymed.2022.0012", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Animal Study,Adolescents,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:40047006", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1089/psymed.2022.0012", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40047006", "source_url": "https://doi.org/10.1089/psymed.2022.0012", "doi": "10.1089/psymed.2022.0012", "pmid": "40047006", "publication_date": "2023-02-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4844, "title": "Psychedelics for the Neuropsychiatric Symptoms of Alzheimer's disease", "authors": "Ashish Sarangi, Omotola Akinkunmi", "journal": "American Journal of Geriatric Psychiatry", "publication_date": "2023-02-15", "publication_year": 2023, "doi": "10.1016/j.jagp.2022.12.201", "pubmed_id": null, "openalex_id": "https://openalex.org/W4321014012", "source_url": "https://doi.org/10.1016/j.jagp.2022.12.201", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-07-04 06:34:46", "bibtex": null, "source_record_id": "DOI:10.1016/j.jagp.2022.12.201", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.jagp.2022.12.201", "source_url": "https://doi.org/10.1016/j.jagp.2022.12.201", "doi": "10.1016/j.jagp.2022.12.201", "pmid": "", "publication_date": "2023-02-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1533, "title": "Personal Psychedelic Use Is Common Among a Sample of Psychedelic Therapists: Implications for Research and Practice", "authors": "Jacob S. Aday, Zachary Skiles, Noa Eaton, Lisa Fredenburg, Mollie Pleet, Jessica Mantia, Ellen Bradley, Gisele Fernandes-Osterhold, Joshua Woolley", "journal": "Psychedelic Medicine", "publication_date": "2023-02-15", "publication_year": 2023, "doi": "10.1089/psymed.2022.0004", "pubmed_id": "40047007", "openalex_id": "https://openalex.org/W4321016287", "source_url": "https://doi.org/10.1089/psymed.2022.0004", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Spirituality,Clinical Trial,Review Article,Observational Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:40047007", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1089/psymed.2022.0004", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40047007", "source_url": "https://doi.org/10.1089/psymed.2022.0004", "doi": "10.1089/psymed.2022.0004", "pmid": "40047007", "publication_date": "2023-02-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4848, "title": "The History, Legalization and Potentials of Psilocybin-Assisted Psychotherapy", "authors": "Jeffery Heilman", "journal": "Journal of Scientific Exploration", "publication_date": "2023-02-10", "publication_year": 2023, "doi": "10.31275/20222633", "pubmed_id": null, "openalex_id": "https://openalex.org/W4320035163", "source_url": "http://dx.doi.org/10.31275/20222633", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.31275/20222633", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.31275/20222633", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.31275/20222633", "source_url": "http://dx.doi.org/10.31275/20222633", "doi": "10.31275/20222633", "pmid": "", "publication_date": "2023-02-10", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1563, "title": "Therapeutic effect of psilocybin in addiction: A systematic review.", "authors": "van der Meer PB, Fuentes JJ, Kaptein AA, Schoones JW, de Waal MM, Goudriaan AE, Kramers K, Schellekens A, Somers M, Bossong MG, Batalla A.", "journal": null, "publication_date": "2023-02-08", "publication_year": 2023, "doi": "10.3389/fpsyt.2023.1134454", "pubmed_id": "36846225", "openalex_id": null, "source_url": "https://doi.org/10.3389/fpsyt.2023.1134454", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:36846225", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2023.1134454", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36846225", "source_url": "https://doi.org/10.3389/fpsyt.2023.1134454", "doi": "10.3389/fpsyt.2023.1134454", "pmid": "36846225", "publication_date": "2023-02-08", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1502, "title": "Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life", "authors": "Guy M. Goodwin, Scott T. Aaronson, Oscar Alvarez, Merve Atli, James Bennett, Megan Croal, Charles DeBattista, Boadie W. Dunlop, David Feifel, David J. Hellerstein, Muhammad Ishrat Husain, John R. Kelly, Molly Lennard-Jones, Rasmus Wentzer Licht, Lindsey Marwood, Sunil Mistry, Tomáš Páleníček, Ozlem Redjep, Dimitris Repantis, Robert A. Schoevers, Batya Septimus, Hollie Simmons, Jair C. Soares, Metten Somers, S. C. Stansfield, Jessica R. Stuart, Hannah H. Tadley, Nisha K. Thiara, Joyce Tsai, Mourad Wahba, Sam Williams, Rachel I. Winzer, Allan H. Young, Matthew B. Young, Sid Zisook, Ekaterina Malievskaia", "journal": "Journal of Affective Disorders", "publication_date": "2023-02-02", "publication_year": 2023, "doi": "10.1016/j.jad.2023.01.108", "pubmed_id": "36740140", "openalex_id": "https://openalex.org/W4319067008", "source_url": "https://doi.org/10.1016/j.jad.2023.01.108", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36740140", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.jad.2023.01.108", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:36740140", "source_url": "https://doi.org/10.1016/j.jad.2023.01.108", "doi": "10.1016/j.jad.2023.01.108", "pmid": "36740140", "publication_date": "2023-02-02", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3695, "title": "SV2A Marker of Synaptogenesis in a Clinical Trial of Psilocybin for Depression", "authors": "Washington University School of Medicine", "journal": "ClinicalTrials.gov", "publication_date": "2023-01-29", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05601648", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Brain Imaging,Receptor Pharmacology,Biomarkers,Aging,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05601648", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05601648", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05601648", "source_url": "https://clinicaltrials.gov/study/NCT05601648", "doi": "", "pmid": "", "publication_date": "2023-01-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1566, "title": "Corrigendum to 'Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial'.", "authors": "von Rotz R, Schindowski EM, Jungwirth J, Schuldt A, Rieser NM, Zahoranszky K, Seifritz E, Nowak A, Nowak P, Jäncke L, Preller KH, Vollenweider FX.", "journal": null, "publication_date": "2023-01-29", "publication_year": 2023, "doi": "10.1016/j.eclinm.2023.101841", "pubmed_id": "36747965", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.eclinm.2023.101841", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:36747965", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.eclinm.2023.101841", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36747965", "source_url": "https://doi.org/10.1016/j.eclinm.2023.101841", "doi": "10.1016/j.eclinm.2023.101841", "pmid": "36747965", "publication_date": "2023-01-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1575, "title": "Medications for the Treatment of Alcohol Dependence-Current State of Knowledge and Future Perspectives from a Public Health Perspective.", "authors": "Stokłosa I, Więckiewicz G, Stokłosa M, Piegza M, Pudlo R, Gorczyca P.", "journal": null, "publication_date": "2023-01-18", "publication_year": 2023, "doi": "10.3390/ijerph20031870", "pubmed_id": "36767234", "openalex_id": null, "source_url": "https://doi.org/10.3390/ijerph20031870", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:36767234", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/ijerph20031870", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36767234", "source_url": "https://doi.org/10.3390/ijerph20031870", "doi": "10.3390/ijerph20031870", "pmid": "36767234", "publication_date": "2023-01-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4855, "title": "Group format psychedelic-assisted therapy interventions: Observations and impressions from the HOPE trial", "authors": "Benjamin R. Lewis, Kevin Byrne, John Hendrick, Eric L. Garland, Paul Thielking, Anna C. Beck", "journal": "Journal of Psychedelic Studies", "publication_date": "2023-01-17", "publication_year": 2023, "doi": "10.1556/2054.2022.00222", "pubmed_id": null, "openalex_id": "https://openalex.org/W4317355030", "source_url": "https://doi.org/10.1556/2054.2022.00222", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Pharmacology,Clinical Trial,Observational Study,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2022.00222", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2022.00222", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2022.00222", "source_url": "https://doi.org/10.1556/2054.2022.00222", "doi": "10.1556/2054.2022.00222", "pmid": "", "publication_date": "2023-01-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3568, "title": "Pilot Trial of Visual Healing®, a Nature-themed Virtual Immersive Experience, to Optimize Set and Setting in Psilocybin-assisted Therapy for Alcohol Use Disorder", "authors": "Keith Heinzerling", "journal": "ClinicalTrials.gov", "publication_date": "2023-01-16", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04410913", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Addiction,Mystical Experience,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04410913", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04410913", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04410913", "source_url": "https://clinicaltrials.gov/study/NCT04410913", "doi": "", "pmid": "", "publication_date": "2023-01-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1579, "title": "The association between naturalistic use of psychedelics and co-occurring substance use disorders", "authors": "Jonina Rabinowitz, Shaul Lev-Ran, Raz Gross", "journal": "Frontiers in Psychiatry", "publication_date": "2023-01-09", "publication_year": 2023, "doi": "10.3389/fpsyt.2022.1066369", "pubmed_id": "36704738", "openalex_id": "https://openalex.org/W4315488427", "source_url": "https://doi.org/10.3389/fpsyt.2022.1066369", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Observational Study,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36704738", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2022.1066369", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:36704738", "source_url": "https://doi.org/10.3389/fpsyt.2022.1066369", "doi": "10.3389/fpsyt.2022.1066369", "pmid": "36704738", "publication_date": "2023-01-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4884, "title": "Withdrawal of antidepressants does not impact the efficacy of COMP360 psilocybin therapy: results from a phase IIb randomised controlled trial", "authors": "Guy M. Goodwin, Megan Croal, J. Chai-Rees, Lindsey Marwood, S. Mistry, Anna Nowakowska, H. Clifton Simmons, Jeng-Yu Tsai", "journal": "Neuroscience Applied", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.1016/j.nsa.2023.103487", "pubmed_id": null, "openalex_id": "https://openalex.org/W4390222321", "source_url": "http://dx.doi.org/10.1016/j.nsa.2023.103487", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:47", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2023.103487", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2023.103487", "source_url": "http://dx.doi.org/10.1016/j.nsa.2023.103487", "doi": "10.1016/j.nsa.2023.103487", "pmid": "", "publication_date": "2022-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4878, "title": "Going on Trial: Serotonin drug; psilocybin phase 2; placebo response data", "authors": "Peter Hess", "journal": "The Transmitter", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.53053/etcr6498", "pubmed_id": null, "openalex_id": "https://openalex.org/W4367666053", "source_url": "http://dx.doi.org/10.53053/etcr6498", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.53053/etcr6498", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.53053/etcr6498", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.53053/etcr6498", "source_url": "http://dx.doi.org/10.53053/etcr6498", "doi": "10.53053/etcr6498", "pmid": "", "publication_date": "2022-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4875, "title": "Going on Trial: Arbaclofen reboot; cell implants; psilocybin microdoses", "authors": "Peter Hess", "journal": "The Transmitter", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.53053/nbdr8957", "pubmed_id": null, "openalex_id": "https://openalex.org/W4317889950", "source_url": "http://dx.doi.org/10.53053/nbdr8957", "substance_tags": "psilocybin", "topic_tags": "Microdosing,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.53053/nbdr8957", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.53053/nbdr8957", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.53053/nbdr8957", "source_url": "http://dx.doi.org/10.53053/nbdr8957", "doi": "10.53053/nbdr8957", "pmid": "", "publication_date": "2022-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4869, "title": "Psychedelic Drug Therapy for Mental Disorders?", "authors": "John R. Rossiter", "journal": "Open Journal of Medical Psychology", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.4236/ojmp.2023.123010", "pubmed_id": null, "openalex_id": "https://openalex.org/W4386593692", "source_url": "http://dx.doi.org/10.4236/ojmp.2023.123010", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Receptor Pharmacology,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.4236/ojmp.2023.123010", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.4236/ojmp.2023.123010", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.4236/ojmp.2023.123010", "source_url": "http://dx.doi.org/10.4236/ojmp.2023.123010", "doi": "10.4236/ojmp.2023.123010", "pmid": "", "publication_date": "2022-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1601, "title": "Should we be leery of being Leary? Concerns about psychedelic use by psychedelic researchers.", "authors": "Kious B, Schwartz Z, Lewis B", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.1177/02698811221133461", "pubmed_id": "36377548", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36377548/", "substance_tags": "psilocybin", "topic_tags": "PTSD,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:38", "bibtex": null, "source_record_id": "PMID:36377548", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36377548/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36377548", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36377548/", "doi": "10.1177/02698811221133461", "pmid": "36377548", "publication_date": "2022-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1595, "title": "Psychedelic drug abuse potential assessment for new drug applications and controlled substance scheduling: A United States perspective", "authors": "Jack E. Henningfield, Judy Ashworth, David J. Heal, Sharon L. Smith", "journal": "Journal of Psychopharmacology", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.1177/02698811221140004", "pubmed_id": "36588452", "openalex_id": "https://openalex.org/W4313424238", "source_url": "https://doi.org/10.1177/02698811221140004", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,In Vitro Study,Safety,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36588452", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/02698811221140004", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:36588452", "source_url": "https://doi.org/10.1177/02698811221140004", "doi": "10.1177/02698811221140004", "pmid": "36588452", "publication_date": "2022-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1585, "title": "Efficacy and Safety of Psychedelics in Treating Anxiety Disorders", "authors": "Leah Feulner, Thanpicha Sermchaiwong, Nathan Rodland, David Galarneau", "journal": "Ochsner Journal", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.31486/toj.23.0076", "pubmed_id": "38143548", "openalex_id": "https://openalex.org/W4389868195", "source_url": "https://doi.org/10.31486/toj.23.0076", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Aging,Clinical Trial,Review Article,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:38143548", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.31486/toj.23.0076", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38143548", "source_url": "https://doi.org/10.31486/toj.23.0076", "doi": "10.31486/toj.23.0076", "pmid": "38143548", "publication_date": "2022-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1584, "title": "Past Is Prologue: Ethical Issues in Pediatric Psychedelics Research and Treatment", "authors": "Gail A. Edelsohn, Dominic Sisti", "journal": "Perspectives in biology and medicine", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.1353/pbm.2023.0007", "pubmed_id": "38662012", "openalex_id": "https://openalex.org/W4324007078", "source_url": "https://doi.org/10.1353/pbm.2023.0007", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Personality Change,Clinical Trial,Adolescents,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:38662012", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1353/pbm.2023.0007", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38662012", "source_url": "https://doi.org/10.1353/pbm.2023.0007", "doi": "10.1353/pbm.2023.0007", "pmid": "38662012", "publication_date": "2022-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1577, "title": "On blinding and suicide risk in a recent trial of psilocybin-assisted therapy for treatment-resistant depression", "authors": "Natalie Gukasyan", "journal": "Med", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.1016/j.medj.2022.12.003", "pubmed_id": "36640755", "openalex_id": "https://openalex.org/W4315874306", "source_url": "https://doi.org/10.1016/j.medj.2022.12.003", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36640755", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:36640755", "source_url": "https://doi.org/10.1016/j.medj.2022.12.003", "doi": "10.1016/j.medj.2022.12.003", "pmid": "36640755", "publication_date": "2022-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1509, "title": "The Impact of Psilocybin on Patients Experiencing Psychiatric Symptoms: A Systematic Review of Randomized Clinical Trials.", "authors": "IsHak WW, Garcia P, Pearl R, Dang J, William C, Totlani J, Danovitch I.", "journal": null, "publication_date": "2022-12-31", "publication_year": 2022, "doi": null, "pubmed_id": "37387703", "openalex_id": null, "source_url": "https://europepmc.org/article/MED/37387703", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Wellbeing,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:37387703", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/MED/37387703", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37387703", "source_url": "https://europepmc.org/article/MED/37387703", "doi": "", "pmid": "37387703", "publication_date": "2022-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1402, "title": "Scoping Review of Experiential Measures from Psychedelic Research and Clinical Trials.", "authors": "Herrmann Z, Earleywine M, De Leo J, Slabaugh S, Kenny T, Rush AJ", "journal": "Journal of psychoactive drugs", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.1080/02791072.2022.2125467", "pubmed_id": "36127639", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36127639/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Consciousness,Wellbeing,Emotional Processing,Mystical Experience,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:38", "bibtex": null, "source_record_id": "PMID:36127639", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36127639/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36127639", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36127639/", "doi": "10.1080/02791072.2022.2125467", "pmid": "36127639", "publication_date": "2022-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1399, "title": "An Assessment of Psychedelic Knowledge Among People Using Psychedelics Naturalistically.", "authors": "Kruger DJ, Glynos NG, Fields CW, Herberholz M, Boehnke KF", "journal": "Journal of psychoactive drugs", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.1080/02791072.2022.2142709", "pubmed_id": "36328419", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36328419/", "substance_tags": "psilocybin", "topic_tags": "Microdosing,Clinical Trial,Observational Study,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:38", "bibtex": null, "source_record_id": "PMID:36328419", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36328419/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36328419", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36328419/", "doi": "10.1080/02791072.2022.2142709", "pmid": "36328419", "publication_date": "2022-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1361, "title": "Bedside to bench: the outlook for psychedelic research.", "authors": "Acero VP, Cribas ES, Browne KD, Rivellini O, Burrell JC, O'Donnell JC, Das S, Cullen DK", "journal": "Frontiers in pharmacology", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.3389/fphar.2023.1240295", "pubmed_id": "37869749", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37869749/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Neuroplasticity,Mechanism of Action,Epigenetics,Clinical Trial,Review Article,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:38", "bibtex": null, "source_record_id": "PMID:37869749", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37869749/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37869749", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37869749/", "doi": "10.3389/fphar.2023.1240295", "pmid": "37869749", "publication_date": "2022-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1256, "title": "Psychedelics, epilepsy, and seizures: a review.", "authors": "Freidel N, Kreuder L, Rabinovitch BS, Chen FY, Huang RST, Lewis EC", "journal": "Frontiers in pharmacology", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.3389/fphar.2023.1326815", "pubmed_id": "38283836", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38283836/", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Review Article,Observational Study,Animal Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:37", "bibtex": null, "source_record_id": "PMID:38283836", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38283836/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38283836", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38283836/", "doi": "10.3389/fphar.2023.1326815", "pmid": "38283836", "publication_date": "2022-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1567, "title": "Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial", "authors": "Robin von Rotz, Eva Maria Schindowski, Johannes Jungwirth, Anna Schuldt, Nathalie M. Rieser, Katharina Zahoranszky, Erich Seifritz, Albina Nowak, Peter J.C.M. Nowak, Lutz Jäncke, Katrin H. Preller, Franz X. Vollenweider", "journal": "EClinicalMedicine", "publication_date": "2022-12-27", "publication_year": 2022, "doi": "10.1016/j.eclinm.2022.101809", "pubmed_id": "36636296", "openalex_id": "https://openalex.org/W4313530670", "source_url": "https://doi.org/10.1016/j.eclinm.2022.101809", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36636296", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.eclinm.2022.101809", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:36636296", "source_url": "https://doi.org/10.1016/j.eclinm.2022.101809", "doi": "10.1016/j.eclinm.2022.101809", "pmid": "36636296", "publication_date": "2022-12-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4893, "title": "High dose of psilocybin effective for treatment-resistant depression", "authors": "", "journal": "The Brown University Psychopharmacology Update", "publication_date": "2022-12-26", "publication_year": 2022, "doi": "10.1002/pu.30970", "pubmed_id": null, "openalex_id": "https://openalex.org/W4312206785", "source_url": "https://doi.org/10.1002/pu.30970", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Clinical Trial,Treatment-Resistant Depression,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:47", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1002/pu.30970", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/pu.30970", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/pu.30970", "source_url": "https://doi.org/10.1002/pu.30970", "doi": "10.1002/pu.30970", "pmid": "", "publication_date": "2022-12-26", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1620, "title": "“A sense of the bigger picture:” A qualitative analysis of follow-up interviews with people with bipolar disorder who self-reported psilocybin use", "authors": "Meghan DellaCrosse, Mollie Pleet, Emma Morton, Amir Ashtari, Kimberly Sakai, Josh Woolley, Erin E. Michalak", "journal": "PLoS ONE", "publication_date": "2022-12-13", "publication_year": 2022, "doi": "10.1371/journal.pone.0279073", "pubmed_id": "36516137", "openalex_id": "https://openalex.org/W4311439362", "source_url": "https://doi.org/10.1371/journal.pone.0279073", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Emotional Processing,Clinical Trial,Observational Study,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36516137", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1371/journal.pone.0279073", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:36516137", "source_url": "https://doi.org/10.1371/journal.pone.0279073", "doi": "10.1371/journal.pone.0279073", "pmid": "36516137", "publication_date": "2022-12-13", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1597, "title": "Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of ‘magic mushroom’ consumption", "authors": "Emma Morton, Kimberly Sakai, Amir Ashtari, Mollie Pleet, Erin E. Michalak, Josh Woolley", "journal": "Journal of Psychopharmacology", "publication_date": "2022-12-13", "publication_year": 2022, "doi": "10.1177/02698811221131997", "pubmed_id": "36515370", "openalex_id": "https://openalex.org/W4311477082", "source_url": "https://doi.org/10.1177/02698811221131997", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Clinical Trial,Observational Study,Safety,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36515370", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/02698811221131997", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:36515370", "source_url": "https://doi.org/10.1177/02698811221131997", "doi": "10.1177/02698811221131997", "pmid": "36515370", "publication_date": "2022-12-13", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1518, "title": "Pharmacokinetics and Pharmacodynamics of Oral Psilocybin Administration in Healthy Participants", "authors": "Friederike Holze, A. Becker, Karolina E. Kolaczynska, Urs Duthaler, Matthias E. Liechti", "journal": "Clinical Pharmacology & Therapeutics", "publication_date": "2022-12-11", "publication_year": 2022, "doi": "10.1002/cpt.2821", "pubmed_id": "36507738", "openalex_id": "https://openalex.org/W4311205265", "source_url": "https://doi.org/10.1002/cpt.2821", "substance_tags": "psilocybin,psilocin", "topic_tags": "Pharmacology,Receptor Pharmacology,Clinical Trial,Healthy Volunteers", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36507738", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/cpt.2821", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:36507738", "source_url": "https://doi.org/10.1002/cpt.2821", "doi": "10.1002/cpt.2821", "pmid": "36507738", "publication_date": "2022-12-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1517, "title": "Psychedelic-Assisted Therapy and Psychedelic Science: A Review and Perspective on Opportunities in Neurosurgery and Neuro-Oncology.", "authors": "Kelly DF, Kelly DF, Heinzerling K, Sharma A, Gowrinathan S, Sergi K, Mallari RJ.", "journal": null, "publication_date": "2022-12-07", "publication_year": 2022, "doi": "10.1227/neu.0000000000002275", "pubmed_id": "36512813", "openalex_id": null, "source_url": "https://doi.org/10.1227/neu.0000000000002275", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Eating Disorders,Chronic Pain,Brain Imaging,Mechanism of Action,Aging,Clinical Trial,Review Article,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:36512813", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1227/neu.0000000000002275", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36512813", "source_url": "https://doi.org/10.1227/neu.0000000000002275", "doi": "10.1227/neu.0000000000002275", "pmid": "36512813", "publication_date": "2022-12-07", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2015, "title": "Direct Quantitation of Psilocybin and Psilocin by One-Dimensional 1H and 31P qNMR in a revived Greek specimen of Psilocybe cyanescens", "authors": "Prokopios Magiatis, Evangelos Dadiotis, Romanos Konstantinos Antonopoulos, K Ioannidis, V Mitsis, E Melliou, Zacharoula Gonou-Zagou", "journal": "Planta Medica", "publication_date": "2022-11-30", "publication_year": 2022, "doi": "10.1055/s-0042-1759062", "pubmed_id": null, "openalex_id": "https://openalex.org/W4317241495", "source_url": "https://doi.org/10.1055/s-0042-1759062", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Addiction,End-of-Life Distress,Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1055/s-0042-1759062", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1055/s-0042-1759062", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1055/s-0042-1759062", "source_url": "https://doi.org/10.1055/s-0042-1759062", "doi": "10.1055/s-0042-1759062", "pmid": "", "publication_date": "2022-11-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1631, "title": "Set and setting in microdosing: an oft-overlooked principle.", "authors": "Hartogsohn I, Petranker R", "journal": "Psychopharmacology", "publication_date": "2022-11-30", "publication_year": 2022, "doi": "10.1007/s00213-022-06249-8", "pubmed_id": "36289109", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36289109/", "substance_tags": "psilocybin", "topic_tags": "Microdosing,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:38", "bibtex": null, "source_record_id": "PMID:36289109", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36289109/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36289109", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36289109/", "doi": "10.1007/s00213-022-06249-8", "pmid": "36289109", "publication_date": "2022-11-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1627, "title": "Psychedelic-Assisted Therapy for People with Eating Disorders.", "authors": "Gukasyan N, Schreyer CC, Griffiths RR, Guarda AS", "journal": "Current psychiatry reports", "publication_date": "2022-11-30", "publication_year": 2022, "doi": "10.1007/s11920-022-01394-5", "pubmed_id": "36374357", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36374357/", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:38", "bibtex": null, "source_record_id": "PMID:36374357", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36374357/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36374357", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36374357/", "doi": "10.1007/s11920-022-01394-5", "pmid": "36374357", "publication_date": "2022-11-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1635, "title": "Psilocybin as a Treatment for Psychiatric Illness: A Meta-Analysis.", "authors": "Irizarry R, Winczura A, Dimassi O, Dhillon N, Minhas A, Larice J.", "journal": null, "publication_date": "2022-11-21", "publication_year": 2022, "doi": "10.7759/cureus.31796", "pubmed_id": "36569662", "openalex_id": null, "source_url": "https://doi.org/10.7759/cureus.31796", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,OCD,Microdosing,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:36569662", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.7759/cureus.31796", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36569662", "source_url": "https://doi.org/10.7759/cureus.31796", "doi": "10.7759/cureus.31796", "pmid": "36569662", "publication_date": "2022-11-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4910, "title": "The psychedelic renaissance: can psilocybin possibly combat depression?", "authors": "Hamna Raheel, Unaiza Naeem, Asim Shaikh, Omer Ahmed Shaikh", "journal": "International Journal of Surgery Global Health", "publication_date": "2022-10-31", "publication_year": 2022, "doi": "10.1097/gh9.0000000000000089", "pubmed_id": null, "openalex_id": "https://openalex.org/W4318965036", "source_url": "http://dx.doi.org/10.1097/gh9.0000000000000089", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Headache / Migraine,Mechanism of Action,Wellbeing,Personality Change,Emotional Processing,Clinical Trial,Systematic Review,Review Article,Observational Study,Cancer Patients,Treatment-Resistant Depression,Safety,Adverse Events,Toxicity", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:56", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1097/gh9.0000000000000089", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1097/gh9.0000000000000089", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1097/gh9.0000000000000089", "source_url": "http://dx.doi.org/10.1097/gh9.0000000000000089", "doi": "10.1097/gh9.0000000000000089", "pmid": "", "publication_date": "2022-10-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1642, "title": "Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.", "authors": "Goodwin GM, Aaronson ST, Alvarez O, Arden PC, Baker A, Bennett JC, Bird C, Blom RE, Brennan C, Brusch D, Burke L, Campbell-Coker K, Carhart-Harris R, Cattell J, Daniel A, DeBattista C, Dunlop BW, Eisen K, Feifel D, Forbes M, Haumann HM, Hellerstein DJ, Hoppe AI, Husain MI, Jelen LA, Kamphuis J, Kawasaki J, Kelly JR, Key RE, Kishon R, Knatz Peck S, Knight G, Koolen MHB, Lean M, Licht RW, Maples-Keller JL, Mars J, Marwood L, McElhiney MC, Miller TL, Mirow A, Mistry S, Mletzko-Crowe T, Modlin LN, Nielsen RE, Nielson EM, Offerhaus SR, O'Keane V, Páleníček T, Printz D, Rademaker MC, van Reemst A, Reinholdt F, Repantis D, Rucker J, Rudow S, Ruffell S, Rush AJ, Schoevers RA, Seynaeve M, Shao S, Soares JC, Somers M, Stansfield SC, Sterling D, Strockis A, Tsai J, Visser L, Wahba M, Williams S, Young AH, Ywema P, Zisook S, Malievskaia E.", "journal": "New England Journal of Medicine", "publication_date": "2022-10-31", "publication_year": 2022, "doi": "10.1056/nejmoa2206443", "pubmed_id": "36322843", "openalex_id": "https://openalex.org/W4308146982", "source_url": "https://doi.org/10.1056/nejmoa2206443", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36322843", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1056/nejmoa2206443", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36322843", "source_url": "https://doi.org/10.1056/nejmoa2206443", "doi": "10.1056/nejmoa2206443", "pmid": "36322843", "publication_date": "2022-10-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1659, "title": "Psilocybin-assisted therapy for reducing alcohol intake in patients with alcohol use disorder: protocol for a randomised, double-blinded, placebo-controlled 12-week clinical trial (The QUANTUM Trip Trial).", "authors": "Jensen ME, Jensen ME, Stenbæk DS, Juul TS, Fisher PM, Ekstrøm CT, Knudsen GM, Fink-Jensen A.", "journal": "BMJ Open", "publication_date": "2022-10-13", "publication_year": 2022, "doi": "10.1136/bmjopen-2022-066019", "pubmed_id": "36241352", "openalex_id": "https://openalex.org/W4306177192", "source_url": "https://doi.org/10.1136/bmjopen-2022-066019", "substance_tags": "psilocybin,psilocin", "topic_tags": "Addiction,Brain Imaging,Mechanism of Action,Biomarkers,Aging,Clinical Trial,Randomized Controlled Trial,Review Article", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36241352", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1136/bmjopen-2022-066019", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36241352", "source_url": "https://doi.org/10.1136/bmjopen-2022-066019", "doi": "10.1136/bmjopen-2022-066019", "pmid": "36241352", "publication_date": "2022-10-13", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3685, "title": "An Exploratory Open-Label, Phase 1b, Ascending Dose Study to Evaluate the Effects of Oral 3-[2-(Dimethylamino)Ethyl]-1h-indol-4-yl Dihydrogen Phosphate (Psilocybin, BPL-PSILO) on Cognition in Patients With Chronic Short-Lasting Unilateral Neuralgiform Headache Attacks (SUNHA)", "authors": "Beckley Psytech Limited", "journal": "ClinicalTrials.gov", "publication_date": "2022-10-11", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04905121", "substance_tags": "psilocybin", "topic_tags": "Headache / Migraine,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04905121", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04905121", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04905121", "source_url": "https://clinicaltrials.gov/study/NCT04905121", "doi": "", "pmid": "", "publication_date": "2022-10-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1572, "title": "Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis.", "authors": "Ko K, Kopra EI, Cleare AJ, Rucker JJ.", "journal": null, "publication_date": "2022-10-06", "publication_year": 2022, "doi": "10.1016/j.jad.2022.09.168", "pubmed_id": "36209780", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jad.2022.09.168", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:36209780", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jad.2022.09.168", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36209780", "source_url": "https://doi.org/10.1016/j.jad.2022.09.168", "doi": "10.1016/j.jad.2022.09.168", "pmid": "36209780", "publication_date": "2022-10-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1649, "title": "A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants: Mind the Evidence Gap.", "authors": "Ledwos N, Rosenblat JD, Blumberger DM, Castle DJ, McIntyre RS, Mulsant BH, Husain MI.", "journal": null, "publication_date": "2022-10-02", "publication_year": 2022, "doi": "10.1097/jcp.0000000000001608", "pubmed_id": "36193898", "openalex_id": null, "source_url": "https://doi.org/10.1097/jcp.0000000000001608", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Review Article,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:36193898", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1097/jcp.0000000000001608", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36193898", "source_url": "https://doi.org/10.1097/jcp.0000000000001608", "doi": "10.1097/jcp.0000000000001608", "pmid": "36193898", "publication_date": "2022-10-02", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1689, "title": "If the Doors of Perception Were Cleansed, Would Chronic Pain be Relieved? Evaluating the Benefits and Risks of Psychedelics.", "authors": "Dworkin RH, Anderson BT, Andrews N, Edwards RR, Grob CS, Ross S, Satterthwaite TD, Strain EC", "journal": "The journal of pain", "publication_date": "2022-09-30", "publication_year": 2022, "doi": "10.1016/j.jpain.2022.05.003", "pubmed_id": "35643270", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35643270/", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Headache / Migraine,Mechanism of Action,Consciousness,Spirituality,Mystical Experience,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:38", "bibtex": null, "source_record_id": "PMID:35643270", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35643270/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35643270", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35643270/", "doi": "10.1016/j.jpain.2022.05.003", "pmid": "35643270", "publication_date": "2022-09-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1681, "title": "Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial.", "authors": "Bogenschutz MP, Ross S, Bhatt S, Baron T, Forcehimes AA, Laska E, Mennenga SE, O'Donnell K, Owens LT, Podrebarac S, Rotrosen J, Tonigan JS, Worth L.", "journal": null, "publication_date": "2022-09-30", "publication_year": 2022, "doi": "10.1001/jamapsychiatry.2022.2096", "pubmed_id": "36001306", "openalex_id": null, "source_url": "https://doi.org/10.1001/jamapsychiatry.2022.2096", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:36001306", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1001/jamapsychiatry.2022.2096", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36001306", "source_url": "https://doi.org/10.1001/jamapsychiatry.2022.2096", "doi": "10.1001/jamapsychiatry.2022.2096", "pmid": "36001306", "publication_date": "2022-09-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1677, "title": "Expectancy in placebo-controlled trials of psychedelics: if so, so what?", "authors": "Butler M, Jelen L, Rucker J", "journal": "Psychopharmacology", "publication_date": "2022-09-30", "publication_year": 2022, "doi": "10.1007/s00213-022-06221-6", "pubmed_id": "36063208", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36063208/", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:38", "bibtex": null, "source_record_id": "PMID:36063208", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36063208/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36063208", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36063208/", "doi": "10.1007/s00213-022-06221-6", "pmid": "36063208", "publication_date": "2022-09-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3244, "title": "Psilocybin Therapy for Treatment Resistant Depression: Prediction of Clinical Outcome by Natural Language Processing", "authors": "Dougherty RF, Clarke P, Alti M, Kuc J, Schlosser D, Dunlop BW, Hellerstein DJ, Aaronson ST, Zisook S, Young AH, Carhart-Harris R, Goodwin G, Ryslik GA.", "journal": "PsyArXiv", "publication_date": "2022-09-29", "publication_year": 2022, "doi": "10.31234/osf.io/kh3cx", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/kh3cx", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Emotional Processing,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/kh3cx", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/kh3cx", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/kh3cx", "source_url": "https://doi.org/10.31234/osf.io/kh3cx", "doi": "10.31234/osf.io/kh3cx", "pmid": "", "publication_date": "2022-09-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 643, "title": "Psilocybin Therapy for Treatment Resistant Depression: Prediction of Clinical Outcome by Natural Language Processing", "authors": "", "journal": "PsyArXiv", "publication_date": "2022-09-29", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/kh3cx_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Emotional Processing,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/kh3cx_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/kh3cx_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/kh3cx_v1", "source_url": "https://osf.io/preprints/psyarxiv/kh3cx_v1", "doi": "", "pmid": "", "publication_date": "2022-09-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4923, "title": "The psychedelic escape from depression", "authors": "Michael Eisenstein", "journal": "Nature", "publication_date": "2022-09-27", "publication_year": 2022, "doi": "10.1038/d41586-022-02872-9", "pubmed_id": "36171370", "openalex_id": "https://openalex.org/W4297493645", "source_url": "https://doi.org/10.1038/d41586-022-02872-9", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:56", "last_checked": "2026-07-04 06:51:56", "bibtex": null, "source_record_id": "PMID:36171370", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:36171370", "source_url": "https://doi.org/10.1038/d41586-022-02872-9", "doi": "10.1038/d41586-022-02872-9", "pmid": "36171370", "publication_date": "2022-09-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3178, "title": "Effective connectivity of emotion and cognition under psilocybin", "authors": "Stoliker D, Novelli L, Vollenweider FX, Egan GF, Preller KH, Razi A.", "journal": "medRxiv", "publication_date": "2022-09-08", "publication_year": 2022, "doi": "10.1101/2022.09.06.22279626", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2022.09.06.22279626", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Default Mode Network,Biomarkers,Emotional Processing,Clinical Trial", "study_type": "Clinical Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "DOI:10.1101/2022.09.06.22279626", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2022.09.06.22279626", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2022.09.06.22279626", "source_url": "https://doi.org/10.1101/2022.09.06.22279626", "doi": "10.1101/2022.09.06.22279626", "pmid": "", "publication_date": "2022-09-08", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1698, "title": "Effects of psilocybin versus escitalopram on rumination and thought suppression in depression.", "authors": "Barba T, Buehler S, Kettner H, Radu C, Cunha BG, Nutt DJ, Erritzoe D, Roseman L, Carhart-Harris R.", "journal": "BJPsych Open", "publication_date": "2022-09-05", "publication_year": 2022, "doi": "10.1192/bjo.2022.565", "pubmed_id": "36065128", "openalex_id": "https://openalex.org/W4294808278", "source_url": "https://doi.org/10.1192/bjo.2022.565", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Drug Interactions", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36065128", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1192/bjo.2022.565", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36065128", "source_url": "https://doi.org/10.1192/bjo.2022.565", "doi": "10.1192/bjo.2022.565", "pmid": "36065128", "publication_date": "2022-09-05", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1606, "title": "The Safety and Efficacy of Psychedelic-Assisted Therapies for Older Adults: Knowns and Unknowns.", "authors": "Johnston CB, Mangini M, Grob C, Anderson B.", "journal": null, "publication_date": "2022-09-05", "publication_year": 2022, "doi": "10.1016/j.jagp.2022.08.007", "pubmed_id": "36184377", "openalex_id": "https://openalex.org/W4294723946", "source_url": "https://doi.org/10.1016/j.jagp.2022.08.007", "substance_tags": "psilocybin", "topic_tags": "PTSD,Receptor Pharmacology,Aging,Clinical Trial,Older Adults,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:36184377", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jagp.2022.08.007", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36184377", "source_url": "https://doi.org/10.1016/j.jagp.2022.08.007", "doi": "10.1016/j.jagp.2022.08.007", "pmid": "36184377", "publication_date": "2022-09-05", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1520, "title": "Microdosing psilocybin for chronic pain: a case series.", "authors": "Lyes M, Yang KH, Castellanos J, Furnish T.", "journal": "Pain", "publication_date": "2022-09-04", "publication_year": 2022, "doi": "10.1097/j.pain.0000000000002778", "pubmed_id": "36066961", "openalex_id": "https://openalex.org/W4294804950", "source_url": "https://doi.org/10.1097/j.pain.0000000000002778", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Neuroplasticity,Microdosing,Clinical Trial,Case Report", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36066961", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1097/j.pain.0000000000002778", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36066961", "source_url": "https://doi.org/10.1097/j.pain.0000000000002778", "doi": "10.1097/j.pain.0000000000002778", "pmid": "36066961", "publication_date": "2022-09-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5632, "title": "Psychedelics’ binding depends on receptor mutations", "authors": "special to C EN Attabey Rodríguez Benítez", "journal": "C&EN Global Enterprise", "publication_date": "2022-09-01", "publication_year": 2022, "doi": "10.1021/cen-10031-scicon6", "pubmed_id": null, "openalex_id": "https://openalex.org/W4294310361", "source_url": "https://doi.org/10.1021/cen-10031-scicon6", "substance_tags": "psilocin", "topic_tags": "Depression,PTSD,Pharmacology,Receptor Pharmacology,Emotional Processing,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:10", "last_checked": "2026-07-04 06:52:10", "bibtex": null, "source_record_id": "DOI:10.1021/cen-10031-scicon6", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1021/cen-10031-scicon6", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1021/cen-10031-scicon6", "source_url": "https://doi.org/10.1021/cen-10031-scicon6", "doi": "10.1021/cen-10031-scicon6", "pmid": "", "publication_date": "2022-09-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4932, "title": "Psychedelics in the Treatment of Substance Use Disorders", "authors": "Brian S. Barnett, Jeremy Weleff", "journal": "Psychiatric Annals", "publication_date": "2022-08-31", "publication_year": 2022, "doi": "10.3928/00485713-20220804-01", "pubmed_id": null, "openalex_id": "https://openalex.org/W4294911981", "source_url": "https://doi.org/10.3928/00485713-20220804-01", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Observational Study,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:56", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.3928/00485713-20220804-01", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3928/00485713-20220804-01", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3928/00485713-20220804-01", "source_url": "https://doi.org/10.3928/00485713-20220804-01", "doi": "10.3928/00485713-20220804-01", "pmid": "", "publication_date": "2022-08-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1702, "title": "[The use of psilocybin for treatment-resistant depression].", "authors": "Johannesdottir A, Sigurdsson E.", "journal": null, "publication_date": "2022-08-31", "publication_year": 2022, "doi": "10.17992/lbl.2022.09.706", "pubmed_id": "36040772", "openalex_id": null, "source_url": "https://doi.org/10.17992/lbl.2022.09.706", "substance_tags": "psilocybin", "topic_tags": "Depression,Headache / Migraine,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:36040772", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.17992/lbl.2022.09.706", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36040772", "source_url": "https://doi.org/10.17992/lbl.2022.09.706", "doi": "10.17992/lbl.2022.09.706", "pmid": "36040772", "publication_date": "2022-08-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1694, "title": "The Use of Psychedelics in the Treatment of Medical Conditions: An Analysis of Currently Registered Psychedelics Studies in the American Drug Trial Registry.", "authors": "Kurtz JS, Patel NA, Gendreau JL, Yang C, Brown N, Bui N, Picton B, Harris M, Hatter M, Beyer R, Sahyouni R, Diaz-Aguilar LD, Castellanos J, Schuster N, Abraham ME", "journal": "Cureus", "publication_date": "2022-08-31", "publication_year": 2022, "doi": "10.7759/cureus.29167", "pubmed_id": "36259015", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36259015/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:38", "bibtex": null, "source_record_id": "PMID:36259015", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36259015/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36259015", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36259015/", "doi": "10.7759/cureus.29167", "pmid": "36259015", "publication_date": "2022-08-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1680, "title": "Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review.", "authors": "Breeksema JJ, Kuin BW, Kamphuis J, van den Brink W, Vermetten E, Schoevers RA.", "journal": null, "publication_date": "2022-08-25", "publication_year": 2022, "doi": "10.1177/02698811221116926", "pubmed_id": "36017784", "openalex_id": null, "source_url": "https://doi.org/10.1177/02698811221116926", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Headache / Migraine,Clinical Trial,Systematic Review,Review Article,Adverse Events", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:36017784", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02698811221116926", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36017784", "source_url": "https://doi.org/10.1177/02698811221116926", "doi": "10.1177/02698811221116926", "pmid": "36017784", "publication_date": "2022-08-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4938, "title": "Dark Side of the Shroom: Erasing Indigenous and Counterculture Wisdoms with Psychedelic Capitalism, and the Open Source Alternative", "authors": "Neşe Devenot, Trey Conner, Richard Doyle", "journal": "Anthropology of Consciousness", "publication_date": "2022-08-21", "publication_year": 2022, "doi": "10.1111/anoc.12154", "pubmed_id": null, "openalex_id": "https://openalex.org/W4292574083", "source_url": "https://doi.org/10.1111/anoc.12154", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Headache / Migraine,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:56", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1111/anoc.12154", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/anoc.12154", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1111/anoc.12154", "source_url": "https://doi.org/10.1111/anoc.12154", "doi": "10.1111/anoc.12154", "pmid": "", "publication_date": "2022-08-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4941, "title": "A-118 Psychedelic Interventions for Neuropsychological Conditions", "authors": "Brian Peacock", "journal": "Archives of Clinical Neuropsychology", "publication_date": "2022-08-16", "publication_year": 2022, "doi": "10.1093/arclin/acac060.118", "pubmed_id": null, "openalex_id": "https://openalex.org/W4292089187", "source_url": "https://doi.org/10.1093/arclin/acac060.118", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Pharmacology,Receptor Pharmacology,Clinical Trial,Safety,Contraindications", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1093/arclin/acac060.118", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/arclin/acac060.118", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1093/arclin/acac060.118", "source_url": "https://doi.org/10.1093/arclin/acac060.118", "doi": "10.1093/arclin/acac060.118", "pmid": "", "publication_date": "2022-08-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1608, "title": "The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder.", "authors": "Rosenblat JD, Husain MI, Lee Y, McIntyre RS, Mansur RB, Castle D, Offman H, Parikh SV, Frey BN, Schaffer A, Greenway KT, Garel N, Beaulieu S, Kennedy SH, Lam RW, Milev R, Ravindran AV, Tourjman V, Ameringen MV, Yatham LN, Taylor V.", "journal": null, "publication_date": "2022-08-16", "publication_year": 2022, "doi": "10.1177/07067437221111371", "pubmed_id": "35975555", "openalex_id": null, "source_url": "https://doi.org/10.1177/07067437221111371", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Cancer Patients,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:35975555", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/07067437221111371", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35975555", "source_url": "https://doi.org/10.1177/07067437221111371", "doi": "10.1177/07067437221111371", "pmid": "35975555", "publication_date": "2022-08-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1686, "title": "Psilocybin Efficacy and Mechanisms of Action in Major Depressive Disorder: a Review.", "authors": "Prouzeau D, Conejero I, Voyvodic PL, Becamel C, Abbar M, Lopez-Castroman J.", "journal": null, "publication_date": "2022-08-11", "publication_year": 2022, "doi": "10.1007/s11920-022-01361-0", "pubmed_id": "35953638", "openalex_id": null, "source_url": "https://doi.org/10.1007/s11920-022-01361-0", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Mechanism of Action,Clinical Trial,Review Article,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:35953638", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s11920-022-01361-0", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35953638", "source_url": "https://doi.org/10.1007/s11920-022-01361-0", "doi": "10.1007/s11920-022-01361-0", "pmid": "35953638", "publication_date": "2022-08-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3554, "title": "Prophylactic Effects of Psilocybin on Chronic Cluster Headache: an Open-label Clinical Trial and Neuroimaging Study", "authors": "Gitte Moos Knudsen", "journal": "ClinicalTrials.gov", "publication_date": "2022-08-09", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04280055", "substance_tags": "psilocybin,psilocin", "topic_tags": "Chronic Pain,Headache / Migraine,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04280055", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04280055", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04280055", "source_url": "https://clinicaltrials.gov/study/NCT04280055", "doi": "", "pmid": "", "publication_date": "2022-08-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1651, "title": "The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world.", "authors": "Watts R, Kettner H, Geerts D, Gandy S, Kartner L, Mertens L, Timmermann C, Nour MM, Kaelen M, Nutt D, Carhart-Harris R, Roseman L.", "journal": "Psychopharmacology", "publication_date": "2022-08-07", "publication_year": 2022, "doi": "10.1007/s00213-022-06187-5", "pubmed_id": "35939083", "openalex_id": "https://openalex.org/W4290631853", "source_url": "https://doi.org/10.1007/s00213-022-06187-5", "substance_tags": "psilocybin", "topic_tags": "Depression,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Observational Study", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:35939083", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s00213-022-06187-5", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35939083", "source_url": "https://doi.org/10.1007/s00213-022-06187-5", "doi": "10.1007/s00213-022-06187-5", "pmid": "35939083", "publication_date": "2022-08-07", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4946, "title": "Med Check: Psilocybin for OCD, Nuplazid Vote, and More", "authors": "Terri D’Arrigo", "journal": "Psychiatric News", "publication_date": "2022-07-31", "publication_year": 2022, "doi": "10.1176/appi.pn.2022.08.8.2", "pubmed_id": null, "openalex_id": "https://openalex.org/W4289781881", "source_url": "https://doi.org/10.1176/appi.pn.2022.08.8.2", "substance_tags": "psilocybin", "topic_tags": "Depression,OCD,Headache / Migraine,Pharmacology,Mechanism of Action,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2022.08.8.2", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2022.08.8.2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2022.08.8.2", "source_url": "https://doi.org/10.1176/appi.pn.2022.08.8.2", "doi": "10.1176/appi.pn.2022.08.8.2", "pmid": "", "publication_date": "2022-07-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4948, "title": "Psilocybin: crystal structure solutions enable phase analysis of prior art and recently patented examples", "authors": "James A. Kaduk, Alexander M. Sherwood, Robert B. Kargbo, Kristi W. Kaylo, Poncho Meisenheimer, Nicholas V. Cozzi", "journal": "Acta Crystallographica Section A Foundations and Advances", "publication_date": "2022-07-28", "publication_year": 2022, "doi": "10.1107/s2053273322097261", "pubmed_id": null, "openalex_id": "https://openalex.org/W4295955816", "source_url": "https://doi.org/10.1107/s2053273322097261", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1107/s2053273322097261", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1107/s2053273322097261", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1107/s2053273322097261", "source_url": "https://doi.org/10.1107/s2053273322097261", "doi": "10.1107/s2053273322097261", "pmid": "", "publication_date": "2022-07-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3594, "title": "Evaluation of Psilocybin in Anorexia Nervosa: Safety and Efficacy", "authors": "University of California, San Diego", "journal": "ClinicalTrials.gov", "publication_date": "2022-07-24", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04661514", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Eating Disorders,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04661514", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04661514", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04661514", "source_url": "https://clinicaltrials.gov/study/NCT04661514", "doi": "", "pmid": "", "publication_date": "2022-07-24", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3220, "title": "Psilocybin-induced reduction in chronic cluster headache attack frequency correlates with changes in hypothalamic functional connectivity", "authors": "Madsen MK, Petersen AS, Stenbæk DS, Sørensen IM, Schiønning H, Fjeld T, Nykjær CH, Ulv Larsen SM, Grzywacz M, Mathiesen T, Klausen IL, Overgaard-Hansen O, Brendstrup-Brix K, Linnet K, Johansen SS, Fisher PM, Jensen RH, Knudsen GM.", "journal": "medRxiv", "publication_date": "2022-07-09", "publication_year": 2022, "doi": "10.1101/2022.07.10.22277414", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2022.07.10.22277414", "substance_tags": "psilocybin", "topic_tags": "Headache / Migraine,Brain Imaging,Mechanism of Action,Aging,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "DOI:10.1101/2022.07.10.22277414", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2022.07.10.22277414", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2022.07.10.22277414", "source_url": "https://doi.org/10.1101/2022.07.10.22277414", "doi": "10.1101/2022.07.10.22277414", "pmid": "", "publication_date": "2022-07-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1738, "title": "Psychedelics in the treatment of unipolar and bipolar depression.", "authors": "Bosch OG, Halm S, Seifritz E.", "journal": null, "publication_date": "2022-07-04", "publication_year": 2022, "doi": "10.1186/s40345-022-00265-5", "pubmed_id": "35788817", "openalex_id": null, "source_url": "https://doi.org/10.1186/s40345-022-00265-5", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:35788817", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1186/s40345-022-00265-5", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35788817", "source_url": "https://doi.org/10.1186/s40345-022-00265-5", "doi": "10.1186/s40345-022-00265-5", "pmid": "35788817", "publication_date": "2022-07-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1693, "title": "Psychedelic drugs for psychiatric disorders.", "authors": "da Costa SC, Oesterle T, Rummans TA, Richelson E, Gold M.", "journal": null, "publication_date": "2022-07-04", "publication_year": 2022, "doi": "10.1016/j.jns.2022.120332", "pubmed_id": "35841696", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jns.2022.120332", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Consciousness,Aging,Spirituality,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:35841696", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jns.2022.120332", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35841696", "source_url": "https://doi.org/10.1016/j.jns.2022.120332", "doi": "10.1016/j.jns.2022.120332", "pmid": "35841696", "publication_date": "2022-07-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3653, "title": "Randomized Double Blind Placebo Controlled Assessing the Efficacy of Micro-dosed Psilocybin in Reducing Anxiety and or Depression Levels in Adults", "authors": "Wake Network, Inc.", "journal": "ClinicalTrials.gov", "publication_date": "2022-06-29", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04989972", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Wellbeing,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04989972", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04989972", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04989972", "source_url": "https://clinicaltrials.gov/study/NCT04989972", "doi": "", "pmid": "", "publication_date": "2022-06-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1753, "title": "3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Therapy in Hawaii: A Brief Review.", "authors": "Inouye A, Wolfgang A.", "journal": null, "publication_date": "2022-06-27", "publication_year": 2022, "doi": "10.7759/cureus.26402", "pubmed_id": "35915689", "openalex_id": null, "source_url": "https://doi.org/10.7759/cureus.26402", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:35915689", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.7759/cureus.26402", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35915689", "source_url": "https://doi.org/10.7759/cureus.26402", "doi": "10.7759/cureus.26402", "pmid": "35915689", "publication_date": "2022-06-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4955, "title": "Applying Lessons From Cannabis to the Psychedelic Highway", "authors": "Kevin F. Boehnke, Alan K. Davis, Jenna McAfee", "journal": "JAMA Health Forum", "publication_date": "2022-06-16", "publication_year": 2022, "doi": "10.1001/jamahealthforum.2022.1618", "pubmed_id": "36219016", "openalex_id": "https://openalex.org/W4283029950", "source_url": "https://doi.org/10.1001/jamahealthforum.2022.1618", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36219016", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1001/jamahealthforum.2022.1618", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:36219016", "source_url": "https://doi.org/10.1001/jamahealthforum.2022.1618", "doi": "10.1001/jamahealthforum.2022.1618", "pmid": "36219016", "publication_date": "2022-06-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1759, "title": "Validation of the forced swim test in Drosophila, and its use to demonstrate psilocybin has long-lasting antidepressant-like effects in flies.", "authors": "Hibicke M, Nichols CD.", "journal": "Scientific Reports", "publication_date": "2022-06-14", "publication_year": 2022, "doi": "10.1038/s41598-022-14165-2", "pubmed_id": "35705666", "openalex_id": "https://openalex.org/W4282963889", "source_url": "https://doi.org/10.1038/s41598-022-14165-2", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:35705666", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1038/s41598-022-14165-2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35705666", "source_url": "https://doi.org/10.1038/s41598-022-14165-2", "doi": "10.1038/s41598-022-14165-2", "pmid": "35705666", "publication_date": "2022-06-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4956, "title": "Psychedelic assisted therapy for major depressive disorder: Recent work and clinical directions", "authors": "Annie M. McCartney, H. T. McGovern, Alexander De Foe", "journal": "Journal of Psychedelic Studies", "publication_date": "2022-06-08", "publication_year": 2022, "doi": "10.1556/2054.2022.00211", "pubmed_id": null, "openalex_id": "https://openalex.org/W4282040347", "source_url": "https://doi.org/10.1556/2054.2022.00211", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2022.00211", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2022.00211", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2022.00211", "source_url": "https://doi.org/10.1556/2054.2022.00211", "doi": "10.1556/2054.2022.00211", "pmid": "", "publication_date": "2022-06-08", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4961, "title": "Neuropharmacological analysis of the anti-addictive and therapeutic effects of psilocybin", "authors": "Anthony Principe", "journal": "SURG Journal", "publication_date": "2022-05-31", "publication_year": 2022, "doi": "10.21083/surg.v14i1.6870", "pubmed_id": null, "openalex_id": "https://openalex.org/W4281736251", "source_url": "https://doi.org/10.21083/surg.v14i1.6870", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.21083/surg.v14i1.6870", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.21083/surg.v14i1.6870", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.21083/surg.v14i1.6870", "source_url": "https://doi.org/10.21083/surg.v14i1.6870", "doi": "10.21083/surg.v14i1.6870", "pmid": "", "publication_date": "2022-05-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4959, "title": "The safety and efficacy of psilocybin therapy in patients with cancer and major depressive disorder.", "authors": "Manish Agrawal, Paul Thambi, Sarah Shnayder", "journal": "Journal of Clinical Oncology", "publication_date": "2022-05-31", "publication_year": 2022, "doi": "10.1200/jco.2022.40.16_suppl.12097", "pubmed_id": null, "openalex_id": "https://openalex.org/W4281784879", "source_url": "https://doi.org/10.1200/jco.2022.40.16_suppl.12097", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Observational Study,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1200/jco.2022.40.16_suppl.12097", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1200/jco.2022.40.16_suppl.12097", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1200/jco.2022.40.16_suppl.12097", "source_url": "https://doi.org/10.1200/jco.2022.40.16_suppl.12097", "doi": "10.1200/jco.2022.40.16_suppl.12097", "pmid": "", "publication_date": "2022-05-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1713, "title": "Review of potential psychedelic treatments for PTSD.", "authors": "Henner RL, Keshavan MS, Hill KP.", "journal": null, "publication_date": "2022-05-29", "publication_year": 2022, "doi": "10.1016/j.jns.2022.120302", "pubmed_id": "35700643", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jns.2022.120302", "substance_tags": "psilocybin", "topic_tags": "PTSD,Mechanism of Action,Clinical Trial,Review Article,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:35700643", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jns.2022.120302", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35700643", "source_url": "https://doi.org/10.1016/j.jns.2022.120302", "doi": "10.1016/j.jns.2022.120302", "pmid": "35700643", "publication_date": "2022-05-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1780, "title": "Unraveling the Mysteries of Mental Illness With Psilocybin.", "authors": "Sotille R, Singh H, Weisman A, Vida T.", "journal": null, "publication_date": "2022-05-26", "publication_year": 2022, "doi": "10.7759/cureus.25414", "pubmed_id": "35769681", "openalex_id": null, "source_url": "https://doi.org/10.7759/cureus.25414", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Neuroplasticity,Receptor Pharmacology,Clinical Trial,Review Article,Animal Study,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:35769681", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.7759/cureus.25414", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35769681", "source_url": "https://doi.org/10.7759/cureus.25414", "doi": "10.7759/cureus.25414", "pmid": "35769681", "publication_date": "2022-05-26", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3676, "title": "Psilocybin Versus Ketamine - Fast Acting Antidepressant Strategies in Treatment-resistant Depression", "authors": "National Institute of Mental Health, Czech Republic", "journal": "ClinicalTrials.gov", "publication_date": "2022-05-19", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05383313", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Neuroplasticity,Brain Imaging,Biomarkers,Aging,Emotional Processing,Clinical Trial,Healthy Volunteers,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05383313", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05383313", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05383313", "source_url": "https://clinicaltrials.gov/study/NCT05383313", "doi": "", "pmid": "", "publication_date": "2022-05-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4968, "title": "The Efficacy of Psilocybin in the Treatment of Depression andAnxiety: A Meta-Analysis", "authors": "Andrew Hodge, Suporn Sukpraprut-Braaten, Robert Strayhan", "journal": "Current Psychiatry Research and Reviews", "publication_date": "2022-05-15", "publication_year": 2022, "doi": "10.2174/2666082218666220513142002", "pubmed_id": null, "openalex_id": "https://openalex.org/W4280584826", "source_url": "https://doi.org/10.2174/2666082218666220513142002", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Meta-Analysis", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.2174/2666082218666220513142002", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.2174/2666082218666220513142002", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.2174/2666082218666220513142002", "source_url": "https://doi.org/10.2174/2666082218666220513142002", "doi": "10.2174/2666082218666220513142002", "pmid": "", "publication_date": "2022-05-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3659, "title": "Phase II, Randomized, Double Blind, Placebo Controlled, Parallel Group, Single Center Study of Psilocybin Efficacy in Major Depression", "authors": "University of Zurich", "journal": "ClinicalTrials.gov", "publication_date": "2022-04-28", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT03715127", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Consciousness,Biomarkers,Aging,Resilience,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Review Article,Cancer Patients", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT03715127", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT03715127", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT03715127", "source_url": "https://clinicaltrials.gov/study/NCT03715127", "doi": "", "pmid": "", "publication_date": "2022-04-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4974, "title": "P388. Open Label Psilocybin Administration in Severely Treatment Resistant Depression", "authors": "Scott Aaronson, Tammy Miller, Samuel Rudow, MacKenzie Forbes, Trisha Suppes", "journal": "Biological Psychiatry", "publication_date": "2022-04-27", "publication_year": 2022, "doi": "10.1016/j.biopsych.2022.02.624", "pubmed_id": null, "openalex_id": "https://openalex.org/W4225010514", "source_url": "https://doi.org/10.1016/j.biopsych.2022.02.624", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1016/j.biopsych.2022.02.624", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.biopsych.2022.02.624", "source_url": "https://doi.org/10.1016/j.biopsych.2022.02.624", "doi": "10.1016/j.biopsych.2022.02.624", "pmid": "", "publication_date": "2022-04-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1761, "title": "Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges.", "authors": "Rossi GN, Hallak JEC, Bouso Saiz JC, Dos Santos RG.", "journal": "Expert Opinion on Drug Safety", "publication_date": "2022-04-26", "publication_year": 2022, "doi": "10.1080/14740338.2022.2066650", "pubmed_id": "35426754", "openalex_id": "https://openalex.org/W4223893856", "source_url": "https://doi.org/10.1080/14740338.2022.2066650", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:35426754", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/14740338.2022.2066650", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35426754", "source_url": "https://doi.org/10.1080/14740338.2022.2066650", "doi": "10.1080/14740338.2022.2066650", "pmid": "35426754", "publication_date": "2022-04-26", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1653, "title": "Diverse therapeutic developments for post-traumatic stress disorder (PTSD) indicate common mechanisms of memory modulation.", "authors": "Raut SB, Marathe PA, van Eijk L, Eri R, Ravindran M, Benedek DM, Ursano RJ, Canales JJ, Johnson LR.", "journal": null, "publication_date": "2022-04-26", "publication_year": 2022, "doi": "10.1016/j.pharmthera.2022.108195", "pubmed_id": "35489438", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.pharmthera.2022.108195", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:35489438", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.pharmthera.2022.108195", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35489438", "source_url": "https://doi.org/10.1016/j.pharmthera.2022.108195", "doi": "10.1016/j.pharmthera.2022.108195", "pmid": "35489438", "publication_date": "2022-04-26", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1798, "title": "Increased global integration in the brain after psilocybin therapy for depression.", "authors": "Daws RE, Timmermann C, Giribaldi B, Sexton JD, Wall MB, Erritzoe D, Roseman L, Nutt D, Carhart-Harris R.", "journal": "Nature Medicine", "publication_date": "2022-04-10", "publication_year": 2022, "doi": "10.1038/s41591-022-01744-z", "pubmed_id": "35411074", "openalex_id": "https://openalex.org/W4223491164", "source_url": "https://doi.org/10.1038/s41591-022-01744-z", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Receptor Pharmacology,Aging,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:35411074", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1038/s41591-022-01744-z", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35411074", "source_url": "https://doi.org/10.1038/s41591-022-01744-z", "doi": "10.1038/s41591-022-01744-z", "pmid": "35411074", "publication_date": "2022-04-10", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1796, "title": "Associations between classic psychedelics and opioid use disorder in a nationally-representative U.S. adult sample.", "authors": "Jones G, Ricard JA, Lipson J, Nock MK.", "journal": "Scientific Reports", "publication_date": "2022-04-06", "publication_year": 2022, "doi": "10.1038/s41598-022-08085-4", "pubmed_id": "35393455", "openalex_id": "https://openalex.org/W4223525754", "source_url": "https://doi.org/10.1038/s41598-022-08085-4", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:35393455", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1038/s41598-022-08085-4", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35393455", "source_url": "https://doi.org/10.1038/s41598-022-08085-4", "doi": "10.1038/s41598-022-08085-4", "pmid": "35393455", "publication_date": "2022-04-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1793, "title": "Psilocybin Therapy of Psychiatric Disorders Is Not Hampered by hERG Potassium Channel-Mediated Cardiotoxicity.", "authors": "Hackl B, Todt H, Kubista H, Kubista H, Hilber K, Koenig X.", "journal": "The International Journal of Neuropsychopharmacology", "publication_date": "2022-03-31", "publication_year": 2022, "doi": "10.1093/ijnp/pyab085", "pubmed_id": "34871422", "openalex_id": "https://openalex.org/W4200455094", "source_url": "https://doi.org/10.1093/ijnp/pyab085", "substance_tags": "psilocybin,psilocin", "topic_tags": "Aging,Clinical Trial,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:34871422", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1093/ijnp/pyab085", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34871422", "source_url": "https://doi.org/10.1093/ijnp/pyab085", "doi": "10.1093/ijnp/pyab085", "pmid": "34871422", "publication_date": "2022-03-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1802, "title": "Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression.", "authors": "Murphy R, Kettner H, Zeifman R, Giribaldi B, Kartner L, Martell J, Read T, Murphy-Beiner A, Baker-Jones M, Nutt D, Erritzoe D, Watts R, Carhart-Harris R.", "journal": "Frontiers in Pharmacology", "publication_date": "2022-03-30", "publication_year": 2022, "doi": "10.3389/fphar.2021.788155", "pubmed_id": "35431912", "openalex_id": "https://openalex.org/W4221001769", "source_url": "https://doi.org/10.3389/fphar.2021.788155", "substance_tags": "psilocybin", "topic_tags": "Depression,Emotional Processing,Mystical Experience,Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:35431912", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fphar.2021.788155", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35431912", "source_url": "https://doi.org/10.3389/fphar.2021.788155", "doi": "10.3389/fphar.2021.788155", "pmid": "35431912", "publication_date": "2022-03-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1745, "title": "Tentative identification of in vitro metabolites of O-acetylpsilocin (psilacetin, 4-AcO-DMT) by UHPLC-Q-Orbitrap MS.", "authors": "Zhai W, Li L, Zhao J, Xiang P, Liu M, Shi Y, Dang Y.", "journal": "Drug Testing and Analysis", "publication_date": "2022-03-28", "publication_year": 2022, "doi": "10.1002/dta.3255", "pubmed_id": "35312166", "openalex_id": "https://openalex.org/W4220970406", "source_url": "https://doi.org/10.1002/dta.3255", "substance_tags": "psilocybin,psilocin", "topic_tags": "Pharmacology,Biomarkers,Epigenetics,Clinical Trial,In Vitro Study", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:35312166", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1002/dta.3255", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35312166", "source_url": "https://doi.org/10.1002/dta.3255", "doi": "10.1002/dta.3255", "pmid": "35312166", "publication_date": "2022-03-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1803, "title": "Psilocybin-Assisted Compassion Focused Therapy for Depression.", "authors": "Pots W, Chakhssi F.", "journal": "Frontiers in Psychology", "publication_date": "2022-03-24", "publication_year": 2022, "doi": "10.3389/fpsyg.2022.812930", "pubmed_id": "35401294", "openalex_id": "https://openalex.org/W4221031753", "source_url": "https://doi.org/10.3389/fpsyg.2022.812930", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:35401294", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fpsyg.2022.812930", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35401294", "source_url": "https://doi.org/10.3389/fpsyg.2022.812930", "doi": "10.3389/fpsyg.2022.812930", "pmid": "35401294", "publication_date": "2022-03-24", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4980, "title": "Demystifying Psychedelic Treatments in Psychiatry: Is Ego Dissolution the Solution?", "authors": "Michael Avissar, Adrian Jacques H. Ambrose", "journal": "Psychiatric News", "publication_date": "2022-03-23", "publication_year": 2022, "doi": "10.1176/appi.pn.2022.04.4.35", "pubmed_id": null, "openalex_id": "https://openalex.org/W4220982704", "source_url": "https://doi.org/10.1176/appi.pn.2022.04.4.35", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Eating Disorders,End-of-Life Distress,Headache / Migraine,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Biomarkers,Personality Change,Emotional Processing,Mystical Experience,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2022.04.4.35", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2022.04.4.35", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2022.04.4.35", "source_url": "https://doi.org/10.1176/appi.pn.2022.04.4.35", "doi": "10.1176/appi.pn.2022.04.4.35", "pmid": "", "publication_date": "2022-03-23", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1765, "title": "The promises and perils of psychedelic pharmacology for psychiatry.", "authors": "McClure-Begley TD, Roth BL.", "journal": null, "publication_date": "2022-03-16", "publication_year": 2022, "doi": "10.1038/s41573-022-00421-7", "pubmed_id": "35301459", "openalex_id": null, "source_url": "https://doi.org/10.1038/s41573-022-00421-7", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:35301459", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1038/s41573-022-00421-7", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35301459", "source_url": "https://doi.org/10.1038/s41573-022-00421-7", "doi": "10.1038/s41573-022-00421-7", "pmid": "35301459", "publication_date": "2022-03-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1811, "title": "Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - Rationale and study design.", "authors": "Mertens LJ, Koslowski M, Betzler F, Evens R, Gilles M, Jungaberle A, Jungaberle H, Majić T, Ströhle A, Wolff M, Wellek S, Gründer G.", "journal": "Neuroscience Applied", "publication_date": "2022-03-06", "publication_year": 2022, "doi": "10.1016/j.nsa.2022.100104", "pubmed_id": "40656230", "openalex_id": "https://openalex.org/W4220708535", "source_url": "https://doi.org/10.1016/j.nsa.2022.100104", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:40656230", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.nsa.2022.100104", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40656230", "source_url": "https://doi.org/10.1016/j.nsa.2022.100104", "doi": "10.1016/j.nsa.2022.100104", "pmid": "40656230", "publication_date": "2022-03-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1769, "title": "The therapeutic potential of psilocybin: a systematic review.", "authors": "van Amsterdam J, van den Brink W.", "journal": null, "publication_date": "2022-03-01", "publication_year": 2022, "doi": "10.1080/14740338.2022.2047929", "pubmed_id": "35225143", "openalex_id": null, "source_url": "https://doi.org/10.1080/14740338.2022.2047929", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:35225143", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/14740338.2022.2047929", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35225143", "source_url": "https://doi.org/10.1080/14740338.2022.2047929", "doi": "10.1080/14740338.2022.2047929", "pmid": "35225143", "publication_date": "2022-03-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1611, "title": "The Use of Psilocybin in the Treatment of Psychiatric Disorders with Attention to Relative Safety Profile: A Systematic Review.", "authors": "Hodge AT, Sukpraprut-Braaten S, Narlesky M, Strayhan RC.", "journal": null, "publication_date": "2022-02-27", "publication_year": 2022, "doi": "10.1080/02791072.2022.2044096", "pubmed_id": "35225726", "openalex_id": null, "source_url": "https://doi.org/10.1080/02791072.2022.2044096", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Clinical Trial,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:35225726", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/02791072.2022.2044096", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35225726", "source_url": "https://doi.org/10.1080/02791072.2022.2044096", "doi": "10.1080/02791072.2022.2044096", "pmid": "35225726", "publication_date": "2022-02-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1821, "title": "Psilocybin: Characterization of the Metastable Zone Width (MSZW), Control of Anhydrous Polymorphs, and Particle Size Distribution (PSD).", "authors": "Kargbo RB, Sherwood AM, Meisenheimer P, Lenoch K, Abebe S.", "journal": "ACS Omega", "publication_date": "2022-02-06", "publication_year": 2022, "doi": "10.1021/acsomega.1c06708", "pubmed_id": "35187358", "openalex_id": "https://openalex.org/W4210846812", "source_url": "https://doi.org/10.1021/acsomega.1c06708", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Drug Interactions", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:35187358", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1021/acsomega.1c06708", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35187358", "source_url": "https://doi.org/10.1021/acsomega.1c06708", "doi": "10.1021/acsomega.1c06708", "pmid": "35187358", "publication_date": "2022-02-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1825, "title": "Analysis of Psilocybin-Assisted Therapy in Medicine: A Narrative Review.", "authors": "Ziff S, Stern B, Lewis G, Majeed M, Gorantla VR.", "journal": null, "publication_date": "2022-02-04", "publication_year": 2022, "doi": "10.7759/cureus.21944", "pubmed_id": "35273885", "openalex_id": null, "source_url": "https://doi.org/10.7759/cureus.21944", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:35273885", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.7759/cureus.21944", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35273885", "source_url": "https://doi.org/10.7759/cureus.21944", "doi": "10.7759/cureus.21944", "pmid": "35273885", "publication_date": "2022-02-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1771, "title": "Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants.", "authors": "Müller F, Kraus E, Holze F, Becker A, Ley L, Schmid Y, Vizeli P, Liechti ME, Borgwardt S.", "journal": "Psychopharmacology", "publication_date": "2022-01-24", "publication_year": 2022, "doi": "10.1007/s00213-022-06066-z", "pubmed_id": "35076721", "openalex_id": "https://openalex.org/W4206965048", "source_url": "https://doi.org/10.1007/s00213-022-06066-z", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Healthy Volunteers", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:35076721", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s00213-022-06066-z", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35076721", "source_url": "https://doi.org/10.1007/s00213-022-06066-z", "doi": "10.1007/s00213-022-06066-z", "pmid": "35076721", "publication_date": "2022-01-24", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1746, "title": "Novel Antidepressants in the Pipeline (Phase II and III): A Systematic Review of the US Clinical Trials Registry.", "authors": "Sakurai H, Yonezawa K, Tani H, Mimura M, Bauer M, Uchida H.", "journal": null, "publication_date": "2022-01-18", "publication_year": 2022, "doi": "10.1055/a-1714-9097", "pubmed_id": "35045580", "openalex_id": null, "source_url": "https://doi.org/10.1055/a-1714-9097", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:35045580", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1055/a-1714-9097", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35045580", "source_url": "https://doi.org/10.1055/a-1714-9097", "doi": "10.1055/a-1714-9097", "pmid": "35045580", "publication_date": "2022-01-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4993, "title": "Psilocybine vergeleken met escitalopram bij depressie", "authors": "Jurriaan F. M. Strous", "journal": "Pure Amsterdam UMC", "publication_date": "2022-01-16", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7132220122", "source_url": "https://pure.amsterdamumc.nl/en/publications/b99a8d48-a871-49d6-978c-969dd09a6dae", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "https://pure.amsterdamumc.nl/en/publications/b99a8d48-a871-49d6-978c-969dd09a6dae", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://pure.amsterdamumc.nl/en/publications/b99a8d48-a871-49d6-978c-969dd09a6dae", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://pure.amsterdamumc.nl/en/publications/b99a8d48-a871-49d6-978c-969dd09a6dae", "source_url": "https://pure.amsterdamumc.nl/en/publications/b99a8d48-a871-49d6-978c-969dd09a6dae", "doi": "", "pmid": "", "publication_date": "2022-01-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1834, "title": "[Psilocybin compared with escitalopram for depression].", "authors": "Strous JFM.", "journal": "PubMed", "publication_date": "2022-01-16", "publication_year": 2022, "doi": null, "pubmed_id": "35138714", "openalex_id": "https://openalex.org/W4221159545", "source_url": "https://europepmc.org/article/MED/35138714", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:35138714", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/MED/35138714", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35138714", "source_url": "https://europepmc.org/article/MED/35138714", "doi": "", "pmid": "35138714", "publication_date": "2022-01-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1829, "title": "Analysis of recreational psychedelic substance use experiences classified by substance.", "authors": "Hase A, Erdmann M, Limbach V, Hasler G.", "journal": "Psychopharmacology", "publication_date": "2022-01-14", "publication_year": 2022, "doi": "10.1007/s00213-022-06062-3", "pubmed_id": "35031816", "openalex_id": "https://openalex.org/W4205576215", "source_url": "https://doi.org/10.1007/s00213-022-06062-3", "substance_tags": "psilocybin", "topic_tags": "Addiction,Biomarkers,Emotional Processing,Mystical Experience,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:35031816", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s00213-022-06062-3", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35031816", "source_url": "https://doi.org/10.1007/s00213-022-06062-3", "doi": "10.1007/s00213-022-06062-3", "pmid": "35031816", "publication_date": "2022-01-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4994, "title": "Pennsylvania bill seeks clinical research on psychedelics", "authors": "Valerie A. Canady", "journal": "Mental Health Weekly", "publication_date": "2022-01-13", "publication_year": 2022, "doi": "10.1002/mhw.33077", "pubmed_id": null, "openalex_id": "https://openalex.org/W4205137701", "source_url": "https://doi.org/10.1002/mhw.33077", "substance_tags": "psilocybin", "topic_tags": "PTSD,Clinical Trial,Veterans", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1002/mhw.33077", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/mhw.33077", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/mhw.33077", "source_url": "https://doi.org/10.1002/mhw.33077", "doi": "10.1002/mhw.33077", "pmid": "", "publication_date": "2022-01-13", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1773, "title": "Assessing the risk-benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research.", "authors": "Bender D, Hellerstein DJ.", "journal": null, "publication_date": "2022-01-12", "publication_year": 2022, "doi": "10.1007/s00213-021-06049-6", "pubmed_id": "35022823", "openalex_id": null, "source_url": "https://doi.org/10.1007/s00213-021-06049-6", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Aging,Clinical Trial,Review Article,Case Report,Observational Study,Healthy Volunteers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:35022823", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s00213-021-06049-6", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35022823", "source_url": "https://doi.org/10.1007/s00213-021-06049-6", "doi": "10.1007/s00213-021-06049-6", "pmid": "35022823", "publication_date": "2022-01-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1847, "title": "The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation.", "authors": "Rucker JJ, Marwood L, Ajantaival RJ, Bird C, Eriksson H, Harrison J, Lennard-Jones M, Mistry S, Saldarini F, Stansfield S, Tai SJ, Williams S, Weston N, Malievskaia E, Young AH.", "journal": "Journal of Psychopharmacology", "publication_date": "2022-01-03", "publication_year": 2022, "doi": "10.1177/02698811211064720", "pubmed_id": "35090363", "openalex_id": "https://openalex.org/W4205906672", "source_url": "https://doi.org/10.1177/02698811211064720", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Healthy Volunteers,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:35090363", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02698811211064720", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35090363", "source_url": "https://doi.org/10.1177/02698811211064720", "doi": "10.1177/02698811211064720", "pmid": "35090363", "publication_date": "2022-01-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5014, "title": "Psilocybin may be effective for treatment-resistant depression", "authors": "", "journal": "Pharmaceutical journal/˜The œpharmaceutical journal", "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.1211/pj.2022.1.164911", "pubmed_id": null, "openalex_id": "https://openalex.org/W4313001717", "source_url": "https://doi.org/10.1211/pj.2022.1.164911", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1211/pj.2022.1.164911", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1211/pj.2022.1.164911", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1211/pj.2022.1.164911", "source_url": "https://doi.org/10.1211/pj.2022.1.164911", "doi": "10.1211/pj.2022.1.164911", "pmid": "", "publication_date": "2021-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5005, "title": "The efficacy of COMP360 psilocybin therapy in treatment-resistant depression: exploratory results from a phase IIb randomised controlled trial", "authors": "G. Goodwin, Scott T. Aaronson, Boadie W. Dunlop, D. Feifel, David J. Hellerstein, L. Marwood, S. Mistry, Metten Somers, S.C. Stansfield, J. Tsai, S. Williams, Allan H. Young, Sidney Zisook, E. Malievskaia", "journal": "Neuroscience Applied", "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.1016/j.nsa.2022.100213", "pubmed_id": null, "openalex_id": "https://openalex.org/W4313200620", "source_url": "https://doi.org/10.1016/j.nsa.2022.100213", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2022.100213", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2022.100213", "source_url": "https://doi.org/10.1016/j.nsa.2022.100213", "doi": "10.1016/j.nsa.2022.100213", "pmid": "", "publication_date": "2021-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5002, "title": "The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a phase IIb randomised controlled trial", "authors": "G.M. Goodwin, Scott T. Aaronson, Boadie W. Dunlop, David Feifel, David J. Hellerstein, N. Hewitt, L. Marwood, S. Mistry, Metten Somers, S.C. Stansfield, J. Tsai, S. Williams, Antony Young, Sidney Zisook, E. Malievskaia", "journal": "Neuroscience Applied", "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.1016/j.nsa.2022.100511", "pubmed_id": null, "openalex_id": "https://openalex.org/W4313199626", "source_url": "https://doi.org/10.1016/j.nsa.2022.100511", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2022.100511", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2022.100511", "source_url": "https://doi.org/10.1016/j.nsa.2022.100511", "doi": "10.1016/j.nsa.2022.100511", "pmid": "", "publication_date": "2021-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4999, "title": "Standards Without Labs: Drug Development in the Psychedelic Underground", "authors": "John Bailey, Joanna Kempner", "journal": "Citizen Science Theory and Practice", "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.5334/cstp.527", "pubmed_id": null, "openalex_id": "https://openalex.org/W4312994437", "source_url": "https://doi.org/10.5334/cstp.527", "substance_tags": "psilocybin", "topic_tags": "Headache / Migraine,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.5334/cstp.527", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5334/cstp.527", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5334/cstp.527", "source_url": "https://doi.org/10.5334/cstp.527", "doi": "10.5334/cstp.527", "pmid": "", "publication_date": "2021-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4998, "title": "An Interpretative Phenomenological Analysis of the use of psilocybin by veterans with symptoms of trauma", "authors": "F. N. Smith, Joanna C. Neill, Verity Wainwright", "journal": "Drug Science Policy and Law", "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.1177/20503245221124117", "pubmed_id": null, "openalex_id": "https://openalex.org/W4295169116", "source_url": "https://doi.org/10.1177/20503245221124117", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Veterans,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1177/20503245221124117", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/20503245221124117", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/20503245221124117", "source_url": "https://doi.org/10.1177/20503245221124117", "doi": "10.1177/20503245221124117", "pmid": "", "publication_date": "2021-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1857, "title": "Psilocybin for the Treatment of Depression: A Promising New Pharmacotherapy Approach.", "authors": "Agin-Liebes G, Davis AK.", "journal": "Current topics in behavioral neurosciences", "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.1007/7854_2021_282", "pubmed_id": "34811715", "openalex_id": "https://openalex.org/W3216485471", "source_url": "https://doi.org/10.1007/7854_2021_282", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Aging,Clinical Trial,Review Article,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:34811715", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/7854_2021_282", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34811715", "source_url": "https://doi.org/10.1007/7854_2021_282", "doi": "10.1007/7854_2021_282", "pmid": "34811715", "publication_date": "2021-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1854, "title": "Psychedelic medicines for mood disorders: current evidence and clinical considerations.", "authors": "Sarris J, Pinzon Rubiano D, Day K, Galvão-Coelho NL, Perkins D.", "journal": "PubMed", "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.1097/yco.0000000000000759", "pubmed_id": "34855694", "openalex_id": "https://openalex.org/W3214407741", "source_url": "https://doi.org/10.1097/yco.0000000000000759", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Neuroplasticity,Neurogenesis,Mechanism of Action,Aging,Microdosing,Clinical Trial,Review Article,Animal Study,Treatment-Resistant Depression,Genomics,Microbiome,Inflammation", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:34855694", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1097/yco.0000000000000759", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34855694", "source_url": "https://doi.org/10.1097/yco.0000000000000759", "doi": "10.1097/yco.0000000000000759", "pmid": "34855694", "publication_date": "2021-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1850, "title": "Psilocybin: crystal structure solutions enable phase analysis of prior art and recently patented examples.", "authors": "Sherwood AM, Kargbo RB, Kaylo KW, Cozzi NV, Meisenheimer P, Kaduk JA.", "journal": "Acta Crystallographica Section C Structural Chemistry", "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.1107/s2053229621013164", "pubmed_id": "34982048", "openalex_id": "https://openalex.org/W4200445562", "source_url": "https://doi.org/10.1107/s2053229621013164", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:34982048", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1107/s2053229621013164", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34982048", "source_url": "https://doi.org/10.1107/s2053229621013164", "doi": "10.1107/s2053229621013164", "pmid": "34982048", "publication_date": "2021-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1844, "title": "Psilocybin Conspectus: Status, Production Methods, and Considerations.", "authors": "Plotnik L, Gibbs G, Graham T.", "journal": "International journal of medicinal mushrooms", "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.1615/intjmedmushrooms.2021041921", "pubmed_id": "35442591", "openalex_id": "https://openalex.org/W3214903520", "source_url": "https://doi.org/10.1615/intjmedmushrooms.2021041921", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:35442591", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1615/intjmedmushrooms.2021041921", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35442591", "source_url": "https://doi.org/10.1615/intjmedmushrooms.2021041921", "doi": "10.1615/intjmedmushrooms.2021041921", "pmid": "35442591", "publication_date": "2021-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1807, "title": "Effects of Naturalistic Psychedelic Use on Depression, Anxiety, and Well-Being: Associations With Patterns of Use, Reported Harms, and Transformative Mental States.", "authors": "Raison CL, Jain R, Penn AD, Cole SP, Jain S", "journal": "Frontiers in psychiatry", "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.3389/fpsyt.2022.831092", "pubmed_id": "35370864", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35370864/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Wellbeing,Emotional Processing,Mystical Experience,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:39", "bibtex": null, "source_record_id": "PMID:35370864", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35370864/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35370864", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35370864/", "doi": "10.3389/fpsyt.2022.831092", "pmid": "35370864", "publication_date": "2021-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1747, "title": "A systematic literature review of clinical trials and therapeutic applications of ibogaine.", "authors": "Köck P, Froelich K, Walter M, Lang U, Dürsteler KM.", "journal": null, "publication_date": "2021-12-29", "publication_year": 2021, "doi": "10.1016/j.jsat.2021.108717", "pubmed_id": "35012793", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jsat.2021.108717", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Case Report,Observational Study", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:35012793", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jsat.2021.108717", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35012793", "source_url": "https://doi.org/10.1016/j.jsat.2021.108717", "doi": "10.1016/j.jsat.2021.108717", "pmid": "35012793", "publication_date": "2021-12-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3526, "title": "LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders: a Randomized, Double-blind, Placebo-controlled Phase II Study", "authors": "University Hospital, Basel, Switzerland", "journal": "ClinicalTrials.gov", "publication_date": "2021-12-21", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT03153579", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT03153579", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT03153579", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT03153579", "source_url": "https://clinicaltrials.gov/study/NCT03153579", "doi": "", "pmid": "", "publication_date": "2021-12-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1871, "title": "Palliative care provider attitudes toward existential distress and treatment with psychedelic-assisted therapies.", "authors": "Niles H, Fogg C, Kelmendi B, Lazenby M", "journal": "BMC palliative care", "publication_date": "2021-12-19", "publication_year": 2021, "doi": "10.1186/s12904-021-00889-x", "pubmed_id": "34930220", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/34930220/", "substance_tags": "psilocybin", "topic_tags": "End-of-Life Distress,Spirituality,Clinical Trial,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:39", "bibtex": null, "source_record_id": "PMID:34930220", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34930220/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34930220", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34930220/", "doi": "10.1186/s12904-021-00889-x", "pmid": "34930220", "publication_date": "2021-12-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1808, "title": "Psilocybin-assisted psychotherapy for depression: Emerging research on a psychedelic compound with a rich history.", "authors": "Pearson C, Siegel J, Gold JA.", "journal": null, "publication_date": "2021-12-15", "publication_year": 2021, "doi": "10.1016/j.jns.2021.120096", "pubmed_id": "34942586", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jns.2021.120096", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:34942586", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jns.2021.120096", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34942586", "source_url": "https://doi.org/10.1016/j.jns.2021.120096", "doi": "10.1016/j.jns.2021.120096", "pmid": "34942586", "publication_date": "2021-12-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5030, "title": "Announcement of two special issues: behavioural pharmacology of synaptopathies and psychedelic drugs", "authors": "Louk J. M. J. Vanderschuren, Paul Willner, Emily M. Jutkiewicz, Bart Ellenbroek", "journal": "Behavioural Pharmacology", "publication_date": "2021-12-12", "publication_year": 2021, "doi": "10.1097/fbp.0000000000000662", "pubmed_id": "35007231", "openalex_id": "https://openalex.org/W4200050959", "source_url": "https://doi.org/10.1097/fbp.0000000000000662", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:35007231", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1097/fbp.0000000000000662", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:35007231", "source_url": "https://doi.org/10.1097/fbp.0000000000000662", "doi": "10.1097/fbp.0000000000000662", "pmid": "35007231", "publication_date": "2021-12-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1845, "title": "Human behavioral pharmacology of psychedelics.", "authors": "Strickland JC, Johnson MW.", "journal": null, "publication_date": "2021-11-10", "publication_year": 2021, "doi": "10.1016/bs.apha.2021.10.003", "pubmed_id": "35341564", "openalex_id": null, "source_url": "https://doi.org/10.1016/bs.apha.2021.10.003", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Pharmacology,Mechanism of Action,Mystical Experience,Clinical Trial,Treatment-Resistant Depression,Abuse Liability", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:35341564", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/bs.apha.2021.10.003", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35341564", "source_url": "https://doi.org/10.1016/bs.apha.2021.10.003", "doi": "10.1016/bs.apha.2021.10.003", "pmid": "35341564", "publication_date": "2021-11-10", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1750, "title": "From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders.", "authors": "Kozlowska U, Nichols C, Wiatr K, Figiel M.", "journal": null, "publication_date": "2021-10-21", "publication_year": 2021, "doi": "10.1111/jnc.15509", "pubmed_id": "34519052", "openalex_id": null, "source_url": "https://doi.org/10.1111/jnc.15509", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Neuroplasticity,Mechanism of Action,Biomarkers,Clinical Trial,Review Article,Animal Study,Drug Interactions,Inflammation", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:34519052", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1111/jnc.15509", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34519052", "source_url": "https://doi.org/10.1111/jnc.15509", "doi": "10.1111/jnc.15509", "pmid": "34519052", "publication_date": "2021-10-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1894, "title": "Study Protocol for \"Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study\".", "authors": "Spriggs MJ, Douglass HM, Park RJ, Read T, Danby JL, de Magalhães FJC, Alderton KL, Williams TM, Blemings A, Lafrance A, Nicholls DE, Erritzoe D, Nutt DJ, Carhart-Harris RL.", "journal": "Frontiers in Psychiatry", "publication_date": "2021-10-19", "publication_year": 2021, "doi": "10.3389/fpsyt.2021.735523", "pubmed_id": "34744825", "openalex_id": "https://openalex.org/W3205506305", "source_url": "https://doi.org/10.3389/fpsyt.2021.735523", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,End-of-Life Distress,Neuroplasticity,Brain Imaging,Mechanism of Action,Biomarkers,Aging,Clinical Trial,Randomized Controlled Trial", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:34744825", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2021.735523", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34744825", "source_url": "https://doi.org/10.3389/fpsyt.2021.735523", "doi": "10.3389/fpsyt.2021.735523", "pmid": "34744825", "publication_date": "2021-10-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3459, "title": "The Safety and Efficacy of Psilocybin in Cancer Patients With Major Depressive Disorder", "authors": "Maryland Oncology Hematology, PA", "journal": "ClinicalTrials.gov", "publication_date": "2021-10-14", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04593563", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04593563", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04593563", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04593563", "source_url": "https://clinicaltrials.gov/study/NCT04593563", "doi": "", "pmid": "", "publication_date": "2021-10-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1899, "title": "Psilocybin for End-of-Life Anxiety Symptoms: A Systematic Review and Meta-Analysis.", "authors": "Yu CL, Yang FC, Yang SN, Tseng PT, Stubbs B, Yeh TC, Hsu CW, Li DJ, Liang CS.", "journal": null, "publication_date": "2021-10-07", "publication_year": 2021, "doi": "10.30773/pi.2021.0209", "pubmed_id": "34619818", "openalex_id": null, "source_url": "https://doi.org/10.30773/pi.2021.0209", "substance_tags": "psilocybin", "topic_tags": "Anxiety,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:34619818", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.30773/pi.2021.0209", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34619818", "source_url": "https://doi.org/10.30773/pi.2021.0209", "doi": "10.30773/pi.2021.0209", "pmid": "34619818", "publication_date": "2021-10-07", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1862, "title": "United States National Institutes of Health grant funding for psychedelic-assisted therapy clinical trials from 2006-2020.", "authors": "Barnett BS, Parker SE, Weleff J.", "journal": null, "publication_date": "2021-10-05", "publication_year": 2021, "doi": "10.1016/j.drugpo.2021.103473", "pubmed_id": "34624734", "openalex_id": "https://openalex.org/W3203419443", "source_url": "https://doi.org/10.1016/j.drugpo.2021.103473", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:34624734", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.drugpo.2021.103473", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34624734", "source_url": "https://doi.org/10.1016/j.drugpo.2021.103473", "doi": "10.1016/j.drugpo.2021.103473", "pmid": "34624734", "publication_date": "2021-10-05", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5054, "title": "Delix to synthesize psychedelic drugs", "authors": "Ryan Cross", "journal": "C&EN Global Enterprise", "publication_date": "2021-10-03", "publication_year": 2021, "doi": "10.1021/cen-09936-buscon3", "pubmed_id": null, "openalex_id": "https://openalex.org/W4367158646", "source_url": "http://dx.doi.org/10.1021/cen-09936-buscon3", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1021/cen-09936-buscon3", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1021/cen-09936-buscon3", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1021/cen-09936-buscon3", "source_url": "http://dx.doi.org/10.1021/cen-09936-buscon3", "doi": "10.1021/cen-09936-buscon3", "pmid": "", "publication_date": "2021-10-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1573, "title": "Novel antidepressant drugs: Beyond monoamine targets.", "authors": "Gonda X, Dome P, Neill JC, Tarazi FI.", "journal": null, "publication_date": "2021-09-29", "publication_year": 2021, "doi": "10.1017/s1092852921000791", "pubmed_id": "34588093", "openalex_id": null, "source_url": "https://doi.org/10.1017/s1092852921000791", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:34588093", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1017/s1092852921000791", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34588093", "source_url": "https://doi.org/10.1017/s1092852921000791", "doi": "10.1017/s1092852921000791", "pmid": "34588093", "publication_date": "2021-09-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5063, "title": "Is MDD the right target for early-stage psychedelic-assisted therapy trials?", "authors": "Benjamin R. Lewis, Kevin Byrne", "journal": "Journal of Psychedelic Studies", "publication_date": "2021-09-14", "publication_year": 2021, "doi": "10.1556/2054.2021.00180", "pubmed_id": null, "openalex_id": "https://openalex.org/W3199274122", "source_url": "https://doi.org/10.1556/2054.2021.00180", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Wellbeing,Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2021.00180", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2021.00180", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2021.00180", "source_url": "https://doi.org/10.1556/2054.2021.00180", "doi": "10.1556/2054.2021.00180", "pmid": "", "publication_date": "2021-09-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1864, "title": "Assessing the effects of methodological differences on outcomes in the use of psychedelics in the treatment of anxiety and depressive disorders: A systematic review and meta-analysis.", "authors": "Leger RF, Unterwald EM.", "journal": null, "publication_date": "2021-09-13", "publication_year": 2021, "doi": "10.1177/02698811211044688", "pubmed_id": "34519567", "openalex_id": null, "source_url": "https://doi.org/10.1177/02698811211044688", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Clinical Trial,Meta-Analysis,Systematic Review,Review Article", "study_type": "Meta-Analysis", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:34519567", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02698811211044688", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34519567", "source_url": "https://doi.org/10.1177/02698811211044688", "doi": "10.1177/02698811211044688", "pmid": "34519567", "publication_date": "2021-09-13", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5065, "title": "New Frontiers or a Bursting Bubble? Psychedelic Therapy Beyond the Dichotomy", "authors": "Tehseen Noorani, Jonny Martell", "journal": "Frontiers in Psychiatry", "publication_date": "2021-09-09", "publication_year": 2021, "doi": "10.3389/fpsyt.2021.727050", "pubmed_id": "34566724", "openalex_id": "https://openalex.org/W3201103091", "source_url": "https://doi.org/10.3389/fpsyt.2021.727050", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Wellbeing,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:34566724", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2021.727050", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:34566724", "source_url": "https://doi.org/10.3389/fpsyt.2021.727050", "doi": "10.3389/fpsyt.2021.727050", "pmid": "34566724", "publication_date": "2021-09-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1915, "title": "Blinding and expectancy confounds in psychedelic randomized controlled trials.", "authors": "Muthukumaraswamy SD, Forsyth A, Lumley T.", "journal": null, "publication_date": "2021-08-25", "publication_year": 2021, "doi": "10.1080/17512433.2021.1933434", "pubmed_id": "34038314", "openalex_id": null, "source_url": "https://doi.org/10.1080/17512433.2021.1933434", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:34038314", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/17512433.2021.1933434", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34038314", "source_url": "https://doi.org/10.1080/17512433.2021.1933434", "doi": "10.1080/17512433.2021.1933434", "pmid": "34038314", "publication_date": "2021-08-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5069, "title": "Beckley raises funds for psychedelic drugs", "authors": "Ryan Cross", "journal": "C&EN Global Enterprise", "publication_date": "2021-08-22", "publication_year": 2021, "doi": "10.1021/cen-09930-buscon17", "pubmed_id": null, "openalex_id": "https://openalex.org/W4367017439", "source_url": "http://dx.doi.org/10.1021/cen-09930-buscon17", "substance_tags": "psilocybin", "topic_tags": "Depression,Headache / Migraine,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1021/cen-09930-buscon17", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1021/cen-09930-buscon17", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1021/cen-09930-buscon17", "source_url": "http://dx.doi.org/10.1021/cen-09930-buscon17", "doi": "10.1021/cen-09930-buscon17", "pmid": "", "publication_date": "2021-08-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3371, "title": "Psychedelics and psychiatric disorders: A emerging role", "authors": "Peixoto C, Santos F, Rego D, Medeiros H.", "journal": null, "publication_date": "2021-08-12", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC9470409", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Headache / Migraine,Receptor Pharmacology,Clinical Trial,Systematic Review,Review Article,Adverse Events", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC9470409", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/PMC/PMC9470409", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC9470409", "source_url": "https://europepmc.org/article/PMC/PMC9470409", "doi": "", "pmid": "", "publication_date": "2021-08-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3211, "title": "Effects of psilocybin-assisted therapy on treatment-resistant depression", "authors": "Fraga A, Esteves-Sousa D, Facucho-Oliveira J, Albuquerque M, Costa M, Dos Santos P, Moura N, Moutinho A.", "journal": null, "publication_date": "2021-08-12", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC9480034", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Review Article,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC9480034", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/PMC/PMC9480034", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC9480034", "source_url": "https://europepmc.org/article/PMC/PMC9480034", "doi": "", "pmid": "", "publication_date": "2021-08-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3156, "title": "Psilocybin in the treatment of obsessive-compulsive disorder: What do we know so far?", "authors": "Descalço N, Medeiros A, Santos C, Borges G.", "journal": null, "publication_date": "2021-08-12", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC9476072", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,OCD,Receptor Pharmacology,Aging,Clinical Trial,Systematic Review,Review Article,Case Report,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC9476072", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/PMC/PMC9476072", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC9476072", "source_url": "https://europepmc.org/article/PMC/PMC9476072", "doi": "", "pmid": "", "publication_date": "2021-08-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5071, "title": "What can we learn from the history of research on psychedelic drugs in the addictions?", "authors": "Wayne Hall, Michael Farrell", "journal": "Addiction", "publication_date": "2021-08-11", "publication_year": 2021, "doi": "10.1111/add.15560", "pubmed_id": "34382252", "openalex_id": "https://openalex.org/W3187445852", "source_url": "https://doi.org/10.1111/add.15560", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Mechanism of Action,Receptor Pharmacology,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Healthcare Workers,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:34382252", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/add.15560", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:34382252", "source_url": "https://doi.org/10.1111/add.15560", "doi": "10.1111/add.15560", "pmid": "34382252", "publication_date": "2021-08-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2139, "title": "The Potential Role of Serotonergic Hallucinogens in Depression Treatment.", "authors": "Psiuk D, Nowak E, Cholewa K, Łopuszańska U, Samardakiewicz M.", "journal": null, "publication_date": "2021-07-28", "publication_year": 2021, "doi": "10.3390/life11080765", "pubmed_id": "34440508", "openalex_id": null, "source_url": "https://doi.org/10.3390/life11080765", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:34440508", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/life11080765", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34440508", "source_url": "https://doi.org/10.3390/life11080765", "doi": "10.3390/life11080765", "pmid": "34440508", "publication_date": "2021-07-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1878, "title": "Classic psychedelics in the treatment of substance use disorder: Potential synergies with twelve-step programs.", "authors": "Yaden DB, Berghella AP, Regier PS, Garcia-Romeu A, Johnson MW, Hendricks PS.", "journal": null, "publication_date": "2021-07-26", "publication_year": 2021, "doi": "10.1016/j.drugpo.2021.103380", "pubmed_id": "34329952", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.drugpo.2021.103380", "substance_tags": "psilocybin", "topic_tags": "Addiction,Aging,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:34329952", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.drugpo.2021.103380", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34329952", "source_url": "https://doi.org/10.1016/j.drugpo.2021.103380", "doi": "10.1016/j.drugpo.2021.103380", "pmid": "34329952", "publication_date": "2021-07-26", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1879, "title": "Systematized Review of Psychotherapeutic Components of Psilocybin-Assisted Psychotherapy.", "authors": "Horton DM, Morrison B, Schmidt J.", "journal": null, "publication_date": "2021-07-22", "publication_year": 2021, "doi": "10.1176/appi.psychotherapy.20200055", "pubmed_id": "34293927", "openalex_id": null, "source_url": "https://doi.org/10.1176/appi.psychotherapy.20200055", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:34293927", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1176/appi.psychotherapy.20200055", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34293927", "source_url": "https://doi.org/10.1176/appi.psychotherapy.20200055", "doi": "10.1176/appi.psychotherapy.20200055", "pmid": "34293927", "publication_date": "2021-07-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3481, "title": "A Randomised, Placebo Controlled Trial of Psilocybin in Treatment Resistant Depression: A Feasibility Study", "authors": "King's College London", "journal": "ClinicalTrials.gov", "publication_date": "2021-07-21", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04959253", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04959253", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04959253", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04959253", "source_url": "https://clinicaltrials.gov/study/NCT04959253", "doi": "", "pmid": "", "publication_date": "2021-07-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3786, "title": "Psychedelic Assisted Therapy for Major Depressive Disorder: A Review", "authors": "McCartney A, McGovern H, De Foe A.", "journal": "PsyArXiv", "publication_date": "2021-06-26", "publication_year": 2021, "doi": "10.31234/osf.io/9kuhs", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/9kuhs", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:22", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/9kuhs", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/9kuhs", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/9kuhs", "source_url": "https://doi.org/10.31234/osf.io/9kuhs", "doi": "10.31234/osf.io/9kuhs", "pmid": "", "publication_date": "2021-06-26", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3336, "title": "Psychedelic Assisted Therapy for Major Depressive Disorder: A Review", "authors": "", "journal": "PsyArXiv", "publication_date": "2021-06-26", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/9kuhs_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/9kuhs_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/9kuhs_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/9kuhs_v1", "source_url": "https://osf.io/preprints/psyarxiv/9kuhs_v1", "doi": "", "pmid": "", "publication_date": "2021-06-26", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3400, "title": "Psychedelic resting-state neuroimaging: a review and perspective on balancing replication and novel analyses", "authors": "McCulloch DE, Knudsen GM, Barrett FS, Doss M, Deco G, Carhart-Harris R, Rosas F, Preller K, Ramaekers J, Mason N, Müller F, Fisher PM.", "journal": "PsyArXiv", "publication_date": "2021-06-09", "publication_year": 2021, "doi": "10.31234/osf.io/64kyg", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/64kyg", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Mechanism of Action,Biomarkers,Aging,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/64kyg", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/64kyg", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/64kyg", "source_url": "https://doi.org/10.31234/osf.io/64kyg", "doi": "10.31234/osf.io/64kyg", "pmid": "", "publication_date": "2021-06-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1743, "title": "Psychedelic resting-state neuroimaging: a review and perspective on balancing replication and novel analyses", "authors": "", "journal": "PsyArXiv", "publication_date": "2021-06-09", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/64kyg_v1", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Mechanism of Action,Biomarkers,Aging,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/64kyg_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/64kyg_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/64kyg_v1", "source_url": "https://osf.io/preprints/psyarxiv/64kyg_v1", "doi": "", "pmid": "", "publication_date": "2021-06-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1901, "title": "Ethnoracial health disparities and the ethnopsychopharmacology of psychedelic-assisted psychotherapies.", "authors": "Fogg C, Michaels TI, de la Salle S, Jahn ZW, Williams MT.", "journal": "Experimental and Clinical Psychopharmacology", "publication_date": "2021-06-06", "publication_year": 2021, "doi": "10.1037/pha0000490", "pubmed_id": "34096755", "openalex_id": "https://openalex.org/W3171546624", "source_url": "https://doi.org/10.1037/pha0000490", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Pharmacology,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:34096755", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1037/pha0000490", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34096755", "source_url": "https://doi.org/10.1037/pha0000490", "doi": "10.1037/pha0000490", "pmid": "34096755", "publication_date": "2021-06-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3385, "title": "Psychedelic-Assisted Psychotherapy for Post-Traumatic Stress Disorder, Anxiety Disorders, Mood Disorders, or Substance Use Disorders", "authors": "Chao YS, Horton J.", "journal": "Canadian Agency for Drugs and Technologies in Health, Ottawa (ON)", "publication_date": "2021-05-31", "publication_year": 2021, "doi": null, "pubmed_id": "36170470", "openalex_id": null, "source_url": "https://europepmc.org/article/MED/36170470", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Receptor Pharmacology,Consciousness,Emotional Processing,Clinical Trial,Review Article,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:36170470", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/MED/36170470", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36170470", "source_url": "https://europepmc.org/article/MED/36170470", "doi": "", "pmid": "36170470", "publication_date": "2021-05-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3230, "title": "Decreased brain modularity after psilocybin therapy for depression.", "authors": "Daws R, Timmerman C, Giribaldi B, Sexton J, Wall M, Erritzoe D, Roseman L, Nutt D, Carhart-Harris R.", "journal": "Research Square", "publication_date": "2021-05-19", "publication_year": 2021, "doi": "10.21203/rs.3.rs-513323/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-513323/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Clinical Trial,Randomized Controlled Trial,Observational Study,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-513323/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-513323/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-513323/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-513323/v1", "doi": "10.21203/rs.3.rs-513323/v1", "pmid": "", "publication_date": "2021-05-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3420, "title": "Future Directions for Clinical Psilocybin Research: The Relaxed Symptom Network", "authors": "", "journal": "PsyArXiv", "publication_date": "2021-05-18", "publication_year": 2021, "doi": "10.1037/pne0000290", "pubmed_id": null, "openalex_id": "https://openalex.org/W4281568156", "source_url": "https://osf.io/preprints/psyarxiv/q3ymd_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:04:24", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1037/pne0000290", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/q3ymd_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.1037/pne0000290", "source_url": "https://osf.io/preprints/psyarxiv/q3ymd_v1", "doi": "10.1037/pne0000290", "pmid": "", "publication_date": "2021-05-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3247, "title": "Future Directions for Clinical Psilocybin Research: The Relaxed Symptom Network", "authors": "Lewis-Healey E, Laukkonen RE, van Elk M.", "journal": "PsyArXiv", "publication_date": "2021-05-18", "publication_year": 2021, "doi": "10.31234/osf.io/q3ymd", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/q3ymd", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/q3ymd", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/q3ymd", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/q3ymd", "source_url": "https://doi.org/10.31234/osf.io/q3ymd", "doi": "10.31234/osf.io/q3ymd", "pmid": "", "publication_date": "2021-05-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5091, "title": "The need for publicly funded research on therapeutic use of psychedelic drugs", "authors": "Wayne Hall", "journal": "World Psychiatry", "publication_date": "2021-05-17", "publication_year": 2021, "doi": "10.1002/wps.20847", "pubmed_id": "34002493", "openalex_id": "https://openalex.org/W3162774823", "source_url": "https://doi.org/10.1002/wps.20847", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Headache / Migraine,Pharmacology,Mechanism of Action,Receptor Pharmacology,Wellbeing,Emotional Processing,Spirituality,Clinical Trial,Randomized Controlled Trial,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:34002493", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/wps.20847", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:34002493", "source_url": "https://doi.org/10.1002/wps.20847", "doi": "10.1002/wps.20847", "pmid": "34002493", "publication_date": "2021-05-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2024, "title": "Effects of the putative antidepressant psilocin on the lipid-raft proteome and lipid-raft signaling", "authors": "Senese Nicolas, Nguyen Thu, Cologna Stephanie, Rasenick Mark", "journal": "The FASEB Journal", "publication_date": "2021-04-30", "publication_year": 2021, "doi": "10.1096/fasebj.2021.35.s1.03168", "pubmed_id": null, "openalex_id": "https://openalex.org/W3168028697", "source_url": "https://doi.org/10.1096/fasebj.2021.35.s1.03168", "substance_tags": "psilocybin,psilocin", "topic_tags": "Mechanism of Action,Biomarkers,Clinical Trial,Proteomics", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1096/fasebj.2021.35.s1.03168", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1096/fasebj.2021.35.s1.03168", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.1096/fasebj.2021.35.s1.03168", "source_url": "https://doi.org/10.1096/fasebj.2021.35.s1.03168", "doi": "10.1096/fasebj.2021.35.s1.03168", "pmid": "", "publication_date": "2021-04-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3487, "title": "Characterization of Altered Waking States of Consciousness in Healthy Humans", "authors": "University of Zurich", "journal": "ClinicalTrials.gov", "publication_date": "2021-04-28", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT03853577", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Consciousness,Emotional Processing,Spirituality,Mystical Experience,Clinical Trial,Toxicity,Drug Interactions", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT03853577", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT03853577", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT03853577", "source_url": "https://clinicaltrials.gov/study/NCT03853577", "doi": "", "pmid": "", "publication_date": "2021-04-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2164, "title": "Psilocybin: From Serendipity to Credibility?", "authors": "Rucker JJ, Young AH.", "journal": "Frontiers in Psychiatry", "publication_date": "2021-04-20", "publication_year": 2021, "doi": "10.3389/fpsyt.2021.659044", "pubmed_id": "33967860", "openalex_id": "https://openalex.org/W3154999065", "source_url": "https://doi.org/10.3389/fpsyt.2021.659044", "substance_tags": "psilocybin", "topic_tags": "Aging,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:33967860", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2021.659044", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33967860", "source_url": "https://doi.org/10.3389/fpsyt.2021.659044", "doi": "10.3389/fpsyt.2021.659044", "pmid": "33967860", "publication_date": "2021-04-20", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5105, "title": "Have Norwegians tried psilocybin, and do they accept it as a medicine?", "authors": "Henrik Børsting Jacobsen, Audun Stubhaug, Bjørn Holmøy, Tor Morten Kvam, Silje Endresen Rème", "journal": "Journal of Psychedelic Studies", "publication_date": "2021-04-15", "publication_year": 2021, "doi": "10.1556/2054.2021.00167", "pubmed_id": null, "openalex_id": "https://openalex.org/W3152965122", "source_url": "https://doi.org/10.1556/2054.2021.00167", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Observational Study,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2021.00167", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2021.00167", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2021.00167", "source_url": "https://doi.org/10.1556/2054.2021.00167", "doi": "10.1556/2054.2021.00167", "pmid": "", "publication_date": "2021-04-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3255, "title": "Evaluating the Risk of Psilocybin for the Treatment of Bipolar Depression: A Review of the Research Literature and Published Case Studies", "authors": "Gard DE, Pleet MM, Bradley ER, Penn A, Gallenstein ML, Riley LS, DellaCrosse M, Garfinkle E, Michalak EE, Woolley JD.", "journal": "medRxiv", "publication_date": "2021-04-06", "publication_year": 2021, "doi": "10.1101/2021.04.02.21254838", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2021.04.02.21254838", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "DOI:10.1101/2021.04.02.21254838", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2021.04.02.21254838", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2021.04.02.21254838", "source_url": "https://doi.org/10.1101/2021.04.02.21254838", "doi": "10.1101/2021.04.02.21254838", "pmid": "", "publication_date": "2021-04-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5113, "title": "Psilocybin in the treatment of obsessive-compulsive disorder: What do we know so far?", "authors": "Nelson Descalço, Ana Beatriz Medeiros, Cátia Fernandes Santos, Guilherme Borges", "journal": "European Psychiatry", "publication_date": "2021-03-31", "publication_year": 2021, "doi": "10.1192/j.eurpsy.2021.1114", "pubmed_id": null, "openalex_id": "https://openalex.org/W4212954018", "source_url": "https://doi.org/10.1192/j.eurpsy.2021.1114", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,OCD,Receptor Pharmacology,Aging,Clinical Trial,Systematic Review,Review Article,Case Report,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1192/j.eurpsy.2021.1114", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1192/j.eurpsy.2021.1114", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1192/j.eurpsy.2021.1114", "source_url": "https://doi.org/10.1192/j.eurpsy.2021.1114", "doi": "10.1192/j.eurpsy.2021.1114", "pmid": "", "publication_date": "2021-03-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5112, "title": "Effects of psilocybin-assisted therapy on treatment-resistant depression", "authors": "A. Fraga, Daniel Esteves-Sousa, João Facucho-Oliveira, Margarida Albuquerque, M. Costa, Paulo Santos, Nuno Moura, A. Moutinho", "journal": "European Psychiatry", "publication_date": "2021-03-31", "publication_year": 2021, "doi": "10.1192/j.eurpsy.2021.1836", "pubmed_id": null, "openalex_id": "https://openalex.org/W3212256162", "source_url": "https://doi.org/10.1192/j.eurpsy.2021.1836", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1192/j.eurpsy.2021.1836", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1192/j.eurpsy.2021.1836", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1192/j.eurpsy.2021.1836", "source_url": "https://doi.org/10.1192/j.eurpsy.2021.1836", "doi": "10.1192/j.eurpsy.2021.1836", "pmid": "", "publication_date": "2021-03-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2165, "title": "Trial of Psilocybin versus Escitalopram for Depression.", "authors": "Carhart-Harris R, Giribaldi B, Watts R, Baker-Jones M, Murphy-Beiner A, Murphy R, Martell J, Blemings A, Erritzoe D, Nutt DJ.", "journal": "New England Journal of Medicine", "publication_date": "2021-03-31", "publication_year": 2021, "doi": "10.1056/nejmoa2032994", "pubmed_id": "33852780", "openalex_id": "https://openalex.org/W3156937150", "source_url": "https://doi.org/10.1056/nejmoa2032994", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Clinical Trial,Observational Study,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:33852780", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1056/nejmoa2032994", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33852780", "source_url": "https://doi.org/10.1056/nejmoa2032994", "doi": "10.1056/nejmoa2032994", "pmid": "33852780", "publication_date": "2021-03-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5115, "title": "The Return of Psychedelics: Still Time to Prevent Tragedy", "authors": "Stanley N. Caroff", "journal": "Psychiatric News", "publication_date": "2021-03-30", "publication_year": 2021, "doi": "10.1176/appi.pn.2021.4.8", "pubmed_id": null, "openalex_id": "https://openalex.org/W3147930394", "source_url": "https://doi.org/10.1176/appi.pn.2021.4.8", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,End-of-Life Distress,Chronic Pain,Headache / Migraine,Pharmacology,Consciousness,Emotional Processing,Clinical Trial,Review Article,Case Report,Observational Study,Adolescents,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2021.4.8", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2021.4.8", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2021.4.8", "source_url": "https://doi.org/10.1176/appi.pn.2021.4.8", "doi": "10.1176/appi.pn.2021.4.8", "pmid": "", "publication_date": "2021-03-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2147, "title": "Cannabis-induced oceanic boundlessness.", "authors": "Earleywine M, Ueno LF, Mian MN, Altman BR.", "journal": "Journal of Psychopharmacology", "publication_date": "2021-03-27", "publication_year": 2021, "doi": "10.1177/0269881121997099", "pubmed_id": "33779383", "openalex_id": "https://openalex.org/W3151652679", "source_url": "https://doi.org/10.1177/0269881121997099", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Mystical Experience,Clinical Trial,Adolescents,Cancer Patients,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:33779383", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/0269881121997099", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33779383", "source_url": "https://doi.org/10.1177/0269881121997099", "doi": "10.1177/0269881121997099", "pmid": "33779383", "publication_date": "2021-03-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2175, "title": "Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action.", "authors": "Dos Santos RG, Hallak JE, Baker G, Dursun S.", "journal": "Journal of Psychopharmacology", "publication_date": "2021-03-18", "publication_year": 2021, "doi": "10.1177/0269881120986422", "pubmed_id": "33740877", "openalex_id": "https://openalex.org/W3137933781", "source_url": "https://doi.org/10.1177/0269881120986422", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Animal Study,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:33740877", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/0269881120986422", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33740877", "source_url": "https://doi.org/10.1177/0269881120986422", "doi": "10.1177/0269881120986422", "pmid": "33740877", "publication_date": "2021-03-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2168, "title": "Acute and Sustained Reductions in Loss of Meaning and Suicidal Ideation Following Psilocybin-Assisted Psychotherapy for Psychiatric and Existential Distress in Life-Threatening Cancer.", "authors": "Ross S, Agin-Liebes G, Lo S, Zeifman RJ, Ghazal L, Benville J, Franco Corso S, Bjerre Real C, Guss J, Bossis A, Mennenga SE.", "journal": "ACS Pharmacology & Translational Science", "publication_date": "2021-03-17", "publication_year": 2021, "doi": "10.1021/acsptsci.1c00020", "pubmed_id": "33860185", "openalex_id": "https://openalex.org/W3138429576", "source_url": "https://doi.org/10.1021/acsptsci.1c00020", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:33860185", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1021/acsptsci.1c00020", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33860185", "source_url": "https://doi.org/10.1021/acsptsci.1c00020", "doi": "10.1021/acsptsci.1c00020", "pmid": "33860185", "publication_date": "2021-03-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2173, "title": "On the Relationship between Classic Psychedelics and Suicidality: A Systematic Review.", "authors": "Zeifman RJ, Singhal N, Breslow L, Weissman CR.", "journal": null, "publication_date": "2021-03-10", "publication_year": 2021, "doi": "10.1021/acsptsci.1c00024", "pubmed_id": "33860173", "openalex_id": null, "source_url": "https://doi.org/10.1021/acsptsci.1c00024", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:33860173", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1021/acsptsci.1c00024", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33860173", "source_url": "https://doi.org/10.1021/acsptsci.1c00024", "doi": "10.1021/acsptsci.1c00024", "pmid": "33860173", "publication_date": "2021-03-10", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3804, "title": "Blinding and Expectancy Confounds in Psychedelic Randomised Controlled Trials", "authors": "Muthukumaraswamy S, Forsyth A, Lumley T.", "journal": "PsyArXiv", "publication_date": "2021-03-07", "publication_year": 2021, "doi": "10.31234/osf.io/q2hzm", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/q2hzm", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article", "study_type": "Randomized Controlled Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:23", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/q2hzm", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/q2hzm", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/q2hzm", "source_url": "https://doi.org/10.31234/osf.io/q2hzm", "doi": "10.31234/osf.io/q2hzm", "pmid": "", "publication_date": "2021-03-07", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3390, "title": "Blinding and Expectancy Confounds in Psychedelic Randomised Controlled Trials", "authors": "", "journal": "PsyArXiv", "publication_date": "2021-03-07", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/q2hzm_v1", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article", "study_type": "Randomized Controlled Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/q2hzm_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/q2hzm_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/q2hzm_v1", "source_url": "https://osf.io/preprints/psyarxiv/q2hzm_v1", "doi": "", "pmid": "", "publication_date": "2021-03-07", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2191, "title": "The Use of Classic Hallucinogens/Psychedelics in a Therapeutic Context: Healthcare Policy Opportunities and Challenges.", "authors": "Dos Santos RG, Bouso JC, Rocha JM, Rossi GN, Hallak JE.", "journal": "DOAJ (DOAJ: Directory of Open Access Journals)", "publication_date": "2021-03-04", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W4392135761", "source_url": "https://doi.org/10.2147/rmhp.s300656", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "https://doi.org/10.2147/rmhp.s300656", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.2147/rmhp.s300656", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://doi.org/10.2147/rmhp.s300656", "source_url": "https://doi.org/10.2147/rmhp.s300656", "doi": "", "pmid": "", "publication_date": "2021-03-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2198, "title": "Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research.", "authors": "Tai SJ, Nielson EM, Lennard-Jones M, Johanna Ajantaival RL, Winzer R, Richards WA, Reinholdt F, Richards BD, Gasser P, Malievskaia E.", "journal": "Frontiers in Psychiatry", "publication_date": "2021-02-02", "publication_year": 2021, "doi": "10.3389/fpsyt.2021.586682", "pubmed_id": "33643087", "openalex_id": "https://openalex.org/W3127909847", "source_url": "https://doi.org/10.3389/fpsyt.2021.586682", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:33643087", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2021.586682", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33643087", "source_url": "https://doi.org/10.3389/fpsyt.2021.586682", "doi": "10.3389/fpsyt.2021.586682", "pmid": "33643087", "publication_date": "2021-02-02", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5126, "title": "Behandeling met psilocybine", "authors": "Joost J. Breeksema, Martijn H B Koolen, Metten Somers, Robert A. Schoevers", "journal": "Data Archiving and Networked Services (DANS)", "publication_date": "2021-01-20", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3169076037", "source_url": "https://research.rug.nl/en/publications/5e83b45d-b208-402a-a435-f0380fad6429", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,End-of-Life Distress,Mechanism of Action,Aging,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:00", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "https://research.rug.nl/en/publications/5e83b45d-b208-402a-a435-f0380fad6429", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://research.rug.nl/en/publications/5e83b45d-b208-402a-a435-f0380fad6429", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://research.rug.nl/en/publications/5e83b45d-b208-402a-a435-f0380fad6429", "source_url": "https://research.rug.nl/en/publications/5e83b45d-b208-402a-a435-f0380fad6429", "doi": "", "pmid": "", "publication_date": "2021-01-20", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2203, "title": "[Treatment with psilocybin: applications for patients with psychiatric disorders].", "authors": "Breeksema JJ, Koolen MHB, Somers M, Schoevers RA.", "journal": "PubMed", "publication_date": "2021-01-20", "publication_year": 2021, "doi": null, "pubmed_id": "33560605", "openalex_id": "https://openalex.org/W3127548368", "source_url": "https://europepmc.org/article/MED/33560605", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,End-of-Life Distress,Mechanism of Action,Aging,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:33560605", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/MED/33560605", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33560605", "source_url": "https://europepmc.org/article/MED/33560605", "doi": "", "pmid": "33560605", "publication_date": "2021-01-20", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2148, "title": "Classical Psychedelics as Therapeutics in Psychiatry - Current Clinical Evidence and Potential Therapeutic Mechanisms in Substance Use and Mood Disorders.", "authors": "Mertens LJ, Preller KH.", "journal": null, "publication_date": "2021-01-19", "publication_year": 2021, "doi": "10.1055/a-1341-1907", "pubmed_id": "33472250", "openalex_id": null, "source_url": "https://doi.org/10.1055/a-1341-1907", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Review Article,Animal Study,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:33472250", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1055/a-1341-1907", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33472250", "source_url": "https://doi.org/10.1055/a-1341-1907", "doi": "10.1055/a-1341-1907", "pmid": "33472250", "publication_date": "2021-01-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2200, "title": "Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants.", "authors": "Galvão-Coelho NL, Marx W, Gonzalez M, Sinclair J, de Manincor M, Perkins D, Sarris J.", "journal": null, "publication_date": "2021-01-10", "publication_year": 2021, "doi": "10.1007/s00213-020-05719-1", "pubmed_id": "33427944", "openalex_id": null, "source_url": "https://doi.org/10.1007/s00213-020-05719-1", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Review Article,Healthy Volunteers", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:33427944", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s00213-020-05719-1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33427944", "source_url": "https://doi.org/10.1007/s00213-020-05719-1", "doi": "10.1007/s00213-020-05719-1", "pmid": "33427944", "publication_date": "2021-01-10", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5145, "title": "Psilocybin therapy appears as effective as escitalopram, small study finds", "authors": "", "journal": "Pharmaceutical journal/˜The œpharmaceutical journal", "publication_date": "2020-12-31", "publication_year": 2020, "doi": "10.1211/pj.2021.1.91592", "pubmed_id": null, "openalex_id": "https://openalex.org/W4246962837", "source_url": "https://doi.org/10.1211/pj.2021.1.91592", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:00", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1211/pj.2021.1.91592", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1211/pj.2021.1.91592", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1211/pj.2021.1.91592", "source_url": "https://doi.org/10.1211/pj.2021.1.91592", "doi": "10.1211/pj.2021.1.91592", "pmid": "", "publication_date": "2020-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2214, "title": "Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms.", "authors": "Inserra A, De Gregorio D, Gobbi G.", "journal": null, "publication_date": "2020-12-31", "publication_year": 2020, "doi": "10.1124/pharmrev.120.000056", "pubmed_id": "33328244", "openalex_id": null, "source_url": "https://doi.org/10.1124/pharmrev.120.000056", "substance_tags": "psilocybin", "topic_tags": "PTSD,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:33328244", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1124/pharmrev.120.000056", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33328244", "source_url": "https://doi.org/10.1124/pharmrev.120.000056", "doi": "10.1124/pharmrev.120.000056", "pmid": "33328244", "publication_date": "2020-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2213, "title": "How ecstasy and psilocybin are shaking up psychiatry.", "authors": "Tullis P.", "journal": "Nature", "publication_date": "2020-12-31", "publication_year": 2020, "doi": "10.1038/d41586-021-00187-9", "pubmed_id": "33505033", "openalex_id": "https://openalex.org/W3125143320", "source_url": "https://doi.org/10.1038/d41586-021-00187-9", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:33505033", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33505033", "source_url": "https://doi.org/10.1038/d41586-021-00187-9", "doi": "10.1038/d41586-021-00187-9", "pmid": "33505033", "publication_date": "2020-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2211, "title": "Psychedelic Medicines in Major Depression: Progress and Future Challenges.", "authors": "Bouso JC, Ona G, Dos Santos RG, Hallak JEC.", "journal": null, "publication_date": "2020-12-31", "publication_year": 2020, "doi": "10.1007/978-981-33-6044-0_26", "pubmed_id": "33834416", "openalex_id": null, "source_url": "https://doi.org/10.1007/978-981-33-6044-0_26", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:33834416", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/978-981-33-6044-0_26", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33834416", "source_url": "https://doi.org/10.1007/978-981-33-6044-0_26", "doi": "10.1007/978-981-33-6044-0_26", "pmid": "33834416", "publication_date": "2020-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2197, "title": "What is the clinical evidence on psilocybin for the treatment of psychiatric disorders? A systematic review.", "authors": "Castro Santos H, Gama Marques J.", "journal": null, "publication_date": "2020-12-31", "publication_year": 2020, "doi": "10.1097/j.pbj.0000000000000128", "pubmed_id": "33884324", "openalex_id": null, "source_url": "https://doi.org/10.1097/j.pbj.0000000000000128", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,OCD,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:33884324", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1097/j.pbj.0000000000000128", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33884324", "source_url": "https://doi.org/10.1097/j.pbj.0000000000000128", "doi": "10.1097/j.pbj.0000000000000128", "pmid": "33884324", "publication_date": "2020-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1889, "title": "Translating Psychedelic Therapies From Clinical Trials to Community Clinics: Building Bridges and Addressing Potential Challenges Ahead.", "authors": "Williams ML, Korevaar D, Harvey R, Fitzgerald PB, Liknaitzky P, O'Carroll S, Puspanathan P, Ross M, Strauss N, Bennett-Levy J", "journal": "Frontiers in psychiatry", "publication_date": "2020-12-31", "publication_year": 2020, "doi": "10.3389/fpsyt.2021.737738", "pubmed_id": "34803761", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/34803761/", "substance_tags": "psilocybin", "topic_tags": "Depression,Creativity,Clinical Trial,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-07-01 11:20:39", "bibtex": null, "source_record_id": "PMID:34803761", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34803761/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34803761", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34803761/", "doi": "10.3389/fpsyt.2021.737738", "pmid": "34803761", "publication_date": "2020-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2217, "title": "Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin", "authors": "Emmanuelle A. D. Schindler, R. Andrew Sewell, Christopher Gottschalk, Christina Luddy, L. Taylor Flynn, Hayley Lindsey, Brian Pittman, Nicholas V. Cozzi, Deepak Cyril D’Souza", "journal": "Neurotherapeutics", "publication_date": "2020-11-11", "publication_year": 2020, "doi": "10.1007/s13311-020-00962-y", "pubmed_id": "33184743", "openalex_id": "https://openalex.org/W3105240299", "source_url": "https://doi.org/10.1007/s13311-020-00962-y", "substance_tags": "psilocybin", "topic_tags": "Headache / Migraine,Pharmacology,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "PMID:33184743", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:33184743", "source_url": "https://doi.org/10.1007/s13311-020-00962-y", "doi": "10.1007/s13311-020-00962-y", "pmid": "33184743", "publication_date": "2020-11-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2160, "title": "Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder", "authors": "Alan K. Davis, Frederick S. Barrett, Darrick G. May, Mary P Cosimano, Nathan D. Sepeda, Matthew W. Johnson, Patrick H. Finan, Roland R. Griffiths", "journal": "JAMA Psychiatry", "publication_date": "2020-11-03", "publication_year": 2020, "doi": "10.1001/jamapsychiatry.2020.3285", "pubmed_id": "33146667", "openalex_id": "https://openalex.org/W3096208965", "source_url": "https://doi.org/10.1001/jamapsychiatry.2020.3285", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Consciousness,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "PMID:33146667", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1001/jamapsychiatry.2020.3285", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:33146667", "source_url": "https://doi.org/10.1001/jamapsychiatry.2020.3285", "doi": "10.1001/jamapsychiatry.2020.3285", "pmid": "33146667", "publication_date": "2020-11-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3402, "title": "A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy", "authors": "Luoma JB, Chwyl C, Bathje G, Davis AK, Lancelotta RL.", "journal": "PsyArXiv", "publication_date": "2020-10-27", "publication_year": 2020, "doi": "10.31234/osf.io/nhbjk", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/nhbjk", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,End-of-Life Distress,Clinical Trial,Meta-Analysis", "study_type": "Meta-Analysis", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/nhbjk", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/nhbjk", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/nhbjk", "source_url": "https://doi.org/10.31234/osf.io/nhbjk", "doi": "10.31234/osf.io/nhbjk", "pmid": "", "publication_date": "2020-10-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3829, "title": "The use of psychedelics in the treatment of disorders of consciousness. An interview with Olivia Gosseries by Charlotte Martial.", "authors": "Olivia Gosseries, Charlotte Martial", "journal": "Open Repository and Bibliography (University of Liège)", "publication_date": "2020-10-12", "publication_year": 2020, "doi": "10.34700/gv0w-y052", "pubmed_id": null, "openalex_id": "https://openalex.org/W3118817849", "source_url": "https://orbi.uliege.be/handle/2268/254726", "substance_tags": "psilocybin", "topic_tags": "Consciousness,Clinical Trial,Healthy Volunteers", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.34700/gv0w-y052", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://orbi.uliege.be/handle/2268/254726", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.34700/gv0w-y052", "source_url": "https://orbi.uliege.be/handle/2268/254726", "doi": "10.34700/gv0w-y052", "pmid": "", "publication_date": "2020-10-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3831, "title": "The Role of Psychedelics and Counseling in Mental Health Treatment", "authors": "Russ Curtis, Lisen C. Roberts, Elizabeth Graves, Heather Thompson Rainey, D. D. Wynn, Daphne Krantz, Verena Wieloch", "journal": "Journal of Mental Health Counseling", "publication_date": "2020-09-30", "publication_year": 2020, "doi": "10.17744/mehc.42.4.03", "pubmed_id": null, "openalex_id": "https://openalex.org/W3094549229", "source_url": "https://doi.org/10.17744/mehc.42.4.03", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.17744/mehc.42.4.03", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.17744/mehc.42.4.03", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.17744/mehc.42.4.03", "source_url": "https://doi.org/10.17744/mehc.42.4.03", "doi": "10.17744/mehc.42.4.03", "pmid": "", "publication_date": "2020-09-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2228, "title": "The emerging role of psilocybin and MDMA in the treatment of mental illness.", "authors": "Gill H, Gill B, Chen-Li D, El-Halabi S, Rodrigues NB, Cha DS, Lipsitz O, Lee Y, Rosenblat JD, Majeed A, Mansur RB, Nasri F, Ho R, McIntyre RS.", "journal": null, "publication_date": "2020-09-29", "publication_year": 2020, "doi": "10.1080/14737175.2020.1826931", "pubmed_id": "32954860", "openalex_id": null, "source_url": "https://doi.org/10.1080/14737175.2020.1826931", "substance_tags": "psilocybin", "topic_tags": "Emotional Processing,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:32954860", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/14737175.2020.1826931", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:32954860", "source_url": "https://doi.org/10.1080/14737175.2020.1826931", "doi": "10.1080/14737175.2020.1826931", "pmid": "32954860", "publication_date": "2020-09-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3834, "title": "Wait for the Science Before Widespread Use of Psilocybin", "authors": "Nicole Harrington Cirino", "journal": "Psychiatric News", "publication_date": "2020-09-28", "publication_year": 2020, "doi": "10.1176/appi.pn.2020.10a32", "pubmed_id": null, "openalex_id": "https://openalex.org/W3091539953", "source_url": "https://doi.org/10.1176/appi.pn.2020.10a32", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2020.10a32", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2020.10a32", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2020.10a32", "source_url": "https://doi.org/10.1176/appi.pn.2020.10a32", "doi": "10.1176/appi.pn.2020.10a32", "pmid": "", "publication_date": "2020-09-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2246, "title": "Total Recall: Lateral Habenula and Psychedelics in the Study of Depression and Comorbid Brain Disorders.", "authors": "Vitkauskas M, Mathuru AS.", "journal": null, "publication_date": "2020-09-06", "publication_year": 2020, "doi": "10.3390/ijms21186525", "pubmed_id": "32906643", "openalex_id": null, "source_url": "https://doi.org/10.3390/ijms21186525", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Aging,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:32906643", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/ijms21186525", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:32906643", "source_url": "https://doi.org/10.3390/ijms21186525", "doi": "10.3390/ijms21186525", "pmid": "32906643", "publication_date": "2020-09-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2247, "title": "Psilocybin as a New Approach to Treat Depression and Anxiety in the Context of Life-Threatening Diseases-A Systematic Review and Meta-Analysis of Clinical Trials.", "authors": "Vargas AS, Luís Â, Barroso M, Gallardo E, Pereira L.", "journal": null, "publication_date": "2020-09-04", "publication_year": 2020, "doi": "10.3390/biomedicines8090331", "pubmed_id": "32899469", "openalex_id": null, "source_url": "https://doi.org/10.3390/biomedicines8090331", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Clinical Trial,Meta-Analysis,Systematic Review,Review Article,Safety", "study_type": "Meta-Analysis", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:32899469", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/biomedicines8090331", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:32899469", "source_url": "https://doi.org/10.3390/biomedicines8090331", "doi": "10.3390/biomedicines8090331", "pmid": "32899469", "publication_date": "2020-09-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2151, "title": "Psychedelic science in post-COVID-19 psychiatry", "authors": "John R. Kelly, Matthew Crockett, Laith Alexander, Martin Haran, Amanda Baker, Lisa M. Burke, Christine Brennan, Veronica O’Keane", "journal": "Irish Journal of Psychological Medicine", "publication_date": "2020-08-18", "publication_year": 2020, "doi": "10.1017/ipm.2020.94", "pubmed_id": "32811575", "openalex_id": "https://openalex.org/W3054886531", "source_url": "https://doi.org/10.1017/ipm.2020.94", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "PMID:32811575", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1017/ipm.2020.94", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:32811575", "source_url": "https://doi.org/10.1017/ipm.2020.94", "doi": "10.1017/ipm.2020.94", "pmid": "32811575", "publication_date": "2020-08-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3842, "title": "4 Psychedelics: therapeutic mechanisms", "authors": "Robin Carhart-Harris", "journal": "Journal of Neurology Neurosurgery & Psychiatry", "publication_date": "2020-07-19", "publication_year": 2020, "doi": "10.1136/jnnp-2020-bnpa.4", "pubmed_id": null, "openalex_id": "https://openalex.org/W3044110502", "source_url": "https://doi.org/10.1136/jnnp-2020-bnpa.4", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.1136/jnnp-2020-bnpa.4", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1136/jnnp-2020-bnpa.4", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1136/jnnp-2020-bnpa.4", "source_url": "https://doi.org/10.1136/jnnp-2020-bnpa.4", "doi": "10.1136/jnnp-2020-bnpa.4", "pmid": "", "publication_date": "2020-07-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2251, "title": "Psilocybin occasioned mystical-type experiences.", "authors": "James E, Robertshaw TL, Hoskins M, Sessa B.", "journal": null, "publication_date": "2020-06-22", "publication_year": 2020, "doi": "10.1002/hup.2742", "pubmed_id": "32573835", "openalex_id": null, "source_url": "https://doi.org/10.1002/hup.2742", "substance_tags": "psilocybin", "topic_tags": "Mystical Experience,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:32573835", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1002/hup.2742", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:32573835", "source_url": "https://doi.org/10.1002/hup.2742", "doi": "10.1002/hup.2742", "pmid": "32573835", "publication_date": "2020-06-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3404, "title": "A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy", "authors": "Luoma JB.", "journal": "PsyArXiv", "publication_date": "2020-06-11", "publication_year": 2020, "doi": "10.31234/osf.io/sgujx", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/sgujx", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,End-of-Life Distress,Clinical Trial,Meta-Analysis", "study_type": "Meta-Analysis", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/sgujx", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/sgujx", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/sgujx", "source_url": "https://doi.org/10.31234/osf.io/sgujx", "doi": "10.31234/osf.io/sgujx", "pmid": "", "publication_date": "2020-06-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2269, "title": "Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments.", "authors": "Greenway KT, Garel N, Jerome L, Feduccia AA", "journal": "Expert review of clinical pharmacology", "publication_date": "2020-05-31", "publication_year": 2020, "doi": "10.1080/17512433.2020.1772054", "pubmed_id": "32478631", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/32478631/", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Mechanism of Action,Clinical Trial,Review Article,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:20:39", "bibtex": null, "source_record_id": "PMID:32478631", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32478631/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32478631", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32478631/", "doi": "10.1080/17512433.2020.1772054", "pmid": "32478631", "publication_date": "2020-05-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2233, "title": "Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin", "authors": "Natasha L. Mason, Kim P. C. Kuypers, Felix Müller, Johannes T. Reckweg, Desmond H. Y. Tse, Stefan W. Toennes, Nadia R. P. W. Hutten, Jacobus F.A. Jansen, Peter Stiers, Amanda Feilding, Johannes G. Ramaekers", "journal": "Neuropsychopharmacology", "publication_date": "2020-05-22", "publication_year": 2020, "doi": "10.1038/s41386-020-0718-8", "pubmed_id": "32446245", "openalex_id": "https://openalex.org/W3027590463", "source_url": "https://doi.org/10.1038/s41386-020-0718-8", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "PMID:32446245", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41386-020-0718-8", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:32446245", "source_url": "https://doi.org/10.1038/s41386-020-0718-8", "doi": "10.1038/s41386-020-0718-8", "pmid": "32446245", "publication_date": "2020-05-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3850, "title": "Psychedelics, Safety and Clinical Trial Design", "authors": "Ron Shore", "journal": "QSpace (Queen's University Library)", "publication_date": "2020-05-19", "publication_year": 2020, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3043468905", "source_url": "http://hdl.handle.net/1974/27835", "substance_tags": "psilocybin", "topic_tags": "Headache / Migraine,Clinical Trial,Review Article,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "http://hdl.handle.net/1974/27835", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://hdl.handle.net/1974/27835", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "http://hdl.handle.net/1974/27835", "source_url": "http://hdl.handle.net/1974/27835", "doi": "", "pmid": "", "publication_date": "2020-05-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2266, "title": "Psilocybin and LSD have no long-lasting effects in an animal model of alcohol relapse", "authors": "Marcus W. Meinhardt, Cansu Güngör, Ivan Skorodumov, Lea J. Mertens, Rainer Spanagel", "journal": "Neuropsychopharmacology", "publication_date": "2020-05-04", "publication_year": 2020, "doi": "10.1038/s41386-020-0694-z", "pubmed_id": "32369828", "openalex_id": "https://openalex.org/W3020950088", "source_url": "https://doi.org/10.1038/s41386-020-0694-z", "substance_tags": "psilocybin", "topic_tags": "Addiction,Pharmacology,Receptor Pharmacology,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "PMID:32369828", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:32369828", "source_url": "https://doi.org/10.1038/s41386-020-0694-z", "doi": "10.1038/s41386-020-0694-z", "pmid": "32369828", "publication_date": "2020-05-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2279, "title": "Perceived outcomes of psychedelic microdosing as self-managed therapies for mental and substance use disorders.", "authors": "Lea T, Amada N, Jungaberle H, Schecke H, Scherbaum N, Klein M", "journal": "Psychopharmacology", "publication_date": "2020-04-30", "publication_year": 2020, "doi": "10.1007/s00213-020-05477-0", "pubmed_id": "32043165", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/32043165/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Microdosing,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:20:39", "bibtex": null, "source_record_id": "PMID:32043165", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32043165/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32043165", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32043165/", "doi": "10.1007/s00213-020-05477-0", "pmid": "32043165", "publication_date": "2020-04-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3451, "title": "Pharmacokinetics of Psilocybin in Normal Adult Volunteers", "authors": "University of Wisconsin, Madison", "journal": "ClinicalTrials.gov", "publication_date": "2020-04-14", "publication_year": 2020, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT02163707", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT02163707", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT02163707", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT02163707", "source_url": "https://clinicaltrials.gov/study/NCT02163707", "doi": "", "pmid": "", "publication_date": "2020-04-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3858, "title": "Psychedelics for Psychiatric Disorders: More Research Needed", "authors": "Nick Zagorski", "journal": "Psychiatric News", "publication_date": "2020-04-12", "publication_year": 2020, "doi": "10.1176/appi.pn.2020.4a14", "pubmed_id": null, "openalex_id": "https://openalex.org/W3017294991", "source_url": "https://doi.org/10.1176/appi.pn.2020.4a14", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Pharmacology,Receptor Pharmacology,Biomarkers,Clinical Trial,Review Article,Cancer Patients", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2020.4a14", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2020.4a14", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2020.4a14", "source_url": "https://doi.org/10.1176/appi.pn.2020.4a14", "doi": "10.1176/appi.pn.2020.4a14", "pmid": "", "publication_date": "2020-04-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2036, "title": "Exposure-Response Analysis to Assess the Concentration-QTc Relationship of Psilocybin/Psilocin", "authors": "Elyes Dahmane, Paul R. Hutson, Jogarao Gobburu", "journal": "Clinical Pharmacology in Drug Development", "publication_date": "2020-04-05", "publication_year": 2020, "doi": "10.1002/cpdd.796", "pubmed_id": "32250059", "openalex_id": "https://openalex.org/W3014341075", "source_url": "https://doi.org/10.1002/cpdd.796", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "PMID:32250059", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/cpdd.796", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:32250059", "source_url": "https://doi.org/10.1002/cpdd.796", "doi": "10.1002/cpdd.796", "pmid": "32250059", "publication_date": "2020-04-05", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2267, "title": "Metabolic engineering of Saccharomyces cerevisiae for the de novo production of psilocybin and related tryptamine derivatives", "authors": "N. Milne, Philip Tinggaard Thomsen, Niels Aage Tvis Knudsen, P. Rubaszka, Mette Kristensen, Irina Borodina", "journal": "Metabolic Engineering", "publication_date": "2020-03-25", "publication_year": 2020, "doi": "10.1016/j.ymben.2019.12.007", "pubmed_id": "32224264", "openalex_id": "https://openalex.org/W3013100262", "source_url": "https://doi.org/10.1016/j.ymben.2019.12.007", "substance_tags": "psilocybin,psilocin", "topic_tags": "Pharmacology,Mechanism of Action,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "PMID:32224264", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.ymben.2019.12.007", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:32224264", "source_url": "https://doi.org/10.1016/j.ymben.2019.12.007", "doi": "10.1016/j.ymben.2019.12.007", "pmid": "32224264", "publication_date": "2020-03-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3863, "title": "Can Psychedelics Radically Change SUD Treatment?", "authors": "Katie O’Connor", "journal": "Psychiatric News", "publication_date": "2020-03-19", "publication_year": 2020, "doi": "10.1176/appi.pn.2020.2a12", "pubmed_id": null, "openalex_id": "https://openalex.org/W3012401750", "source_url": "https://doi.org/10.1176/appi.pn.2020.2a12", "substance_tags": "psilocybin", "topic_tags": "Anxiety,PTSD,Addiction,Chronic Pain,Pharmacology,Consciousness,Clinical Trial,Observational Study,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2020.2a12", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2020.2a12", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2020.2a12", "source_url": "https://doi.org/10.1176/appi.pn.2020.2a12", "doi": "10.1176/appi.pn.2020.2a12", "pmid": "", "publication_date": "2020-03-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2289, "title": "Psychedelics, but Not Ketamine, Produce Persistent Antidepressant-like Effects in a Rodent Experimental System for the Study of Depression", "authors": "Meghan Hibicke, Alexus N. Landry, Hannah M. Kramer, Zoe K. Talman, Charles D. Nichols", "journal": "ACS Chemical Neuroscience", "publication_date": "2020-03-04", "publication_year": 2020, "doi": "10.1021/acschemneuro.9b00493", "pubmed_id": "32133835", "openalex_id": "https://openalex.org/W3010499243", "source_url": "https://doi.org/10.1021/acschemneuro.9b00493", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Receptor Pharmacology,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "PMID:32133835", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1021/acschemneuro.9b00493", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:32133835", "source_url": "https://doi.org/10.1021/acschemneuro.9b00493", "doi": "10.1021/acschemneuro.9b00493", "pmid": "32133835", "publication_date": "2020-03-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2265, "title": "Scalable Hybrid Synthetic/Biocatalytic Route to Psilocybin", "authors": "Janis Fricke, Robert B. Kargbo, Lars Regestein, Claudius Lenz, Gundela Peschel, Miriam A. Rosenbaum, Alexander M. Sherwood, Dirk Hoffmeister", "journal": "Chemistry - A European Journal", "publication_date": "2020-02-25", "publication_year": 2020, "doi": "10.1002/chem.202000134", "pubmed_id": "32101345", "openalex_id": "https://openalex.org/W3007311584", "source_url": "https://doi.org/10.1002/chem.202000134", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Pharmacology,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "PMID:32101345", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/chem.202000134", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:32101345", "source_url": "https://doi.org/10.1002/chem.202000134", "doi": "10.1002/chem.202000134", "pmid": "32101345", "publication_date": "2020-02-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2209, "title": "Psychedelics and Psychedelic-Assisted Psychotherapy.", "authors": "Reiff CM, Richman EE, Nemeroff CB, Carpenter LL, Widge AS, Rodriguez CI, Kalin NH, McDonald WM, the Work Group on Biomarkers and Novel Treatments, a Division of the American Psychiatric Association Council of Research.", "journal": "Diseño interior", "publication_date": "2020-02-25", "publication_year": 2020, "doi": "10.1176/appi.ajp.2019.19010035", "pubmed_id": null, "openalex_id": "https://openalex.org/W32098487", "source_url": "https://doi.org/10.1176/appi.ajp.2019.19010035", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,End-of-Life Distress,Brain Imaging,Aging,Clinical Trial,Review Article,Observational Study,Cancer Patients,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:41", "bibtex": null, "source_record_id": "DOI:10.1176/appi.ajp.2019.19010035", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1176/appi.ajp.2019.19010035", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.1176/appi.ajp.2019.19010035", "source_url": "https://doi.org/10.1176/appi.ajp.2019.19010035", "doi": "10.1176/appi.ajp.2019.19010035", "pmid": "", "publication_date": "2020-02-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1083, "title": "Rethinking Therapeutic Strategies for Anorexia Nervosa: Insights From Psychedelic Medicine and Animal Models.", "authors": "Foldi CJ, Liknaitzky P, Williams M, Oldfield BJ.", "journal": null, "publication_date": "2020-02-03", "publication_year": 2020, "doi": "10.3389/fnins.2020.00043", "pubmed_id": "32116500", "openalex_id": null, "source_url": "https://doi.org/10.3389/fnins.2020.00043", "substance_tags": "psilocybin", "topic_tags": "Depression,Eating Disorders,Pharmacology,Mechanism of Action,Clinical Trial,Animal Study,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:32116500", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fnins.2020.00043", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:32116500", "source_url": "https://doi.org/10.3389/fnins.2020.00043", "doi": "10.3389/fnins.2020.00043", "pmid": "32116500", "publication_date": "2020-02-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3891, "title": "The Therapeutic Potential of Psilocybin and 3,4-Methylenedioxymethamphetamine in the Treatment of Depression and Post-Traumatic Stress Disorder", "authors": "Sofia Gyllvik", "journal": "Diva portal (Dalarna University Library)", "publication_date": "2019-12-31", "publication_year": 2019, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3083741926", "source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18729", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18729", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18729", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18729", "source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18729", "doi": "", "pmid": "", "publication_date": "2019-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3883, "title": "Development of an improved psilocybin synthesis", "authors": "Reham Shaba", "journal": "Uppsala University Publications (Uppsala University)", "publication_date": "2019-12-31", "publication_year": 2019, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3089446948", "source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-420295", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-420295", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-420295", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-420295", "source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-420295", "doi": "", "pmid": "", "publication_date": "2019-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5713, "title": "Psilocybin Therapy for Depression: A Scoping Review Protocol", "authors": "Dalton Budhram, Preet Dhaliwal", "journal": "Open MIND", "publication_date": "2019-12-30", "publication_year": 2019, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7167303937", "source_url": "https://osf.io/4syt6", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Review Article,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-11 19:28:11", "last_checked": "2026-07-11 19:28:11", "bibtex": null, "source_record_id": "https://osf.io/4syt6", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://osf.io/4syt6", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://osf.io/4syt6", "source_url": "https://osf.io/4syt6", "doi": "", "pmid": "", "publication_date": "2019-12-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3285, "title": "Mapping Psilocybin-Assisted Therapies: A Scoping Review", "authors": "Shore R, Ioudovski P, Goldie C, McKeown S, Dumont E, Queen’s University, Kingston On.", "journal": "medRxiv", "publication_date": "2019-12-11", "publication_year": 2019, "doi": "10.1101/2019.12.04.19013896", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2019.12.04.19013896", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,End-of-Life Distress,Headache / Migraine,Clinical Trial,Randomized Controlled Trial,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "DOI:10.1101/2019.12.04.19013896", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2019.12.04.19013896", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2019.12.04.19013896", "source_url": "https://doi.org/10.1101/2019.12.04.19013896", "doi": "10.1101/2019.12.04.19013896", "pmid": "", "publication_date": "2019-12-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3905, "title": "P.609 Therapeutic mechanisms of psychedelic drugs: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression", "authors": "Laura Mertens, M.B. Wall, L. Roseman, L. Demetriou, D.J. Nutt, R.L. Carhart-Harris", "journal": "European Neuropsychopharmacology", "publication_date": "2019-11-30", "publication_year": 2019, "doi": "10.1016/j.euroneuro.2019.09.593", "pubmed_id": null, "openalex_id": "https://openalex.org/W4248055189", "source_url": "https://doi.org/10.1016/j.euroneuro.2019.09.593", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Emotional Processing,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.1016/j.euroneuro.2019.09.593", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.euroneuro.2019.09.593", "source_url": "https://doi.org/10.1016/j.euroneuro.2019.09.593", "doi": "10.1016/j.euroneuro.2019.09.593", "pmid": "", "publication_date": "2019-11-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3915, "title": "Johns Hopkins Opens Research Center on Psychedelics", "authors": "Nick Zagorski", "journal": "Psychiatric News", "publication_date": "2019-10-27", "publication_year": 2019, "doi": "10.1176/appi.pn.2019.10a16", "pubmed_id": null, "openalex_id": "https://openalex.org/W2982427347", "source_url": "https://doi.org/10.1176/appi.pn.2019.10a16", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Eating Disorders,Consciousness,Biomarkers,Clinical Trial,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2019.10a16", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2019.10a16", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2019.10a16", "source_url": "https://doi.org/10.1176/appi.pn.2019.10a16", "doi": "10.1176/appi.pn.2019.10a16", "pmid": "", "publication_date": "2019-10-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2322, "title": "Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer.", "authors": "Dos Santos RG, Bouso JC, Hallak JEC.", "journal": null, "publication_date": "2019-10-27", "publication_year": 2019, "doi": "10.1186/s12888-019-2288-z", "pubmed_id": "31660905", "openalex_id": null, "source_url": "https://doi.org/10.1186/s12888-019-2288-z", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Spirituality,Clinical Trial,Review Article,Cancer Patients", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:31660905", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1186/s12888-019-2288-z", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:31660905", "source_url": "https://doi.org/10.1186/s12888-019-2288-z", "doi": "10.1186/s12888-019-2288-z", "pmid": "31660905", "publication_date": "2019-10-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3918, "title": "Modified E. coli pump out psilocybin", "authors": "Megha Satyanarayana", "journal": "C&EN Global Enterprise", "publication_date": "2019-10-06", "publication_year": 2019, "doi": "10.1021/cen-09739-scicon9", "pubmed_id": null, "openalex_id": "https://openalex.org/W2981873322", "source_url": "https://doi.org/10.1021/cen-09739-scicon9", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.1021/cen-09739-scicon9", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1021/cen-09739-scicon9", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1021/cen-09739-scicon9", "source_url": "https://doi.org/10.1021/cen-09739-scicon9", "doi": "10.1021/cen-09739-scicon9", "pmid": "", "publication_date": "2019-10-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3920, "title": "Psilocybin for depression: Considerations for clinical trial design", "authors": "Kelley C. O’Donnell, Sarah E. Mennenga, Michael P. Bogenschutz", "journal": "Journal of Psychedelic Studies", "publication_date": "2019-08-31", "publication_year": 2019, "doi": "10.1556/2054.2019.026", "pubmed_id": null, "openalex_id": "https://openalex.org/W2974814938", "source_url": "https://doi.org/10.1556/2054.2019.026", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2019.026", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2019.026", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2019.026", "source_url": "https://doi.org/10.1556/2054.2019.026", "doi": "10.1556/2054.2019.026", "pmid": "", "publication_date": "2019-08-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2320, "title": "Classical psychedelics for the treatment of depression and anxiety: A systematic review.", "authors": "Muttoni S, Ardissino M, John C.", "journal": null, "publication_date": "2019-07-29", "publication_year": 2019, "doi": "10.1016/j.jad.2019.07.076", "pubmed_id": "31382100", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jad.2019.07.076", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Clinical Trial,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:31382100", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jad.2019.07.076", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:31382100", "source_url": "https://doi.org/10.1016/j.jad.2019.07.076", "doi": "10.1016/j.jad.2019.07.076", "pmid": "31382100", "publication_date": "2019-07-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2338, "title": "REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics.", "authors": "Carhart-Harris RL, Friston KJ.", "journal": null, "publication_date": "2019-06-30", "publication_year": 2019, "doi": "10.1124/pr.118.017160", "pubmed_id": "31221820", "openalex_id": null, "source_url": "https://doi.org/10.1124/pr.118.017160", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Consciousness,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:31221820", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1124/pr.118.017160", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:31221820", "source_url": "https://doi.org/10.1124/pr.118.017160", "doi": "10.1124/pr.118.017160", "pmid": "31221820", "publication_date": "2019-06-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3926, "title": "The Potential of Psilocybin Administration in Terminal Cancer Patients", "authors": "Richard Simoneaux", "journal": "Oncology Times", "publication_date": "2019-06-27", "publication_year": 2019, "doi": "10.1097/01.cot.0000574916.46844.cf", "pubmed_id": null, "openalex_id": "https://openalex.org/W2956046898", "source_url": "https://doi.org/10.1097/01.cot.0000574916.46844.cf", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Chronic Pain,Pharmacology,Receptor Pharmacology,Consciousness,Clinical Trial,Cancer Patients,Treatment-Resistant Depression,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.1097/01.cot.0000574916.46844.cf", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1097/01.cot.0000574916.46844.cf", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1097/01.cot.0000574916.46844.cf", "source_url": "https://doi.org/10.1097/01.cot.0000574916.46844.cf", "doi": "10.1097/01.cot.0000574916.46844.cf", "pmid": "", "publication_date": "2019-06-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2319, "title": "Enzymatic Route toward 6-Methylated Baeocystin and Psilocybin", "authors": "Janis Fricke, Alexander M. Sherwood, Robert B. Kargbo, Andrew Orry, Felix Blei, Andreas Naschberger, Bernhard Rupp, Dirk Hoffmeister", "journal": "ChemBioChem", "publication_date": "2019-05-30", "publication_year": 2019, "doi": "10.1002/cbic.201900358", "pubmed_id": "31150155", "openalex_id": "https://openalex.org/W2948005519", "source_url": "https://doi.org/10.1002/cbic.201900358", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Epigenetics,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "PMID:31150155", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/cbic.201900358", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:31150155", "source_url": "https://doi.org/10.1002/cbic.201900358", "doi": "10.1002/cbic.201900358", "pmid": "31150155", "publication_date": "2019-05-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3940, "title": "Psychedelics Improve the Mental Health of Rats", "authors": "Meghan Hibicke, Alexus N. Landry, Zoe K. Talman, Charles D. Nichols", "journal": "The FASEB Journal", "publication_date": "2019-03-31", "publication_year": 2019, "doi": "10.1096/fasebj.2019.33.1_supplement.666.1", "pubmed_id": null, "openalex_id": "https://openalex.org/W3175025894", "source_url": "https://doi.org/10.1096/fasebj.2019.33.1_supplement.666.1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Receptor Pharmacology,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.1096/fasebj.2019.33.1_supplement.666.1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1096/fasebj.2019.33.1_supplement.666.1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1096/fasebj.2019.33.1_supplement.666.1", "source_url": "https://doi.org/10.1096/fasebj.2019.33.1_supplement.666.1", "doi": "10.1096/fasebj.2019.33.1_supplement.666.1", "pmid": "", "publication_date": "2019-03-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2351, "title": "The Past and Future of Psychedelic Science: An Introduction to This Issue", "authors": "Richard Doblin, Merete Bruun Christiansen, Lisa Jerome, Brad Burge", "journal": "Journal of Psychoactive Drugs", "publication_date": "2019-03-14", "publication_year": 2019, "doi": "10.1080/02791072.2019.1606472", "pubmed_id": "31132970", "openalex_id": "https://openalex.org/W2947995541", "source_url": "https://doi.org/10.1080/02791072.2019.1606472", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Receptor Pharmacology,Creativity,Spirituality,Mystical Experience,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "PMID:31132970", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/02791072.2019.1606472", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:31132970", "source_url": "https://doi.org/10.1080/02791072.2019.1606472", "doi": "10.1080/02791072.2019.1606472", "pmid": "31132970", "publication_date": "2019-03-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2329, "title": "Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers.", "authors": "Hutten NRPW, Mason NL, Dolder PC, Kuypers KPC", "journal": "Frontiers in psychiatry", "publication_date": "2018-12-31", "publication_year": 2018, "doi": "10.3389/fpsyt.2019.00672", "pubmed_id": "31572246", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/31572246/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Microdosing,Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:20:40", "bibtex": null, "source_record_id": "PMID:31572246", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/31572246/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:31572246", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31572246/", "doi": "10.3389/fpsyt.2019.00672", "pmid": "31572246", "publication_date": "2018-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2361, "title": "Production Options for Psilocybin: Making of the Magic.", "authors": "Fricke J, Lenz C, Wick J, Blei F, Hoffmeister D.", "journal": "Chemistry - A European Journal", "publication_date": "2018-11-14", "publication_year": 2018, "doi": "10.1002/chem.201802758", "pubmed_id": "30011099", "openalex_id": "https://openalex.org/W2884828036", "source_url": "https://doi.org/10.1002/chem.201802758", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Pharmacology,Clinical Trial,In Vitro Study", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:30011099", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1002/chem.201802758", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:30011099", "source_url": "https://doi.org/10.1002/chem.201802758", "doi": "10.1002/chem.201802758", "pmid": "30011099", "publication_date": "2018-11-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2380, "title": "DARK Classics in Chemical Neuroscience: Ibogaine.", "authors": "Wasko MJ, Witt-Enderby PA, Surratt CK.", "journal": null, "publication_date": "2018-10-08", "publication_year": 2018, "doi": "10.1021/acschemneuro.8b00294", "pubmed_id": "30216039", "openalex_id": null, "source_url": "https://doi.org/10.1021/acschemneuro.8b00294", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Receptor Pharmacology,Clinical Trial,Animal Study,Toxicity", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:30216039", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1021/acschemneuro.8b00294", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:30216039", "source_url": "https://doi.org/10.1021/acschemneuro.8b00294", "doi": "10.1021/acschemneuro.8b00294", "pmid": "30216039", "publication_date": "2018-10-08", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2394, "title": "Therapeutic use of classic psychedelics to treat cancer-related psychiatric distress.", "authors": "Ross S.", "journal": null, "publication_date": "2018-08-12", "publication_year": 2018, "doi": "10.1080/09540261.2018.1482261", "pubmed_id": "30102082", "openalex_id": null, "source_url": "https://doi.org/10.1080/09540261.2018.1482261", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Review Article,Cancer Patients", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:30102082", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/09540261.2018.1482261", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:30102082", "source_url": "https://doi.org/10.1080/09540261.2018.1482261", "doi": "10.1080/09540261.2018.1482261", "pmid": "30102082", "publication_date": "2018-08-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2383, "title": "Psychedelics and Personality.", "authors": "Aixalà M, Dos Santos RG, Hallak JEC, Bouso JC.", "journal": "ACS Chemical Neuroscience", "publication_date": "2018-06-03", "publication_year": 2018, "doi": "10.1021/acschemneuro.8b00237", "pubmed_id": "29863323", "openalex_id": "https://openalex.org/W2805186158", "source_url": "https://doi.org/10.1021/acschemneuro.8b00237", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Addiction,Mechanism of Action,Receptor Pharmacology,Personality Change,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:29863323", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1021/acschemneuro.8b00237", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:29863323", "source_url": "https://doi.org/10.1021/acschemneuro.8b00237", "doi": "10.1021/acschemneuro.8b00237", "pmid": "29863323", "publication_date": "2018-06-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2384, "title": "Dark Classics in Chemical Neuroscience: Lysergic Acid Diethylamide (LSD).", "authors": "Nichols DE.", "journal": null, "publication_date": "2018-02-28", "publication_year": 2018, "doi": "10.1021/acschemneuro.8b00043", "pubmed_id": "29461039", "openalex_id": null, "source_url": "https://doi.org/10.1021/acschemneuro.8b00043", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Brain Imaging,Receptor Pharmacology,Consciousness,Aging,Clinical Trial,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:29461039", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1021/acschemneuro.8b00043", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:29461039", "source_url": "https://doi.org/10.1021/acschemneuro.8b00043", "doi": "10.1021/acschemneuro.8b00043", "pmid": "29461039", "publication_date": "2018-02-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2422, "title": "The Psychedelic Debriefing in Alcohol Dependence Treatment: Illustrating Key Change Phenomena through Qualitative Content Analysis of Clinical Sessions.", "authors": "Nielson EM, May DG, Forcehimes AA, Bogenschutz MP.", "journal": "Frontiers in Pharmacology", "publication_date": "2018-02-20", "publication_year": 2018, "doi": "10.3389/fphar.2018.00132", "pubmed_id": "29515449", "openalex_id": "https://openalex.org/W2793096639", "source_url": "https://doi.org/10.3389/fphar.2018.00132", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:29515449", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fphar.2018.00132", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:29515449", "source_url": "https://doi.org/10.3389/fphar.2018.00132", "doi": "10.3389/fphar.2018.00132", "pmid": "29515449", "publication_date": "2018-02-20", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2423, "title": "Clinical Interpretations of Patient Experience in a Trial of Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder.", "authors": "Bogenschutz MP, Podrebarac SK, Duane JH, Amegadzie SS, Malone TC, Owens LT, Ross S, Mennenga SE.", "journal": "Frontiers in Pharmacology", "publication_date": "2018-02-19", "publication_year": 2018, "doi": "10.3389/fphar.2018.00100", "pubmed_id": "29515439", "openalex_id": "https://openalex.org/W2788524689", "source_url": "https://doi.org/10.3389/fphar.2018.00100", "substance_tags": "psilocybin", "topic_tags": "Addiction,Consciousness,Mystical Experience,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:29515439", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fphar.2018.00100", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:29515439", "source_url": "https://doi.org/10.3389/fphar.2018.00100", "doi": "10.3389/fphar.2018.00100", "pmid": "29515439", "publication_date": "2018-02-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2431, "title": "Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression.", "authors": "Roseman L, Nutt DJ, Carhart-Harris RL.", "journal": "Frontiers in Pharmacology", "publication_date": "2018-01-16", "publication_year": 2018, "doi": "10.3389/fphar.2017.00974", "pubmed_id": "29387009", "openalex_id": "https://openalex.org/W2792444257", "source_url": "https://doi.org/10.3389/fphar.2017.00974", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Consciousness,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Drug Interactions", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:29387009", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fphar.2017.00974", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:29387009", "source_url": "https://doi.org/10.3389/fphar.2017.00974", "doi": "10.3389/fphar.2017.00974", "pmid": "29387009", "publication_date": "2018-01-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5178, "title": "Unlearning to See: Linking the Perceptual and Clinical Effects of Psychedelic Drugs.", "authors": "Link Swanson", "journal": "eScholarship (California Digital Library)", "publication_date": "2017-12-31", "publication_year": 2017, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W2941699004", "source_url": "https://escholarship.org/uc/item/67x0n7rq", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Emotional Processing,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:02", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "https://escholarship.org/uc/item/67x0n7rq", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://escholarship.org/uc/item/67x0n7rq", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://escholarship.org/uc/item/67x0n7rq", "source_url": "https://escholarship.org/uc/item/67x0n7rq", "doi": "", "pmid": "", "publication_date": "2017-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5176, "title": "Cancer at the Dinner Table: Experiences of Psilocybin-Assisted Psychotherapy for the Treatment of Cancer-Related Psychological Distress", "authors": "Thomas Cody Swift", "journal": "Western CEDAR (Western Washington University)", "publication_date": "2017-12-31", "publication_year": 2017, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W2911249940", "source_url": "https://cedar.wwu.edu/pci/lectures_events/holistic_pain_management/3", "substance_tags": "psilocybin", "topic_tags": "Anxiety,End-of-Life Distress,Clinical Trial,Cancer Patients", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:02", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "https://cedar.wwu.edu/pci/lectures_events/holistic_pain_management/3", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://cedar.wwu.edu/pci/lectures_events/holistic_pain_management/3", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://cedar.wwu.edu/pci/lectures_events/holistic_pain_management/3", "source_url": "https://cedar.wwu.edu/pci/lectures_events/holistic_pain_management/3", "doi": "", "pmid": "", "publication_date": "2017-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2441, "title": "Therapeutic Applications of Classic Hallucinogens.", "authors": "Bogenschutz MP, Ross S.", "journal": null, "publication_date": "2017-12-31", "publication_year": 2017, "doi": "10.1007/7854_2016_464", "pubmed_id": "28512684", "openalex_id": null, "source_url": "https://doi.org/10.1007/7854_2016_464", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Observational Study,In Vitro Study,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:28512684", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/7854_2016_464", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:28512684", "source_url": "https://doi.org/10.1007/7854_2016_464", "doi": "10.1007/7854_2016_464", "pmid": "28512684", "publication_date": "2017-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2435, "title": "Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action.", "authors": "Canal CE.", "journal": null, "publication_date": "2017-12-31", "publication_year": 2017, "doi": "10.1007/164_2018_107", "pubmed_id": "29532180", "openalex_id": "https://openalex.org/W2789541163", "source_url": "https://doi.org/10.1007/164_2018_107", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Animal Study,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:29532180", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/164_2018_107", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:29532180", "source_url": "https://doi.org/10.1007/164_2018_107", "doi": "10.1007/164_2018_107", "pmid": "29532180", "publication_date": "2017-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2377, "title": "Psychiatry & the psychedelic drugs. Past, present & future.", "authors": "Rucker JJH, Iliff J, Nutt DJ.", "journal": null, "publication_date": "2017-12-24", "publication_year": 2017, "doi": "10.1016/j.neuropharm.2017.12.040", "pubmed_id": "29284138", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.neuropharm.2017.12.040", "substance_tags": "psilocybin", "topic_tags": "Aging,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:29284138", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.neuropharm.2017.12.040", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:29284138", "source_url": "https://doi.org/10.1016/j.neuropharm.2017.12.040", "doi": "10.1016/j.neuropharm.2017.12.040", "pmid": "29284138", "publication_date": "2017-12-24", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2446, "title": "Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults.", "authors": "Brown RT, Nicholas CR, Cozzi NV, Gassman MC, Cooper KM, Muller D, Thomas CD, Hetzel SJ, Henriquez KM, Ribaudo AS, Hutson PR.", "journal": "Clinical Pharmacokinetics", "publication_date": "2017-11-30", "publication_year": 2017, "doi": "10.1007/s40262-017-0540-6", "pubmed_id": "28353056", "openalex_id": "https://openalex.org/W2600624779", "source_url": "https://doi.org/10.1007/s40262-017-0540-6", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Addiction,Pharmacology,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:28353056", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s40262-017-0540-6", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:28353056", "source_url": "https://doi.org/10.1007/s40262-017-0540-6", "doi": "10.1007/s40262-017-0540-6", "pmid": "28353056", "publication_date": "2017-11-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2427, "title": "Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.", "authors": "Carhart-Harris RL, Bolstridge M, Day CMJ, Rucker J, Watts R, Erritzoe DE, Kaelen M, Giribaldi B, Bloomfield M, Pilling S, Rickard JA, Forbes B, Feilding A, Taylor D, Curran HV, Nutt DJ.", "journal": "Psychopharmacology", "publication_date": "2017-11-07", "publication_year": 2017, "doi": "10.1007/s00213-017-4771-x", "pubmed_id": "29119217", "openalex_id": "https://openalex.org/W2767530231", "source_url": "https://doi.org/10.1007/s00213-017-4771-x", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:29119217", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s00213-017-4771-x", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:29119217", "source_url": "https://doi.org/10.1007/s00213-017-4771-x", "doi": "10.1007/s00213-017-4771-x", "pmid": "29119217", "publication_date": "2017-11-07", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2449, "title": "Psychedelic Drugs in Biomedicine.", "authors": "Kyzar EJ, Nichols CD, Gainetdinov RR, Nichols DE, Kalueff AV.", "journal": null, "publication_date": "2017-09-21", "publication_year": 2017, "doi": "10.1016/j.tips.2017.08.003", "pubmed_id": "28947075", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.tips.2017.08.003", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Brain Imaging,Mechanism of Action,Aging,Clinical Trial,Animal Study,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:28947075", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.tips.2017.08.003", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:28947075", "source_url": "https://doi.org/10.1016/j.tips.2017.08.003", "doi": "10.1016/j.tips.2017.08.003", "pmid": "28947075", "publication_date": "2017-09-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2424, "title": "Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic review.", "authors": "Reiche S, Hermle L, Gutwinski S, Jungaberle H, Gasser P, Majić T.", "journal": null, "publication_date": "2017-09-21", "publication_year": 2017, "doi": "10.1016/j.pnpbp.2017.09.012", "pubmed_id": "28947181", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.pnpbp.2017.09.012", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:28947181", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.pnpbp.2017.09.012", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:28947181", "source_url": "https://doi.org/10.1016/j.pnpbp.2017.09.012", "doi": "10.1016/j.pnpbp.2017.09.012", "pmid": "28947181", "publication_date": "2017-09-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2464, "title": "Qualitative and Quantitative Features of Music Reported to Support Peak Mystical Experiences during Psychedelic Therapy Sessions.", "authors": "Barrett FS, Robbins H, Smooke D, Brown JL, Griffiths RR.", "journal": "Frontiers in Psychology", "publication_date": "2017-07-24", "publication_year": 2017, "doi": "10.3389/fpsyg.2017.01238", "pubmed_id": "28790944", "openalex_id": "https://openalex.org/W2738683289", "source_url": "https://doi.org/10.3389/fpsyg.2017.01238", "substance_tags": "psilocybin", "topic_tags": "Mystical Experience,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:28790944", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fpsyg.2017.01238", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:28790944", "source_url": "https://doi.org/10.3389/fpsyg.2017.01238", "doi": "10.3389/fpsyg.2017.01238", "pmid": "28790944", "publication_date": "2017-07-24", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5198, "title": "Navigating Psychedelic Medicines through (Inter)national Regulation", "authors": "Jonathan Nash", "journal": "Northumbria Research Link (Northumbria University)", "publication_date": "2017-07-01", "publication_year": 2017, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W2756506476", "source_url": "http://nrl.northumbria.ac.uk/id/eprint/31692/1/__Client_H%24_Documents_Breaking%20Convention%202017%20Final.pptx", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:02", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "http://nrl.northumbria.ac.uk/id/eprint/31692/1/__Client_H%24_Documents_Breaking%20Convention%202017%20Final.pptx", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://nrl.northumbria.ac.uk/id/eprint/31692/1/__Client_H%24_Documents_Breaking%20Convention%202017%20Final.pptx", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "http://nrl.northumbria.ac.uk/id/eprint/31692/1/__Client_H%24_Documents_Breaking%20Convention%202017%20Final.pptx", "source_url": "http://nrl.northumbria.ac.uk/id/eprint/31692/1/__Client_H%24_Documents_Breaking%20Convention%202017%20Final.pptx", "doi": "", "pmid": "", "publication_date": "2017-07-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2450, "title": "Psilocybin-Assisted Therapy: A Review of a Novel Treatment for Psychiatric Disorders.", "authors": "Thomas K, Malcolm B, Lastra D.", "journal": null, "publication_date": "2017-05-07", "publication_year": 2017, "doi": "10.1080/02791072.2017.1320734", "pubmed_id": "28481178", "openalex_id": null, "source_url": "https://doi.org/10.1080/02791072.2017.1320734", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Receptor Pharmacology,Default Mode Network,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:28481178", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/02791072.2017.1320734", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:28481178", "source_url": "https://doi.org/10.1080/02791072.2017.1320734", "doi": "10.1080/02791072.2017.1320734", "pmid": "28481178", "publication_date": "2017-05-07", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2456, "title": "The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future.", "authors": "Carhart-Harris RL, Goodwin GM.", "journal": null, "publication_date": "2017-04-25", "publication_year": 2017, "doi": "10.1038/npp.2017.84", "pubmed_id": "28443617", "openalex_id": null, "source_url": "https://doi.org/10.1038/npp.2017.84", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Aging,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:28443617", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1038/npp.2017.84", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:28443617", "source_url": "https://doi.org/10.1038/npp.2017.84", "doi": "10.1038/npp.2017.84", "pmid": "28443617", "publication_date": "2017-04-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5208, "title": "Anti-inflammatory effects of serotonin 5-HT2A receptor activation in ovalbumin-induced allergic asthma models", "authors": "Thomas W. Flanagan, Melaine N. Sebastian, Charles D. Nichols", "journal": "The FASEB Journal", "publication_date": "2017-03-31", "publication_year": 2017, "doi": "10.1096/fasebj.31.1_supplement.820.4", "pubmed_id": null, "openalex_id": "https://openalex.org/W2970574043", "source_url": "https://doi.org/10.1096/fasebj.31.1_supplement.820.4", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology,Biomarkers,Clinical Trial,Inflammation,Immune Function", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:02", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "DOI:10.1096/fasebj.31.1_supplement.820.4", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1096/fasebj.31.1_supplement.820.4", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1096/fasebj.31.1_supplement.820.4", "source_url": "https://doi.org/10.1096/fasebj.31.1_supplement.820.4", "doi": "10.1096/fasebj.31.1_supplement.820.4", "pmid": "", "publication_date": "2017-03-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2477, "title": "Psychedelics as Medicines: An Emerging New Paradigm.", "authors": "Nichols DE, Johnson MW, Nichols CD.", "journal": null, "publication_date": "2016-12-25", "publication_year": 2016, "doi": "10.1002/cpt.557", "pubmed_id": "28019026", "openalex_id": null, "source_url": "https://doi.org/10.1002/cpt.557", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Inflammation", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:28019026", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1002/cpt.557", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:28019026", "source_url": "https://doi.org/10.1002/cpt.557", "doi": "10.1002/cpt.557", "pmid": "28019026", "publication_date": "2016-12-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2497, "title": "Psychedelics in the treatment of unipolar mood disorders: a systematic review.", "authors": "Rucker JJ, Jelen LA, Flynn S, Frowde KD, Young AH.", "journal": null, "publication_date": "2016-11-16", "publication_year": 2016, "doi": "10.1177/0269881116679368", "pubmed_id": "27856684", "openalex_id": null, "source_url": "https://doi.org/10.1177/0269881116679368", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Systematic Review,Review Article,Healthcare Workers,Safety", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:27856684", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/0269881116679368", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:27856684", "source_url": "https://doi.org/10.1177/0269881116679368", "doi": "10.1177/0269881116679368", "pmid": "27856684", "publication_date": "2016-11-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5227, "title": "Development of a Psychotherapeutic Model for Psilocybin-Assisted Treatment of Alcoholism", "authors": "Michael P. Bogenschutz, Alyssa A. Forcehimes", "journal": "Journal of Humanistic Psychology", "publication_date": "2016-10-15", "publication_year": 2016, "doi": "10.1177/0022167816673493", "pubmed_id": null, "openalex_id": "https://openalex.org/W2537388000", "source_url": "https://doi.org/10.1177/0022167816673493", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:03", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "DOI:10.1177/0022167816673493", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/0022167816673493", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/0022167816673493", "source_url": "https://doi.org/10.1177/0022167816673493", "doi": "10.1177/0022167816673493", "pmid": "", "publication_date": "2016-10-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2486, "title": "Return of the psychedelics: Psilocybin for treatment resistant depression.", "authors": "Patra S.", "journal": null, "publication_date": "2016-08-22", "publication_year": 2016, "doi": "10.1016/j.ajp.2016.08.010", "pubmed_id": "27931907", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.ajp.2016.08.010", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Brain Imaging,Mechanism of Action,Aging,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:27931907", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.ajp.2016.08.010", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:27931907", "source_url": "https://doi.org/10.1016/j.ajp.2016.08.010", "doi": "10.1016/j.ajp.2016.08.010", "pmid": "27931907", "publication_date": "2016-08-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2508, "title": "Antidepressant, Antipsychotic, and Hallucinogen Drugs for the Treatment of Psychiatric Disorders: A Convergence at the Serotonin-2A Receptor.", "authors": "Howland RH.", "journal": "Journal of Psychosocial Nursing and Mental Health Services", "publication_date": "2016-06-30", "publication_year": 2016, "doi": "10.3928/02793695-20160616-09", "pubmed_id": "27362381", "openalex_id": "https://openalex.org/W2470545286", "source_url": "https://doi.org/10.3928/02793695-20160616-09", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Receptor Pharmacology,Clinical Trial,Drug Interactions", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:27362381", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3928/02793695-20160616-09", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:27362381", "source_url": "https://doi.org/10.3928/02793695-20160616-09", "doi": "10.3928/02793695-20160616-09", "pmid": "27362381", "publication_date": "2016-06-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2048, "title": "Sex differences and serotonergic mechanisms in the behavioural effects of psilocin.", "authors": "Tylš F, Páleníček T, Kadeřábek L, Lipski M, Kubešová A, Horáček J.", "journal": "Behavioural Pharmacology", "publication_date": "2016-05-31", "publication_year": 2016, "doi": "10.1097/fbp.0000000000000198", "pubmed_id": "26461483", "openalex_id": "https://openalex.org/W2318447563", "source_url": "https://doi.org/10.1097/fbp.0000000000000198", "substance_tags": "psilocybin,psilocin", "topic_tags": "Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:26461483", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1097/fbp.0000000000000198", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:26461483", "source_url": "https://doi.org/10.1097/fbp.0000000000000198", "doi": "10.1097/fbp.0000000000000198", "pmid": "26461483", "publication_date": "2016-05-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5238, "title": "PM506. Psilocybin Clinical Trial: Acute Effects and its relationship to the brain activity as measured by quantitative EEG", "authors": "Filip Tylš, Michaela Viktorinová, Dominika Prokopcova, Jakub Korčák, Renata Androvičová, Martin Brunovský, Jiřı́ Horáček", "journal": "The International Journal of Neuropsychopharmacology", "publication_date": "2016-05-26", "publication_year": 2016, "doi": "10.1093/ijnp/pyw041.506", "pubmed_id": null, "openalex_id": "https://openalex.org/W3095530399", "source_url": "https://doi.org/10.1093/ijnp/pyw041.506", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Pharmacology,Receptor Pharmacology,Emotional Processing,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:03", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "DOI:10.1093/ijnp/pyw041.506", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/ijnp/pyw041.506", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1093/ijnp/pyw041.506", "source_url": "https://doi.org/10.1093/ijnp/pyw041.506", "doi": "10.1093/ijnp/pyw041.506", "pmid": "", "publication_date": "2016-05-26", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3410, "title": "PM506. Psilocybin Clinical Trial: Acute Effects and its relationship to the brain activity as measured by quantitative EEG", "authors": "Tyls F, Michaela Viktorinova T, Prokopcova D, Korcak J, Androvicova R, Brunovsky M, Horacek J.", "journal": null, "publication_date": "2016-05-26", "publication_year": 2016, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC5616440", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:53", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC5616440", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC5616440", "source_url": "https://europepmc.org/article/PMC/PMC5616440", "doi": "", "pmid": "", "publication_date": "2016-05-26", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2519, "title": "Psychedelics.", "authors": "Nichols DE.", "journal": null, "publication_date": "2016-03-31", "publication_year": 2016, "doi": "10.1124/pr.115.011478", "pubmed_id": "26841800", "openalex_id": null, "source_url": "https://doi.org/10.1124/pr.115.011478", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Brain Imaging,Receptor Pharmacology,Default Mode Network,Aging,Clinical Trial,Cancer Patients", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:26841800", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1124/pr.115.011478", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:26841800", "source_url": "https://doi.org/10.1124/pr.115.011478", "doi": "10.1124/pr.115.011478", "pmid": "26841800", "publication_date": "2016-03-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2513, "title": "Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years.", "authors": "Dos Santos RG, Osório FL, Crippa JA, Riba J, Zuardi AW, Hallak JE.", "journal": null, "publication_date": "2016-03-17", "publication_year": 2016, "doi": "10.1177/2045125316638008", "pubmed_id": "27354908", "openalex_id": null, "source_url": "https://doi.org/10.1177/2045125316638008", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:27354908", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/2045125316638008", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:27354908", "source_url": "https://doi.org/10.1177/2045125316638008", "doi": "10.1177/2045125316638008", "pmid": "27354908", "publication_date": "2016-03-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5261, "title": "The Psyche in Psychedelic", "authors": "Stephen Mo Hanan", "journal": "Tikkun", "publication_date": "2015-10-29", "publication_year": 2015, "doi": "10.1215/08879982-3328661", "pubmed_id": null, "openalex_id": "https://openalex.org/W2272829599", "source_url": "https://doi.org/10.1215/08879982-3328661", "substance_tags": "psilocybin", "topic_tags": "PTSD,End-of-Life Distress,Chronic Pain,Consciousness,Aging,Creativity,Spirituality,Clinical Trial,Cancer Patients,Veterans", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:03", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "DOI:10.1215/08879982-3328661", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1215/08879982-3328661", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1215/08879982-3328661", "source_url": "https://doi.org/10.1215/08879982-3328661", "doi": "10.1215/08879982-3328661", "pmid": "", "publication_date": "2015-10-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5266, "title": "Discovery of a new caerulescent Psilocybe mushroom in Germany: Psilocybe germanica sp.nov.", "authors": "Jochen Gartz, Georg Wiedemann", "journal": "Drug Testing and Analysis", "publication_date": "2015-03-30", "publication_year": 2015, "doi": "10.1002/dta.1795", "pubmed_id": "25826697", "openalex_id": "https://openalex.org/W2111988752", "source_url": "https://doi.org/10.1002/dta.1795", "substance_tags": "psilocybin,psilocin", "topic_tags": "Pharmacology,Aging,Clinical Trial,Case Report", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:04", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:25826697", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/dta.1795", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:25826697", "source_url": "https://doi.org/10.1002/dta.1795", "doi": "10.1002/dta.1795", "pmid": "25826697", "publication_date": "2015-03-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2523, "title": "Classic hallucinogens in the treatment of addictions.", "authors": "Bogenschutz MP, Johnson MW.", "journal": null, "publication_date": "2015-03-13", "publication_year": 2015, "doi": "10.1016/j.pnpbp.2015.03.002", "pubmed_id": "25784600", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.pnpbp.2015.03.002", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Mystical Experience,Clinical Trial,Meta-Analysis,Review Article,Safety", "study_type": "Meta-Analysis", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:07", "bibtex": null, "source_record_id": "PMID:25784600", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.pnpbp.2015.03.002", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:25784600", "source_url": "https://doi.org/10.1016/j.pnpbp.2015.03.002", "doi": "10.1016/j.pnpbp.2015.03.002", "pmid": "25784600", "publication_date": "2015-03-13", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2558, "title": "Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles.", "authors": "Baumeister D, Barnes G, Giaroli G, Tracy D", "journal": "Therapeutic advances in psychopharmacology", "publication_date": "2014-07-31", "publication_year": 2014, "doi": "10.1177/2045125314527985", "pubmed_id": "25083275", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/25083275/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Mechanism of Action,Receptor Pharmacology,Consciousness,Spirituality,Clinical Trial,Review Article,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:20:40", "bibtex": null, "source_record_id": "PMID:25083275", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/25083275/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:25083275", "source_url": "https://pubmed.ncbi.nlm.nih.gov/25083275/", "doi": "10.1177/2045125314527985", "pmid": "25083275", "publication_date": "2014-07-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2548, "title": "Recent advances in the neuropsychopharmacology of serotonergic hallucinogens.", "authors": "Halberstadt AL.", "journal": null, "publication_date": "2014-07-14", "publication_year": 2014, "doi": "10.1016/j.bbr.2014.07.016", "pubmed_id": "25036425", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.bbr.2014.07.016", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Pharmacology,Receptor Pharmacology,Aging,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:25036425", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.bbr.2014.07.016", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:25036425", "source_url": "https://doi.org/10.1016/j.bbr.2014.07.016", "doi": "10.1016/j.bbr.2014.07.016", "pmid": "25036425", "publication_date": "2014-07-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5304, "title": "Stanislav Grof's Contributions to FDA Drug Development Research with Psychedelics", "authors": "Rick Doblin", "journal": "CIIS Digital Commons (California Institute of Integral Studies)", "publication_date": "2013-12-31", "publication_year": 2013, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W2550063776", "source_url": "https://digitalcommons.ciis.edu/stanislavgrof2014/12", "substance_tags": "psilocybin", "topic_tags": "Anxiety,PTSD,Addiction,End-of-Life Distress,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:04", "last_checked": "2026-07-04 07:00:41", "bibtex": null, "source_record_id": "https://digitalcommons.ciis.edu/stanislavgrof2014/12", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://digitalcommons.ciis.edu/stanislavgrof2014/12", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://digitalcommons.ciis.edu/stanislavgrof2014/12", "source_url": "https://digitalcommons.ciis.edu/stanislavgrof2014/12", "doi": "", "pmid": "", "publication_date": "2013-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2567, "title": "The Heffter Research Institute: past and hopeful future.", "authors": "Nichols DE.", "journal": "Journal of Psychoactive Drugs", "publication_date": "2013-12-31", "publication_year": 2013, "doi": "10.1080/02791072.2014.873688", "pubmed_id": "24830182", "openalex_id": "https://openalex.org/W1982006269", "source_url": "https://doi.org/10.1080/02791072.2014.873688", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,End-of-Life Distress,Clinical Trial,Cancer Patients", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:41", "bibtex": null, "source_record_id": "PMID:24830182", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/02791072.2014.873688", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:24830182", "source_url": "https://doi.org/10.1080/02791072.2014.873688", "doi": "10.1080/02791072.2014.873688", "pmid": "24830182", "publication_date": "2013-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2577, "title": "A proposal to evaluate mechanistic efficacy of hallucinogens in addiction treatment.", "authors": "Burdick BV, Adinoff B.", "journal": "The American Journal of Drug and Alcohol Abuse", "publication_date": "2013-08-31", "publication_year": 2013, "doi": "10.3109/00952990.2013.811513", "pubmed_id": "23968172", "openalex_id": "https://openalex.org/W2043530175", "source_url": "https://doi.org/10.3109/00952990.2013.811513", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:41", "bibtex": null, "source_record_id": "PMID:23968172", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3109/00952990.2013.811513", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:23968172", "source_url": "https://doi.org/10.3109/00952990.2013.811513", "doi": "10.3109/00952990.2013.811513", "pmid": "23968172", "publication_date": "2013-08-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2591, "title": "Single treatments that have lasting effects: some thoughts on the antidepressant effects of ketamine and botulinum toxin and the anxiolytic effect of psilocybin.", "authors": "Young SN.", "journal": "Фундаментальные исследования (Fundamental Research)", "publication_date": "2013-02-28", "publication_year": 2013, "doi": "10.1503/jpn.120128", "pubmed_id": null, "openalex_id": "https://openalex.org/W23171696", "source_url": "https://doi.org/10.1503/jpn.120128", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:41", "bibtex": null, "source_record_id": "DOI:10.1503/jpn.120128", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1503/jpn.120128", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.1503/jpn.120128", "source_url": "https://doi.org/10.1503/jpn.120128", "doi": "10.1503/jpn.120128", "pmid": "", "publication_date": "2013-02-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2589, "title": "Studying the effects of classic hallucinogens in the treatment of alcoholism: rationale, methodology, and current research with psilocybin.", "authors": "Bogenschutz MP.", "journal": null, "publication_date": "2013-02-28", "publication_year": 2013, "doi": "10.2174/15733998113099990002", "pubmed_id": "23627783", "openalex_id": null, "source_url": "https://doi.org/10.2174/15733998113099990002", "substance_tags": "psilocybin", "topic_tags": "Addiction,Brain Imaging,Aging,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:23627783", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.2174/15733998113099990002", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:23627783", "source_url": "https://doi.org/10.2174/15733998113099990002", "doi": "10.2174/15733998113099990002", "pmid": "23627783", "publication_date": "2013-02-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2606, "title": "Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin.", "authors": "Carhart-Harris RL, Leech R, Williams TM, Erritzoe D, Abbasi N, Bargiotas T, Hobden P, Sharp DJ, Evans J, Feilding A, Wise RG, Nutt DJ.", "journal": "The British Journal of Psychiatry", "publication_date": "2012-01-25", "publication_year": 2012, "doi": "10.1192/bjp.bp.111.103309", "pubmed_id": "22282432", "openalex_id": "https://openalex.org/W2119134849", "source_url": "https://doi.org/10.1192/bjp.bp.111.103309", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Aging,Emotional Processing,Clinical Trial,Healthy Volunteers", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:41", "bibtex": null, "source_record_id": "PMID:22282432", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1192/bjp.bp.111.103309", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:22282432", "source_url": "https://doi.org/10.1192/bjp.bp.111.103309", "doi": "10.1192/bjp.bp.111.103309", "pmid": "22282432", "publication_date": "2012-01-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2634, "title": "Glucuronidation of psilocin and 4-hydroxyindole by the human UDP-glucuronosyltransferases.", "authors": "Manevski N, Kurkela M, Höglund C, Mauriala T, Court MH, Yli-Kauhaluoma J, Finel M.", "journal": null, "publication_date": "2009-12-09", "publication_year": 2009, "doi": "10.1124/dmd.109.031138", "pubmed_id": "20007669", "openalex_id": "https://openalex.org/W2132624405", "source_url": "https://doi.org/10.1124/dmd.109.031138", "substance_tags": "psilocybin,psilocin", "topic_tags": "Clinical Trial", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:20007669", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1124/dmd.109.031138", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:20007669", "source_url": "https://doi.org/10.1124/dmd.109.031138", "doi": "10.1124/dmd.109.031138", "pmid": "20007669", "publication_date": "2009-12-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2675, "title": "The adverse effects of hallucinogens from intramural perspective.", "authors": "Frecska E, Luna LE.", "journal": "PubMed", "publication_date": "2006-11-30", "publication_year": 2006, "doi": null, "pubmed_id": "17211054", "openalex_id": "https://openalex.org/W110752286", "source_url": "https://europepmc.org/article/MED/17211054", "substance_tags": "psilocybin", "topic_tags": "Personality Change,Clinical Trial,Review Article,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:41", "bibtex": null, "source_record_id": "PMID:17211054", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/MED/17211054", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:17211054", "source_url": "https://europepmc.org/article/MED/17211054", "doi": "", "pmid": "17211054", "publication_date": "2006-11-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2714, "title": "Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively.", "authors": "Riba J, Rodríguez-Fornells A, Barbanoj MJ.", "journal": null, "publication_date": "2002-10-11", "publication_year": 2002, "doi": "10.1007/s00213-002-1237-5", "pubmed_id": "12474114", "openalex_id": "https://openalex.org/W2129582923", "source_url": "https://doi.org/10.1007/s00213-002-1237-5", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Receptor Pharmacology,Clinical Trial,Observational Study,Healthy Volunteers", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:07", "bibtex": null, "source_record_id": "PMID:12474114", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s00213-002-1237-5", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:12474114", "source_url": "https://doi.org/10.1007/s00213-002-1237-5", "doi": "10.1007/s00213-002-1237-5", "pmid": "12474114", "publication_date": "2002-10-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2716, "title": "The pharmacology of psilocybin.", "authors": "Passie T, Seifert J, Schneider U, Emrich HM.", "journal": null, "publication_date": "2002-09-30", "publication_year": 2002, "doi": "10.1080/1355621021000005937", "pubmed_id": "14578010", "openalex_id": null, "source_url": "https://doi.org/10.1080/1355621021000005937", "substance_tags": "psilocybin", "topic_tags": "Neuroplasticity,Pharmacology,Receptor Pharmacology,Clinical Trial,Review Article,Animal Study", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:14578010", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/1355621021000005937", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:14578010", "source_url": "https://doi.org/10.1080/1355621021000005937", "doi": "10.1080/1355621021000005937", "pmid": "14578010", "publication_date": "2002-09-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2884, "title": "Effects of psychodysleptic drug psilocybin on visual perception. Changes in brightness preference.", "authors": "Fischer R, Hill RM, Warshay D.", "journal": null, "publication_date": "1969-01-31", "publication_year": 1969, "doi": "10.1007/bf01899102", "pubmed_id": "4389138", "openalex_id": "https://openalex.org/W2000021284", "source_url": "https://doi.org/10.1007/bf01899102", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:15", "last_checked": "2026-07-01 11:22:07", "bibtex": null, "source_record_id": "PMID:4389138", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:4389138", "source_url": "https://doi.org/10.1007/bf01899102", "doi": "10.1007/bf01899102", "pmid": "4389138", "publication_date": "1969-01-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2895, "title": "2,5-dimethoxy-4-methyl-amphetamine (STP): a new hallucinogenic drug.", "authors": "Snyder SH, Faillace L, Hollister L.", "journal": null, "publication_date": "1967-10-31", "publication_year": 1967, "doi": "10.1126/science.158.3801.669", "pubmed_id": "4860952", "openalex_id": "https://openalex.org/W2055598723", "source_url": "https://doi.org/10.1126/science.158.3801.669", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:15", "last_checked": "2026-07-01 11:22:07", "bibtex": null, "source_record_id": "PMID:4860952", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1126/science.158.3801.669", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:4860952", "source_url": "https://doi.org/10.1126/science.158.3801.669", "doi": "10.1126/science.158.3801.669", "pmid": "4860952", "publication_date": "1967-10-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2906, "title": "Lysergic acid diethylamide (LSD-25). 38. Comparison with action of methysergide and psilocybin on test subjects.", "authors": "Abramson HA, Rolo A.", "journal": null, "publication_date": "1965-08-31", "publication_year": 1965, "doi": "10.3109/02770906509106904", "pubmed_id": "5318626", "openalex_id": "https://openalex.org/W2205661146", "source_url": "https://doi.org/10.3109/02770906509106904", "substance_tags": "psilocybin", "topic_tags": "Headache / Migraine,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:15", "last_checked": "2026-07-01 11:22:07", "bibtex": null, "source_record_id": "PMID:5318626", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:5318626", "source_url": "https://doi.org/10.3109/02770906509106904", "doi": "10.3109/02770906509106904", "pmid": "5318626", "publication_date": "1965-08-31", "importer_version": "2.1.2", "text_redistributed": false } } ] }